10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q

þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2017

o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ___ to ___ 

Commission File Number 001-31792

CNO Financial Group, Inc.

Delaware	75-3108137
State of Incorporation	IRS Employer Identification No.
11825 N. Pennsylvania Street
Carmel, Indiana  46032	(317) 817-6100
Address of principal executive offices	Telephone

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days:  Yes [ X ]  No [   ]

Indicate by check mark whether the Registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes [ X ]  No [   ]

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company.  See the definitions of "large accelerated filer", "accelerated filer", "smaller reporting company", and "emerging growth company" in Rule 12b-2 of the Exchange Act.  Large accelerated filer [ X ]  Accelerated filer [   ] Non-accelerated filer [   ] Smaller reporting company [   ] Emerging growth company [   ]

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [   ]

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act):  Yes [   ] No [ X ]

Shares of common stock outstanding as of October 19, 2017:  167,762,323

TABLE OF CONTENTS

PART I - FINANCIAL INFORMATION		Page
Item 1.	Financial Statements (unaudited)
	Consolidated Balance Sheet as of September 30, 2017 and December 31, 2016	3
	Consolidated Statement of Operations for the three and nine months ended September 30, 2017 and 2016	5
	Consolidated Statement of Comprehensive Income for the three and nine months ended September 30, 2017 and 2016	6
	Consolidated Statement of Shareholders' Equity for the nine months ended September 30, 2017 and 2016	7
	Consolidated Statement of Cash Flows for the nine months ended September 30, 2017 and 2016	8
	Notes to Consolidated Financial Statements	9
Item 2.	Management's Discussion and Analysis of Consolidated Financial Condition and Results of Operations	59
	Cautionary Statement Regarding Forward-Looking Statements	59
	Overview	61
	Critical Accounting Policies	63
	Results of Operations	64
	Premium Collections	82
	Liquidity and Capital Resources	88
	Investments	96
	Investments in Variable Interest Entities	105
	New Accounting Standards	107
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	108
Item 4.	Controls and Procedures	108
PART II - OTHER INFORMATION
Item 1.	Legal Proceedings	109
Item 1A.	Risk Factors	109
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	110
Item 5.	Other Information	110
Item 6.	Exhibits	111

2

PART I - FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS.

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEET

(Dollars in millions)

(unaudited)

ASSETS

	September 30, 2017		December 31, 2016
Investments:
Fixed maturities, available for sale, at fair value (amortized cost:  September 30, 2017 - $20,092.5; December 31, 2016 - $19,803.1)	$	22,129.9	$	21,096.2
Equity securities at fair value (cost: September 30, 2017 - $688.7; December 31, 2016 - $580.7)	713.3		584.2
Mortgage loans	1,667.8		1,768.0
Policy loans	114.6		112.0
Trading securities	294.4		363.4
Investments held by variable interest entities	1,382.5		1,724.3
Other invested assets	752.1		589.5
Total investments	27,054.6		26,237.6
Cash and cash equivalents - unrestricted	765.9		478.9
Cash and cash equivalents held by variable interest entities	105.9		189.3
Accrued investment income	268.0		239.6
Present value of future profits	368.5		401.8
Deferred acquisition costs	1,023.8		1,044.7
Reinsurance receivables	2,195.5		2,260.4
Income tax assets, net	567.4		789.7
Assets held in separate accounts	4.8		4.7
Other assets	350.2		328.5
Total assets	$	32,704.6	$	31,975.2

(continued on next page)

The accompanying notes are an integral part

of the consolidated financial statements.

3

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEET, continued

(Dollars in millions)

(unaudited)

LIABILITIES AND SHAREHOLDERS' EQUITY

	September 30, 2017		December 31, 2016
Liabilities:
Liabilities for insurance products:
Policyholder account balances	$	11,113.5	$	10,912.7
Future policy benefits	11,374.1		10,953.3
Liability for policy and contract claims	519.5		500.6
Unearned and advanced premiums	262.4		282.5
Liabilities related to separate accounts	4.8		4.7
Other liabilities	789.1		611.4
Investment borrowings	1,646.9		1,647.4
Borrowings related to variable interest entities	1,198.2		1,662.8
Notes payable – direct corporate obligations	914.4		912.9
Total liabilities	27,822.9		27,488.3
Commitments and Contingencies
Shareholders' equity:
Common stock ($0.01 par value, 8,000,000,000 shares authorized, shares issued and outstanding:  September 30, 2017 – 167,762,323; December 31, 2016 – 173,753,614)	1.7		1.7
Additional paid-in capital	3,094.5		3,212.1
Accumulated other comprehensive income	933.6		622.4
Retained earnings	851.9		650.7
Total shareholders' equity	4,881.7		4,486.9
Total liabilities and shareholders' equity	$	32,704.6	$	31,975.2

The accompanying notes are an integral part

of the consolidated financial statements.

4

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENT OF OPERATIONS

(Dollars in millions, except per share data)

(unaudited)

	Three months ended						Nine months ended
	September 30,						September 30,
	2017			2016			2017			2016
Revenues:
Insurance policy income	$	659.3		$	649.0		$	1,987.2		$	1,947.0
Net investment income:
General account assets	325.9			301.7			960.3			888.5
Policyholder and other special-purpose portfolios	52.7			43.1			171.8			82.7
Realized investment gains (losses):
Net realized investment gains (losses), excluding impairment losses	34.5			12.8			74.8			55.4
Other-than-temporary impairments:
Total other-than-temporary impairment losses	(4.7		)	(1.2		)	(17.3		)	(24.8		)
Portion of other-than-temporary impairment losses recognized in accumulated other comprehensive income	—			—			(.9		)	—
Net impairment losses recognized	(4.7		)	(1.2		)	(18.2		)	(24.8		)
Loss on dissolution of variable interest entities	(.6		)	—			(4.3		)	(7.3		)
Total realized gains	29.2			11.6			52.3			23.3
Fee revenue and other income	12.2			10.5			35.5			38.7
Total revenues	1,079.3			1,015.9			3,207.1			2,980.2
Benefits and expenses:
Insurance policy benefits	638.1			609.8			1,941.6			1,861.2
Loss on reinsurance transaction	—			75.4			—			75.4
Interest expense	30.1			29.4			92.3			86.0
Amortization	58.2			64.7			181.3			181.6
Loss on extinguishment of borrowings related to a variable interest entity	5.5			—			5.5			—
Other operating costs and expenses	217.5			187.3			631.3			603.5
Total benefits and expenses	949.4			966.6			2,852.0			2,807.7
Income before income taxes	129.9			49.3			355.1			172.5
Income tax expense (benefit):
Tax expense on period income	44.1			16.9			123.6			61.7
Valuation allowance for deferred tax assets and other tax items	(15.0		)	13.8			(15.0		)	(13.2		)
Net income	$	100.8		$	18.6		$	246.5		$	124.0
Earnings per common share:
Basic:
Weighted average shares outstanding	168,684,000			174,247,000			170,890,000			177,640,000
Net income	$	.60		$	.11		$	1.44		$	.70
Diluted:
Weighted average shares outstanding	170,982,000			175,723,000			172,800,000			179,373,000
Net income	$	.59		$	.11		$	1.43		$	.69

The accompanying notes are an integral part

of the consolidated financial statements.

5

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

(Dollars in millions)

(unaudited)

	Three months ended						Nine months ended
	September 30,						September 30,
	2017			2016			2017			2016
Net income	$	100.8		$	18.6		$	246.5		$	124.0
Other comprehensive income, before tax:
Unrealized gains for the period	120.9			228.3			794.5			1,329.2
Adjustment to present value of future profits and deferred acquisition costs	(1.8		)	(11.3		)	(25.3		)	(119.6		)
Amount related to premium deficiencies assuming the net unrealized gains (losses) had been realized	(31.0		)	(82.8		)	(243.0		)	(493.4		)
Reclassification adjustments:
For net realized investment (gains) losses included in net income	(27.7		)	(14.6		)	(44.0		)	(24.2		)
For amortization of the present value of future profits and deferred acquisition costs related to net realized investment gains (losses) included in net income	.7			.2			1.0			.9
Unrealized gains on investments	61.1			119.8			483.2			692.9
Change related to deferred compensation plan	—			—			—			8.6
Other comprehensive income before tax	61.1			119.8			483.2			701.5
Income tax expense related to items of accumulated other comprehensive income	(22.0		)	(42.1		)	(172.0		)	(248.8		)
Other comprehensive income, net of tax	39.1			77.7			311.2			452.7
Comprehensive income	$	139.9		$	96.3		$	557.7		$	576.7

The accompanying notes are an integral part

of the consolidated financial statements.

6

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY

(Dollars in millions)

(unaudited)

	Common stock and additional paid-in capital			Accumulated other  comprehensive income		Retained earnings			Total
Balance, December 31, 2015	$	3,388.6		$	402.8	$	347.1		$	4,138.5
Net income	—			—		124.0			124.0
Change in unrealized appreciation (depreciation) of investments and other (net of applicable income tax expense of $248.1)	—			451.5		—			451.5
Change in noncredit component of impairment losses on fixed maturities, available for sale (net of applicable income tax expense of $.7)	—			1.2		—			1.2
Cost of common stock repurchased	(203.0		)	—		—			(203.0		)
Dividends on common stock	—			—		(40.8		)	(40.8		)
Stock options, restricted stock and performance units	22.4			—		—			22.4
Balance, September 30, 2016	$	3,208.0		$	855.5	$	430.3		$	4,493.8
Balance, December 31, 2016	$	3,213.8		$	622.4	$	650.7		$	4,486.9
Cumulative effect of accounting change	.9			—		(.6		)	.3
Net income	—			—		246.5			246.5
Change in unrealized appreciation (depreciation) of investments (net of applicable income tax expense of $170.9)	—			309.1		—			309.1
Change in noncredit component of impairment losses on fixed maturities, available for sale (net of applicable income tax expense of $1.1)	—			2.1		—			2.1
Cost of common stock repurchased	(140.1		)	—		—			(140.1		)
Dividends on common stock	—			—		(44.7		)	(44.7		)
Stock options, restricted stock and performance units	21.6			—		—			21.6
Balance, September 30, 2017	$	3,096.2		$	933.6	$	851.9		$	4,881.7

The accompanying notes are an integral part

of the consolidated financial statements.

7

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENT OF CASH FLOWS

(Dollars in millions)

(unaudited)

	Nine months ended
	September 30,
	2017			2016
Cash flows from operating activities:
Insurance policy income	$	1,859.4		$	1,837.9
Net investment income	898.9			877.7
Fee revenue and other income	35.5			38.7
Cash and cash equivalents received upon recapture of reinsurance	—			73.6
Insurance policy benefits	(1,491.7		)	(1,439.6		)
Interest expense	(81.0		)	(66.5		)
Deferrable policy acquisition costs	(183.4		)	(179.4		)
Other operating costs	(546.0		)	(552.1		)
Income taxes	(58.0		)	(5.5		)
Net cash from operating activities	433.7			584.8
Cash flows from investing activities:
Sales of investments	1,742.5			2,225.7
Maturities and redemptions of investments	2,543.0			1,529.5
Purchases of investments	(4,076.8		)	(4,196.7		)
Net sales (purchases) of trading securities	94.8			(31.0		)
Change in cash and cash equivalents held by variable interest entities	83.4			216.7
Other	(23.6		)	(17.8		)
Net cash provided (used) by investing activities	363.3			(273.6		)
Cash flows from financing activities:
Issuance of common stock	6.0			6.9
Payments to repurchase common stock	(142.3		)	(210.0		)
Common stock dividends paid	(44.5		)	(40.9		)
Amounts received for deposit products	1,067.2			992.1
Withdrawals from deposit products	(920.8		)	(891.5		)
Issuance of investment borrowings:
Federal Home Loan Bank	332.0			432.7
Related to variable interest entities	387.3			477.1
Payments on investment borrowings:
Federal Home Loan Bank	(332.6		)	(333.3		)
Related to variable interest entities	(862.3		)	(470.6		)
Net cash used by financing activities	(510.0		)	(37.5		)
Net increase in cash and cash equivalents	287.0			273.7
Cash and cash equivalents, beginning of period	478.9			432.3
Cash and cash equivalents, end of period	$	765.9		$	706.0

The accompanying notes are an integral part

of the consolidated financial statements.

8

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

BUSINESS AND BASIS OF PRESENTATION

The following notes should be read together with the notes to the consolidated financial statements included in our 2016 Annual Report on Form 10-K.

CNO Financial Group, Inc., a Delaware corporation ("CNO"), is a holding company for a group of insurance companies operating throughout the United States that develop, market and administer health insurance, annuity, individual life insurance and other insurance products.  The terms "CNO Financial Group, Inc.", "CNO", the "Company", "we", "us", and "our" as used in these financial statements refer to CNO and its subsidiaries.  Such terms, when used to describe insurance business and products, refer to the insurance business and products of CNO's insurance subsidiaries.

We focus on serving middle-income pre-retiree and retired Americans, which we believe are attractive, underserved, high growth markets.  We sell our products through three distribution channels: career agents, independent producers (some of whom sell one or more of our product lines exclusively) and direct marketing.

Our unaudited consolidated financial statements reflect normal recurring adjustments that, in the opinion of management, are necessary for a fair statement of our financial position, results of operations and cash flows for the periods presented.  As permitted by rules and regulations of the Securities and Exchange Commission (the "SEC") applicable to quarterly reports on Form 10-Q, we have condensed or omitted certain information and disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP").  We have reclassified certain amounts from the prior periods to conform to the 2017 presentation.  These reclassifications have no effect on net income or shareholders' equity.  Results for interim periods are not necessarily indicative of the results that may be expected for a full year.

The balance sheet at December 31, 2016, presented herein, has been derived from the audited financial statements at that date but does not include all of the information and footnotes required by GAAP for complete financial statements.

When we prepare financial statements in conformity with GAAP, we are required to make estimates and assumptions that significantly affect reported amounts of various assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the reporting periods.  For example, we use significant estimates and assumptions to calculate values for deferred acquisition costs, the present value of future profits, fair value measurements of certain investments (including derivatives), other-than-temporary impairments of investments, assets and liabilities related to income taxes, liabilities for insurance products, liabilities related to litigation and guaranty fund assessment accruals.  If our future experience differs from these estimates and assumptions, our financial statements would be materially affected.

The accompanying financial statements include the accounts of the Company and its subsidiaries. Our consolidated financial statements exclude transactions between us and our consolidated affiliates, or among our consolidated affiliates.

INVESTMENTS

We classify our fixed maturity securities into one of two categories: (i) "available for sale" (which we carry at estimated fair value with any unrealized gain or loss, net of tax and related adjustments, recorded as a component of shareholders' equity); or (ii) "trading" (which we carry at estimated fair value with changes in such value recognized as net investment income (classified as investment income from policyholder and other special-purpose portfolios)).

Ourtrading securities include: (i) investments purchased with the intent of selling in the near term to generate income; (ii) investments supporting certain insurance liabilities (including investments backing the market strategies of our multibucket annuity products); and (iii) certain fixed maturity securities containing embedded derivatives for which we have elected the fair value option.  The change in fair value of the income generating investments and investments supporting insurance liabilities is recognized in income from policyholder and other special-purpose portfolios (a component of net investment income). The change in fair value of securities with embedded derivatives is recognized in realized investment gains (losses). Investment income related to investments supporting certain insurance liabilities is substantially offset by the change in insurance policy benefits related to certain products.

9

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

Accumulated other comprehensive income is primarily comprised of the net effect of unrealized appreciation (depreciation) on our investments.  These amounts, included in shareholders' equity as of September 30, 2017 and December 31, 2016, were as follows (dollars in millions):

	September 30, 2017			December 31, 2016
Net unrealized appreciation (depreciation) on fixed maturity securities, available for sale, on which an other-than-temporary impairment loss has been recognized	$	2.4		$	(1.1	)
Net unrealized gains on all other investments	2,058.9			1,311.9
Adjustment to present value of future profits (a)	(98.1		)	(106.2		)
Adjustment to deferred acquisition costs	(287.9		)	(223.5		)
Adjustment to insurance liabilities	(224.5		)	(13.5		)
Deferred income tax liabilities	(517.2		)	(345.2		)
Accumulated other comprehensive income	$	933.6		$	622.4

________

(a) The present value of future profits is the value assigned to the right to receive future cash flows from contracts existing at September 10, 2003, the date Conseco, Inc., an Indiana corporation, emerged from bankruptcy.

At September 30, 2017, adjustments to the present value of future profits, deferred acquisition costs, insurance liabilities and deferred tax assets included $(86.7) million, $(135.8) million, $(224.5) million and $159.1 million, respectively, for premium deficiencies that would exist on certain blocks of business (primarily long-term care products) if unrealized gains on the assets backing such products had been realized and the proceeds from the sales of such assets were invested at then current yields.

At September 30, 2017, the amortized cost, gross unrealized gains and losses, estimated fair value, other-than-temporary impairments in accumulated other comprehensive income of fixed maturities, available for sale, and equity securities were as follows (dollars in millions):

	Amortized cost		Gross unrealized gains		Gross unrealized losses			Estimated fair value		Other-than-temporary impairments included in accumulated other comprehensive income
Corporate securities	$	13,145.4	$	1,537.6	$	(33.0	)	$	14,650.0	$	(3.6	)
United States Treasury securities and obligations of United States government corporations and agencies	145.4		26.9		—			172.3		—
States and political subdivisions	1,857.2		220.7		(.9		)	2,077.0		—
Debt securities issued by foreign governments	58.1		3.1		(.1		)	61.1		—
Asset-backed securities	2,608.6		180.6		(3.1		)	2,786.1		—
Collateralized debt obligations	236.5		1.4		—			237.9		—
Commercial mortgage-backed securities	1,311.6		37.4		(10.1		)	1,338.9		—
Mortgage pass-through securities	2.0		.2		—			2.2		—
Collateralized mortgage obligations	727.7		77.3		(.6		)	804.4		(1.1		)
Total fixed maturities, available for sale	$	20,092.5	$	2,085.2	$	(47.8	)	$	22,129.9	$	(4.7	)
Equity securities	$	688.7	$	27.2	$	(2.6	)	$	713.3

10

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

At December 31, 2016, the amortized cost, gross unrealized gains and losses, estimated fair value, other-than-temporary impairments in accumulated other comprehensive income of fixed maturities, available for sale, and equity securities were as follows (dollars in millions):

	Amortized cost		Gross unrealized gains		Gross unrealized losses			Estimated fair value		Other-than-temporary impairments included in accumulated other comprehensive income
Corporate securities	$	12,549.9	$	1,100.0	$	(139.0	)	$	13,510.9	$	(3.6	)
United States Treasury securities and obligations of United States government corporations and agencies	143.8		20.5		—			164.3		—
States and political subdivisions	1,811.8		186.7		(9.6		)	1,988.9		(3.0		)
Debt securities issued by foreign governments	37.1		.2		(.4		)	36.9		—
Asset-backed securities	2,641.5		84.3		(15.5		)	2,710.3		—
Collateralized debt obligations	230.0		1.0		(.3		)	230.7		—
Commercial mortgage-backed securities	1,531.0		33.1		(27.9		)	1,536.2		—
Mortgage pass-through securities	2.3		.2		—			2.5		—
Collateralized mortgage obligations	855.7		61.4		(1.6		)	915.5		(1.4		)
Total fixed maturities, available for sale	$	19,803.1	$	1,487.4	$	(194.3	)	$	21,096.2	$	(8.0	)
Equity securities	$	580.7	$	11.5	$	(8.0	)	$	584.2

The following table sets forth the amortized cost and estimated fair value of fixed maturities, available for sale, at September 30, 2017, by contractual maturity.  Actual maturities will differ from contractual maturities because certain borrowers may have the right to call or prepay obligations with or without penalties.  Structured securities (such as asset-backed securities, collateralized debt obligations, commercial mortgage-backed securities, mortgage pass-through securities and collateralized mortgage obligations, collectively referred to as "structured securities") frequently include provisions for periodic principal payments and permit periodic unscheduled payments.

	Amortized cost		Estimated fair value
	(Dollars in millions)
Due in one year or less	$	398.1	$	406.1
Due after one year through five years	2,004.8		2,131.7
Due after five years through ten years	1,562.8		1,671.1
Due after ten years	11,240.4		12,751.5
Subtotal	15,206.1		16,960.4
Structured securities	4,886.4		5,169.5
Total fixed maturities, available for sale	$	20,092.5	$	22,129.9

11

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

The following table sets forth the amortized cost and estimated fair value of fixed maturities, available for sale, at December 31, 2016, by contractual maturity.

	Amortized cost		Estimated fair value
	(Dollars in millions)
Due in one year or less	$	354.7	$	359.8
Due after one year through five years	2,243.8		2,399.5
Due after five years through ten years	1,549.1		1,620.8
Due after ten years	10,395.0		11,320.9
Subtotal	14,542.6		15,701.0
Structured securities	5,260.5		5,395.2
Total fixed maturities, available for sale	$	19,803.1	$	21,096.2

Net Realized Investment Gains (Losses)

The following table sets forth the net realized investment gains (losses) for the periods indicated (dollars in millions):

	Three months ended						Nine months ended
	September 30,						September 30,
	2017			2016			2017			2016
Fixed maturity securities, available for sale:
Gross realized gains on sale	$	32.3		$	7.3		$	60.4		$	127.1
Gross realized losses on sale	(8.5		)	(2.8		)	(16.4		)	(84.4		)
Impairments:
Total other-than-temporary impairment losses	(3.2		)	—			(10.0		)	(6.3		)
Other-than-temporary impairment losses recognized in accumulated other comprehensive income	—			—			(.9		)	—
Net impairment losses recognized	(3.2		)	—			(10.9		)	(6.3		)
Net realized investment gains from fixed maturities	20.6			4.5			33.1			36.4
Equity securities	7.7			17.2			9.6			21.3
Commercial mortgage loans	—			—			1.0			—
Impairments of other investments	(1.5		)	(1.2		)	(7.3		)	(18.5		)
Loss on dissolution of variable interest entities	(.6		)	—			(4.3		)	(7.3		)
Other (a)	3.0			(8.9		)	20.2			(8.6		)
Net realized investment gains	$	29.2		$	11.6		$	52.3		$	23.3

_________________

(a) Changes in the estimated fair value of trading securities that we have elected the fair value option (and are still held as of the end of the respective periods) were $13.0 million and $.8 million for the nine months ended September 30, 2017 and 2016, respectively.

During the first nine months of 2017, we recognized net realized investment gains of $52.3 million, which were comprised of: (i) $60.1 million of net gains from the sales of investments; (ii) $4.3 million of losses on the dissolution of variable interest entities ("VIEs"); (iii) the increase in fair value of certain fixed maturity investments with embedded derivatives of $12.3 million; (iv) the increase in fair value of embedded derivatives related to a modified coinsurance agreement of $2.4 million; and (v) $18.2 million of writedowns of investments for other than temporary declines in fair value recognized through net income.

12

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

During the first nine months of 2016, we recognized net realized investment gains of $23.3 million, which were comprised of: (i) $48.1 million of net gains from the sales of investments; (ii) a $7.3 million loss on the dissolution of a VIE; (iii) the increase in fair value of certain fixed maturity investments with embedded derivatives of $.6 million; (iv) the increase in fair value of embedded derivatives related to a modified coinsurance agreement of $6.7 million; and (v) $24.8 million of writedowns of investments for other than temporary declines in fair value recognized through net income.

During the first nine months of 2017 and 2016, certain VIEs that were required to be consolidated were dissolved. We recognized a loss of $4.3 million and $7.3 million during the first nine months of 2017 and 2016, respectively, representing the difference between the carrying value of the investment borrowings of such VIEs and the contractual distributions required following the liquidation of the underlying assets.

Our fixed maturity investments are generally purchased in the context of various long-term strategies, including funding insurance liabilities, so we do not generally seek to generate short-term realized gains through the purchase and sale of such securities.  In certain circumstances, including those in which securities are selling at prices which exceed our view of their underlying economic value, or when it is possible to reinvest the proceeds to better meet our long-term asset-liability objectives, we may sell certain securities.

During the first nine months of 2017, the $16.4 million of gross realized losses on sales of $290.8 million of fixed maturity securities, available for sale included: (i) $9.7 million related to various corporate securities; (ii) $3.1 million related to commercial mortgage-backed securities; and (iii) $3.6 million related to various other investments. Securities are generally sold at a loss following unforeseen issue-specific events or conditions or shifts in perceived relative values.  These reasons include but are not limited to:  (i) changes in the investment environment; (ii) expectation that the market value could deteriorate; (iii) our desire to reduce our exposure to an asset class, an issuer or an industry; (iv) prospective or actual changes in credit quality; or (v) changes in expected portfolio cash flows.

During the first nine months of 2017, we recognized $18.2 million of impairment losses recorded in earnings which included: (i) $5.7 million of writedowns on fixed maturities in the energy sector; (ii) $5.2 million of writedowns related to a mortgage loan; and (iii) $7.3 million of writedowns on other investments. Factors considered in determining the writedowns of investments in the first nine months of 2017 included changes in the estimated recoverable value of the assets related to each investment and the timing of and complexities related to the recovery process.

During the first nine months of 2016, we recognized $24.8 million of impairment losses recorded in earnings which included: (i) $6.3 million of writedowns on fixed maturities of a single issuer in the energy sector; (ii) $3.7 million of writedowns on a direct loan due to borrower specific events; (iii) $12.7 million of writedowns on a privately placed preferred stock of an entity formed to construct and operate a chemical plant; (iv) $.9 million of writedowns related to a real estate investment; and (v) $1.2 million of writedowns of investments held by VIEs due to other-than-temporary declines in value.

We regularly evaluate all of our investments with unrealized losses for possible impairment.  Our assessment of whether unrealized losses are "other than temporary" requires significant judgment.  Factors considered include:  (i) the extent to which fair value is less than the cost basis; (ii) the length of time that the fair value has been less than cost; (iii) whether the unrealized loss is event driven, credit-driven or a result of changes in market interest rates or risk premium; (iv) the near-term prospects for specific events, developments or circumstances likely to affect the value of the investment; (v) the investment's rating and whether the investment is investment-grade and/or has been downgraded since its purchase; (vi) whether the issuer is current on all payments in accordance with the contractual terms of the investment and is expected to meet all of its obligations under the terms of the investment; (vii) whether we intend to sell the investment or it is more likely than not that circumstances will require us to sell the investment before recovery occurs; (viii) the underlying current and prospective asset and enterprise values of the issuer and the extent to which the recoverability of the carrying value of our investment may be affected by changes in such values; (ix) projections of, and unfavorable changes in, cash flows on structured securities including mortgage-backed and asset-backed securities; (x) our best estimate of the value of any collateral; and (xi) other objective and subjective factors.

Future events may occur, or additional information may become available, which may necessitate future realized losses in our portfolio.  Significant losses could have a material adverse effect on our consolidated financial statements in future periods.

13

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

Impairment losses on equity securities are recognized in net income.  The manner in which impairment losses on fixed maturity securities, available for sale, are recognized in the financial statements is dependent on the facts and circumstances related to the specific security.  If we intend to sell a security or it is more likely than not that we would be required to sell a security before the recovery of its amortized cost, the security is other-than-temporarily impaired and the full amount of the impairment is recognized as a loss through earnings.  If we do not expect to recover the amortized cost basis, we do not plan to sell the security, and if it is not more likely than not that we would be required to sell a security before the recovery of its amortized cost, less any current period credit loss, the recognition of the other-than-temporary impairment is bifurcated.  We recognize the credit loss portion in net income and the noncredit loss portion in accumulated other comprehensive income.

We estimate the amount of the credit loss component of a fixed maturity security impairment as the difference between amortized cost and the present value of the expected cash flows of the security.  The present value is determined using the best estimate of future cash flows discounted at the effective interest rate implicit to the security at the date of purchase or the current yield to accrete an asset-backed or floating-rate security.  The methodology and assumptions for establishing the best estimate of future cash flows vary depending on the type of security.

For most structured securities, cash flow estimates are based on bond-specific facts and circumstances that may include collateral characteristics, expectations of delinquency and default rates, loss severity, prepayment speeds and structural support, including excess spread, subordination and guarantees.  For corporate bonds, cash flow estimates are derived from scenario-based outcomes of expected corporate restructurings or the disposition of assets using bond specific facts and circumstances. The previous amortized cost basis less the impairment recognized in net income becomes the security's new cost basis.  We accrete the new cost basis to the estimated future cash flows over the expected remaining life of the security, except when the security is in default or considered nonperforming.

The remaining noncredit impairment, which is recorded in accumulated other comprehensive income, is the difference between the security's estimated fair value and our best estimate of future cash flows discounted at the effective interest rate prior to impairment.  The remaining noncredit impairment typically represents changes in the market interest rates, current market liquidity and risk premiums.  As of September 30, 2017, other-than-temporary impairments included in accumulated other comprehensive income totaled $4.7 million (before taxes and related amortization).

The following table summarizes the amount of credit losses recognized in earnings on fixed maturity securities, available for sale, held at the beginning of the period, for which a portion of the other-than-temporary impairment was also recognized in accumulated other comprehensive income for the three and nine months ended September 30, 2017 and 2016 (dollars in millions):

	Three months ended						Nine months ended
	September 30,						September 30,
	2017			2016			2017			2016
Credit losses on fixed maturity securities, available for sale, beginning of period	$	(4.9	)	$	(2.6	)	$	(5.5	)	$	(2.6	)
Add: credit losses on other-than-temporary impairments not previously recognized	—			—			—			—
Less: credit losses on securities sold	—			.1			1.6			.1
Less: credit losses on securities impaired due to intent to sell (a)	—			—			—			—
Add: credit losses on previously impaired securities	—			—			(1.0		)	—
Less: increases in cash flows expected on previously impaired securities	—			—			—			—
Credit losses on fixed maturity securities, available for sale, end of period	$	(4.9	)	$	(2.5	)	$	(4.9	)	$	(2.5	)

14

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

__________

(a) Represents securities for which the amount previously recognized in accumulated other comprehensive income was recognized in earnings because we intend to sell the security or we more likely than not will be required to sell the security before recovery of its amortized cost basis.

Gross Unrealized Investment Losses

Our investment strategy is to maximize, over a sustained period and within acceptable parameters of quality and risk, investment income and total investment return through active investment management. Accordingly, we may sell securities at a gain or a loss to enhance the projected total return of the portfolio as market opportunities change, to reflect changing perceptions of risk, or to better match certain characteristics of our investment portfolio with the corresponding characteristics of our insurance liabilities.

The following table summarizes the gross unrealized losses and fair values of our investments with unrealized losses that are not deemed to be other-than-temporarily impaired, aggregated by investment category and length of time that such securities have been in a continuous unrealized loss position, at September 30, 2017 (dollars in millions):

	Less than 12 months					12 months or greater					Total
Description of securities	Fair value		Unrealized losses			Fair value		Unrealized losses			Fair value		Unrealized losses
United States Treasury securities and obligations of United States government corporations and agencies	$	20.3	$	—		$	.6	$	—		$	20.9	$	—
States and political subdivisions	35.1		(.6		)	19.3		(.3		)	54.4		(.9		)
Debt securities issued by foreign governments	10.5		(.1		)	—		—			10.5		(.1		)
Corporate securities	666.9		(7.8		)	400.4		(25.2		)	1,067.3		(33.0		)
Asset-backed securities	276.7		(1.3		)	79.6		(1.8		)	356.3		(3.1		)
Collateralized debt obligations	24.0		—			—		—			24.0		—
Commercial mortgage-backed securities	226.2		(1.3		)	221.9		(8.8		)	448.1		(10.1		)
Collateralized mortgage obligations	72.8		(.5		)	11.6		(.1		)	84.4		(.6		)
Total fixed maturities, available for sale	$	1,332.5	$	(11.6	)	$	733.4	$	(36.2	)	$	2,065.9	$	(47.8	)
Equity securities	$	37.4	$	(.8	)	$	89.7	$	(1.8	)	$	127.1	$	(2.6	)

15

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

The following table summarizes the gross unrealized losses and fair values of our investments with unrealized losses that are not deemed to be other-than-temporarily impaired, aggregated by investment category and length of time that such securities have been in a continuous unrealized loss position, at December 31, 2016 (dollars in millions):

	Less than 12 months					12 months or greater					Total
Description of securities	Fair value		Unrealized losses			Fair value		Unrealized losses			Fair value		Unrealized losses
United States Treasury securities and obligations of United States government corporations and agencies	$	8.0	$	—		$	—	$	—		$	8.0	$	—
States and political subdivisions	176.3		(7.8		)	18.3		(1.8		)	194.6		(9.6		)
Debt securities issued by foreign governments	18.9		(.4		)	—		—			18.9		(.4		)
Corporate securities	1,907.6		(75.5		)	559.6		(63.5		)	2,467.2		(139.0		)
Asset-backed securities	692.9		(8.5		)	262.5		(7.0		)	955.4		(15.5		)
Collateralized debt obligations	38.3		(.1		)	30.8		(.2		)	69.1		(.3		)
Commercial mortgage-backed securities	525.2		(16.6		)	154.0		(11.3		)	679.2		(27.9		)
Collateralized mortgage obligations	73.6		(.6		)	34.6		(1.0		)	108.2		(1.6		)
Total fixed maturities, available for sale	$	3,440.8	$	(109.5	)	$	1,059.8	$	(84.8	)	$	4,500.6	$	(194.3	)
Equity securities	$	239.4	$	(8.0	)	$	—	$	—		$	239.4	$	(8.0	)

Based on management's current assessment of investments with unrealized losses at September 30, 2017, the Company believes the issuers of the securities will continue to meet their obligations (or with respect to equity-type securities, the investment value will recover to its cost basis).  While we do not have the intent to sell securities with unrealized losses and it is not more likely than not that we will be required to sell securities with unrealized losses prior to their anticipated recovery, our intent on an individual security may change, based upon market or other unforeseen developments.  In such instances, if a loss is recognized from a sale subsequent to a balance sheet date due to these unexpected developments, the loss is recognized in the period in which we had the intent to sell the security before its anticipated recovery.

EARNINGS PER SHARE

A reconciliation of net income and shares used to calculate basic and diluted earnings per share is as follows (dollars in millions and shares in thousands):

	Three months ended				Nine months ended
	September 30,				September 30,
	2017		2016		2017		2016
Net income for basic and diluted earnings per share	$	100.8	$	18.6	$	246.5	$	124.0
Shares:
Weighted average shares outstanding for basic earnings per share	168,684		174,247		170,890		177,640
Effect of dilutive securities on weighted average shares:
Stock options, restricted stock and performance units	2,298		1,476		1,910		1,733
Weighted average shares outstanding for diluted earnings per share	170,982		175,723		172,800		179,373

16

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

Basic earnings per common share is computed by dividing net income by the weighted average number of common shares outstanding for the period.  Restricted shares (including our performance units) are not included in basic earnings per share until vested.  Diluted earnings per share reflect the potential dilution that could occur if outstanding stock options were exercised and restricted stock was vested.  The dilution from options and restricted shares is calculated using the treasury stock method.  Under this method, we assume the proceeds from the exercise of the options (or the unrecognized compensation expense with respect to restricted stock and performance units) will be used to purchase shares of our common stock at the average market price during the period, reducing the dilutive effect of the exercise of the options (or the vesting of the restricted stock and performance units).

BUSINESS SEGMENTS

The Company manages its business through the following operating segments: Bankers Life, Washington National and Colonial Penn, which are defined on the basis of product distribution; and corporate operations, comprised of holding company activities and certain noninsurance company businesses. In the fourth quarter of 2016, we began reporting the long-term care block recaptured from Beechwood Re Ltd ("BRe") effective September 30, 2016, as an additional business segment.

We measure segment performance by excluding net realized investment gains (losses), fair value changes in embedded derivative liabilities (net of related amortization), fair value changes and an amendment to the agent deferred compensation plan, loss on reinsurance transaction, income taxes and other non-operating items consisting primarily of earnings attributable to VIEs ("pre-tax operating earnings") because we believe that this performance measure is a better indicator of the ongoing business and trends in our business.  Our primary investment focus is on investment income to support our liabilities for insurance products as opposed to the generation of net realized investment gains (losses), and a long-term focus is necessary to maintain profitability over the life of the business.

The net realized investment gains (losses), fair value changes in embedded derivative liabilities (net of related amortization), fair value changes and an amendment to the agent deferred compensation plan, loss on reinsurance transaction and other non-operating items consisting primarily of earnings attributable to VIEs depend on market conditions or represent unusual items that do not necessarily relate to the underlying business of our segments.  Net realized investment gains (losses) and fair value changes in embedded derivative liabilities (net of related amortization) may affect future earnings levels since our underlying business is long-term in nature and changes in our investment portfolio may impact our ability to earn the assumed interest rates needed to maintain the profitability of our business.

17

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

Operating information by segment was as follows (dollars in millions):

	Three months ended				Nine months ended
	September 30,				September 30,
	2017		2016		2017		2016
Revenues:
Bankers Life:
Insurance policy income:
Annuities	$	3.7	$	6.8	$	15.5	$	17.4
Health	307.2		310.3		926.9		933.3
Life	103.7		96.6		310.4		295.8
Net investment income (a)	270.6		244.7		800.4		686.8
Fee revenue and other income (a)	11.3		9.6		32.5		23.5
Total Bankers Life revenues	696.5		668.0		2,085.7		1,956.8
Washington National:
Insurance policy income:
Annuities	.5		1.2		1.6		2.3
Health	160.4		156.9		480.3		469.1
Life	6.5		6.3		20.1		18.6
Net investment income (a)	68.0		67.1		201.9		191.3
Fee revenue and other income (a)	.3		.4		.8		1.0
Total Washington National revenues	235.7		231.9		704.7		682.3
Colonial Penn:
Insurance policy income:
Health	.5		.6		1.6		2.0
Life	72.6		70.3		217.5		208.5
Net investment income (a)	11.0		11.1		33.1		33.0
Fee revenue and other income (a)	.3		.2		.9		.8
Total Colonial Penn revenues	84.4		82.2		253.1		244.3
Long-term care in run-off:
Insurance policy income - health	4.2		—		13.3		—
Net investment income (a)	6.8		—		26.5		—
Total Long-term care in run-off revenues	11.0		—		39.8		—
Corporate operations:
Net investment income	7.0		6.7		24.8		16.6
Fee and other income	1.8		2.5		6.5		7.6
Total corporate revenues	8.8		9.2		31.3		24.2
Total revenues	$	1,036.4	$	991.3	$	3,114.6	$	2,907.6

(continued on next page)

18

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

(continued from previous page)

	Three months ended						Nine months ended
	September 30,						September 30,
	2017			2016			2017			2016
Expenses:
Bankers Life:
Insurance policy benefits	$	437.2		$	427.1		$	1,307.7		$	1,240.9
Amortization	38.7			43.8			126.3			135.3
Interest expense on investment borrowings	5.3			3.5			14.3			9.4
Other operating costs and expenses	108.4			105.5			328.2			312.2
Total Bankers Life expenses	589.6			579.9			1,776.5			1,697.8
Washington National:
Insurance policy benefits	144.7			144.5			436.7			422.0
Amortization	14.3			14.3			43.9			44.5
Interest expense on investment borrowings	1.7			.9			4.5			2.5
Other operating costs and expenses	47.5			47.0			145.0			140.3
Total Washington National expenses	208.2			206.7			630.1			609.3
Colonial Penn:
Insurance policy benefits	47.7			50.3			150.8			151.3
Amortization	3.9			3.7			11.9			11.3
Interest expense on investment borrowings	.3			.1			.7			.4
Other operating costs and expenses	23.5			27.2			73.0			84.2
Total Colonial Penn expenses	75.4			81.3			236.4			247.2
Long-term care in run-off:
Insurance policy benefits	11.4			—			36.6			—
Other operating costs and expenses	.6			—			2.1			—
Total Long-term care in run-off expenses	12.0			—			38.7			—
Corporate operations:
Interest expense on corporate debt	11.7			11.5			34.8			34.3
Other operating costs and expenses	23.7			13.6			68.3			43.7
Total corporate expenses	35.4			25.1			103.1			78.0
Total expenses	920.6			893.0			2,784.8			2,632.3
Pre-tax operating earnings by segment:
Bankers Life	106.9			88.1			309.2			259.0
Washington National	27.5			25.2			74.6			73.0
Colonial Penn	9.0			.9			16.7			(2.9		)
Long-term care in run-off	(1.0		)	—			1.1			—
Corporate operations	(26.6		)	(15.9		)	(71.8		)	(53.8		)
Pre-tax operating earnings	$	115.8		$	98.3		$	329.8		$	275.3

___________________

(a) It is not practicable to provide additional components of revenue by product or services.

19

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

A reconciliation of segment revenues and expenses to consolidated revenues and expenses and net income (loss) is as follows (dollars in millions):

	Three months ended						Nine months ended
	September 30,						September 30,
	2017			2016			2017			2016
Total segment revenues	$	1,036.4		$	991.3		$	3,114.6		$	2,907.6
Net realized investment gains	29.2			11.6			52.3			23.3
Revenues related to VIEs	13.7			13.0			40.2			39.3
Fee revenue related to transition and support services agreements	—			—			—			10.0
Consolidated revenues	1,079.3			1,015.9			3,207.1			2,980.2
Total segment expenses	920.6			893.0			2,784.8			2,632.3
Insurance policy benefits - fair value changes in embedded derivative liabilities	(2.9		)	(12.1		)	9.8			47.0
Amortization related to fair value changes in embedded derivative liabilities	.6			2.7			(1.8		)	(10.4		)
Amortization related to net realized investment gains	.7			.2			1.0			.9
Expenses related to VIEs	17.0			13.7			44.8			40.5
Fair value changes and amendment related to agent deferred compensation plan	13.4			(6.3		)	13.4			12.0
Loss on reinsurance transaction	—			75.4			—			75.4
Expenses related to transition and support services agreements	—			—			—			10.0
Consolidated expenses	949.4			966.6			2,852.0			2,807.7
Income before tax	129.9			49.3			355.1			172.5
Income tax expense (benefit):
Tax expense on period income	44.1			16.9			123.6			61.7
Valuation allowance for deferred tax assets and other tax items	(15.0		)	13.8			(15.0		)	(13.2		)
Net income	$	100.8		$	18.6		$	246.5		$	124.0

20

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

ACCOUNTING FOR DERIVATIVES

Our freestanding and embedded derivatives, which are not designated as hedging instruments, are held at fair value and are summarized as follows (dollars in millions):

	Fair value
	September 30, 2017			December 31, 2016
Assets:
Other invested assets:
Fixed index call options	$	142.2		$	111.9
Reinsurance receivables	(1.8		)	(4.2		)
Total assets	$	140.4		$	107.7
Liabilities:
Future policy benefits:
Fixed index products	$	1,249.3		$	1,092.3
Total liabilities	$	1,249.3		$	1,092.3

Our fixed index annuity products provide a guaranteed minimum rate of return and a higher potential return that is based on a percentage (the "participation rate") of the amount of increase in the value of a particular index, such as the Standard & Poor's 500 Index, over a specified period.  Typically, on each policy anniversary date, a new index period begins.  We are generally able to change the participation rate at the beginning of each index period during a policy year, subject to contractual minimums.  The Company accounts for the options attributed to the policyholder for the estimated life of the contract as embedded derivatives. These accounting requirements often create volatility in the earnings from these products. We typically buy call options (including call spreads) referenced to the applicable indices in an effort to offset or hedge potential increases to policyholder benefits resulting from increases in the particular index to which the policy's return is linked.  The notional amount of these options was $2.9 billion and $2.5 billion at September 30, 2017 and December 31, 2016, respectively.

From time to time, we utilize United States Treasury interest rate futures primarily to hedge interest rate risk related to anticipated mortgage loan transactions.

We are required to establish an embedded derivative related to a modified coinsurance agreement pursuant to which we assume the risks of a block of health insurance business. The embedded derivative represents the mark-to-market adjustment for approximately $125 million in underlying investments held by the ceding reinsurer.

We purchase certain fixed maturity securities that contain embedded derivatives that are required to be held at fair value on the consolidated balance sheet. We have elected the fair value option to carry the entire security at fair value with changes in fair value recognized in net income.

21

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

The following table provides the pre-tax gains (losses) recognized in net income for derivative instruments, which are not designated as hedges for the periods indicated (dollars in millions):

	Three months ended				Nine months ended
	September 30,				September 30,
	2017		2016		2017		2016
Net investment income from policyholder and other special-purpose portfolios:
Fixed index call options	$	30.6	$	17.0	$	95.4	$	10.9
Net realized gains (losses):
Interest rate futures	—		—		—		(1.1		)
Embedded derivative related to modified coinsurance agreement	.3		.1		2.4		6.7
Total	.3		.1		2.4		5.6
Insurance policy benefits:
Embedded derivative related to fixed index annuities	—		18.3		—		(33.3		)
Total	$	30.9	$	35.4	$	97.8	$	(16.8	)

Derivative Counterparty Risk

If the counterparties to the call options fail to meet their obligations, we may recognize a loss.  We limit our exposure to such a loss by diversifying among several counterparties believed to be strong and creditworthy.  At September 30, 2017, all of our counterparties were rated "A-" or higher by S&P Global Ratings ("S&P").

We also enter into exchange-traded interest rate future contracts. The contracts are marked to market and margined on a daily basis. The Company has minimal exposure to credit-related losses in the event of nonperformance.

The Company and its subsidiaries are parties to master netting arrangements with its counterparties related to entering into various derivative contracts. Exchange-traded derivatives require margin accounts which we offset.

The following table summarizes information related to derivatives with master netting arrangements or collateral as of September 30, 2017 and December 31, 2016 (dollars in millions):

								Gross amounts not offset in the balance sheet
		Gross amounts recognized		Gross amounts offset in the balance sheet		Net amounts of assets presented in the balance sheet		Financial instruments		Cash collateral received		Net amount
September 30, 2017:
	Fixed index call options	$	142.2	$	—	$	142.2	$	—	$	—	$	142.2
December 31, 2016:
	Fixed index call options	111.9		—		111.9		—		—		111.9

22

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

REINSURANCE

The cost of reinsurance ceded totaled $27.1 million and $32.2 million in the third quarters of 2017 and 2016, respectively, and $79.9 million and $97.3 million in the first nine months of 2017 and 2016, respectively.  We deduct this cost from insurance policy income.  Reinsurance recoveries netted against insurance policy benefits totaled $22.6 million and $31.7 million in the third quarters of 2017 and 2016, respectively, and $69.1 million and $113.3 million in the first nine months of 2017 and 2016, respectively.

From time to time, we assume insurance from other companies.  Any costs associated with the assumption of insurance are amortized consistent with the method used to amortize deferred acquisition costs.  Reinsurance premiums assumed totaled $7.4 million and $8.3 million in the third quarters of 2017 and 2016, respectively, and $23.1 million and $25.8 million in the first nine months of 2017 and 2016, respectively.

INCOME TAXES

The Company's interim tax expense is based upon the estimated annual effective tax rate for the respective period. Under authoritative guidance, certain items are required to be excluded from the estimated annual effective tax rate calculation. Such items include changes in judgment about the realizability of deferred tax assets resulting from changes in projections of income expected to be available in future years, and items deemed to be unusual, infrequent, or that can not be reliably estimated. In these cases, the actual tax expense or benefit applicable to that item is treated discretely and is reported in the same period as the related item. The components of income tax expense are as follows (dollars in millions):

	Three months ended						Nine months ended
	September 30,						September 30,
	2017			2016			2017			2016
Current tax expense	$	25.9		$	46.8		$	68.5		$	51.6
Deferred tax expense (benefit)	18.2			(29.9		)	55.1			10.1
Valuation allowance applicable to current year income	(2.2		)	(10.5		)	(2.2		)	(10.5		)
Income tax expense calculated based on estimated annual effective tax rate	41.9			6.4			121.4			51.2
Income tax expense on discrete items:
Change in valuation allowance	(12.8		)	16.0			(12.8		)	(11.0		)
Other items	—			8.3			—			8.3
Total income tax expense	$	29.1		$	30.7		$	108.6		$	48.5

A reconciliation of the U.S. statutory corporate tax rate to the estimated annual effective rate, before discrete items, reflected in the consolidated statement of operations is as follows:

	Nine months ended
	September 30,
	2017		2016
U.S. statutory corporate rate	35.0	%	35.0	%
Valuation allowance	(.6	)	(6.1	)
Non-taxable income and nondeductible benefits, net	(1.5	)	(1.0	)
State taxes	1.3		1.8
Estimated annual effective tax rate	34.2	%	29.7	%

23

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

The effective tax rate for the nine months ended September 30, 2017 and 2016 included reductions in the deferred tax valuation allowance of $2.2 million and $10.5 million, respectively, reflecting higher current year expected taxable income than previously reflected in our deferred tax valuation allowance model in each year.

Our total tax expense for the nine months ended September 30, 2017, includes $12.8 million of reductions to the deferred tax valuation allowance primarily related to the recognition of capital gains. Our total tax expense for the nine months ended September 30, 2016, includes $11.0 million of reductions to the deferred tax valuation allowance related to adjustments to future expected taxable income reflected in our deferred tax valuation allowance model and $8.3 million of increased tax expense primarily related to IRS exam adjustments. The reduction to the deferred tax valuation allowance primarily relates to higher expected non-life income consistent with our current investment strategies, the impacts of the recapture of certain reinsurance agreements and IRS examination adjustments.

Effective January 1, 2017, the Company adopted new authoritative guidance related to several aspects of the accounting for share-based payment transactions, including the income tax consequences. Under the new guidance, any excess tax benefits are recognized as an income tax benefit in the income statement. The new guidance is applied on a modified retrospective basis through a cumulative-effect adjustment to retained earnings for all tax benefits that were not previously recognized because the related tax deduction had not reduced taxes payable. The Company had NOL carryforwards of $15.7 million related to deductions for stock options and restricted stock on the date of adoption. However, a corresponding valuation allowance of $15.7 million was recognized as a result of adopting this guidance. Therefore, there was no impact to our consolidated financial statements related to the initial adoption of this provision of the new guidance.

The components of the Company's income tax assets and liabilities are summarized below (dollars in millions):

	September 30, 2017			December 31, 2016
Deferred tax assets:
Net federal operating loss carryforwards	$	841.8		$	882.9
Net state operating loss carryforwards	12.2			12.3
Investments	13.7			17.8
Insurance liabilities	678.9			668.4
Other	60.1			66.3
Gross deferred tax assets	1,606.7			1,647.7
Deferred tax liabilities:
Present value of future profits and deferred acquisition costs	(275.0		)	(277.8		)
Accumulated other comprehensive income	(516.9		)	(344.1		)
Gross deferred tax liabilities	(791.9		)	(621.9		)
Net deferred tax assets before valuation allowance	814.8			1,025.8
Valuation allowance	(240.9		)	(240.2		)
Net deferred tax assets	573.9			785.6
Current income taxes prepaid (accrued)	(6.5		)	4.1
Income tax assets, net	$	567.4		$	789.7

Our income tax expense includes deferred income taxes arising from temporary differences between the financial reporting and tax bases of assets and liabilities and net operating loss carryforwards ("NOLs"). Deferred tax assets and liabilities are measured using enacted tax rates expected to apply in the years in which temporary differences are expected to be recovered or paid.  The effect of a change in tax rates on deferred tax assets and liabilities is recognized in earnings in the period when the changes are enacted.

A reduction of the net carrying amount of deferred tax assets by establishing a valuation allowance is required if, based on the available evidence, it is more likely than not that such assets will not be realized. In assessing the need for a valuation allowance, all available evidence, both positive and negative, shall be considered to determine whether, based on the weight of

24

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

that evidence, a valuation allowance for deferred tax assets is needed. This assessment requires significant judgment and considers, among other matters, the nature, frequency and severity of current and cumulative losses, forecasts of future profitability, the duration of carryforward periods, our experience with operating loss and tax credit carryforwards expiring unused, and tax planning strategies. We evaluate the need to establish a valuation allowance for our deferred income tax assets on an ongoing basis. The realization of our deferred tax assets depends upon generating sufficient future taxable income of the appropriate type during the periods in which our temporary differences become deductible and before our NOLs expire.

Based on our assessment, it appears more likely than not that $573.9 million of our net deferred tax assets of $814.8 million will be realized through future taxable earnings. Accordingly, we have established a deferred tax valuation allowance of $240.9 million at September 30, 2017 ($230.9 million of which relates to our net federal operating loss carryforwards and $10.0 million relates to state operating loss carryforwards). We will continue to assess the need for a valuation allowance in the future. If future results are less than projected, an increase to the valuation allowance may be required to reduce the deferred tax asset, which could have a material impact on our results of operations in the period in which it is recorded.

We use a deferred tax valuation model to assess the need for a valuation allowance. Our model is adjusted to reflect changes in our projections of future taxable income including changes resulting from investment strategies, the impact of the sale or reinsurance of business and the recapture of business previously ceded. Our estimates of future taxable income are based on evidence we consider to be objective and verifiable.

Our projection of future taxable income for purposes of determining the valuation allowance is based on our adjusted average annual taxable income which is assumed to increase by 3 percent for the next five years, and level taxable income is assumed thereafter. In the projections used for our analysis, our adjusted average taxable income of approximately $335 million consisted of $85 million of non-life taxable income and $250 million of life taxable income.

Recovery of our deferred tax asset is dependent on achieving the level of future taxable income projected in our deferred tax valuation model and failure to do so could result in an increase in the valuation allowance in a future period.  Any future increase in the valuation allowance may result in additional income tax expense and reduce shareholders' equity, and such an increase could have a significant impact upon our earnings in the future.

The Internal Revenue Code (the "Code") limits the extent to which losses realized by a non-life entity (or entities) may offset income from a life insurance company (or companies) to the lesser of:  (i) 35 percent of the income of the life insurance company; or (ii) 35 percent of the total loss of the non-life entities (including NOLs of the non-life entities).  There is no similar limitation on the extent to which losses realized by a life insurance entity (or entities) may offset income from a non-life entity (or entities). This limitation is the primary reason a valuation allowance for NOLs is required.

Section 382 of the Code imposes limitations on a corporation's ability to use its NOLs when the company undergoes an ownership change.  Future transactions and the timing of such transactions could cause an ownership change for Section 382 income tax purposes.  Such transactions may include, but are not limited to, additional repurchases under our securities repurchase program, issuances of common stock and acquisitions or sales of shares of CNO stock by certain holders of our shares, including persons who have held, currently hold or may accumulate in the future five percent or more of our outstanding common stock for their own account.  Many of these transactions are beyond our control.  If an additional ownership change were to occur for purposes of Section 382, we would be required to calculate an annual restriction on the use of our NOLs to offset future taxable income.  The annual restriction would be calculated based upon the value of CNO's equity at the time of such ownership change, multiplied by a federal long-term tax exempt rate (1.93 percent at September 30, 2017), and the annual restriction could limit our ability to use a substantial portion of our NOLs to offset future taxable income.  We regularly monitor ownership change (as calculated for purposes of Section 382) and, as of September 30, 2017, we were below the 50 percent ownership change level that would trigger further impairment of our ability to utilize our NOLs.

25

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

As of September 30, 2017, we had $2.4 billion of federal NOLs (all of which were non-life NOLs). The following table summarizes the expiration dates of our loss carryforwards (dollars in millions):

	Net operating loss
Year of expiration	carryforwards
2023	$	1,818.5
2025	85.2
2026	149.9
2027	10.8
2028	80.3
2029	213.2
2030	.3
2031	.2
2032	44.4
2033	.6
2034	.9
2035	.8
Total federal NOLs	$	2,405.1

We also had deferred tax assets related to NOLs for state income taxes of $12.2 million and $12.3 million at September 30, 2017 and December 31, 2016, respectively.  The related state NOLs are available to offset future state taxable income in certain states through 2025.

All of the life NOLs were utilized by December 31, 2016. Accordingly, we began making estimated federal tax payments equal to the prescribed federal tax rate applied to 65 percent of our life insurance company taxable income due to the limitations on the extent to which we can use non-life NOLs to offset life insurance company taxable income. Under current law, we will continue to pay tax on 65 percent of our life insurance company taxable income until all non-life NOLs are utilized or expire.

The Internal Revenue Service ("IRS") is conducting an examination of 2013 through 2014. In connection with this exam, we have agreed to extend the statute of limitation for 2013 through September 30, 2018. The Company’s various state income tax returns are generally open for tax years beginning in 2014, based on individual state statutes of limitation. Generally, for tax years which generate NOLs, capital losses or tax credit carryforwards, the statute remains open until the expiration of the statute of limitations for the tax year in which such carryforwards are utilized. The outcome of the tax audit cannot be predicted with certainty. If the Company’s tax audit is not resolved in a manner consistent with management’s expectations, the Company may be required to adjust its provision for income taxes.

26

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

NOTES PAYABLE - DIRECT CORPORATE OBLIGATIONS

The following notes payable were direct corporate obligations of the Company as of September 30, 2017 and December 31, 2016 (dollars in millions):

	September 30, 2017			December 31, 2016
4.500% Senior Notes due May 2020	$	325.0		$	325.0
5.250% Senior Notes due May 2025	500.0			500.0
Revolving Credit Agreement (as defined below)	100.0			100.0
Unamortized debt issue costs	(10.6		)	(12.1		)
Direct corporate obligations	$	914.4		$	912.9

Revolving Credit Agreement

On May 19, 2015, the Company entered into a revolving credit agreement with KeyBank National Association, as administrative agent (the "Agent"), and the lenders from time to time party thereto (the "Revolving Credit Agreement"). On May 19, 2015, the Company made an initial drawing of $100.0 million under the Revolving Credit Agreement, resulting in $50.0 million available for additional borrowings.

The interest rates with respect to loans under the Revolving Credit Agreement are based on, at the Company's option, a floating base rate (defined as a per annum rate equal to the highest of: (i) the federal funds rate plus 0.50%; (ii) the "prime rate" of the Agent; and (iii) the eurodollar rate for a one-month interest period plus an applicable margin of initially 1.00% per annum), or a eurodollar rate plus an applicable margin of initially 2.00% per annum. At September 30, 2017, the interest rate on the amounts outstanding under the Revolving Credit Agreement was 3.24 percent. In addition, the daily average undrawn portion of the Revolving Credit Agreement accrues a commitment fee payable quarterly in arrears. The applicable margin for, and the commitment fee applicable to, the Revolving Credit Agreement, will be adjusted from time to time pursuant to a ratings based pricing grid.

The Revolving Credit Agreement requires the Company to maintain (each as calculated in accordance with the Revolving Credit Agreement): (i) a debt to total capitalization ratio of not more than 30.0 percent (such ratio was 19.2 percent at September 30, 2017); (ii) an aggregate ratio of total adjusted capital to company action level risk-based capital for the Company's insurance subsidiaries of not less than 250 percent (such ratio was estimated to be 450 percent at September 30, 2017); and (iii) a minimum consolidated net worth of not less than the sum of (x) $2,674 million plus (y) 50.0% of the net equity proceeds received by the Company from the issuance and sale of equity interests in the Company (the Company's consolidated net worth was $3,948.1 million at September 30, 2017 compared to the minimum requirement of $2,683.8 million).

As further described in the note to the consolidated financial statements entitled "Subsequent Event", the Revolving Credit Agreement was amended and restated in October 2017.

27

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

Scheduled Repayment of our Direct Corporate Obligations

The scheduled repayment of our direct corporate obligations was as follows at September 30, 2017 (dollars in millions):

Year ending September 30,
2018	$	—
2019	100.0
2020	325.0
2021	—
2022	—
Thereafter	500.0
	$	925.0

INVESTMENT BORROWINGS

Three of the Company's insurance subsidiaries (Washington National Insurance Company ("Washington National"), Bankers Life and Casualty Company ("Bankers Life") and Colonial Penn Life Insurance Company ("Colonial Penn")) are members of the Federal Home Loan Bank ("FHLB").  As members of the FHLB, our insurance subsidiaries have the ability to borrow on a collateralized basis from the FHLB. We are required to hold certain minimum amounts of FHLB common stock as a condition of membership in the FHLB, and additional amounts based on the amount of the borrowings.  At September 30, 2017, the carrying value of the FHLB common stock was $71.2 million.  As of September 30, 2017, collateralized borrowings from the FHLB totaled $1.6 billion and the proceeds were used to purchase fixed maturity securities.  The borrowings are classified as investment borrowings in the accompanying consolidated balance sheet.  The borrowings are collateralized by investments with an estimated fair value of $2.0 billion at September 30, 2017, which are maintained in a custodial account for the benefit of the FHLB.  Substantially all of such investments are classified as fixed maturities, available for sale, in our consolidated balance sheet.  

28

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

The following summarizes the terms of the borrowings from the FHLB by our insurance subsidiaries (dollars in millions):

Amount		Maturity	Interest rate at
borrowed		date	September 30, 2017
$	50.0	February 2018	Variable rate – 1.404%
50.0		August 2018	Variable rate – 1.435%
50.0		January 2019	Variable rate – 1.724%
50.0		February 2019	Variable rate – 1.404%
100.0		March 2019	Variable rate – 1.714%
21.8		July 2019	Variable rate – 1.727%
15.0		October 2019	Variable rate – 1.830%
50.0		May 2020	Variable rate – 1.754%
21.8		June 2020	Fixed rate – 1.960%
25.0		September 2020	Variable rate – 1.953%
100.0		September 2020	Variable rate – 1.897%
50.0		September 2020	Variable rate – 1.894%
75.0		September 2020	Variable rate – 1.453%
100.0		October 2020	Variable rate – 1.409%
50.0		December 2020	Variable rate – 1.932%
100.0		July 2021	Variable rate – 1.854%
100.0		July 2021	Variable rate – 1.824%
28.2		August 2021	Fixed rate – 2.550%
57.7		August 2021	Variable rate - 1.842%
125.0		August 2021	Variable rate – 1.717%
50.0		September 2021	Variable rate – 1.857%
22.0		May 2022	Variable rate – 1.668%
100.0		May 2022	Variable rate – 1.666%
10.0		June 2022	Variable rate – 1.931%
50.0		July 2022	Variable rate – 1.675%
50.0		July 2022	Variable rate – 1.693%
50.0		July 2022	Variable rate – 1.694%
50.0		August 2022	Variable rate – 1.702%
24.9		March 2023	Fixed rate – 2.160%
20.5		June 2025	Fixed rate – 2.940%
$	1,646.9

The variable rate borrowings are pre-payable on each interest reset date without penalty.  The fixed rate borrowings are pre-payable subject to payment of a yield maintenance fee based on prevailing market interest rates.  At September 30, 2017, the aggregate yield maintenance fee to prepay all fixed rate borrowings was $3.2 million.

Interest expense of $19.5 million and $12.3 million in the first nine months of 2017 and 2016, respectively, was recognized related to total borrowings from the FHLB.

29

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

CHANGES IN COMMON STOCK

Changes in the number of shares of common stock outstanding were as follows (shares in thousands):

Balance, December 31, 2016	173,754
Treasury stock purchased and retired	(6,701	)
Stock options exercised	524
Restricted and performance stock vested	185		(a)
Balance, September 30, 2017	167,762

____________________

(a) Such amount was reduced by 103 thousand shares which were tendered to the Company for the payment of required federal and state tax withholdings owed on the vesting of restricted and performance stock.

In the first nine months of 2017, we repurchased 6.7 million shares of common stock for $140.1 million under our securities repurchase program. In May 2017, the Company announced that its Board of Directors approved an additional $300.0 million to repurchase the Company's outstanding common stock. The Company had remaining repurchase authority of $412.6 million as of September 30, 2017.

In the first nine months of 2017, dividends declared on common stock totaled $44.7 million ($0.26 per common share). In May 2017, the Company increased its quarterly common stock dividend to $0.09 per share from $0.08 per share.

SALES INDUCEMENTS

Certain of our annuity products offer sales inducements to contract holders in the form of enhanced crediting rates or bonus payments in the initial period of the contract.  Certain of our life insurance products offer persistency bonuses credited to the contract holder's balance after the policy has been outstanding for a specified period of time.  These enhanced rates and persistency bonuses are considered sales inducements in accordance with GAAP.  Such amounts are deferred and amortized in the same manner as deferred acquisition costs.  Sales inducements deferred totaled $1.5 million and $2.8 million during the nine months ended September 30, 2017 and 2016, respectively.  Amounts amortized totaled $6.6 million and $7.1 million during the nine months ended September 30, 2017 and 2016, respectively.  The unamortized balance of deferred sales inducements was $44.3 million and $49.4 million at September 30, 2017 and December 31, 2016, respectively.  The balance of insurance liabilities for persistency bonus benefits was $.4 million and $.5 million at September 30, 2017 and December 31, 2016, respectively.

OUT-OF-PERIOD ADJUSTMENTS

In the third quarter of 2017, we recorded the net effect of an out-of-period adjustment related to the calculation of certain life insurance liabilities in our Colonial Penn segment which decreased insurance policy benefits by $2.5 million, increased tax expense by $.9 million and increased our net income by $1.6 million (or 1 cent per diluted share). In the second quarter of 2017, we recorded the net effect of an out-of-period adjustment related to the calculation of certain long-term care insurance liabilities in our Bankers Life segment which decreased insurance policy benefits by $1.7 million, increased tax expense by $.6 million and increased our net income by $1.1 million (or 1 cent per diluted share). We evaluated these adjustments taking into account both qualitative and quantitative factors and considered the impact of these adjustments in relation to each period, as well as the periods in which they originated. The impact of recognizing these adjustments in prior years was not significant to any individual period. Management believes these adjustments are immaterial to the consolidated financial statements and all previously issued financial statements.

RECENTLY ISSUED ACCOUNTING STANDARDS

Pending Accounting Standards

In May 2014, the Financial Accounting Standards Board (the "FASB") issued authoritative guidance for recognizing revenue from contracts with customers. Certain contracts with customers are specifically excluded from this guidance,

30

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

including insurance contracts. The core principle of the new guidance is that an entity should recognize revenue when it transfers promised goods or services in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The guidance also requires additional disclosures about the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. The guidance will be effective for the Company on January 1, 2018 and permits two methods of transition upon adoption; full retrospective and modified retrospective. Under the full retrospective method, prior periods would be restated under the new revenue standard, providing for comparability in all periods presented. Under the modified retrospective method, prior periods would not be restated. Instead, revenues and other disclosures for pre-2018 periods would be provided in the notes to the financial statements as previously reported under the current revenue standard. The new guidance will impact our accounting for various distribution and marketing agreements with other insurance companies pursuant to which Bankers Life's career agents distribute third party products including prescription drug and Medicare Advantage plans. The revenue associated with these distribution agreements has been less than 1 percent of our total revenue. Our annual fee income earned during a calendar year will not change, but the amount recognized during each quarterly period will vary based on the sales of such products in each period. Accordingly, the adoption of this guidance is not expected to have a material impact on our consolidated financial statements. The Company expects to adopt the new guidance using the modified retrospective method.

In January 2016, the FASB issued authoritative guidance related to the recognition and measurement of financial assets and financial liabilities which made targeted improvements to GAAP as follows:

(i) Require equity investments (except those accounted for under the equity method of accounting or those that result in consolidation of the investee) to be measured at fair value with changes in fair value recognized in net income. However, an entity may choose to measure equity investments that do not have readily determinable fair values at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer.

(ii) Simplify the impairment assessment of equity investments without readily determinable fair values by requiring a qualitative assessment to identify impairment. When a qualitative assessment indicates that impairment exists, an entity is required to measure the investment at fair value.

(iii) Eliminate the requirement for public business entities to disclose the method(s) and significant assumptions used to estimate the fair value that is required to be disclosed for financial instruments measured at amortized cost on the balance sheet.

(iv) Require public business entities to use the exit price notion when measuring the fair value of financial instruments for disclosure purposes.

(v) Require an entity to present separately in other comprehensive income the portion of the total change in the fair value of a liability resulting from a change in the instrument-specific credit risk when the entity has elected to measure the liability at fair value in accordance with the fair value option for financial instruments.

(vi) Require separate presentation of financial assets and financial liabilities by measurement category and form of financial asset (that is, securities or loans and receivables) on the balance sheet or the accompanying notes to the financial statements.

(vii) Clarify that an entity should evaluate the need for a valuation allowance on a deferred tax asset related to available-for-sale securities in combination with the entity's other deferred tax assets.

An entity should apply this guidance by means of a cumulative-effect adjustment to the balance sheet as of the beginning of the fiscal year of adoption. The amendments related to equity securities without readily determinable fair values (including disclosure requirements) should be applied prospectively to equity investments that exist as of the date of adoption of the guidance. The guidance will be effective for the Company for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. Early adoption of the guidance is not permitted; except that item (v) above is permitted to be adopted early as of the beginning of the fiscal year of adoption. The Company currently holds equity securities classified as available for sale securities that are measured at fair value with changes in fair value recognized through accumulated other comprehensive income. Upon adoption of this guidance, changes in fair value of such equity securities will be recognized through net income. Based upon the equity securities held at September 30, 2017, the estimated impact of the new guidance, assuming it was adopted on October 1, 2017, would be a cumulative effect adjustment that would increase retained earnings by approximately $15 million with a corresponding decrease to accumulated other comprehensive income of approximately $15 million. The Company may experience an increase in volatility in the income statement due to the requirement to measure equity investments at fair value with changes in fair value recognized in income. In addition, the Company will be required to modify certain disclosures upon adoption.

31

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

In February 2016, the FASB issued authoritative guidance related to accounting for leases, requiring lessees to report most leases on their balance sheets, regardless of whether the lease is classified as a finance lease or an operating lease. For lessees, the initial lease liability is equal to the present value of future lease payments, and a corresponding asset, adjusted for certain items, is also recorded. Expense recognition for lessees will remain similar to current accounting requirements for capital and operating leases. The accounting applied by a lessor is largely unchanged from that applied under previous GAAP. In transition, lessees and lessors are required to recognize and measure leases at the beginning of the earliest period presented using a modified retrospective approach. The guidance will be effective for the Company for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Early adoption is permitted. The Company has not yet determined the expected impact of adoption of this guidance on its consolidated financial position, results of operations or cash flows.

In June 2016, the FASB issued authoritative guidance related to the measurement of credit losses on financial instruments. The new guidance replaces the incurred loss impairment methodology with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to form credit loss estimates. The guidance will be effective for the Company for fiscal years beginning in 2020, including interim periods within the fiscal year. Early adoption is permitted as of the fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. The Company has not yet determined the expected impact of adoption of this guidance on its consolidated financial position, results of operations or cash flows.

In August 2016, the FASB issued authoritative guidance related to how certain cash receipts and cash payments are presented and classified in the statement of cash flows. The guidance addresses eight specific cash flow issues including debt prepayment or debt extinguishment costs, proceeds from the settlement of corporate-owned life insurance policies, distributions received from equity method investees, and others. The guidance will be effective for the Company for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years. Early adoption is permitted. The adoption of this guidance will result in reclassifications to certain cash receipts and payments within our consolidated statement of cash flows, but will have no impact on our consolidated financial position, results of operations or cash flows.

In November 2016, the FASB issued authoritative guidance to address the diversity in practice that currently exists regarding the classification and presentation of changes in restricted cash on the statement of cash flows. The new guidance requires that a statement of cash flows explain the change during the period in the total of cash, cash equivalents and amounts generally described as restricted cash or restricted cash equivalents. Therefore, amounts generally described as restricted cash and restricted cash equivalents should be included with cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown on the statement of cash flows. Entities will also be required to disclose information about the nature of their restricted cash and restricted cash equivalents. Additionally, if cash, cash equivalents, restricted cash and restricted cash equivalents are presented in more than one line item in the statement of financial position, entities will be required to present a reconciliation, either on the face of the statement of cash flows or disclosed in the notes, of the totals in the statement of cash flows to the related line item captions in the statement of financial position. The guidance will be effective for the Company for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years. Early adoption is permitted, including adoption in an interim period. The adoption of this guidance will impact the presentation of our consolidated statement of cash flows and related cash flow disclosures, but will have no impact on our consolidated financial position, results of operations or cash flows.

In January 2017, the FASB issued authoritative guidance that removes Step 2 of the goodwill impairment test under current guidance, which requires a hypothetical purchase price allocation. The new guidance requires an impairment charge to be recognized for the amount by which the carrying amount exceeds the reported unit's fair value. Upon adoption, the guidance is to be applied prospectively. The guidance will be effective for the Company on January 1, 2020, with early adoption permitted. The adoption of this guidance is not expected to have a material impact on the Company's consolidated financial position, results of operations or cash flows.

In March 2017, the FASB issued authoritative guidance related to the premium amortization on purchased callable debt securities. The guidance shortens the amortization period for certain callable debt securities held at a premium. Specifically, the new guidance requires the premium to be amortized to the earliest call date. The guidance does not require an accounting change for securities held at a discount; the discount continues to be amortized to maturity. The guidance will be effective for the Company for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. Early adoption

32

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

is permitted, including adoption in an interim period. If an entity early adopts the guidance in an interim period, any adjustments should be reflected as of the beginning of the fiscal year that includes that interim period. The guidance should be applied on a modified retrospective basis through a cumulative-effect adjustment directly to retained earnings as of the beginning of the period of adoption. The Company has not yet determined the expected impact of adoption of this guidance on our consolidated financial position, results of operations or cash flows.

In May 2017, the FASB issued authoritative guidance related to which changes to the terms or conditions of a share-based award require an entity to apply modification accounting. The guidance will be effective for the Company in 2018. The guidance is to be applied prospectively to an award modified on or after the adoption date. The adoption of this guidance is not expected to have a material impact to the Company's consolidated financial position, results of operations or cash flows.

In August 2017, the FASB issued authoritative guidance related to derivatives and hedging. The new guidance expands and refines hedge accounting for both nonfinancial and financial risk components and aligns the recognition and presentation of the effects of the hedging instruments and the hedged item in the financial statements. The new guidance also includes certain targeted improvements to ease the application of current guidance related to the assessment of hedge effectiveness. The guidance will be effective for the Company for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. Early adoption is permitted, including adoption in an interim period. The Company has not yet determined the expected impact of adoption of this guidance on its consolidated financial position, results of operations or cash flows.

Adopted Accounting Standards

In March 2016, the FASB issued authoritative guidance that clarifies the requirements for assessing whether contingent call (put) options that can accelerate the payment of principal on debt instruments are clearly and closely related to their debt hosts. An entity performing the assessment under this guidance is required to assess the embedded call (put) options solely in accordance with a four-step decision sequence. The guidance is effective for the Company on January 1, 2017. The adoption of this guidance had no effect on our consolidated financial statements.

33

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

In March 2016, the FASB issued authoritative guidance related to several aspects of the accounting for share-based payment transactions, including the income tax consequences, accounting policy for forfeiture rate assumptions, classification of awards as either equity or liabilities and classification on the statement of cash flows. The new guidance requires all income tax effects of stock-based compensation awards to be recognized in the income statement when the awards vest or are settled. The new guidance also allows an employer to withhold shares upon settlement of an award to satisfy the employer's tax withholding requirements up to the highest marginal tax rate applicable to employees, without resulting in liability classification of the award. Current guidance strictly limits the withholding to the employer's minimum statutory tax withholding requirement. The guidance was effective for the Company on January 1, 2017. The impact of adoption was as follows (dollars in millions):

	January 1, 2017
				Effect of Adoption of Authoritative Guidance
	Amounts prior to effect of adoption of authoritative guidance			Election to account for forfeitures as they occur			Recognition of excess tax benefits			As adjusted
Income tax assets	$	1,029.9		$	.3		$	15.7		$	1,045.9
Valuation allowance for deferred income tax assets	(240.2		)	—			(15.7		)	(255.9		)
Income tax assets, net	789.7			.3			—			790.0
Total assets	31,975.2			.3			—			31,975.5
Additional paid-in capital	3,212.1			.9			—			3,213.0
Retained earnings	650.7			(.6		)	—			650.1
Total shareholders' equity	4,486.9			.3			—			4,487.2
Total liabilities and shareholders' equity	31,975.2			.3			—			31,975.5

	Nine months ended
	September 30, 2016
	Amounts prior to effect of adoption of authoritative guidance			Effect of adoption of authoritative guidance			As adjusted
Cash flows from operating activities:
Other operating costs	$	(555.4	)	$	3.3		$	(552.1	)
Net cash flow from operating activities	581.5			3.3			584.8
Cash flows from financing activities:
Payments to repurchase common stock	(206.7		)	(3.3		)	(210.0		)
Net cash used by financing activities	(34.2		)	(3.3		)	(37.5		)
Net increase in cash and cash equivalents	273.7			—			273.7

34

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

In October 2016, the FASB issued authoritative guidance to amend the consolidation guidance on how a reporting entity that is the single decision maker of a VIE should treat indirect interests in the entity held through related parties that are under common control with the reporting entity when determining whether it is the primary beneficiary of that VIE. The guidance is effective for the Company on January 1, 2017. The adoption of this guidance had no impact on our consolidated financial statements.

LITIGATION AND OTHER LEGAL PROCEEDINGS

Legal Proceedings

The Company and its subsidiaries are involved in various legal actions in the normal course of business, in which claims for compensatory and punitive damages are asserted, some for substantial amounts.  We recognize an estimated loss from these loss contingencies when we believe it is probable that a loss has been incurred and the amount of the loss can be reasonably estimated. Some of the pending matters have been filed as purported class actions and some actions have been filed in certain jurisdictions that permit punitive damage awards that are disproportionate to the actual damages incurred.  The amounts sought in certain of these actions are often large or indeterminate and the ultimate outcome of certain actions is difficult to predict.  In the event of an adverse outcome in one or more of these matters, there is a possibility that the ultimate liability may be in excess of the liabilities we have established and could have a material adverse effect on our business, financial condition, results of operations and cash flows.  In addition, the resolution of pending or future litigation may involve modifications to the terms of outstanding insurance policies or could impact the timing and amount of rate increases, which could adversely affect the future profitability of the related insurance policies.  Based upon information presently available, and in light of legal, factual and other defenses available to the Company and its subsidiaries, the Company does not believe that it is probable that the ultimate liability from either pending or threatened legal actions, after consideration of existing loss provisions, will have a material adverse effect on the Company's consolidated financial condition, operating results or cash flows. However, given the inherent difficulty in predicting the outcome of legal proceedings, there exists the possibility that such legal actions could have a material adverse effect on the Company's consolidated financial condition, operating results or cash flows.

In addition to the inherent difficulty of predicting litigation outcomes, particularly those that will be decided by a jury, some matters purport to seek substantial or an unspecified amount of damages for unsubstantiated conduct spanning several years based on complex legal theories and damages models. The alleged damages typically are indeterminate or not factually supported in the complaint, and, in any event, the Company's experience indicates that monetary demands for damages often bear little relation to the ultimate loss. In some cases, plaintiffs are seeking to certify classes in the litigation and class certification either has been denied or is pending and we have filed oppositions to class certification or sought to decertify a prior class certification. In addition, for many of these cases: (i) there is uncertainty as to the outcome of pending appeals or motions; (ii) there are significant factual issues to be resolved; and/or (iii) there are novel legal issues presented. Accordingly, the Company cannot reasonably estimate the possible loss or range of loss in excess of amounts accrued, if any, or predict the timing of the eventual resolution of these matters.  The Company reviews these matters on an ongoing basis.  When assessing reasonably possible and probable outcomes, the Company bases its assessment on the expected ultimate outcome following all appeals.

On September 29, 2016, Washington National and Bankers Conseco Life Insurance Company ("BCLIC") commenced an arbitration proceeding seeking compensatory, consequential and punitive damages against BRe based upon BRe’s incurable material breaches of the long-term care reinsurance agreements, conversion, fraud, and breaches of fiduciary duties and the obligation to deal honestly and in good faith. BRe filed a counterclaim against Washington National and BCLIC in the arbitration alleging damages relating to the reinsurance agreements and their termination. In addition, on September 29, 2016, a complaint was filed by BCLIC and Washington National in the United States District Court for the Southern District of New York, Bankers Conseco Life Insurance Company and Washington National Insurance Company v. Moshe M. Feuer, Scott Taylor and David Levy, Case No. 16-cv-7646, alleging, among other claims, fraud/fraudulent concealment, and violation of the Racketeer Influenced and Corrupt Organizations Act. These allegations relate to the long-term care reinsurance agreements between BRe and Washington National and BCLIC, respectively, and emanate from the undisclosed relationships between and among the defendants (who were the principal owners and officers of BRe) and Platinum Partners, LP ("Platinum") and its affiliates. On April 27, 2017, an amended complaint was filed adding Beechwood Capital Group, LLC as a defendant. Feuer, Taylor and Levy have moved to compel arbitration of Washington National's and BCLIC's claims. Washington National and BCLIC intend to vigorously pursue their claims for damages and other remedies in the arbitration and the litigation described above.

35

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

By public notice dated July 26, 2017, the Cayman Islands Monetary Authority advised that, effective July 25, 2017, two individuals (the "Controllers") had been appointed pursuant to Section 24(2)(h) of the Cayman Islands Insurance Law to assume control of the affairs of BRe.  According to the public notice, effective with their appointment, the Controllers assumed immediate control of the affairs of BRe and have all the powers necessary to administer the affairs of BRe including power to terminate its insurance business.  The Controllers are responsible for assessing the financial position of BRe and submitting a report to the Cayman Islands Monetary Authority by a date to be specified.  We are in the process of assessing the potential impact of this action on the proceedings described in the foregoing paragraph.

On July 20, 2007, a complaint was filed in the Hamilton County, Indiana Circuit Court, Signature Estates of Indiana, Inc. d/b/a Gordon Marketing, Stephens-Matthews Marketing, Inc., Shields Brokerage, Inc. and Edwin A. Hildebrand d/b/a Hildebrand Insurance Services v. Conseco Medical Insurance Company, Conseco Medical Insurance Company a/k/a Washington National Insurance Company and Washington National Insurance Company, Cause No. 29D02- 0707-PL-790.  The Plaintiffs are independent insurance marketing organizations which previously marketed Conseco Medical Insurance Company ("CMIC") individual major medical products and which are claiming damages for allegedly fraudulent conduct by CMIC in withdrawing from this business in 2002.  The Plaintiffs contend that they relied on CMIC’s alleged representations that its major medical business was profitable and that CMIC was committed to it.  The Plaintiffs further allege that when CMIC exited the market, it caused agents that were previously writing business through their organizations to cease doing business with them, thereby causing irreparable damage.  CMIC merged into Washington National, effective July 1, 2003.  On December 16, 2016, following a jury trial, verdicts were entered in favor of the plaintiffs, and compensatory damages aggregating $4.7 million and punitive damages aggregating $6.0 million were awarded to the plaintiffs.  Washington National filed post-trial motions requesting the court correct errors, grant a new trial, find that punitive damages were improper, and reduce both compensatory and punitive damages.  Plaintiffs filed motions requesting pre-judgment interest and attorney fees.  On June 19, 2017, the court reduced punitive damages by $1.5 million and denied plaintiffs' motions for pre-judgment interest and attorney fees. Both sides have filed a Notice of Appeal. We believe the case is without merit and intend to defend it vigorously.

Regulatory Examinations and Fines

Insurance companies face significant risks related to regulatory investigations and actions.  Regulatory investigations generally result from matters related to sales or underwriting practices, payment of contingent or other sales commissions, claim payments and procedures, product design, product disclosure, additional premium charges for premiums paid on a periodic basis, denial or delay of benefits, charging excessive or impermissible fees on products, procedures related to canceling policies, changing the way cost of insurance charges are calculated for certain life insurance products or recommending unsuitable products to customers.  We are, in the ordinary course of our business, subject to various examinations, inquiries and information requests from state, federal and other authorities.  The ultimate outcome of these regulatory actions (including the costs of complying with information requests and policy reviews) cannot be predicted with certainty.  In the event of an unfavorable outcome in one or more of these matters, the ultimate liability may be in excess of liabilities we have established and we could suffer significant reputational harm as a result of these matters, which could also have a material adverse effect on our business, financial condition, results of operations or cash flows.

In August 2011, we were notified of an examination to be done on behalf of a number of states for the purpose of determining compliance with unclaimed property laws by the Company and its subsidiaries.  Such examination has included inquiries related to the use of data available on the U.S. Social Security Administration's Death Master File to identify instances where benefits under life insurance policies, annuities and retained asset accounts are payable. We are continuing to provide information to the examiners in response to their requests. A total of 38 states and the District of Columbia are currently participating in this examination.

36

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

CONSOLIDATED STATEMENT OF CASH FLOWS

The following disclosures supplement our consolidated statement of cash flows.

The following reconciles net income to net cash from operating activities (dollars in millions):

	Nine months ended
	September 30,
	2017			2016
Cash flows from operating activities:
Net income	$	246.5		$	124.0
Adjustments to reconcile net income to net cash from operating activities:
Amortization and depreciation	200.8			199.1
Income taxes	50.6			43.0
Insurance liabilities	321.5			310.2
Accrual and amortization of investment income	(233.2		)	(93.4		)
Deferral of policy acquisition costs	(183.4		)	(179.4		)
Net realized investment gains	(52.3		)	(23.3		)
Loss on reinsurance transaction	—			75.4
Cash and cash equivalents received upon recapture of reinsurance	—			73.6
Loss on extinguishment of borrowings related to a variable interest entity	5.5			—
Other	77.7			55.6
Net cash from operating activities	$	433.7		$	584.8

Other non-cash items not reflected in the investing and financing activities sections of the consolidated statement of cash flows (dollars in millions):

	Nine months ended
	September 30,
	2017		2016
Stock options, restricted stock and performance units	$	17.8	$	18.9
Market value of investments recaptured in connection with the termination of reinsurance agreements with BRe	—		431.1

37

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

INVESTMENTS IN VARIABLE INTEREST ENTITIES

We have concluded that we are the primary beneficiary with respect to certain VIEs, which are consolidated in our financial statements.  In consolidating the VIEs, we consistently use the financial information most recently distributed to investors in the VIE.

All of the VIEs are collateralized loan trusts that were established to issue securities to finance the purchase of corporate loans and other permitted investments.  The assets held by the trusts are legally isolated and not available to the Company.  The liabilities of the VIEs are expected to be satisfied from the cash flows generated by the underlying loans held by the trusts, not from the assets of the Company.  The Company has no financial obligation to the VIEs beyond its investment in each VIE.

Certain of our insurance subsidiaries are noteholders of the VIEs.  Another subsidiary of the Company is the investment manager for the VIEs.  As such, it has the power to direct the most significant activities of the VIEs which materially impacts the economic performance of the VIEs.

The following tables provide supplemental information about the assets and liabilities of the VIEs which have been consolidated in accordance with authoritative guidance (dollars in millions):

	September 30, 2017
	VIEs			Eliminations			Net effect on consolidated balance sheet
Assets:
Investments held by variable interest entities	$	1,382.5		$	—		$	1,382.5
Notes receivable of VIEs held by insurance subsidiaries	—			(159.9		)	(159.9		)
Cash and cash equivalents held by variable interest entities	105.9			—			105.9
Accrued investment income	2.0			(.1		)	1.9
Income tax assets, net	(.6		)	—			(.6		)
Other assets	13.3			(1.4		)	11.9
Total assets	$	1,503.1		$	(161.4	)	$	1,341.7
Liabilities:
Other liabilities	$	145.9		$	(3.5	)	$	142.4
Borrowings related to variable interest entities	1,198.2			—			1,198.2
Notes payable of VIEs held by insurance subsidiaries	172.9			(172.9		)	—
Total liabilities	$	1,517.0		$	(176.4	)	$	1,340.6

38

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

	December 31, 2016
	VIEs		Eliminations			Net effect on consolidated balance sheet
Assets:
Investments held by variable interest entities	$	1,724.3	$	—		$	1,724.3
Notes receivable of VIEs held by insurance subsidiaries	—		(204.2		)	(204.2		)
Cash and cash equivalents held by variable interest entities	189.3		—			189.3
Accrued investment income	3.0		(.1		)	2.9
Income tax assets, net	6.4		(1.3		)	5.1
Other assets	13.1		(1.8		)	11.3
Total assets	$	1,936.1	$	(207.4	)	$	1,728.7
Liabilities:
Other liabilities	$	81.8	$	(6.4	)	$	75.4
Borrowings related to variable interest entities	1,662.8		—			1,662.8
Notes payable of VIEs held by insurance subsidiaries	203.3		(203.3		)	—
Total liabilities	$	1,947.9	$	(209.7	)	$	1,738.2

The investment portfolios held by the VIEs are primarily comprised of commercial bank loans to corporate obligors which are almost entirely rated below-investment grade.  At September 30, 2017, such loans had an amortized cost of $1,381.7 million; gross unrealized gains of $8.4 million; gross unrealized losses of $7.6 million; and an estimated fair value of $1,382.5 million.

The following table sets forth the amortized cost and estimated fair value of the investments held by the VIEs at September 30, 2017, by contractual maturity.  Actual maturities will differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without penalties.

	Amortized cost		Estimated fair value
	(Dollars in millions)
Due in one year or less	$	5.9	$	5.9
Due after one year through five years	499.4		500.1
Due after five years through ten years	876.4		876.5
Total	$	1,381.7	$	1,382.5

During the first nine months of 2017, the VIEs recognized net realized investment losses of $2.5 million, which were comprised of: (i) $2.2 million of net gains from the sales of investments; (ii) $4.3 million of losses on the dissolution of VIEs; and (iii) $.4 million of writedowns of investments for other than temporary declines in fair value recognized through net income. During the first nine months of 2016, the VIEs recognized net realized investment losses of $20.6 million, which were comprised of: (i) $12.1 million of net losses from the sales of fixed maturities; (ii) a $7.3 million loss on the dissolution of a VIE; and (iii) $1.2 million of writedowns of investments for other than temporary declines in fair value recognized through net income.

At September 30, 2017, there were no investments held by the VIEs that were in default or considered nonperforming.

During the first nine months of 2017, $2.2 million of net gains from the sale of investments included sales of $86.0 million which resulted in gross investment losses (before income taxes) of $2.0 million. During the first nine months of 2016, $186.6 million of investments held by the VIEs were sold which resulted in gross investment losses (before income taxes) of $20.3 million.

39

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

At September 30, 2017, the VIEs held:  (i) investments with a fair value of $382.5 million and gross unrealized losses of $7.1 million that had been in an unrealized loss position for less than twelve months; and (ii) investments with a fair value of $11.0 million and gross unrealized losses of $.5 million that had been in an unrealized loss position for greater than twelve months.

At December 31, 2016, the VIEs held: (i) investments with a fair value of $93.8 million and gross unrealized losses of $.9 million that had been in an unrealized loss position for less than twelve months; and (ii) investments with a fair value of $143.9 million and gross unrealized losses of $2.9 million that had been in an unrealized loss position for greater than twelve months.

The investments held by the VIEs are evaluated for other-than-temporary declines in fair value in a manner that is consistent with the Company's fixed maturities, available for sale.

In addition, the Company, in the normal course of business, makes passive investments in structured securities issued by VIEs for which the Company is not the investment manager.  These structured securities include asset-backed securities, collateralized debt obligations, commercial mortgage-backed securities, residential mortgage-backed securities and collateralized mortgage obligations.  Our maximum exposure to loss on these securities is limited to our cost basis in the investment.  We have determined that we are not the primary beneficiary of these structured securities due to the relative size of our investment in comparison to the total principal amount of the individual structured securities and the level of credit subordination which reduces our obligation to absorb gains or losses.

At September 30, 2017, we held investments in various limited partnerships, in which we are not the primary beneficiary, totaling $315.1 million (classified as other invested assets).  At September 30, 2017, we had unfunded commitments to these partnerships and other investments of $266.2 million.  Our maximum exposure to loss on these investments is limited to the amount of our investment.

40

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

FAIR VALUE MEASUREMENTS

Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date and, therefore, represents an exit price, not an entry price.  We carry certain assets and liabilities at fair value on a recurring basis, including fixed maturities, equity securities, trading securities, investments held by VIEs, derivatives, separate account assets and embedded derivatives.  We carry our company-owned life insurance policy, which is invested in a series of mutual funds, at its cash surrender value which approximates fair value. In addition, we disclose fair value for certain financial instruments, including mortgage loans, policy loans, cash and cash equivalents, insurance liabilities for interest-sensitive products, investment borrowings, notes payable and borrowings related to VIEs.

The degree of judgment utilized in measuring the fair value of financial instruments is largely dependent on the level to which pricing is based on observable inputs.  Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect our view of market assumptions in the absence of observable market information.  Financial instruments with readily available active quoted prices would be considered to have fair values based on the highest level of observable inputs, and little judgment would be utilized in measuring fair value.  Financial instruments that rarely trade would often have fair value based on a lower level of observable inputs, and more judgment would be utilized in measuring fair value.

Valuation Hierarchy

There is a three-level hierarchy for valuing assets or liabilities at fair value based on whether inputs are observable or unobservable.

• Level 1 – includes assets and liabilities valued using inputs that are unadjusted quoted prices in active markets for identical assets or liabilities.  Our Level 1 assets primarily include cash and cash equivalents and exchange traded securities.

• Level 2 – includes assets and liabilities valued using inputs that are quoted prices for similar assets in an active market, quoted prices for identical or similar assets in a market that is not active, observable inputs, or observable inputs that can be corroborated by market data.  Level 2 assets and liabilities include those financial instruments that are valued by independent pricing services using models or other valuation methodologies.  These models consider various inputs such as credit rating, maturity, corporate credit spreads, reported trades and other inputs that are observable or derived from observable information in the marketplace or are supported by transactions executed in the marketplace. Financial assets in this category primarily include:  certain publicly registered and privately placed corporate fixed maturity securities; certain government or agency securities; certain mortgage and asset-backed securities; certain equity securities; most investments held by our consolidated VIEs; certain mutual fund investments; most short-term investments; and non-exchange-traded derivatives such as call options. Financial liabilities in this category include investment borrowings, notes payable and borrowings related to VIEs.

• Level 3 – includes assets and liabilities valued using unobservable inputs that are used in model-based valuations that contain management assumptions.  Level 3 assets and liabilities include those financial instruments whose fair value is estimated based on broker/dealer quotes, pricing services or internally developed models or methodologies utilizing significant inputs not based on, or corroborated by, readily available market information.  Financial assets in this category include certain corporate securities (primarily certain below-investment grade privately placed securities), certain structured securities, mortgage loans, and other less liquid securities.  Financial liabilities in this category include our insurance liabilities for interest-sensitive products, which includes embedded derivatives (including embedded derivatives related to our fixed index annuity products and to a modified coinsurance arrangement) since their values include significant unobservable inputs including actuarial assumptions.

At each reporting date, we classify assets and liabilities into the three input levels based on the lowest level of input that is significant to the measurement of fair value for each asset and liability reported at fair value.  This classification is impacted by a number of factors, including the type of financial instrument, whether the financial instrument is new to the market and not yet established, the characteristics specific to the transaction and overall market conditions.  Our assessment of the significance of a particular input to the fair value measurement and the ultimate classification of each asset and liability requires judgment and is subject to change from period to period based on the observability of the valuation inputs. Any transfers between levels

41

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

are reported as having occurred at the beginning of the period. There were no transfers between Level 1 and Level 2 in both the first nine months of 2017 and 2016.

The vast majority of our fixed maturity and equity securities, including those held in trading portfolios and those held by consolidated VIEs, short-term and separate account assets use Level 2 inputs for the determination of fair value.  These fair values are obtained primarily from independent pricing services, which use Level 2 inputs for the determination of fair value.  Our Level 2 assets are valued as follows:

•Fixed maturities available for sale, equity securities and trading securities

Corporate securities are generally priced using market and income approaches. Inputs generally consist of trades of identical or similar securities, quoted prices in inactive markets, issuer rating, benchmark yields, maturity, and credit spreads.

U.S. Treasuries and obligations of U.S. Government corporations and agencies are generally priced using the market approach. Inputs generally consist of trades of identical or similar securities, quoted prices in inactive markets and maturity.

States and political subdivisions are generally priced using the market approach. Inputs generally consist of trades of identical or similar securities, quoted prices in inactive markets, new issuances and credit spreads.

Asset-backed securities, collateralized debt obligations, commercial mortgage-backed securities, mortgage pass-through securities and collateralized mortgage obligations are generally priced using market and income approaches. Inputs generally consist of quoted prices in inactive markets, spreads on actively traded securities, expected prepayments, expected default rates, expected recovery rates, and issue specific information including, but not limited to, collateral type, seniority and vintage.

Equity securities (primarily comprised of non-redeemable preferred stock) are generally priced using the market approach. Inputs generally consist of trades of identical or similar securities, quoted prices in inactive markets, issuer rating, benchmark yields, maturity, and credit spreads.

• Investments held by VIEs

Corporate securities are generally priced using market and income approaches using pricing vendors. Inputs generally consist of issuer rating, benchmark yields, maturity, and credit spreads.

• Other invested assets - derivatives

The fair value measurements for derivative instruments, including embedded derivatives requiring bifurcation, are determined based on the consideration of several inputs including closing exchange or over-the-counter market price quotes; time value and volatility factors underlying options; market interest rates; and non-performance risk.

Third party pricing services normally derive security prices through recently reported trades for identical or similar securities making adjustments through the reporting date based upon available market observable information.  If there are no recently reported trades, the third party pricing services may use matrix or model processes to develop a security price where future cash flow expectations are discounted at an estimated risk-adjusted market rate.  The number of prices obtained for a given security is dependent on the Company's analysis of such prices as further described below.

As the Company is responsible for the determination of fair value, we have control processes designed to ensure that the fair values received from third-party pricing sources are reasonable and the valuation techniques and assumptions used appear reasonable and consistent with prevailing market conditions. Additionally, when inputs are provided by third-party pricing sources, we have controls in place to review those inputs for reasonableness. As part of these controls, we perform monthly quantitative and qualitative analysis on the prices received from third parties to determine whether the prices are reasonable estimates of fair value.  The Company's analysis includes:  (i) a review of the methodology used by third party pricing services;

42

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

(ii) where available, a comparison of multiple pricing services' valuations for the same security; (iii) a review of month to month price fluctuations; (iv) a review to ensure valuations are not unreasonably dated; and (v) back testing to compare actual purchase and sale transactions with valuations received from third parties.  As a result of such procedures, the Company may conclude the prices received from third parties are not reflective of current market conditions.  In those instances, we may request additional pricing quotes or apply internally developed valuations.  However, the number of such instances is insignificant and the aggregate change in value of such investments is not materially different from the original prices received.

The categorization of the fair value measurements of our investments priced by independent pricing services was based upon the Company's judgment of the inputs or methodologies used by the independent pricing services to value different asset classes.  Such inputs typically include:  benchmark yields, reported trades, broker dealer quotes, issuer spreads, benchmark securities, bids, offers and other relevant data.  The Company categorizes such fair value measurements based upon asset classes and the underlying observable or unobservable inputs used to value such investments.

For securities that are not priced by pricing services and may not be reliably priced using pricing models, we obtain broker quotes.  These broker quotes are non-binding andrepresent an exit price, but assumptions used to establish the fair value may not be observable and therefore represent Level 3 inputs.  Approximately 45 percent of our Level 3 fixed maturity securities were valued using unadjusted broker quotes or broker-provided valuation inputs.  The remaining Level 3 fixed maturity investments do not have readily determinable market prices and/or observable inputs.  For these securities, we use internally developed valuations.  Key assumptions used to determine fair value for these securities may include risk premiums, projected performance of underlying collateral and other factors involving significant assumptions which may not be reflective of an active market.  For certain investments, we use a matrix or model process to develop a security price where future cash flow expectations are discounted at an estimated market rate.  The pricing matrix incorporates term interest rates as well as a spread level based on the issuer's credit rating, other factors relating to the issuer, and the security's maturity.  In some instances issuer-specific spread adjustments, which can be positive or negative, are made based upon internal analysis of security specifics such as liquidity, deal size, and time to maturity.

For certain embedded derivatives, we use actuarial assumptions in the determination of fair value which we consider to be Level 3 inputs.

43

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

The categorization of fair value measurements, by input level, for our financial instruments carried at fair value on a recurring basis at September 30, 2017 is as follows (dollars in millions):

	Quoted prices in active markets for identical assets or liabilities (Level 1)		Significant other observable inputs (Level 2)		Significant unobservable inputs  (Level 3)		Total
Assets:
Fixed maturities, available for sale:
Corporate securities	$	—	$	14,394.3	$	255.7	$	14,650.0
United States Treasury securities and obligations of United States government corporations and agencies	—		172.3		—		172.3
States and political subdivisions	—		2,077.0		—		2,077.0
Debt securities issued by foreign governments	—		57.1		4.0		61.1
Asset-backed securities	—		2,726.2		59.9		2,786.1
Collateralized debt obligations	—		237.9		—		237.9
Commercial mortgage-backed securities	—		1,338.9		—		1,338.9
Mortgage pass-through securities	—		2.2		—		2.2
Collateralized mortgage obligations	—		804.4		—		804.4
Total fixed maturities, available for sale	—		21,810.3		319.6		22,129.9
Equity securities - corporate securities	477.8		213.9		21.6		713.3
Trading securities:
Corporate securities	—		21.1		—		21.1
United States Treasury securities and obligations of United States government corporations and agencies	—		.5		—		.5
Asset-backed securities	—		101.2		—		101.2
Collateralized debt obligations	—		2.7		—		2.7
Commercial mortgage-backed securities	—		93.3		—		93.3
Collateralized mortgage obligations	—		72.5		—		72.5
Equity securities	3.1		—		—		3.1
Total trading securities	3.1		291.3		—		294.4
Investments held by variable interest entities - corporate securities	—		1,377.5		5.0		1,382.5
Other invested assets - derivatives	—		142.2		—		142.2
Assets held in separate accounts	—		4.8		—		4.8
Total assets carried at fair value by category	$	480.9	$	23,840.0	$	346.2	$	24,667.1
Liabilities:
Future policy benefits - embedded derivatives associated with fixed index annuity products	$	—	$	—	$	1,249.3	$	1,249.3

44

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

The categorization of fair value measurements, by input level, for our financial instruments carried at fair value on a recurring basis at December 31, 2016 is as follows (dollars in millions):

	Quoted prices in active markets  for identical assets or liabilities (Level 1)		Significant other observable inputs  (Level 2)		Significant unobservable inputs  (Level 3)		Total
Assets:
Fixed maturities, available for sale:
Corporate securities	$	—	$	13,252.4	$	258.5	$	13,510.9
United States Treasury securities and obligations of United States government corporations and agencies	—		164.3		—		164.3
States and political subdivisions	—		1,988.9		—		1,988.9
Debt securities issued by foreign governments	—		33.0		3.9		36.9
Asset-backed securities	—		2,649.9		60.4		2,710.3
Collateralized debt obligations	—		225.3		5.4		230.7
Commercial mortgage-backed securities	—		1,504.2		32.0		1,536.2
Mortgage pass-through securities	—		2.5		—		2.5
Collateralized mortgage obligations	—		915.5		—		915.5
Total fixed maturities, available for sale	—		20,736.0		360.2		21,096.2
Equity securities - corporate securities	359.9		199.1		25.2		584.2
Trading securities:
Corporate securities	—		19.0		—		19.0
United States Treasury securities and obligations of United States government corporations and agencies	—		.5		—		.5
Asset-backed securities	—		94.3		—		94.3
Collateralized debt obligations	—		2.4		—		2.4
Commercial mortgage-backed securities	—		163.9		—		163.9
Collateralized mortgage obligations	—		78.4		—		78.4
Equity securities	4.9		—		—		4.9
Total trading securities	4.9		358.5		—		363.4
Investments held by variable interest entities - corporate securities	—		1,724.3		—		1,724.3
Other invested assets - derivatives	—		111.9		—		111.9
Assets held in separate accounts	—		4.7		—		4.7
Total assets carried at fair value by category	$	364.8	$	23,134.5	$	385.4	$	23,884.7
Liabilities:
Future policy benefits - embedded derivatives associated with fixed index annuity products	$	—	$	—	$	1,092.3	$	1,092.3

45

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

For those financial instruments disclosed at fair value, we use the following methods and assumptions to determine the estimated fair values:

Mortgage loans and policy loans.  We discount future expected cash flows based on interest rates currently being offered for similar loans with similar risk characteristics.  We aggregate loans with similar characteristics in our calculations.  The fair value of policy loans approximates their carrying value.

Company-owned life insurance is backed by a series of mutual funds and is carried at cash surrender value which approximates estimated fair value.

Cash and cash equivalents include commercial paper, invested cash and other investments purchased with original maturities of less than three months. We carry them at amortized cost, which approximates estimated fair value.

Liabilities for policyholder account balances.  The estimated fair value of insurance liabilities for policyholder account balances was approximately equal to its carrying value as interest rates credited on the vast majority of account balances approximate current rates paid on similar products and because these rates are not generally guaranteed beyond one year.

Investment borrowings, notes payable and borrowings related to variable interest entities.  For publicly traded debt, we use current fair values.  For other notes, we use discounted cash flow analyses based on our current incremental borrowing rates for similar types of borrowing arrangements.

The fair value measurements for our financial instruments disclosed at fair value on a recurring basis are as follows (dollars in millions):

	September 30, 2017
	Quoted prices in active markets for identical assets or liabilities (Level 1)		Significant other observable inputs  (Level 2)		Significant unobservable inputs  (Level 3)		Total estimated fair value		Total carrying amount
Assets:
Mortgage loans	$	—	$	—	$	1,705.8	$	1,705.8	$	1,667.8
Policy loans	—		—		114.6		114.6		114.6
Other invested assets:
Company-owned life insurance	—		178.8		—		178.8		178.8
Cash and cash equivalents:
Unrestricted	765.9		—		—		765.9		765.9
Held by variable interest entities	105.9		—		—		105.9		105.9
Liabilities:
Policyholder account balances	—		—		11,113.5		11,113.5		11,113.5
Investment borrowings	—		1,650.1		—		1,650.1		1,646.9
Borrowings related to variable interest entities	—		1,215.1		—		1,215.1		1,198.2
Notes payable – direct corporate obligations	—		970.5		—		970.5		914.4

46

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

	December 31, 2016
	Quoted prices in active markets for identical assets or liabilities (Level 1)		Significant other observable inputs  (Level 2)		Significant unobservable inputs  (Level 3)		Total estimated fair value		Total carrying amount
Assets:
Mortgage loans	$	—	$	—	$	1,800.1	$	1,800.1	$	1,768.0
Policy loans	—		—		112.0		112.0		112.0
Other invested assets:
Company-owned life insurance	—		165.0		—		165.0		165.0
Cash and cash equivalents:
Unrestricted	473.6		5.3		—		478.9		478.9
Held by variable interest entities	189.3		—		—		189.3		189.3
Liabilities:
Policyholder account balances	—		—		10,912.7		10,912.7		10,912.7
Investment borrowings	—		1,650.0		—		1,650.0		1,647.4
Borrowings related to variable interest entities	—		1,675.2		—		1,675.2		1,662.8
Notes payable – direct corporate obligations	—		931.9		—		931.9		912.9

47

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

The following table presents additional information about assets and liabilities measured at fair value on a recurring basis and for which we have utilized significant unobservable (Level 3) inputs to determine fair value for the three months ended September 30, 2017 (dollars in millions):

	September 30, 2017
	Beginning balance as of June 30, 2017			Purchases, sales, issuances and settlements, net (b)			Total realized and unrealized gains (losses) included in net income		Total realized and unrealized gains (losses) included in accumulated other comprehensive income (loss)			Transfers into Level 3 (a)		Transfers out of Level 3 (a)			Ending balance as of September 30, 2017			Amount of total gains (losses) for the three months ended September 30, 2017 included in our net income relating to assets and liabilities still held as of the reporting date
Assets:
Fixed maturities, available for sale:
Corporate securities	$	263.3		$	(44.8	)	$	1.7	$	1.3		$	34.2	$	—		$	255.7		$	(3.2	)
Debt securities issued by foreign governments	3.9			—			—		.1			—		—			4.0			—
Asset-backed securities	59.6			(1.3		)	—		.7			7.1		(6.2		)	59.9			—
Collateralized debt obligations	2.5			(2.5		)	—		—			—		—			—			—
Collateralized mortgage obligations	.2			—			—		(.2		)	—		—			—			—
Total fixed maturities, available for sale	329.5			(48.6		)	1.7		1.9			41.3		(6.2		)	319.6			(3.2		)
Equity securities - corporate securities	24.6			(8.3		)	6.4		(1.1		)	—		—			21.6			(.5		)
Investments held by variable interest entities - corporate securities	—			—			—		—			5.0		—			5.0			—
Liabilities:
Future policy benefits - embedded derivatives associated with fixed index annuity products	(1,205.4		)	(56.3		)	12.4		—			—		—			(1,249.3		)	12.4

48

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

_________

(a) Transfers into Level 3 are the result of unobservable inputs utilized within valuation methodologies for assets that were previously valued using observable inputs. Transfers out of Level 3 are due to the use of observable inputs in valuation methodologies as well as the utilization of pricing service information for certain assets that the Company is able to validate.

(b) Purchases, sales, issuances and settlements, net, represent the activity that occurred during the period that results in a change of the asset or liability but does not represent changes in fair value for the instruments held at the beginning of the period.  Such activity primarily consists of purchases and sales of fixed maturity and equity securities and changes to embedded derivative instruments related to insurance products resulting from the issuance of new contracts, or changes to existing contracts.  The following summarizes such activity for the three months ended September 30, 2017 (dollars in millions):

	Purchases			Sales			Issuances			Settlements		Purchases, sales, issuances and settlements, net
Assets:
Fixed maturities, available for sale:
Corporate securities	$	15.3		$	(60.1	)	$	—		$	—	$	(44.8	)
Asset-backed securities	9.9			(11.2		)	—			—		(1.3		)
Collateralized debt obligations	—			(2.5		)	—			—		(2.5		)
Total fixed maturities, available for sale	25.2			(73.8		)	—			—		(48.6		)
Equity securities - corporate securities	—			(8.3		)	—			—		(8.3		)
Liabilities:
Future policy benefits - embedded derivatives associated with fixed index annuity products	(41.0		)	1.8			(31.4		)	14.3		(56.3		)

49

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

The following table presents additional information about assets and liabilities measured at fair value on a recurring basis and for which we have utilized significant unobservable (Level 3) inputs to determine fair value for the nine months ended September 30, 2017 (dollars in millions):

	September 30, 2017
	Beginning balance as of December 31, 2016			Purchases, sales, issuances and settlements, net (b)			Total realized and unrealized gains (losses) included in net income		Total realized and unrealized gains (losses) included in accumulated other comprehensive income (loss)			Transfers into Level 3 (a)		Transfers out of Level 3 (a)			Ending balance as of September 30, 2017			Amount of total gains (losses) for the nine months ended September 30, 2017 included in our net income relating to assets and liabilities still held as of the reporting date
Assets:
Fixed maturities, available for sale:
Corporate securities	$	258.5		$	(44.1	)	$	9.5	$	.6		$	31.2	$	—		$	255.7		$	(6.5	)
Debt securities issued by foreign governments	3.9			—			—		.1			—		—			4.0			—
Asset-backed securities	60.4			3.8			—		2.3			4.2		(10.8		)	59.9			—
Collateralized debt obligations	5.4			(2.5		)	—		—			—		(2.9		)	—			—
Commercial mortgage-backed securities	32.0			—			—		—			—		(32.0		)	—			—
Total fixed maturities, available for sale	360.2			(42.8		)	9.5		3.0			35.4		(45.7		)	319.6			(6.5		)
Equity securities - corporate securities	25.2			(8.5		)	6.3		(1.4		)	—		—			21.6			(.5		)
Investments held by variable interest entities - corporate securities	—			5.0			—		—			—		—			5.0			—
Liabilities:
Future policy benefits - embedded derivatives associated with fixed index annuity products	(1,092.3		)	(174.2		)	17.2		—			—		—			(1,249.3		)	17.2

50

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

_________

(a) Transfers into Level 3 are the result of unobservable inputs utilized within valuation methodologies for assets that were previously valued using observable inputs. Transfers out of Level 3 are due to the use of observable inputs in valuation methodologies as well as the utilization of pricing service information for certain assets that the Company is able to validate.

(b) Purchases, sales, issuances and settlements, net, represent the activity that occurred during the period that results in a change of the asset or liability but does not represent changes in fair value for the instruments held at the beginning of the period.  Such activity primarily consists of purchases and sales of fixed maturity and equity securities and changes to embedded derivative instruments related to insurance products resulting from the issuance of new contracts, or changes to existing contracts.  The following summarizes such activity for the nine months ended September 30, 2017 (dollars in millions):

	Purchases			Sales			Issuances			Settlements		Purchases, sales, issuances and settlements, net
Assets:
Fixed maturities, available for sale:
Corporate securities	$	64.3		$	(108.4	)	$	—		$	—	$	(44.1	)
Asset-backed securities	21.9			(18.1		)	—			—		3.8
Collateralized debt obligations	—			(2.5		)	—			—		(2.5		)
Total fixed maturities, available for sale	86.2			(129.0		)	—			—		(42.8		)
Equity securities - corporate securities	—			(8.5		)	—			—		(8.5		)
Investments held by variable interest entities - corporate securities	5.0			—			—			—		5.0
Liabilities:
Future policy benefits - embedded derivatives associated with fixed index annuity products	(130.1		)	5.3			(95.7		)	46.3		(174.2		)

51

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

The following table presents additional information about assets and liabilities measured at fair value on a recurring basis and for which we have utilized significant unobservable (Level 3) inputs to determine fair value for the three months ended September 30, 2016 (dollars in millions):

	September 30, 2016
	Beginning balance as of June 30, 2016			Purchases, sales, issuances and settlements, net (b)			Total realized and unrealized gains (losses) included in net income		Total realized and unrealized gains (losses) included in accumulated other comprehensive income (loss)			Transfers into Level 3 (a)		Transfers out of Level 3 (a)			Ending balance as of September 30, 2016			Amount of total gains (losses) for the three months ended September 30, 2016 included in our net income relating to assets and liabilities still held as of the reporting date
Assets:
Fixed maturities, available for sale:
Corporate securities	$	174.6		$	118.8		$	—	$	(4.9	)	$	—	$	—		$	288.5		$	—
Debt securities issued by foreign governments	4.1			—			—		—			—		—			4.1			—
Asset-backed securities	39.1			5.7			—		2.1			24.6		(15.0		)	56.5			—
Collateralized debt obligations	—			2.5			—		—			—		—			2.5			—
Commercial mortgage-backed securities	1.1			17.0			—		(.1		)	14.4		—			32.4			—
Collateralized mortgage obligations	—			12.0			—		—			—		—			12.0			—
Total fixed maturities, available for sale	218.9			156.0			—		(2.9		)	39.0		(15.0		)	396.0			—
Equity securities - corporate securities	21.4			3.3			—		(.8		)	—		—			23.9			—
Trading securities - commercial mortgage-backed securities	—			—			—		(1.7		)	10.0		—			8.3			(1.7		)
Liabilities:
Future policy benefits - embedded derivatives associated with fixed index annuity products	(1,127.0		)	(37.0		)	18.3		—			—		—			(1,145.7		)	18.3

52

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

____________

(a) Transfers into Level 3 are the result of unobservable inputs utilized within valuation methodologies for assets that were previously valued using observable inputs. Transfers out of Level 3 are due to the use of observable inputs in valuation methodologies as well as the utilization of pricing service information for certain assets that the Company is able to validate.

(b) Purchases, sales, issuances and settlements, net, represent the activity that occurred during the period that results in a change of the asset or liability but does not represent changes in fair value for the instruments held at the beginning of the period.  Such activity primarily consists of purchases and sales of fixed maturity and equity securities and changes to embedded derivative instruments related to insurance products resulting from the issuance of new contracts, or changes to existing contracts.  In addition, such activity includes the investments received upon the recapture of reinsurance agreements with BRe on September 29, 2016. The following summarizes such activity for the three months ended September 30, 2016 (dollars in millions):

	Purchases			Received in reinsurance recapture		Sales			Issuances			Settlements		Purchases, sales, issuances and settlements, net
Assets:
Fixed maturities, available for sale:
Corporate securities	$	1.1		$	118.6	$	(.9	)	$	—		$	—	$	118.8
Asset-backed securities	7.0			—		(1.3		)	—			—		5.7
Collateralized debt obligations	2.5			—		—			—			—		2.5
Commercial mortgage-backed securities	17.0			—		—			—			—		17.0
Collateralized mortgage obligations	—			12.0		—			—			—		12.0
Total fixed maturities, available for sale	27.6			130.6		(2.2		)	—			—		156.0
Equity securities - corporate securities	1.1			2.2		—			—			—		3.3
Liabilities:
Future policy benefits - embedded derivatives associated with fixed index annuity products	(38.5		)	—		3.1			(14.6		)	13.0		(37.0		)

53

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

The following table presents additional information about assets and liabilities measured at fair value on a recurring basis and for which we have utilized significant unobservable (Level 3) inputs to determine fair value for the nine months ended September 30, 2016 (dollars in millions):

	September 30, 2016
	Beginning balance as of December 31, 2015			Purchases, sales, issuances and settlements, net (b)			Total realized and unrealized gains (losses) included in net income			Total realized and unrealized gains (losses) included in accumulated other comprehensive income (loss)			Transfers into Level 3 (a)		Transfers out of Level 3 (a)			Ending balance as of September 30, 2016			Amount of total gains (losses) for the nine months ended September 30, 2016 included in our net income relating to assets and liabilities still held as of the reporting date
Assets:
Fixed maturities, available for sale:
Corporate securities	$	170.4		$	104.4		$	(7.0	)	$	7.4		$	20.3	$	(7.0	)	$	288.5		$	(5.6	)
Debt securities issued by foreign governments	—			4.0			—			.1			—		—			4.1			—
Asset-backed securities	35.9			1.7			—			4.0			28.6		(13.7		)	56.5			—
Collateralized debt obligations	—			2.5			—			—			—		—			2.5			—
Commercial mortgage-backed securities	1.1			17.0			—			.4			13.9		—			32.4			—
Mortgage pass-through securities	.1			(.1		)	—			—			—		—			—			—
Collateralized mortgage obligations	—			12.0			—			—			—		—			12.0			—
Total fixed maturities, available for sale	207.5			141.5			(7.0		)	11.9			62.8		(20.7		)	396.0			(5.6		)
Equity securities - corporate securities	32.0			5.5			(12.8		)	(.8		)	—		—			23.9			(12.8		)
Trading securities - commercial mortgage-backed securities	39.9			—			—			(1.4		)	—		(30.2		)	8.3			(1.4		)
Liabilities:
Future policy benefits - embedded derivatives associated with fixed index annuity products	(1,057.1		)	(55.3		)	(33.3		)	—			—		—			(1,145.7		)	(33.3		)

54

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

____________

(a) Transfers into Level 3 are the result of unobservable inputs utilized within valuation methodologies for assets that were previously valued using observable inputs. Transfers out of Level 3 are due to the use of observable inputs in valuation methodologies as well as the utilization of pricing service information for certain assets that the Company is able to validate.

(b) Purchases, sales, issuances and settlements, net, represent the activity that occurred during the period that results in a change of the asset or liability but does not represent changes in fair value for the instruments held at the beginning of the period.  Such activity primarily consists of purchases and sales of fixed maturity and equity securities and changes to embedded derivative instruments related to insurance products resulting from the issuance of new contracts, or changes to existing contracts.  In addition, such activity includes the investments received upon the recapture of reinsurance agreements with BRe on September 29, 2016. The following summarizes such activity for the nine months ended September 30, 2016 (dollars in millions):

	Purchases			Received in reinsurance recapture		Sales			Issuances			Settlements		Purchases, sales, issuances and settlements, net
Assets:
Fixed maturities, available for sale:
Corporate securities	$	1.1		$	118.6	$	(15.3	)	$	—		$	—	$	104.4
Debt securities issued by foreign governments	4.0			—		—			—			—		4.0
Asset-backed securities	7.0			—		(5.3		)	—			—		1.7
Collateralized debt obligations	2.5			—		—			—			—		2.5
Commercial mortgage-backed securities	17.0			—		—			—			—		17.0
Mortgage pass-through securities	—			—		(.1		)	—			—		(.1		)
Collateralized mortgage obligations	—			12.0		—			—			—		12.0
Total fixed maturities, available for sale	31.6			130.6		(20.7		)	—			—		141.5
Equity securities - corporate securities	3.3			2.2		—			—			—		5.5
Liabilities:
Future policy benefits - embedded derivatives associated with fixed index annuity products	(101.9		)	—		19.2			(17.5		)	44.9		(55.3		)

At September 30, 2017, 55 percent of our Level 3 fixed maturities, available for sale, were investment grade and 80 percent of our Level 3 fixed maturities, available for sale, consisted of corporate securities.

Realized and unrealized investment gains and losses presented in the preceding tables represent gains and losses during the time the applicable financial instruments were classified as Level 3.

Realized and unrealized gains (losses) on Level 3 assets are primarily reported in either net investment income for policyholder and other special-purpose portfolios, net realized investment gains (losses) or insurance policy benefits within the consolidated statement of operations or accumulated other comprehensive income within shareholders' equity based on the appropriate accounting treatment for the instrument.

55

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

The amount presented for gains (losses) included in our net loss for assets and liabilities still held as of the reporting date primarily represents impairments for fixed maturities, available for sale, changes in fair value of trading securities and certain derivatives and changes in fair value of embedded derivative instruments included in liabilities for insurance products that exist as of the reporting date.

The following table provides additional information about the significant unobservable (Level 3) inputs developed internally by the Company to determine fair value for certain assets and liabilities carried at fair value at September 30, 2017 (dollars in millions):

	Fair value at September 30, 2017		Valuation techniques	Unobservable inputs	Range (weighted average)
Assets:
Corporate securities (a)	$	138.4	Discounted cash flow analysis	Discount margins	1.50% - 61.70% (9.10%)
Corporate securities (b)	3.1		Recovery method	Percent of recovery expected	5% - 38% (17.76%)
Asset-backed securities (c)	24.9		Discounted cash flow analysis	Discount margins	1.77% - 3.36% (2.54%)
Equity securities (d)	21.6		Market comparables	EBITDA multiples	0.5X - 6.2X (5.9X)
Other assets categorized as Level 3 (e)	158.2		Unadjusted third-party price source	Not applicable	Not applicable
Total	346.2
Liabilities:
Future policy benefits (f)	1,249.3		Discounted projected embedded derivatives	Projected portfolio yields	5.15% - 5.61% (5.59%)
				Discount rates	0.44% - 2.80% (1.94%)
				Surrender rates	0.94% - 46.48% (13.52%)

________________________________

(a) Corporate securities - The significant unobservable input used in the fair value measurement of our corporate securities is discount margin added to a riskless market yield. Significant increases (decreases) in discount margin in isolation would result in a significantly lower (higher) fair value measurement.

(b) Corporate securities - The significant unobservable input used in the fair value measurement of these corporate securities is percentage of recovery expected.  Significant increases (decreases) in percentage of recovery expected in isolation would result in a significantly higher (lower) fair value measurement.

(c) Asset-backed securities - The significant unobservable input used in the fair value measurement of these asset-backed securities is discount margin added to a riskless market yield. Significant increases (decreases) in discount margin in isolation would result in a significantly lower (higher) fair value measurement.

(d) Equity securities - The significant unobservable input used in the fair value measurement of these equity securities is multiples of earnings before interest, taxes, depreciation and amortization ("EBITDA"). Generally, increases (decreases) in the EBITDA multiples would result in higher (lower) fair value measurements.

(e) Other assets categorized as Level 3 - For these assets, there were no adjustments to quoted market prices obtained from third-party pricing sources.

(f) Future policy benefits - The significant unobservable inputs used in the fair value measurement of our embedded derivatives associated with fixed index annuity products are projected portfolio yields, discount rates and surrender rates. Increases (decreases) in projected portfolio yields in isolation would lead to a higher (lower) fair value measurement. The discount rate is based on the Treasury rate adjusted by a margin. Increases (decreases) in the discount rates would lead to a lower (higher) fair value measurement. Assumed surrender rates are used to project how long the contracts remain in force. Generally, the longer the contracts are assumed to be in force the higher the fair value of the embedded derivative.

56

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

The following table provides additional information about the significant unobservable (Level 3) inputs developed internally by the Company to determine fair value for certain assets and liabilities carried at fair value at December 31, 2016 (dollars in millions):

	Fair value at December 31, 2016		Valuation techniques	Unobservable inputs	Range (weighted average)
Assets:
Corporate securities (a)	$	148.5	Discounted cash flow analysis	Discount margins	1.35% - 27.71% (13.52%)
Corporate securities (b)	14.8		Recovery method	Percent of recovery expected	5% - 69% (55%)
Asset-backed securities (c)	24.0		Discounted cash flow analysis	Discount margins	2.06% - 3.64% (2.76%)
Equity securities (d)	25.2		Market comparables	EBITDA multiples	0.4X - 6.2X (5.9X)
Other assets categorized as Level 3 (e)	172.9		Unadjusted third-party price source	Not applicable	Not applicable
Total	385.4
Liabilities:
Future policy benefits (f)	1,092.3		Discounted projected embedded derivatives	Projected portfolio yields	5.15% - 5.61% (5.59%)
				Discount rates	0.18% - 3.06% (2.07%)
				Surrender rates	0.94% - 46.48% (13.52%)

________________________________

(a) Corporate securities - The significant unobservable input used in the fair value measurement of our corporate securities is discount margin added to a riskless market yield. Significant increases (decreases) in discount margin in isolation would result in a significantly lower (higher) fair value measurement.

(b) Corporate securities - The significant unobservable input used in the fair value measurement of our corporate securities is percentage of recovery expected.  Significant increases (decreases) in percentage of recovery expected in isolation would result in a significantly higher (lower) fair value measurement.

(c) Asset-backed securities - The significant unobservable input used in the fair value measurement of these asset-backed securities is discount margin added to a riskless market yield. Significant increases (decreases) in discount margin in isolation would result in a significantly lower (higher) fair value measurement.

(d) Equity securities - The significant unobservable input used in the fair value measurement of these equity securities is EBITDA multiples. Generally, increases (decreases) in the EBITDA multiples would result in higher (lower) fair value measurements.

(e) Other assets categorized as Level 3 - For these assets, there were no adjustments to quoted market prices obtained from third-party pricing sources.

(f) Future policy benefits - The significant unobservable inputs used in the fair value measurement of our embedded derivatives associated with fixed index annuity products are projected portfolio yields, discount rates and surrender rates. Increases (decreases) in projected portfolio yields in isolation would lead to a higher (lower) fair value measurement. The discount rate is based on the Treasury rate adjusted by a margin. Increases (decreases) in the discount rates would lead to a lower (higher) fair value measurement. Assumed surrender rates are used to project how long the contracts remain in force. Generally, the longer the contracts are assumed to be in force the higher the fair value of the embedded derivative.

57

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

SUBSEQUENT EVENT

On October 13, 2017, the Company entered into an amendment and restatement agreement (the "Amendment Agreement") with respect to its Revolving Credit Agreement (as amended by the Amendment Agreement, the "Amended Credit Agreement"). The Amendment Agreement, among other things, increases the total commitments available under the revolving credit facility from $150.0 million to $250.0 million, increases the aggregate amount of additional incremental loans the Company may incur from $50.0 million to $100.0 million and extends the maturity date of the revolving credit facility from May 19, 2019 to the earlier of October 13, 2022 and the date that is six months prior to the maturity date of the Company’s 4.50% senior notes due 2020, which is November 30, 2019. The amount drawn under the Amended Credit Agreement continues to be $100.0 million.

The interest rate applicable to loans under the Amended Credit Agreement continues to be calculated as the eurodollar rate or the base rate, at the Company’s option, plus a margin based on the Company’s unsecured debt rating. The margins under the Amended Credit Agreement range from 1.375% to 2.125%, in the case of loans at the eurodollar rate, and 0.375% to 1.125%, in the case of loans at the base rate. The commitment fee under the Amended Credit Agreement continues to be based on the Company’s unsecured debt rating.

Additionally, the Amended Credit Agreement revises the debt to total capitalization ratio that the Company is required to maintain from not more than 30.0 percent to not more than 35.0 percent. The Amended Credit Agreement continues to contain certain other restrictive covenants with which the Company must comply.

58

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF CONSOLIDATED FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

In this section, we review the consolidated financial condition of CNO at September 30, 2017, and its consolidated results of operations for the nine months ended September 30, 2017 and 2016, and, where appropriate, factors that may affect future financial performance. Please read this discussion in conjunction with the accompanying consolidated financial statements and notes.

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

Our statements, trend analyses and other information contained in this report and elsewhere (such as in filings by CNO with the SEC, press releases, presentations by CNO or its management or oral statements) relative to markets for CNO's products and trends in CNO's operations or financial results, as well as other statements, contain forward-looking statements within the meaning of the federal securities laws and the Private Securities Litigation Reform Act of 1995.  Forward-looking statements typically are identified by the use of terms such as "anticipate," "believe," "plan," "estimate," "expect," "project," "intend," "may," "will," "would," "contemplate," "possible," "attempt," "seek," "should," "could," "goal," "target," "on track," "comfortable with," "optimistic," "guidance," "outlook" and similar words, although some forward-looking statements are expressed differently.  You should consider statements that contain these words carefully because they describe our expectations, plans, strategies and goals and our beliefs concerning future business conditions, our results of operations, financial position, and our business outlook or they state other "forward-looking" information based on currently available information.  The "Risk Factors" section of our 2016 Annual Report on Form 10-K and the changes set forth in the Risk Factors section of this Form 10-Q provide examples of risks, uncertainties and events that could cause our actual results to differ materially from the expectations expressed in our forward-looking statements.  Assumptions and other important factors that could cause our actual results to differ materially from those anticipated in our forward-looking statements include, among other things:

• changes in or sustained low interest rates causing reductions in investment income, the margins of our fixed annuity and life insurance businesses, and sales of, and demand for, our products;

• expectations of lower future investment earnings may cause us to accelerate amortization, write down the balance of insurance acquisition costs or establish additional liabilities for insurance products;

• general economic, market and political conditions and uncertainties, including the performance and fluctuations of the financial markets which may affect the value of our investments as well as our ability to raise capital or refinance existing indebtedness and the cost of doing so;

• the ultimate outcome of lawsuits filed against us and other legal and regulatory proceedings to which we are subject;

• our ability to make anticipated changes to certain non-guaranteed elements of our life insurance products;

• our ability to obtain adequate and timely rate increases on our health products, including our long-term care business;

• the receipt of any required regulatory approvals for dividend and surplus debenture interest payments from our insurance subsidiaries;

• mortality, morbidity, the increased cost and usage of health care services, persistency, the adequacy of our previous reserve estimates and other factors which may affect the profitability of our insurance products;

• changes in our assumptions related to deferred acquisition costs or the present value of future profits;

• the recoverability of our deferred tax assets and the effect of potential ownership changes and tax rate changes on their value;

• our assumption that the positions we take on our tax return filings will not be successfully challenged by the IRS;

59

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

• changes in accounting principles and the interpretation thereof;

• our ability to continue to satisfy the financial ratio and balance requirements and other covenants of our debt agreements;

• our ability to achieve anticipated expense reductions and levels of operational efficiencies including improvements in claims adjudication and continued automation and rationalization of operating systems;

• performance and valuation of our investments, including the impact of realized losses (including other-than-temporary impairment charges);

• our ability to identify products and markets in which we can compete effectively against competitors with greater market share, higher ratings, greater financial resources and stronger brand recognition;

• our ability to generate sufficient liquidity to meet our debt service obligations and other cash needs;

• our ability to maintain effective controls over financial reporting;

• our ability to continue to recruit and retain productive agents and distribution partners;

• customer response to new products, distribution channels and marketing initiatives;

• our ability to achieve additional upgrades of the financial strength ratings of CNO and our insurance company subsidiaries as well as the impact of our ratings on our business, our ability to access capital, and the cost of capital;

• regulatory changes or actions, including: those relating to regulation of the financial affairs of our insurance companies, such as the calculation of risk-based capital and minimum capital requirements, and payment of dividends and surplus debenture interest to us; regulation of the sale, underwriting and pricing of products; and health care regulation affecting health insurance products;

• changes in the Federal income tax laws and regulations which may affect or eliminate the relative tax advantages of some of our products or affect the value of our deferred tax assets;

• availability and effectiveness of reinsurance arrangements, as well as the impact of any defaults or failure of reinsurers to perform;

• the amount we may need to pay to a reinsurer and the earnings charge we may incur in connection with a long-term care reinsurance transaction;

• the performance of third party service providers and potential difficulties arising from outsourcing arrangements;

• the growth rate of sales, collected premiums, annuity deposits and assets;

• interruption in telecommunication, information technology or other operational systems or failure to maintain the security, confidentiality or privacy of sensitive data on such systems;

• events of terrorism, cyber attacks, natural disasters or other catastrophic events, including losses from a disease pandemic;

• ineffectiveness of risk management policies and procedures in identifying, monitoring and managing risks; and

• the risk factors or uncertainties listed from time to time in our filings with the SEC.

Other factors and assumptions not identified above are also relevant to the forward-looking statements, and if they prove incorrect, could also cause actual results to differ materially from those projected.

60

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

All written or oral forward-looking statements attributable to us are expressly qualified in their entirety by the foregoing cautionary statement.  Our forward-looking statements speak only as of the date made.  We assume no obligation to update or to publicly announce the results of any revisions to any of the forward-looking statements to reflect actual results, future events or developments, changes in assumptions or changes in other factors affecting the forward-looking statements.

The reporting of risk-based capital ("RBC") measures is not intended for the purpose of ranking any insurance company or for use in connection with any marketing, advertising or promotional activities.

OVERVIEW

We are a holding company for a group of insurance companies operating throughout the United States that develop, market and administer health insurance, annuity, individual life insurance and other insurance products.  We focus on serving the senior and middle-income markets, which we believe are attractive, underserved, high growth markets.  We sell our products through three distribution channels: career agents, independent producers (some of whom sell one or more of our product lines exclusively) and direct marketing. In the fourth quarter of 2016, we began reporting the long-term care block recaptured from BRe as an additional business segment.

The Company’s insurance segments are described below:

• Bankers Life,which markets and distributes Medicare supplement insurance, interest-sensitive life insurance, traditional life insurance, fixed annuities and long-term care insurance products to the middle-income senior market through a dedicated field force of career agents, financial and investment advisors, and sales managers supported by a network of community-based sales offices.  The Bankers Life segment includes primarily the business of Bankers Life.  Bankers Life also has various distribution and marketing agreements with other insurance companies to use Bankers Life's career agents to distribute Medicare Advantage and prescription drug plan products in exchange for a fee.

• Washington National, which markets and distributes supplemental health (including specified disease, accident and hospital indemnity insurance products) and life insurance to middle-income consumers at home and at the worksite.  These products are marketed through Performance Matters Associates, Inc. ("PMA") and through independent marketing organizations and insurance agencies including worksite marketing.  The products being marketed are underwritten by Washington National. This segment's business also includes certain closed blocks of annuities and Medicare supplement policies which are no longer being actively marketed by this segment and were primarily issued or acquired by Washington National.

• Colonial Penn, which markets primarily graded benefit and simplified issue life insurance directly to customers in the senior middle-income market through television advertising, direct mail, the internet and telemarketing.  The Colonial Penn segment includes primarily the business of Colonial Penn.

• Long-term care in run-off consists of the long-term care business that was recaptured due to the termination of certain reinsurance agreements effective September 30, 2016. This business is not actively marketed and was issued or acquired by Washington National and BCLIC.

61

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

The following summarizes our earnings for the three and nine months ending September 30, 2017 and 2016 (dollars in millions, except per share data):

	Three months ended						Nine months ended
	September 30,						September 30,
	2017			2016			2017			2016
Adjusted EBIT (a non-GAAP measure) (a):
Bankers Life	$	106.9		$	88.1		$	309.2		$	259.0
Washington National	27.5			25.2			74.6			73.0
Colonial Penn	9.0			.9			16.7			(2.9		)
Long-term care in run-off	(1.0		)	—			1.1			—
Adjusted EBIT from business segments	142.4			114.2			401.6			329.1
Corporate operations, excluding corporate interest expense	(14.9		)	(4.4		)	(37.0		)	(19.5		)
Adjusted EBIT	127.5			109.8			364.6			309.6
Corporate interest expense	(11.7		)	(11.5		)	(34.8		)	(34.3		)
Operating earnings before taxes	115.8			98.3			329.8			275.3
Tax expense on operating income	39.1			34.0			114.7			97.7
Net operating income (a)	76.7			64.3			215.1			177.6
Net realized investment gains (losses) (net of related amortization)	28.5			11.4			51.3			22.4
Fair value changes in embedded derivative liabilities (net of related amortization)	2.3			9.4			(8.0		)	(36.6		)
Fair value changes and amendment related to agent deferred compensation plan	(13.4		)	6.3			(13.4		)	(12.0		)
Loss on reinsurance transaction	—			(75.4		)	—			(75.4		)
Other	(3.3		)	(.7		)	(4.6		)	(1.2		)
Non-operating income (loss) before taxes	14.1			(49.0		)	25.3			(102.8		)
Income tax expense (benefit):
On non-operating income (loss)	5.0			(17.1		)	8.9			(36.0		)
Valuation allowance for deferred tax assets and other tax items	(15.0		)	13.8			(15.0		)	(13.2		)
Net non-operating income (loss)	24.1			(45.7		)	31.4			(53.6		)
Net income	$	100.8		$	18.6		$	246.5		$	124.0
Per diluted share:
Net operating income	$	.45		$	.37		$	1.25		$	.99
Net realized investment gains (losses) (net of related amortization and taxes)	.11			.04			.19			.08
Fair value changes in embedded derivative liabilities (net of related amortization and taxes)	.01			.04			(.03		)	(.13		)
Fair value changes and amendment related to agent deferred compensation plan (net of taxes)	(.05		)	.02			(.05		)	(.05		)
Loss on reinsurance transaction (net of taxes)	—			(.28		)	—			(.27		)
Valuation allowance for deferred tax assets and other tax items	.09			(.08		)	.09			.07
Other	(.02		)	—			(.02		)	—
Net income	$	.59		$	.11		$	1.43		$	.69

62

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

____________

(a) Management believes that an analysis of net operating income provides a clearer comparison of the operating results of the Company from period to period because it excludes:  (i) net realized investment gains or losses, net of related amortization; (ii) fair value changes due to fluctuations in the interest rates used to discount embedded derivative liabilities related to our fixed index annuities, net of related amortization; (iii) fair value changes and an amendment to the agent deferred compensation plan; (iv) loss on reinsurance transaction; and (v) other non-operating items consisting primarily of earnings attributable to variable interest entities. Net realized investment gains or losses include: (i) gains or losses on the sales of investments; (ii) other-than-temporary impairments recognized through net income; and (iii) changes in fair value of certain fixed maturity investments with embedded derivatives.  Adjusted EBIT is presented as net operating income excluding corporate interest expense and income tax expense. The table above reconciles the non-GAAP measures to the corresponding GAAP measure.

In addition, management uses these non-GAAP financial measures in its budgeting process, financial analysis of segment performance and in assessing the allocation of resources. We believe these non-GAAP financial measures enhance an investor’s understanding of our financial performance and allows them to make more informed judgments about the Company as a whole. These measures also highlight operating trends that might not otherwise be apparent. However, Adjusted EBIT and net operating income are not measurements of financial performance under GAAP and should not be considered as alternatives to cash flow from operating activities, as measures of liquidity, or as alternatives to net income as measures of our operating performance or any other measures of performance derived in accordance with GAAP. In addition, Adjusted EBIT and net operating income should not be construed as an inference that our future results will be unaffected by unusual or non-recurring items. Adjusted EBIT and net operating income have limitations as analytical tools, and you should not consider such measures either in isolation or as substitutes for analyzing our results as reported under GAAP. Our definitions and calculation of Adjusted EBIT and net operating income are not necessarily comparable to other similarly titled measures used by other companies due to different methods of calculation.

CRITICAL ACCOUNTING POLICIES

Refer to "Critical Accounting Policies" in our 2016 Annual Report on Form 10-K for information on our other accounting policies that we consider critical in preparing our consolidated financial statements.

63

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

RESULTS OF OPERATIONS

The following tables and narratives summarize the operating results of our segments (dollars in millions):

	Three months ended						Nine months ended
	September 30,						September 30,
	2017			2016			2017			2016
Pre-tax operating earnings (a non-GAAP measure) (a):
Bankers Life	$	106.9		$	88.1		$	309.2		$	259.0
Washington National	27.5			25.2			74.6			73.0
Colonial Penn	9.0			.9			16.7			(2.9		)
Long-term care in run-off	(1.0		)	—			1.1			—
Corporate operations	(26.6		)	(15.9		)	(71.8		)	(53.8		)
	115.8			98.3			329.8			275.3
Net realized investment gains (losses), net of related amortization:
Bankers Life	14.9			.7			30.1			(1.3		)
Washington National	6.5			.1			12.6			26.9
Colonial Penn	1.0			.3			.8			(.2		)
Long-term care in run-off	6.7			—			7.8			—
Corporate operations	(.6		)	10.3			—			(3.0		)
	28.5			11.4			51.3			22.4
Fair value changes in embedded derivative liabilities, net of related amortization:
Bankers Life	2.3			9.3			(8.0		)	(36.2		)
Washington National	—			.1			—			(.4		)
	2.3			9.4			(8.0		)	(36.6		)
Earnings attributable to VIEs:
Corporate operations	(3.3		)	(.7		)	(4.6		)	(1.2		)
Fair value changes and amendment related to agent deferred compensation plan:
Corporate operations	(13.4		)	6.3			(13.4		)	(12.0		)
Loss on reinsurance transaction:
Corporate operations	—			(75.4		)	—			(75.4		)
Income (loss) before income taxes:
Bankers Life	124.1			98.1			331.3			221.5
Washington National	34.0			25.4			87.2			99.5
Colonial Penn	10.0			1.2			17.5			(3.1		)
Long-term care in run-off	5.7			—			8.9			—
Corporate operations	(43.9		)	(75.4		)	(89.8		)	(145.4		)
Income before income taxes	$	129.9		$	49.3		$	355.1		$	172.5

64

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

____________________

(a) These non-GAAP measures as presented in the above table and in the following segment financial data and discussions of segment results exclude net realized investment gains (losses), fair value changes in embedded derivative liabilities, net of related amortization, fair value changes and an amendment to the agent deferred compensation plan, earnings attributable to VIEs and loss on reinsurance transaction and before income taxes.  These are considered non-GAAP financial measures.  A non-GAAP measure is a numerical measure of a company's performance, financial position, or cash flows that excludes or includes amounts that are normally excluded or included in the most directly comparable measure calculated and presented in accordance with GAAP.

These non-GAAP financial measures of "pre-tax operating earnings" differ from "income (loss) before income taxes" as presented in our consolidated statement of operations prepared in accordance with GAAP due to the exclusion of realized investment gains (losses), fair value changes in embedded derivative liabilities, net of related amortization, fair value changes and an amendment to the agent deferred compensation plan, earnings attributable to VIEs and loss on reinsurance transaction.  We measure segment performance excluding these items because we believe that this performance measure is a better indicator of the ongoing businesses and trends in our business. Our primary investment focus is on investment income to support our liabilities for insurance products as opposed to the generation of realized investment gains (losses), and a long-term focus is necessary to maintain profitability over the life of the business. Realized investment gains (losses), fair value changes in embedded derivative liabilities, fair value changes and an amendment to the agent deferred compensation plan, earnings attributable to VIEs and loss on reinsurance transaction depend on market conditions and do not necessarily relate to decisions regarding the underlying business of our segments.  However, "pre-tax operating earnings" does not replace "income (loss) before income taxes" as a measure of overall profitability.

We may experience realized investment gains (losses), which may affect future earnings levels since our underlying business is long-term in nature and we need to earn the assumed interest rates on the investments backing our liabilities for insurance products to maintain the profitability of our business.  In addition, management uses this non-GAAP financial measure in its budgeting process, financial analysis of segment performance and in assessing the allocation of resources. We believe these non-GAAP financial measures enhance an investor's understanding of our financial performance and allows them to make more informed judgments about the Company as a whole.  These measures also highlight operating trends that might not otherwise be apparent.  The table above reconciles the non-GAAP measure to the corresponding GAAP measure.

General: CNO is the top tier holding company for a group of insurance companies operating throughout the United States that develop, market and administer health insurance, annuity, individual life insurance and other insurance products. We distribute these products through our Bankers Life segment, which utilizes a career agency force, through our Washington National segment, which utilizes independent producers and through our Colonial Penn segment, which utilizes direct response marketing. In the fourth quarter of 2016, we began reporting as an additional business segment, the long-term care block that was recaptured in September 2016.

65

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

Bankers Life (dollars in millions)

	Three months ended						Nine months ended
	September 30,						September 30,
	2017			2016			2017			2016
Premium collections:
Annuities	$	236.5		$	245.1		$	758.3		$	685.1
Medicare supplement and other supplemental health	291.5			305.4			906.4			922.4
Life	113.7			115.4			345.4			347.3
Total collections	$	641.7		$	665.9		$	2,010.1		$	1,954.8
Average liabilities for insurance products:
Fixed index annuities	$	5,222.5		$	4,597.1		$	5,048.2		$	4,461.9
Fixed interest annuities	2,860.5			3,149.7			2,935.9			3,222.7
SPIAs and supplemental contracts:
Mortality based	159.2			172.7			162.1			177.1
Deposit based	148.1			152.9			149.8			154.0
Health:
Long-term care	5,038.4			5,161.2			4,950.4			4,985.4
Medicare supplement	329.8			333.0			336.7			335.9
Other health	56.5			50.8			55.3			49.7
Life:
Interest sensitive	785.6			722.7			771.7			706.2
Non-interest sensitive	1,099.1			1,027.9			1,080.8			1,009.1
Total average liabilities for insurance products, net of reinsurance ceded	$	15,699.7		$	15,368.0		$	15,490.9		$	15,102.0
Revenues:
Insurance policy income	$	414.6		$	413.7		$	1,252.8		$	1,246.5
Net investment income:
General account invested assets	242.1			229.1			710.9			676.2
Fixed index products	28.5			15.6			89.5			10.6
Fee revenue and other income	11.3			9.6			32.5			23.5
Total revenues	696.5			668.0			2,085.7			1,956.8
Expenses:
Insurance policy benefits	364.7			368.4			1,089.9			1,098.7
Amounts added to policyholder account balances:
Cost of interest credited to policyholders	26.3			27.7			79.3			83.3
Cost of options to fund index credits, net of forfeitures	16.0			15.7			47.1			49.2
Market value changes credited to policyholders	30.2			15.3			91.4			9.7
Amortization related to operations	38.7			43.8			126.3			135.3
Interest expense on investment borrowings	5.3			3.5			14.3			9.4
Other operating costs and expenses	108.4			105.5			328.2			312.2
Total benefits and expenses	589.6			579.9			1,776.5			1,697.8
Income before net realized investment gains (losses), net of related amortization, and fair value changes in embedded derivative liabilities, net of related amortization, and income taxes	106.9			88.1			309.2			259.0
Net realized investment gains (losses)	15.6			.9			31.1			(.7		)
Amortization related to net realized investment gains (losses)	(.7		)	(.2		)	(1.0		)	(.6		)
Net realized investment gains (losses), net of related amortization	14.9			.7			30.1			(1.3		)
Insurance policy benefits - fair value changes in embedded derivative liabilities	2.8			11.6			(9.8		)	(45.7		)
Amortization related to fair value changes in embedded derivative liabilities	(.5		)	(2.3		)	1.8			9.5
Fair value changes in embedded derivative liabilities, net of related amortization	2.3			9.3			(8.0		)	(36.2		)
Income before income taxes	$	124.1		$	98.1		$	331.3		$	221.5

66

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

	Three months ended						Nine months ended
	September 30,						September 30,
	2017			2016			2017			2016
Health benefit ratios:
All health lines:
Insurance policy benefits	$	291.3		$	301.2		$	863.0		$	896.2
Benefit ratio (a)	94.8		%	97.0		%	93.1		%	96.0		%
Medicare supplement:
Insurance policy benefits	$	140.0		$	140.5		$	414.1		$	418.7
Benefit ratio (a)	72.0		%	72.5		%	70.8		%	72.2		%
Long-term care:
Insurance policy benefits	$	151.3		$	160.7		$	448.9		$	477.5
Benefit ratio (a)	134.2		%	137.7		%	131.2		%	135.1		%
Interest-adjusted benefit ratio (b)	72.9		%	77.7		%	70.5		%	76.9		%

______________

(a) We calculate benefit ratios by dividing the related product's insurance policy benefits by insurance policy income.

(b) We calculate the interest-adjusted benefit ratio (a non-GAAP measure) for Bankers Life's long-term care products by dividing such product's insurance policy benefits less the imputed interest income on the accumulated assets backing the insurance liabilities by policy income. These are considered non-GAAP financial measures. A non-GAAP measure is a numerical measure of a company's performance, financial position, or cash flows that excludes or includes amounts that are normally excluded or included in the most directly comparable measure calculated and presented in accordance with GAAP.

These non-GAAP financial measures of "interest-adjusted benefit ratios" differ from "benefit ratios" due to the deduction of imputed interest income on the accumulated assets backing the insurance liabilities from the product's insurance policy benefits used to determine the ratio. Interest income is an important factor in measuring the performance of health products that are expected to be inforce for a longer duration of time, are not subject to unilateral changes in provisions (such as non-cancelable or guaranteed renewable contracts) and require the performance of various functions and services (including insurance protection) for an extended period of time. The net cash flows from long-term care products generally cause an accumulation of amounts in the early years of a policy (accounted for as reserve increases) that will be paid out as benefits in later policy years (accounted for as reserve decreases). Accordingly, as the policies age, the benefit ratio will typically increase, but the increase in benefits will be partially offset by the imputed interest income earned on the accumulated assets. The interest-adjusted benefit ratio reflects the effects of such interest income offset (which is equal to the tabular interest on the related insurance liabilities). Since interest income is an important factor in measuring the performance of this product, management believes a benefit ratio that includes the effect of interest income is useful in analyzing product performance. We utilize the interest-adjusted benefit ratio in measuring segment performance because we believe that this performance measure is a better indicator of the ongoing businesses and trends in the business. However, the "interest-adjusted benefit ratio" does not replace the "benefit ratio" as a measure of current period benefits to current period insurance policy income. Accordingly, management reviews both "benefit ratios" and "interest-adjusted benefit ratios" when analyzing the financial results attributable to these products. The imputed investment income earned on the accumulated assets backing Bankers Life's long-term care reserves was $69.1 million and $70.1 million in the three months ended September 30, 2017 and 2016, respectively, and was $207.6 million and $205.6 million in the nine months ended September 30, 2017 and 2016, respectively.

Total premium collections were $641.7 million in the third quarter of 2017, down 3.6 percent from 2016, and were $2,010.1 million in the first nine months of 2017, up 2.8 percent from 2016. See "Premium Collections" for further analysis of Bankers Life's premium collections.

Average liabilities for insurance products, net of reinsurance ceded were $15.7 billion in the third quarter of 2017, up 2.2 percent from 2016, and were $15.5 billion in the first nine months of 2017, up 2.6 percent from 2016. Such average liabilities for long-term care products were increased by $154.7 million and $337.8 million in the third quarters of 2017 and

67

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

2016, respectively, and $75.9 million and $182.0 million in the first nine months of 2017 and 2016, respectively, to reflect the premium deficiencies that would exist if unrealized gains on the assets backing such products had been realized and the proceeds from the sales of such assets were invested at then current yields. Such increase is reflected as a reduction of accumulated other comprehensive income. Excluding the impact of the aforementioned item, the increase in average liabilities for insurance products was primarily due to new sales and the amounts added to policyholder account balances on interest-sensitive products.

Insurance policy income is comprised of premiums earned on policies which provide mortality or morbidity coverage and fees and other charges assessed on other policies.

Net investment income on general account invested assets (which excludes income on policyholder portfolios) was $242.1 million in the third quarter of 2017, up 5.7 percent from 2016, and was $710.9 million in the first nine months of 2017, up 5.1 percent from 2016. In the three and nine months ended September 30, 2017, net investment income reflects $3 million and $14 million, respectively, of higher investment income from alternative investments compared to the 2016 periods. Such increases reflect higher returns from credit and equity related strategies and a larger average alternative investment portfolio in the 2017 periods. Prepayment income (including call premiums) was $14.1 million and $2.3 million in the third quarters of 2017 and 2016, respectively, and was $21.9 million and $8.8 million in the first nine months of 2017 and 2016, respectively.

Net investment income related to fixed index products represents the change in the estimated fair value of options which are purchased in an effort to offset or hedge certain potential benefits accruing to the policyholders of our fixed index products. Our fixed index products are designed so that investment income spread is expected to be more than adequate to cover the cost of the options and other costs related to these policies.  Net investment income related to fixed index products was $28.5 million and $15.6 million in the third quarters of 2017 and 2016, respectively, and was $89.5 million and $10.6 million in the first nine months of 2017 and 2016, respectively. Such amounts were substantially offset by the corresponding charge (credit) to amounts added to policyholder account balances - market value changes credited to policyholders.Such income and related charges fluctuate based on the value of options embedded in the segment's fixed index annuity policyholder account balances subject to this benefit and to the performance of the index to which the returns on such products are linked.

Fee revenue and other income was $11.3 million and $9.6 million in the third quarters of 2017 and 2016, respectively, and was $32.5 million and $23.5 million in the first nine months of 2017 and 2016, respectively. The increase in the 2017 periods is attributable to fee income earned by our broker-dealer and registered investment advisor subsidiaries and revenues earned related to sales of Medicare Advantage products of other insurance companies.

Insurance policy benefits fluctuated as a result of the factors summarized below for benefit ratios.  Benefit ratios are calculated by dividing the related insurance product’s insurance policy benefits by insurance policy income.

The Medicare supplement business consists of both individual and group policies.  Government regulations generally require us to attain and maintain a ratio of total benefits incurred to total premiums earned (excluding changes in policy benefit reserves), after three years from the original issuance of the policy and over the lifetime of the policy, of not less than 65 percent on individual products and not less than 75 percent on group products, as determined in accordance with statutory accounting principles.  Since the insurance product liabilities we establish for Medicare supplement business are subject to significant estimates, the ultimate claim liability we incur for a particular period is likely to be different than our initial estimate. Our benefit ratios were 72.0 percent and 72.5 percent in the third quarters of 2017 and 2016, respectively, and were 70.8 percent and 72.2 percent in the first nine months of 2017 and 2016, respectively. The benefit ratio in the 2017 periods reflected favorable claim experience compared to the 2016 periods. We currently expect the Medicare supplement benefit ratio to be in the range of 70 percent to 73 percent during the fourth quarter of 2017.

The net cash flows from our long-term care products generally cause an accumulation of amounts in the early years of a policy (accounted for as reserve increases) which will be paid out as benefits in later policy years (accounted for as reserve decreases). Accordingly, as the policies age, the benefit ratio typically increases, but the increase in reserves is partially offset by investment income earned on the accumulated assets.  The benefit ratio on our long-term care business in the Bankers Life segment was 134.2 percent and 137.7 percent in the third quarters of 2017 and 2016, respectively, and was 131.2 percent and 135.1 percent in the first nine months of 2017 and 2016, respectively.  The interest-adjusted benefit ratio on this business was 72.9 percent and 77.7 percent in the third quarters of 2017 and 2016, respectively, and was 70.5 percent and 76.9 percent in the first nine months of 2017 and 2016, respectively.  The interest-adjusted benefit ratio in the first nine months of 2017 was

68

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

favorably impacted by $11.6 million of one-time reserve releases which was comprised of: (i) $6.5 million recognized in the second quarter of 2017 related to lower persistency (including the results of procedures performed to identify policies that had terminated prior to June 30, 2017 due to death); (ii) $1.7 million related to an out-of-period adjustment recognized in the second quarter of 2017 that reduced reserves; and (iii) $3.4 million related to the impact of policyholder decisions to surrender or reduce coverage following rate increases (such amount was not significant in the third quarter of 2017 and had no impact on the interest-adjusted benefit ratio). Such ratio in the third quarter of 2016 was favorably impacted by $6 million of reserve releases related to policyholder decisions to surrender or reduce coverage following rate increases. The interest-adjusted benefit ratio in the third quarter of 2016, excluding these favorable reserve releases was 82.6 percent. The interest-adjusted benefit ratio in the first nine months of 2017 and 2016, was favorably impacted by the aforementioned reserve releases of $12 million and $19 million, respectively. The interest-adjusted benefit ratio in the first nine months of 2017 and 2016, excluding these favorable reserve releases was 73.9 percent and 82.4 percent, respectively. The interest-adjusted benefit ratio in the three and nine months ended September 30, 2017 also reflected no increase to the future loss reserve, given the outcome of the year-end 2016 actuarial review, compared to an $8.4 million and $25.4 million increase in the three and nine months ended September 30, 2016, respectively. We currently expect the long-term care interest-adjusted benefit ratio to be in the range of 75 percent to 80 percent during the fourth quarter of 2017, excluding the reserve-related impacts of rate increase actions. We expect that the rate increases will have a minor impact on the interest-adjusted benefit ratio in the fourth quarter of 2017.

Amounts added to policyholder account balances - cost of interest credited to policyholders were $26.3 million and $27.7 million in the third quarters of 2017 and 2016, respectively, and were $79.3 million and $83.3 million in the first nine months of 2017 and 2016, respectively. The weighted average crediting rate for these products was 2.8 percent in both the third quarters of 2017 and 2016 and the first nine months of 2017 and 2016. The average liabilities of the fixed interest annuity block were $2.9 billion and $3.2 billion in the first nine months of 2017 and 2016, respectively. The decrease in the liabilities related to these annuities reflects the lower sales of these products in the current low interest rate environment and consumer preference for fixed index products.

Amounts added to policyholder account balances for fixed index products represent a guaranteed minimum rate of return and a higher potential return that is based on a percentage (the "participation rate") of the amount of increase in the value of a particular index, such as the S&P 500 Index, over a specified period. Such amounts include our cost to fund the annual index credits, net of policies that are canceled prior to their anniversary date (classified as cost of options to fund index credits, net of forfeitures). Market value changes in the underlying indices during a specified period of time are classified as market value changes credited to policyholders. Such market value changes are generally offset by the net investment income related to fixed index products discussed above.

Amortization related to operations includes amortization of deferred acquisition costs and the present value of future profits. Deferred acquisition costs and the present value of future profits are collectively referred to as "insurance acquisition costs". Insurance acquisition costs are generally amortized either:  (i) in relation to the estimated gross profits for interest-sensitive life and annuity products; or (ii) in relation to actual and expected premium revenue for other products.  In addition, for interest-sensitive life and annuity products, we are required to adjust the total amortization recorded to date through the statement of operations if actual experience or other evidence suggests that earlier estimates of future gross profits should be revised. Accordingly, amortization for interest-sensitive life and annuity products is dependent on the profits realized during the period and on our expectation of future profits.  For other products, we amortize insurance acquisition costs in relation to actual and expected premium revenue, and amortization is only adjusted if expected premium revenue changes or if we determine the balance of these costs is not recoverable from future profits.  Bankers Life’s amortization expense was $38.7 million and $43.8 million in the third quarters of 2017 and 2016, respectively, and was $126.3 million and $135.3 million in the first nine months of 2017 and 2016, respectively. The lower amortization in the 2017 periods generally reflects the favorable persistency experienced as compared to the prior year.

Interest expense on investment borrowings represents interest expense on collateralized borrowings as further described in the note to the consolidated financial statements entitled "Investment Borrowings". The increase in interest expense in the 2017 periods is primarily due to higher interest rates on the variable rate investment borrowings.

69

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

Other operating costs and expenses in our Bankers Life segment were $108.4 million in the third quarter of 2017, up 2.7 percent from 2016, and were $328.2 million in the first nine months of 2017, up 5.1 percent from 2016. Such expenses in the first nine months of 2017 include $3.5 million for estimated future state guaranty association assessments, net of premium tax offsets, related to the liquidation of Penn Treaty Network America Insurance Company ("Penn Treaty"). Other operating costs and expenses include the following (dollars in millions):

	Three months ended				Nine months ended
	September 30,				September 30,
	2017		2016		2017		2016
Commission expense and agent manager benefits	$	17.3	$	19.8	$	53.5	$	52.3
Other operating expenses	91.1		85.7		274.7		259.9
Total	$	108.4	$	105.5	$	328.2	$	312.2

Net realized investment gains (losses) fluctuate from period to period. During the first nine months of 2017, we recognized net realized investment gains of $31.1 million, which were comprised of: (i) $22.2 million of net gains from the sales of investments; and (ii) the increase in fair value of certain fixed maturity investments with embedded derivatives of $8.9 million. During the first nine months of 2016, we recognized net realized investment losses of $.7 million, which were comprised of: (i) $17.6 million of net gains from the sales of investments; (ii) the increase in fair value of certain fixed maturity investments with embedded derivatives of $.1 million; and (iii) $18.4 million of writedowns of investments for other than temporary declines in fair value recognized through net income.

Amortization related to net realized investment gains (losses) is the increase or decrease in the amortization of insurance acquisition costs which results from realized investment gains or losses. When we sell securities which back our interest-sensitive life and annuity products at a gain (loss) and reinvest the proceeds at a different yield, we increase (reduce) the amortization of insurance acquisition costs in order to reflect the change in estimated gross profits due to the gains (losses) realized and the resulting effect on estimated future yields. Sales of fixed maturity investments resulted in an increase in the amortization of insurance acquisition costs of $.7 million and $.2 million in the third quarters of 2017 and 2016, respectively, and $1.0 million and $.6 million in the first nine months of 2017 and 2016, respectively.

Insurance policy benefits - fair value changes in embedded derivative liabilities represents fair value changes due to fluctuations in the interest rates used to discount embedded derivative liabilities related to our fixed index annuities.

Amortization related to fair value changes in embedded derivative liabilities is the increase or decrease in the amortization of insurance acquisition costs which results from changes in interest rates used to discount embedded derivative liabilities related to our fixed index annuities.

70

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

Washington National (dollars in millions)

	Three months ended						Nine months ended
	September 30,						September 30,
	2017			2016			2017		2016
Premium collections:
Supplemental health and other health	$	145.2		$	141.5		$	443.2	$	425.3
Medicare supplement	11.7			14.6			38.7		46.1
Life	7.1			7.1			22.3		21.7
Annuity	.2			.2			.6		1.0
Total collections	$	164.2		$	163.4		$	504.8	$	494.1
Average liabilities for insurance products:
Fixed index annuities	$	309.9		$	346.0		$	317.9	$	355.1
Fixed interest annuities	96.6			105.6			98.9		108.4
SPIAs and supplemental contracts:
Mortality based	231.8			251.9			232.5		250.4
Deposit based	267.8			267.1			269.7		266.5
Separate Accounts	4.8			4.7			4.7		4.7
Health:
Supplemental health	2,749.9			2,621.7			2,715.3		2,589.1
Medicare supplement	23.9			27.8			25.4		28.5
Other health	13.4			14.1			13.7		14.2
Life:
Interest sensitive	148.9			150.3			149.0		150.5
Non-interest sensitive	174.1			178.9			174.2		180.6
Total average liabilities for insurance products, net of reinsurance ceded	$	4,021.1		$	3,968.1		$	4,001.3	$	3,948.0
Revenues:
Insurance policy income	$	167.4		$	164.4		$	502.0	$	490.0
Net investment income:
General account invested assets	65.5			66.0			193.7		190.3
Fixed index products	2.0			1.5			5.8		.3
Trading account income (loss) related to policyholder accounts	.5			(.4		)	2.4		.7
Fee revenue and other income	.3			.4			.8		1.0
Total revenues	235.7			231.9			704.7		682.3
Expenses:
Insurance policy benefits	138.0			138.7			415.7		405.6
Amounts added to policyholder account balances:
Cost of interest credited to policyholders	3.2			3.3			9.7		10.3
Cost of options to fund index credits, net of forfeitures	1.2			1.2			3.2		4.4
Market value changes credited to policyholders	2.3			1.3			8.1		1.7
Amortization related to operations	14.3			14.3			43.9		44.5
Interest expense on investment borrowings	1.7			.9			4.5		2.5
Other operating costs and expenses	47.5			47.0			145.0		140.3
Total benefits and expenses	208.2			206.7			630.1		609.3
Income before net realized investment gains and fair value changes in embedded derivative liabilities, net of related amortization, and income taxes	27.5			25.2			74.6		73.0
Net realized investment gains	6.5			.1			12.6		27.2
Amortization related to net realized investment gains	—			—			—		(.3		)
Net realized investment gains, net of related amortization	6.5			.1			12.6		26.9
Insurance policy benefits - fair value changes in embedded derivative liabilities	.1			.5			—		(1.3		)
Amortization related to fair value changes in embedded derivative liabilities	(.1		)	(.4		)	—		.9
Fair value changes in embedded derivative liabilities, net of related amortization	—			.1			—		(.4		)
Income before income taxes	$	34.0		$	25.4		$	87.2	$	99.5

71

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

	Three months ended						Nine months ended
	September 30,						September 30,
	2017			2016			2017			2016
Health benefit ratios:
Medicare supplement:
Insurance policy benefits	$	9.1		$	10.7		$	28.3		$	33.0
Benefit ratio (a)	68.1		%	69.5		%	68.4		%	69.5		%
Supplemental health and other:
Insurance policy benefits	$	122.4		$	118.8		$	369.2		$	352.6
Benefit ratio (a)	83.2		%	84.0		%	84.1		%	83.6		%
Interest-adjusted benefit ratio (b)	59.0		%	59.8		%	60.0		%	59.7		%

_________________

(a) We calculate benefit ratios by dividing the related product’s insurance policy benefits by insurance policy income.

(b) We calculate the interest-adjusted benefit ratio (a non-GAAP measure) for Washington National's supplemental health products by dividing such product’s insurance policy benefits less the imputed interest income on the accumulated assets backing the insurance liabilities by policy income.  These are considered non-GAAP financial measures.  A non-GAAP measure is a numerical measure of a company's performance, financial position, or cash flows that excludes or includes amounts that are normally excluded or included in the most directly comparable measure calculated and presented in accordance with GAAP.

These non-GAAP financial measures of "interest-adjusted benefit ratios" differ from "benefit ratios" due to the deduction of imputed interest income on the accumulated assets backing the insurance liabilities from the product’s insurance policy benefits used to determine the ratio.  Interest income is an important factor in measuring the performance of health products that are expected to be inforce for a longer duration of time, are not subject to unilateral changes in provisions (such as non-cancelable or guaranteed renewable contracts) and require the performance of various functions and services (including insurance protection) for an extended period of time.  The net cash flows from supplemental health products generally cause an accumulation of amounts in the early years of a policy (accounted for as reserve increases) that will be paid out as benefits in later policy years (accounted for as reserve decreases).  Accordingly, as the policies age, the benefit ratio will typically increase, but the increase in benefits will be partially offset by the imputed interest income earned on the accumulated assets.  The interest-adjusted benefit ratio reflects the effects of such interest income offset (which is equal to the tabular interest on the related insurance liabilities). Since interest income is an important factor in measuring the performance of these products, management believes a benefit ratio that includes the effect of interest income is useful in analyzing product performance.  We utilize the interest-adjusted benefit ratio in measuring segment performance because we believe that this performance measure is a better indicator of the ongoing businesses and trends in the business.  However, the "interest-adjusted benefit ratio" does not replace the "benefit ratio" as a measure of current period benefits to current period insurance policy income. Accordingly, management reviews both "benefit ratios" and "interest-adjusted benefit ratios" when analyzing the financial results attributable to these products.  The imputed investment income earned on the accumulated assets backing the supplemental health reserves was $35.6 million and $34.3 million in the three months ended September 30, 2017 and 2016, respectively, and was $105.7 million and $100.9 million in the nine months ended September 30, 2017 and 2016, respectively.

Total premium collections were $164.2 million in the third quarter of 2017, up .5 percent from 2016, and were $504.8 million in the first nine months of 2017, up 2.2 percent from 2016, driven by sales and persistency of the segment's supplemental health block; partially offset by lower Medicare supplement collected premiums due to the run-off of this block of business. This segment no longer markets Medicare supplement products and no longer actively pursues sales of annuity products. See "Premium Collections" for further analysis of fluctuations in premiums collected by product.

Average liabilities for insurance products, net of reinsurance ceded were $4.0 billion in the third quarter of 2017, up 1.3 percent from 2016, and were $4.0 billion in the first nine months of 2017, up 1.4 percent from 2016, reflecting an increase in the supplemental health block; partially offset by the run-off of the annuity blocks.

72

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

Insurance policy income is comprised of premiums earned on traditional insurance policies which provide mortality or morbidity coverage and fees and other charges assessed on other policies. Such income increased in recent periods as supplemental health premiums have increased consistent with sales; partially offset by the decrease in Medicare supplement premiums.

Net investment income on general account invested assets (which excludes income on policyholder portfolios) was $65.5 million in the third quarter of 2017, down .8 percent from 2016, and was $193.7 million in the first nine months of 2017, up 1.8 percent from 2016. Prepayment income (including call premiums) was $2.6 million and $2.7 million in the third quarters of 2017 and 2016, respectively, and was $4.7 million and $4.3 million in the first nine months of 2017 and 2016, respectively.

Net investment income related to fixed index products represents the change in the estimated fair value of options which are purchased in an effort to offset or hedge certain potential benefits accruing to the policyholders of our fixed index products. Our fixed index products are designed so that investment income spread is expected to be more than adequate to cover the cost of the options and other costs related to these policies. Net investment income related to fixed index products was $2.0 million and $1.5 million in the third quarters of 2017 and 2016, respectively, and was $5.8 million and $.3 million in the first nine months of 2017 and 2016, respectively. Such amounts were substantially offset by the corresponding charge to amounts added to policyholder account balances - market value changes credited to policyholders.  Such income and related charges fluctuate based on the value of options embedded in the segment's fixed index annuity policyholder account balances subject to this benefit and to the performance of the index to which the returns on such products are linked.

Trading account income related to policyholder accounts represents the income on investments backing the market strategies of certain annuity products which provide for different rates of cash value growth based on the experience of a particular market strategy. The income on our trading account securities is designed to substantially offset certain amounts included in insurance policy benefits related to the aforementioned annuity products.

Insurance policy benefits fluctuated as a result of the factors summarized below. Benefit ratios are calculated by dividing the related insurance product's insurance policy benefits by insurance policy income.

Washington National's supplemental health products (including specified disease, accident and hospital indemnity products) generally provide fixed or limited benefits. For example, payments under cancer insurance policies are generally made directly to, or at the direction of, the policyholder following diagnosis of, or treatment for, a covered type of cancer. Approximately three-fourths of our supplemental health policies inforce (based on policy count) are sold with return of premium or cash value riders. The return of premium rider generally provides that after a policy has been inforce for a specified number of years or upon the policyholder reaching a specified age, we will pay to the policyholder, or a beneficiary under the policy, the aggregate amount of all premiums paid under the policy, without interest, less the aggregate amount of all claims incurred under the policy. The cash value rider is similar to the return of premium rider, but also provides for payment of a graded portion of the return of premium benefit if the policy terminates before the return of premium benefit is earned. Accordingly, the net cash flows from these products generally result in the accumulation of amounts in the early years of a policy (reflected in our earnings as reserve increases) which will be paid out as benefits in later policy years (reflected in our earnings as reserve decreases which offset the recording of benefit payments). As the policies age, the benefit ratio will typically increase, but the increase in benefits will be partially offset by investment income earned on the accumulated assets. The benefit ratio will fluctuate depending on the claim experience during the year.

Insurance margins (insurance policy income less insurance policy benefits) on supplemental health products were $24.8 million and $22.6 million in the third quarters of 2017 and 2016, respectively, and were $69.9 million and $68.9 million in the first nine months of 2017 and 2016, respectively. The higher margins in the 2017 periods primarily reflects the growth in the block. The interest-adjusted benefit ratio on this supplemental health business was 59.0 percent and 59.8 percent in the third quarters of 2017 and 2016, respectively, and was 60.0 percent and 59.7 percent in the first nine months of 2017 and 2016, respectively. We continue to expect the supplemental health interest-adjusted benefit ratio to be in the range of 58 percent to 61 percent during the fourth quarter of 2017.

Washington National's Medicare supplement business primarily consists of individual policies. The insurance product liabilities we establish for our Medicare supplement business are subject to significant estimates and the ultimate claim liability we incur for a particular period is likely to be different than our initial estimate.  Governmental regulations generally require us

73

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

to attain and maintain a ratio of total benefits incurred to total premiums earned (excluding changes in policy benefit reserves), after three years from the original issuance of the policy and over the lifetime of the policy, of not less than 65 percent on these products, as determined in accordance with statutory accounting principles. Insurance margins (insurance policy income less insurance policy benefits) on these products were $4.2 million and $4.7 million in the third quarters of 2017 and 2016, respectively, and were $13.0 million and $14.5 million in the first nine months of 2017 and 2016, respectively. Such decrease reflects the run-off of this block of business.

Amounts added to policyholder account balances - cost of interest credited to policyholders were $3.2 million and $3.3 million in the third quarters of 2017 and 2016, respectively, and were $9.7 million and $10.3 million in the first nine months of 2017 and 2016, respectively.

Amounts added to policyholder account balances for fixed index products represent a guaranteed minimum rate of return and a higher potential return that is based on a percentage (the "participation rate") of the amount of increase in the value of a particular index, such as the S&P 500 Index, over a specified period. Such amounts include our cost to fund the annual index credits, net of policies that are canceled prior to their anniversary date (classified as cost of options to fund index credits, net of forfeitures). Market value changes in the underlying indices during a specified period of time are classified as market value changes credited to policyholders. Such market value changes are generally offset by the net investment income related to fixed index products discussed above.

Amortization related to operations includes amortization of insurance acquisition costs. Insurance acquisition costs are generally amortized in relation to actual and expected premium revenue, and amortization is only adjusted if expected premium revenue changes or if we determine the balance of these costs is not recoverable from future profits. Such amounts were generally consistent with the related premium revenue. A revision to our current assumptions could result in increases or decreases to amortization expense in future periods. Washington National's amortization expense was $14.3 million in both the third quarters of 2017 and 2016, and was $43.9 million and $44.5 million in the first nine months of 2017 and 2016, respectively.

Interest expense on investment borrowings represents interest expense on collateralized borrowings as further described in the note to the consolidated financial statements entitled "Investment Borrowings". The increase in interest expense in the 2017 periods is due to higher interest rates on the variable rate investment borrowings.

Other operating costs and expenses were $47.5 million and $47.0 million in the third quarters of 2017 and 2016, respectively, and were $145.0 million and $140.3 million in the first nine months of 2017 and 2016, respectively. Such expenses in the first nine months of 2017 include $1.3 million for estimated future state guaranty association assessments, net of premium tax offsets, related to the liquidation of Penn Treaty. Other operating costs and expenses also include commission expense of $17.8 million and $17.7 million in the third quarters of 2017 and 2016, respectively, and $51.9 million and $52.6 million in the first nine months of 2017 and 2016, respectively.

Net realized investment gains (losses) fluctuate each period. During the first nine months of 2017, we recognized net realized investment gains of $12.6 million, which were comprised of: (i) $7.7 million of net gains from the sales of investments; (ii) the increase in fair value of certain fixed maturity investments with embedded derivatives of $3.0 million; (iii) the increase in fair value of embedded derivatives related to a modified coinsurance agreement of $2.4 million; and (iv) $.5 million of writedowns of investments for other than temporary declines in fair value which were recorded in earnings. During the first nine months of 2016, we recognized net realized investment gains of $27.2 million, which were comprised of: (i) $24.3 million of net gains from the sales of investments; (ii) the increase in fair value of certain fixed maturity investments with embedded derivatives of $.6 million; (iii) the increase in fair value of embedded derivatives related to a modified coinsurance agreement of $6.7 million; and (iv) $4.4 million of writedowns of investments for other than temporary declines in fair value recognized through net income.

Amortization related to net realized investment gains (losses) is the increase or decrease in the amortization of insurance acquisition costs which results from realized investment gains or losses. When we sell securities which back our interest-sensitive life and annuity products at a gain (loss) and reinvest the proceeds at a different yield (or when we have the intent to sell the impaired investments before an anticipated recovery in value occurs), we increase (reduce) the amortization of insurance acquisition costs in order to reflect the change in estimated gross profits due to the gains (losses) realized and the

74

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

resulting effect on estimated future yields. Sales of fixed maturity investments resulted in an increase in the amortization of insurance acquisition costs of $.3 million in the first nine months of 2016.

Insurance policy benefits - fair value changes in embedded derivative liabilities represents fair value changes due to fluctuations in the interest rates used to discount embedded derivative liabilities related to our fixed index annuities.

Amortization related to fair value changes in embedded derivative liabilities is the increase or decrease in the amortization of insurance acquisition costs which results from changes in interest rates used to discount embedded derivative liabilities related to our fixed index annuities.

75

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

Colonial Penn (dollars in millions)

	Three months ended				Nine months ended
	September 30,				September 30,
	2017		2016		2017		2016
Premium collections:
Life	$	72.2	$	70.1	$	218.1	$	208.6
Supplemental health	.4		.6		1.5		1.8
Total collections	$	72.6	$	70.7	$	219.6	$	210.4
Average liabilities for insurance products:
SPIAs - mortality based	$	73.6	$	76.1	$	73.0	$	73.8
Health:
Medicare supplement	5.6		6.4		5.8		6.6
Other health	4.1		4.2		4.1		4.3
Life:
Interest sensitive	15.4		16.3		15.6		16.2
Non-interest sensitive	720.1		691.9		714.3		685.8
Total average liabilities for insurance products, net of reinsurance ceded	$	818.8	$	794.9	$	812.8	$	786.7
Revenues:
Insurance policy income	$	73.1	$	70.9	$	219.1	$	210.5
Net investment income on general account invested assets	11.0		11.1		33.1		33.0
Fee revenue and other income	.3		.2		.9		.8
Total revenues	84.4		82.2		253.1		244.3
Expenses:
Insurance policy benefits	47.5		50.1		150.3		150.8
Amounts added to annuity and interest-sensitive life product account balances	.2		.2		.5		.5
Amortization related to operations	3.9		3.7		11.9		11.3
Interest expense on investment borrowings	.3		.1		.7		.4
Other operating costs and expenses	23.5		27.2		73.0		84.2
Total benefits and expenses	75.4		81.3		236.4		247.2
Income (loss) before net realized investment gains (losses) and income taxes	9.0		.9		16.7		(2.9		)
Net realized investment gains (losses)	1.0		.3		.8		(.2		)
Income (loss) before income taxes	$	10.0	$	1.2	$	17.5	$	(3.1	)

This segment's results are significantly impacted by the accounting standard related to deferred acquisition costs. We are not able to defer most of Colonial Penn's direct response advertising costs although such costs generate predictable sales and future in-force profits. We plan to continue to invest in this segment's business, including the development of new products and markets. The amount of our investment in new business during a particular period will have a significant impact on this segment's results. We currently expect this segment to report earnings (before net realized investment gains (losses) and income taxes) in 2017 in the range of $18 million to $23 million (or $15 million to $20 million, excluding the favorable impact of $3.0 million related to an out-of-period adjustment and refinement to liabilities for insurance products recognized in the third quarter of 2017).

76

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

Total premium collections were $72.6 million in the third quarter of 2017, up 2.7 percent from 2016, and were $219.6 million in the first nine months of 2017, up 4.4 percent from 2016. The increase was driven by recent sales activity and steady persistency. See "Premium Collections" for further analysis of Colonial Penn's premium collections.

Average liabilities for insurance products, net of reinsurance ceded have increased as a result of growth in the core graded benefit and simplified issue life insurance block in this segment.

Insurance policy income is comprised of premiums earned on policies which provide mortality or morbidity coverage and fees and other charges assessed on other policies. The increase in such income reflects the growth in the block of graded benefit and simplified issue life insurance business.

Net investment income on general account invested assets in the 2017 periods was comparable to the corresponding periods in 2016.

Insurance policy benefits in the 2017 periods reflect: (i) growth in this segment; (ii) the favorable changes to liabilities for insurance products including a $2.5 million out-of-period adjustment and a $.5 million refinement to the calculation; and (iii) favorable mortality as compared to the corresponding periods in 2016.

Amortization related to operations includes amortization of insurance acquisition costs. Insurance acquisition costs in the Colonial Penn segment are amortized in relation to actual and expected premium revenue, and amortization is only adjusted if expected premium revenue changes or if we determine the balance of these costs is not recoverable from future profits. Such amounts were generally consistent with the related premium revenue and gross profits for such periods and the assumptions we made when we established the present value of future profits. A revision to our current assumptions could result in increases or decreases to amortization expense in future periods.

Other operating costs and expenses in our Colonial Penn segment fluctuate primarily due to changes in the marketing expenses incurred to generate new business. Marketing expenses were lower in the 2017 periods as compared to the corresponding periods in 2016. The demand and cost of television advertising appropriate for Colonial Penn's campaigns has fluctuated widely in certain periods. In the first nine months of 2017, higher advertising costs resulted in our decision to lower our planned spending. We are disciplined with our marketing expenditures and will increase or decrease our advertising spend depending on prices.

Net realized investment gains (losses) fluctuated each period. During the first nine months of 2017, we recognized net realized investment gains of $.8 million, which were comprised of: (i) $.9 million of net gains from the sales of investments; (ii) the increase in fair value of certain fixed maturity investments with embedded derivatives of $.4 million; and (iii) $.5 million of writedowns of investments for other than temporary declines in fair value which were recorded in earnings. During the first nine months of 2016, we recognized net realized investment losses of $.2 million, which were comprised of: (i) $.7 million of net gains from the sales of investments; (ii) the decrease in fair value of certain fixed maturity investments with embedded derivatives of $.1 million; and (iii) $.8 million of writedowns of investments for other than temporary declines in fair value recognized through net income.

Management believes that an analysis of Adjusted EBIT for Colonial Penn, separated between in-force and new business, provides increased clarity for this segment as the vast majority of the costs to generate new business in this segment are not deferrable and Adjusted EBIT will fluctuate based on management's decisions on how much marketing costs to incur in each period. Adjusted EBIT from new business includes pre-tax revenues and expenses associated with new sales of our insurance products during the first year after the sale is completed. Adjusted EBIT from in-force business includes all pre-tax revenues and expenses associated with sales of insurance products that were completed more than one year before the end of the reporting period. The allocation of certain revenues and expenses between new and in-force business is based on estimates, which we believe are reasonable.

77

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

Recognizing the accounting standard that requires us to expense certain direct response advertising costs (rather than deferring such costs as deferred acquisition costs), the amount of our investment in new business in the Colonial Penn segment during a particular period will have a significant impact on the segment results. The following summarizes our earnings, separated between in-force and new business for Colonial Penn (dollars in millions):

	Three months ended						Nine months ended
	September 30,						September 30,
	2017			2016			2017			2016
Adjusted EBIT from In-Force Business
Revenues:
Insurance policy income	$	61.0		$	57.2		$	180.8		$	169.0
Net investment income and other	11.3			11.3			34.0			33.8
Total revenues	72.3			68.5			214.8			202.8
Benefits and expenses:
Insurance policy benefits	40.3			41.9			127.5			126.0
Amortization	3.7			3.5			11.3			10.7
Other expenses	8.5			8.9			24.7			25.1
Total benefits and expenses	52.5			54.3			163.5			161.8
Adjusted EBIT from In-Force Business	$	19.8		$	14.2		$	51.3		$	41.0
Adjusted EBIT from New Business
Revenues:
Insurance policy income	$	12.1		$	13.7		$	38.3		$	41.5
Net investment income and other	—			—			—			—
Total revenues	12.1			13.7			38.3			41.5
Benefits and expenses:
Insurance policy benefits	7.4			8.4			23.3			25.3
Amortization	.2			.2			.6			.6
Other expenses	15.3			18.4			49.0			59.5
Total benefits and expenses	22.9			27.0			72.9			85.4
Adjusted EBIT from New Business	$	(10.8	)	$	(13.3	)	$	(34.6	)	$	(43.9	)
Adjusted EBIT from In-Force and New Business
Revenues:
Insurance policy income	$	73.1		$	70.9		$	219.1		$	210.5
Net investment income and other	11.3			11.3			34.0			33.8
Total revenues	84.4			82.2			253.1			244.3
Benefits and expenses:
Insurance policy benefits	47.7			50.3			150.8			151.3
Amortization	3.9			3.7			11.9			11.3
Other expenses	23.8			27.3			73.7			84.6
Total benefits and expenses	75.4			81.3			236.4			247.2
Adjusted EBIT from In-Force and New Business	$	9.0		$	.9		$	16.7		$	(2.9	)

The Adjusted EBIT from in-force business in the Colonial Penn segment in the 2017 periods reflects growth in the block; the aforementioned $3.0 million favorable impact related to liabilities for insurance products; and favorable mortality as compared to the same periods in 2016. The Adjusted EBIT from new business in the Colonial Penn segment in the 2017 periods primarily reflects lower marketing costs. The vast majority of the costs to generate new business in this segment are

78

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

not deferrable and Adjusted EBIT will fluctuate based on management's decisions on how much marketing costs to incur in each period.

Long-term care in run-off (dollars in millions)

In September 2016, we terminated certain reinsurance agreements and recaptured the ceded business. The long-term care in run-off segment is comprised of the long-term care business that was recaptured.

	Three months ended			Nine months ended
	September 30, 2017			September 30, 2017
Premium collections:
Long-term care (all renewal)	$	3.9		$	12.9
Average liabilities for insurance products:
Average liabilities for long-term care products	$	579.6		$	571.2
Revenues:
Insurance policy income	$	4.2		$	13.3
Net investment income on general account invested assets	6.8			26.5
Total revenues	11.0			39.8
Expenses:
Insurance policy benefits	11.4			36.6
Other operating costs and expenses	.6			2.1
Total benefits and expenses	12.0			38.7
Income (loss) before net realized investment gains and income taxes	(1.0		)	1.1
Net realized investment gains	6.7			7.8
Income before income taxes	$	5.7		$	8.9

	Three months ended			Nine months ended
	September 30, 2017			September 30, 2017
Health benefit ratios:
Long-term care:
Insurance policy benefits	$	11.4		$	36.6
Benefit ratio (a)	274.3		%	276.5		%
Interest-adjusted benefit ratio (b)	99.4		%	111.2		%

_______________

(a) We calculate benefit ratios by dividing the related product's insurance policy benefits by insurance policy income.

(b) We calculate the interest-adjusted benefit ratio (a non-GAAP measure) for long-term care products in this segment by dividing such product's insurance policy benefits less the imputed interest income on the accumulated assets backing the insurance liabilities by policy income. These are considered non-GAAP financial measures. A non-GAAP measure is a numerical measure of a company's performance, financial position, or cash flows that excludes or includes amounts that are normally excluded or included in the most directly comparable measure calculated and presented in accordance with GAAP.

These non-GAAP financial measures of "interest-adjusted benefit ratios" differ from "benefit ratios" due to the deduction of imputed interest income on the accumulated assets backing the insurance liabilities from the product's insurance policy benefits used to determine the ratio. Interest income is an important factor in measuring the performance of health products that are expected to be inforce for a longer duration of time, are not subject to unilateral changes in provisions (such as non-cancelable or guaranteed renewable contracts) and require the performance of various functions and services (including insurance protection) for an extended period of time. The net cash flows from long-term care

79

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

products generally cause an accumulation of amounts in the early years of a policy (accounted for as reserve increases) that will be paid out as benefits in later policy years (accounted for as reserve decreases). Accordingly, as the policies age, the benefit ratio will typically increase, but the increase in benefits will be partially offset by the imputed interest income earned on the accumulated assets. The interest-adjusted benefit ratio reflects the effects of such interest income offset (which is equal to the tabular interest on the related insurance liabilities). Since interest income is an important factor in measuring the performance of these products, management believes a benefit ratio that includes the effect of interest income is useful in analyzing product performance. We utilize the interest-adjusted benefit ratio in measuring segment performance because we believe that this performance measure is a better indicator of the ongoing businesses and trends in the business. However, the "interest-adjusted benefit ratio" does not replace the "benefit ratio" as a measure of current period benefits to current period insurance policy income. Accordingly, management reviews both "benefit ratios" and "interest-adjusted benefit ratios" when analyzing the financial results attributable to these products. The imputed investment income earned on the accumulated assets backing the long-term care reserves was $7.3 million and $21.9 million in the three and nine months ended September 30, 2017, respectively.

Average liabilities for long-term care products were increased by $32 million and $20 million in the three and nine months ended September 30, 2017, respectively, to reflect the premium deficiencies that would exist if unrealized gains on the assets backing such products had been realized and the proceeds from the sales of such assets were invested at then current yields. Such increase is reflected as a reduction of accumulated other comprehensive income.

Insurance policy benefits were $11.4 million and $36.6 million in the three and nine months ended 2017, respectively. The interest-adjusted benefit ratio for this long-term care block was 99.4 percent in the third quarter of 2017 and 111.2 percent in the first nine months of 2017. Since this block of long-term care business is in loss recognition status, our valuation assumptions reflect no profits or losses on the block over its remaining life. Accordingly, changes in assumptions which adversely impact future earnings will result in an immediate charge to current earnings. This block of business is particularly sensitive to changes in assumptions related to expected future investment yields. For example, we estimate that a 50 basis point reduction in the ultimate new money rate assumption would result in a $10 million pre-tax charge.

Net realized investment gains fluctuated each period. During the first nine months of 2017, we recognized net realized investment gains of $7.8 million, which were comprised of: (i) $24.6 million of net gains from the sales of investments; and (ii) $16.8 million of writedowns of investments for other than temporary declines in fair value recognized through net income.

80

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

Corporate Operations (dollars in millions)

	Three months ended						Nine months ended
	September 30,						September 30,
	2017			2016			2017			2016
Corporate operations:
Interest expense on corporate debt	$	(11.7	)	$	(11.5	)	$	(34.8	)	$	(34.3	)
Net investment income (loss):
General investment portfolio	1.4			1.5			3.7			4.4
Other special-purpose portfolios:
COLI	2.3			2.3			11.6			2.0
Investments held in a rabbi trust	.9			.6			2.4			1.0
Other trading account activities	2.4			2.3			7.1			9.2
Fee revenue and other income	1.8			2.5			6.5			7.6
Other operating costs and expenses	(23.7		)	(13.6		)	(68.3		)	(43.7		)
Loss before net realized investment gains (losses), earnings attributable to VIEs, fair value changes and amendment related to agent deferred compensation plan, loss on reinsurance transaction and income taxes	(26.6		)	(15.9		)	(71.8		)	(53.8		)
Net realized investment gains (losses)	(.6		)	10.3			—			(3.0		)
Earnings attributable to VIEs	(3.3		)	(.7		)	(4.6		)	(1.2		)
Fair value changes and amendment related to agent deferred compensation plan	(13.4		)	6.3			(13.4		)	(12.0		)
Loss on reinsurance transaction	—			(75.4		)	—			(75.4		)
Loss before income taxes	$	(43.9	)	$	(75.4	)	$	(89.8	)	$	(145.4	)

Interest expense on corporate debt was $34.8 million and $34.3 million in the first nine months of 2017 and 2016, respectively. Our average corporate debt outstanding was $925.0 million in both the first nine months of 2017 and 2016. The average interest rate on our debt was 4.7 percent in both the first nine months of 2017 and 2016.

Net investment income on general investment portfolio fluctuates based on the amount and type of invested assets in the corporate operations segment.

Net investment income on other special-purpose portfolios includes the income (loss) from:  (i) investments related to deferred compensation plans held in a rabbi trust (which is offset by amounts included in other operating costs and expenses as the investment results are allocated to participants' account balances); (ii) trading account activities; and (iii) income (loss) from Company-owned life insurance ("COLI") equal to the difference between the return on these investments (representing the change in value of the underlying investments) and our overall portfolio yield.  COLI is utilized as an investment vehicle to fund Bankers Life's agent deferred compensation plan.  For segment reporting, the Bankers Life segment is allocated a return on these investments equivalent to the yield on the Company’s overall portfolio, with any difference in the actual COLI return allocated to the Corporate operations segment. In the first quarter of 2017, we recognized a death benefit, net of cash surrender value, of $2.0 million related to the COLI.

Fee revenue and other income includes the fees our wholly-owned investment advisor earns for managing portfolios of commercial bank loans for investment trusts. These trusts are consolidated as VIEs in our consolidated financial statements, but the fees are reflected as revenues and the fee expense is reflected in the earnings attributable to VIEs. This fee revenue fluctuates consistent with the size of the loan portfolios.

81

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

Other operating costs and expenses include general corporate expenses, net of amounts charged to subsidiaries for services provided by the corporate operations. These amounts fluctuate as a result of expenses such as legal and consulting costs and performance-based compensation expense which were higher in the 2017 periods as compared to the 2016 periods.

Net realized investment gains (losses) often fluctuate each period. During the first nine months of 2017, net realized investment gains in this segment were nil and were comprised of: (i) $4.7 million of net gains from the sales of investments (including $2.2 million of net gains recognized by the VIEs and $2.5 million of net gains on other investment sales); (ii) $4.3 million of losses on the dissolution of VIEs; and (iii) $.4 million of writedowns of investments held by VIEs due to other-than-temporary declines in value. During the first nine months of 2016, net realized investment losses in this segment were $3.0 million and were comprised of: (i) $5.5 million of net gains from the sales of investments (including $12.1 million of losses recognized by the VIEs and $17.6 million of net gains on other investment sales); (ii) $7.3 million of losses on the dissolution of a VIE; and (iii) $1.2 million of writedowns of investments held by VIEs due to other-than-temporary declines in value.

Earnings attributable to VIEs include the earnings in certain VIEs that we are required to consolidate, net of affiliated amounts. Such earnings are not indicative of, and are unrelated to, the Company's underlying fundamentals.

Fair value changes and amendment related to agent deferred compensation plan related to: (i) changes in the underlying actuarial assumptions used to value liabilities for our agent deferred compensation plan; and (ii) an amendment made to the plan in the third quarter of 2016. The agent deferred compensation plan was amended to: (i) freeze participation in the plan; (ii) freeze benefits accrued under the plan; and (iii) add a limited cashout feature. During the third quarter of 2016, we made lump sum settlement distributions to plan participants with account balances that were below a certain threshold consistent with the provision of the amended plan. We recognized a pre-tax gain of $6.3 million related to the settlement distributions in the third quarter of 2016.

Loss on reinsurance transaction of $75.4 million resulted from the termination of the reinsurance agreements with BRe and recapture of the ceded business as further described in "Liquidity and Capital Resources - Termination of Long-Term Care Reinsurance Agreements and Recapture of Related Long-Term Care Business in Run-off".

PREMIUM COLLECTIONS

In accordance with GAAP, insurance policy income in our consolidated statement of operations consists of premiums earned for traditional insurance policies that have life contingencies or morbidity features.  For annuity and interest-sensitive life contracts, premiums collected are not reported as revenues, but as deposits to insurance liabilities.  We recognize revenues for these products over time in the form of investment income and surrender or other charges.

Our insurance segments sell products through three primary distribution channels - career agents (our Bankers Life segment), direct marketing (our Colonial Penn segment) and independent producers (our Washington National segment).  Our career agency force in the Bankers Life segment sells primarily Medicare supplement and long-term care insurance policies, life insurance and annuities.  These agents visit the customer's home, which permits one-on-one contact with potential policyholders and promotes strong personal relationships with existing policyholders.  Our direct marketing distribution channel in the Colonial Penn segment is engaged primarily in the sale of graded benefit life and simplified issue life insurance policies which are sold directly to the policyholder.  Our Washington National segment sells primarily supplemental health and life insurance.  These products are marketed through PMA, a wholly-owned subsidiary that specializes in marketing and distributing health products, and through independent marketing organizations and insurance agencies, including worksite marketing.

Agents, insurance brokers and marketing companies who market our products and prospective purchasers of our products use the financial strength ratings of our insurance subsidiaries as an important factor in determining whether to market or purchase.  Ratings have the most impact on our sales of supplemental health and life products to consumers at the worksite.  The current financial strength ratings of our primary insurance subsidiaries from Fitch Ratings ("Fitch"), S&P, A.M. Best Company ("A.M. Best") and Moody's Investor Services, Inc. ("Moody's") are "BBB+", "BBB+", "A-" and "Baa1", respectively.  For a description of these ratings and additional information on our ratings, see "Financial Strength Ratings of our Insurance Subsidiaries".

82

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

We set premium rates on our health insurance policies based on facts and circumstances known at the time we issue the policies using assumptions about numerous variables, including the actuarial probability of a policyholder incurring a claim, the probable size of the claim, and the interest rate earned on our investment of premiums.  We also consider historical claims information, industry statistics, the rates of our competitors and other factors.  If our actual claims experience is less favorable than we anticipated and we are unable to raise our premium rates, our financial results may be adversely affected.  We generally cannot raise our health insurance premiums in any state until we obtain the approval of the state insurance regulator.  We review the adequacy of our premium rates regularly and file for rate increases on our products when we believe such rates are too low.  It is likely that we will not be able to obtain approval for all requested premium rate increases.  If such requests are denied in one or more states, our net income may decrease.  If such requests are approved, increased premium rates may reduce the volume of our new sales and may cause existing policyholders to lapse their policies.  If the healthier policyholders allow their policies to lapse, this would reduce our premium income and profitability in the future.

Total premium collections were $882.4 million in the third quarter of 2017, down 2.0 percent from 2016, and were $2,747.4 million in the first nine months of 2017, up 3.3 percent from 2016. First year collected premiums were $319.2 million in the third quarter of 2017, down 5.5 percent from 2016, and were $1,016.8 million in the first nine months of 2017, up 4.8 percent from 2016. The recent natural disasters affected our premium collections from our policyholders in Florida, Texas and Puerto Rico. We estimate that total first year premium collections were down approximately 2 percent in the three months ended September 30, 2017 due to the hurricanes. Total premiums collected are summarized as follows (dollars in millions):

	Three months ended				Nine months ended
	September 30,				September 30,
	2017		2016		2017		2016
First year:
Bankers Life	$	288.2	$	304.8	$	919.2	$	869.7
Washington National	18.9		19.0		59.1		58.9
Colonial Penn	12.1		13.8		38.5		41.6
Total first year	319.2		337.6		1,016.8		970.2
Renewal:
Bankers Life	353.5		361.1		1,090.9		1,085.1
Washington National	145.3		144.4		445.7		435.2
Colonial Penn	60.5		56.9		181.1		168.8
Long-term care in run-off	3.9		—		12.9		—
Total renewal	563.2		562.4		1,730.6		1,689.1
Total premiums collected	$	882.4	$	900.0	$	2,747.4	$	2,659.3

83

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

Total premium collections by segment were as follows:

Bankers Life (dollars in millions)

	Three months ended				Nine months ended
	September 30,				September 30,
	2017		2016		2017		2016
Premiums collected by product:
Annuities:
Fixed index (first-year)	$	222.6	$	218.1	$	705.1	$	597.6
Other fixed interest (first-year)	12.9		25.4		48.6		82.8
Other fixed interest (renewal)	1.0		1.6		4.6		4.7
Subtotal - other fixed interest annuities	13.9		27.0		53.2		87.5
Total annuities	236.5		245.1		758.3		685.1
Health:
Medicare supplement (first-year)	16.8		18.8		51.9		56.3
Medicare supplement (renewal)	160.4		163.4		496.7		491.8
Subtotal - Medicare supplement	177.2		182.2		548.6		548.1
Long-term care (first-year)	3.8		4.4		12.1		13.2
Long-term care (renewal)	103.5		111.9		324.3		340.7
Subtotal - long-term care	107.3		116.3		336.4		353.9
Supplemental health (first-year)	1.1		1.4		3.8		4.1
Supplemental health (renewal)	4.4		4.0		13.0		11.6
Subtotal – supplemental health	5.5		5.4		16.8		15.7
Other health (first-year)	.2		—		.6		—
Other health (renewal)	1.3		1.5		4.0		4.7
Subtotal - other health	1.5		1.5		4.6		4.7
Total health	291.5		305.4		906.4		922.4
Life insurance:
Traditional (first-year)	19.8		18.8		62.1		61.8
Traditional (renewal)	53.9		52.3		162.3		154.5
Subtotal - traditional	73.7		71.1		224.4		216.3
Interest-sensitive (first-year)	11.0		17.9		35.0		53.9
Interest-sensitive (renewal)	29.0		26.4		86.0		77.1
Subtotal - interest-sensitive	40.0		44.3		121.0		131.0
Total life insurance	113.7		115.4		345.4		347.3
Collections on insurance products:
Total first-year premium collections on insurance products	288.2		304.8		919.2		869.7
Total renewal premium collections on insurance products	353.5		361.1		1,090.9		1,085.1
Total collections on insurance products	$	641.7	$	665.9	$	2,010.1	$	1,954.8

Annuities in this segment include fixed index and other fixed interest annuities sold to the senior market. Annuity collections in this segment decreased 3.5 percent, to $236.5 million, in the third quarter of 2017, and increased 11 percent, to $758.3 million, in the first nine months of 2017, as compared to the same periods in 2016. The increase in premium collections from our fixed index products in the 2017 periods is due primarily to sales of annuity contracts with living benefits following

84

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

the introduction of that product in the third quarter of 2016. Premium collections from our other fixed interest products decreased due to lower sales of these products in the current low interest rate environment and consumer preference for fixed index products.

Health products include Medicare supplement, long-term care and other insurance products. Our profits on health policies depend on the overall level of sales, the length of time the business remains inforce, investment yields, claims experience and expense management.

Collected premiums on Medicare supplement policies in the Bankers Life segment decreased 2.7 percent, to $177.2 million, in the third quarter of 2017, and increased .1 percent, to $548.6 million, in the first nine months of 2017, as compared to the same periods in 2016.

Premiums collected on Bankers Life's long-term care policies decreased 7.7 percent, to $107.3 million, in the third quarter of 2017, and 4.9 percent, to $336.4 million, in the first nine months of 2017, as compared to the same periods in 2016. Such decreases reflect the run-off of this business and a continuing shift in the mix of new business to shorter duration long-term care sales, which have lower premiums per policy.

Life products in this segment include traditional and interest-sensitive life products. Life premiums collected in this segment in the 2017 periods were slightly lower than the comparable periods in 2016 reflecting lower premiums from interest-sensitive products.

85

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

Washington National (dollars in millions)

	Three months ended				Nine months ended
	September 30,				September 30,
	2017		2016		2017		2016
Premiums collected by product:
Health:
Medicare supplement (renewal)	$	11.7	$	14.6	$	38.7	$	46.1
Supplemental health (first-year)	17.8		17.7		55.2		54.5
Supplemental health (renewal)	127.0		123.3		386.7		369.4
Subtotal – supplemental health	144.8		141.0		441.9		423.9
Other health (first-year)	.1		.1		.2		.2
Other health (renewal)	.3		.4		1.1		1.2
Subtotal - other health	.4		.5		1.3		1.4
Total health	156.9		156.1		481.9		471.4
Life insurance:
Traditional (first-year)	.1		.2		.5		.6
Traditional (renewal)	2.5		2.6		7.7		8.0
Subtotal - traditional	2.6		2.8		8.2		8.6
Interest-sensitive (first-year)	.9		1.0		3.2		3.6
Interest-sensitive (renewal)	3.6		3.3		10.9		9.5
Subtotal - interest-sensitive	4.5		4.3		14.1		13.1
Total life insurance	7.1		7.1		22.3		21.7
Annuities:
Fixed index (renewal)	.1		.2		.4		.8
Other fixed interest (renewal)	.1		—		.2		.2
Total annuities	.2		.2		.6		1.0
Collections on insurance products:
Total first-year premium collections on insurance products	18.9		19.0		59.1		58.9
Total renewal premium collections on insurance products	145.3		144.4		445.7		435.2
Total collections on insurance products	$	164.2	$	163.4	$	504.8	$	494.1

Health products in the Washington National segment include Medicare supplement, supplemental health and other insurance products. Our profits on health policies depend on the overall level of sales, the length of time the business remains inforce, investment yields, claim experience and expense management.

Collected premiums on Medicare supplement policies in the Washington National segment decreased in the 2017 periods due to the run-off of this block of business.

Premiums collected on supplemental health products (including specified disease, accident and hospital indemnity insurance products) increased 2.7 percent, to $144.8 million, in the third quarter of 2017, and 4.2 percent, to $441.9 million, in the first nine months of 2017, as compared to the same periods in 2016. Such increase is due to new sales in recent periods and persistency.

Overall, excluding premiums from the Washington National Medicare supplement and annuity blocks which are in run-off, collected premiums were up 2.5 percent, to $152.3 million, in the third quarter of 2017, and 4.1 percent, to $465.5 million, in the first nine months of 2017, as compared to the same periods in 2016, driven by sales in recent periods and persistency.

Life premiums collected in the Washington National segment in the 2017 periods were comparable to the same periods in 2016.

86

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

Annuities in this segment include fixed index and other fixed interest annuities. We are no longer actively pursuing sales of annuity products in this segment.

Colonial Penn (dollars in millions)

	Three months ended				Nine months ended
	September 30,				September 30,
	2017		2016		2017		2016
Premiums collected by product:
Life insurance:
Traditional (first-year)	$	12.1	$	13.8	$	38.5	$	41.6
Traditional (renewal)	60.0		56.2		179.4		166.7
Subtotal - traditional	72.1		70.0		217.9		208.3
Interest-sensitive (all renewal)	.1		.1		.2		.3
Total life insurance	72.2		70.1		218.1		208.6
Health (all renewal):
Medicare supplement	.4		.6		1.4		1.7
Other health	—		—		.1		.1
Total health	.4		.6		1.5		1.8
Collections on insurance products:
Total first-year premium collections on insurance products	12.1		13.8		38.5		41.6
Total renewal premium collections on insurance products	60.5		56.9		181.1		168.8
Total collections on insurance products	$	72.6	$	70.7	$	219.6	$	210.4

Life products in this segment are sold primarily to the senior market. Life premiums collected in this segment increased 3.0 percent, to $72.2 million, in the third quarter of 2017, and 4.6 percent, to $218.1 million, in the first nine months of 2017, as compared to the same periods in 2016. The increase in premiums collected reflects both recent sales activity and steady persistency.

Health products include Medicare supplement and other insurance products. Our profits on health policies depend on the overall level of sales, the length of time the business remains in-force, investment yields, claims experience and expense management. Premiums collected on these products have decreased as we do not currently market these products through this segment.

Long-term care in run-off (dollars in millions)

	Three months ended		Nine months ended
	September 30, 2017		September 30, 2017
Premiums collected by product:
Health:
Long-term care (renewal)	$	3.9	$	12.9

The Long-term care in run-off segment only includes the premiums collected from the long-term care block that was recaptured in September 2016.

87

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

LIQUIDITY AND CAPITAL RESOURCES

Our capital structure as of September 30, 2017 and December 31, 2016 was as follows (dollars in millions):

	September 30, 2017		December 31, 2016
Total capital:
Corporate notes payable	$	914.4	$	912.9
Shareholders’ equity:
Common stock	1.7		1.7
Additional paid-in capital	3,094.5		3,212.1
Accumulated other comprehensive income	933.6		622.4
Retained earnings	851.9		650.7
Total shareholders’ equity	4,881.7		4,486.9
Total capital	$	5,796.1	$	5,399.8

The following table summarizes certain financial ratios as of and for the nine months ended September 30, 2017 and as of and for the year ended December 31, 2016:

	September 30, 2017			December 31, 2016
Book value per common share	$	29.10		$	25.82
Book value per common share, excluding accumulated other comprehensive income (a)	23.53			22.24
Ratio of earnings to fixed charges	2.92X			2.43X
Debt to total capital ratios:
Corporate debt to total capital	15.8		%	16.9		%
Corporate debt to total capital, excluding accumulated other comprehensive income (a)	18.8		%	19.1		%

_____________________

(a) This non-GAAP measure differs from the corresponding GAAP measure presented immediately above, because accumulated other comprehensive income has been excluded from the value of capital used to determine this measure.  Management believes this non-GAAP measure is useful because it removes the volatility that arises from changes in accumulated other comprehensive income.  Such volatility is often caused by changes in the estimated fair value of our investment portfolio resulting from changes in general market interest rates rather than the business decisions made by management.  However, this measure does not replace the corresponding GAAP measure.

Termination of Long-Term Care Reinsurance Agreements and Recapture of Related Long-Term Care Business in Run-off

In December 2013, two of our insurance subsidiaries with long-term care business (Washington National and BCLIC) entered into 100% coinsurance agreements ceding $495 million of long-term care reserves to BRe. BRe was a reinsurer that was not licensed or accredited by the states of domicile (Indiana and New York, respectively) of the insurance subsidiaries ceding the long-term care business and BRe was not rated by A.M. Best. As a result of its non-accredited status, BRe was required to provide collateral which met the regulatory requirements of the states of domicile in order for our insurance subsidiaries to obtain full credit in their statutory financial statements for the reinsurance receivables due from BRe. Such collateral was required to be held in market value trusts subject to 7% over collateralization, investment guidelines and periodic true-up provisions. In September 2016, we terminated the reinsurance agreements with BRe and recaptured the ceded business.

Prior to the recapture, certain irregularities had come to our attention regarding BRe (including its relationship with Platinum Partners, LP ("Platinum") and the valuation and appropriateness of the collateral deposited in trusts by BRe for Washington National and BCLIC). As a result, CNO commenced an independent third-party audit by a forensic accounting

88

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

firm in late June 2016 of certain investments deposited in the trusts by BRe. Such investments included assets valued at that time using unobservable inputs that contained assumptions determined by BRe. The initial scope of CNO’s audit was a subset of investments which had an estimated fair value of approximately $62 million as of September 30, 2016. In September 2016, Washington National and BCLIC expanded the scope of the independent audit to include additional investments for which we estimated the fair value to be approximately $63 million as of September 30, 2016.

The aforementioned independent audit of these investments was completed in the fourth quarter of 2016. The audit confirmed that the assets in the initial scope of the audit bore some connection to Platinum or to parties that have had past or present associations with Platinum. Based on information obtained through the audit, the investments included in the additional scope of the audit did not appear to have clear connections to Platinum or to parties that have had past or present associations with Platinum. However, CNO and the auditor retained by CNO also concluded that many of the values that had been assigned to these investments by BRe, and summarized in reports prepared by its valuation firm, were inaccurate due to the use of flawed methodologies.

In addition to the investments subject to the independent audits, Washington National and BCLIC received approximately $380 million in other investments and cash balances in the recapture. A substantial portion of these investments have been sold or redeemed since the recapture. The activity since the date of the recapture with respect to the assets received in the recapture is summarized below (dollars in millions):

							Investments not included in scope of audit
	Investments included in initial scope of audit			Investments included in additional scope of audit			Cash, fixed maturities and other invested assets			Total investments
September 30, 2016 values	$	62.2		$	62.6		$	379.8		$	504.6
Net cash flows (1)	(13.5		)	(11.6		)	(359.5		)	(384.6		)
Realized gains (losses) and impairments (2)	.4			(1.7		)	(4.0		)	(5.3		)
Other activity (6)	3.9			1.9			.6			6.4
December 31, 2016 values	53.0			51.2			16.9			121.1
Net cash flows (1)	(16.7		)	(5.5		)	(8.7		)	(30.9		)
Realized gains (losses) and impairments (3)	3.2			(4.5		)	1.0			(.3		)
Other activity (6)	(1.8		)	1.3			(1.4		)	(1.9		)
March 31, 2017 values	37.7			42.5			7.8			88.0
Net cash flows (1)	.5			(14.4		)	—			(13.9		)
Realized gains (losses) and impairments (4)	(3.1		)	4.5			—			1.4
Other activity (6)	(.6		)	(.4		)	.3			(.7		)
June 30, 2017 values	34.5			32.2			8.1			74.8
Net cash flows (1)	(33.5		)	(9.1		)	(1.3		)	(43.9		)
Realized gains (losses) and impairments (5)	7.0			(.6		)	.3			6.7
Other activity (6)	(.9		)	(.3		)	(3.0		)	(4.2		)
September 30, 2017 values	$	7.1		$	22.2		$	4.1		$	33.4

89

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

A summary of the values as of September 30, 2017, for the remaining investments that were included in the aforementioned independent audits is summarized below (dollars in millions):

	Investments included in initial scope of audit		Investments included in additional scope of audit		Total investments included in the scope of audit
Lease related investments	$	—	$	11.1	$	11.1
Mortgage loans secured by real estate	—		10.6		10.6
Senior secured loans to companies in the energy sector (7)	2.1		—		2.1
Senior secured loans to other companies	—		.5		.5
Secured term loan issued by Platinum Partners Credit Opportunity Master Fund L.P.	5.0		—		5.0
Total investments	$	7.1	$	22.2	$	29.3

________________

(1) Net cash inflows from sales and redemptions of investments during the period.

(2) Includes $4.6 million of impairment charges and $.7 million of net realized losses recognized on the sale of transferred investments.

(3) Includes $8.4 million of impairment charges and $8.1 million of net realized gains recognized on the sale of transferred investments.

(4) Includes $3.7 million of impairment charges and $5.1 million of net realized gains recognized on the sale of transferred investments.

(5) Includes $4.7 million of impairment charges and $11.4 million of net realized gains on the sale of transferred investments.

(6) Includes amortization of discount and premium and changes in estimated fair values of investments during the period.

(7) Includes $1.2 million of loans issued by Golden Gate Oil, LLC with a par value of $11.7 million. The issuer of this debt has been referred to in articles regarding Platinum.

Liquidity for Insurance Operations

Our insurance companies generally receive adequate cash flows from premium collections and investment income to meet their obligations.  Life insurance, long-term care insurance and annuity liabilities are generally long-term in nature.  Life and annuity policyholders may, however, withdraw funds or surrender their policies, subject to any applicable penalty provisions; there are generally no withdrawal or surrender benefits for long-term care insurance.  We actively manage the relationship between the duration of our invested assets and the estimated duration of benefit payments arising from contract liabilities.

Three of the Company's insurance subsidiaries (Washington National, Bankers Life and Colonial Penn) are members of the FHLB.  As members of the FHLB, our insurance subsidiaries have the ability to borrow on a collateralized basis from the FHLB.  We are required to hold certain minimum amounts of FHLB common stock as a condition of membership in the FHLB, and additional amounts based on the amount of the borrowings.  At September 30, 2017, the carrying value of the FHLB common stock was $71.2 million.  As of September 30, 2017, collateralized borrowings from the FHLB totaled $1.6 billion and the proceeds were used to purchase fixed maturity securities.  The borrowings are classified as investment borrowings in the accompanying consolidated balance sheet.  The borrowings are collateralized by investments with an estimated fair value of $2.0 billion at September 30, 2017, which are maintained in custodial accounts for the benefit of the FHLB.  

90

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

The following summarizes the terms of the borrowings from the FHLB by our insurance subsidiaries (dollars in millions):

Amount		Maturity	Interest rate at
borrowed		date	September 30, 2017
$	50.0	February 2018	Variable rate – 1.404%
50.0		August 2018	Variable rate – 1.435%
50.0		January 2019	Variable rate – 1.724%
50.0		February 2019	Variable rate – 1.404%
100.0		March 2019	Variable rate – 1.714%
21.8		July 2019	Variable rate – 1.727%
15.0		October 2019	Variable rate – 1.830%
50.0		May 2020	Variable rate – 1.754%
21.8		June 2020	Fixed rate – 1.960%
25.0		September 2020	Variable rate – 1.953%
100.0		September 2020	Variable rate – 1.897%
50.0		September 2020	Variable rate – 1.894%
75.0		September 2020	Variable rate – 1.453%
100.0		October 2020	Variable rate – 1.409%
50.0		December 2020	Variable rate – 1.932%
100.0		July 2021	Variable rate – 1.854%
100.0		July 2021	Variable rate – 1.824%
28.2		August 2021	Fixed rate – 2.550%
57.7		August 2021	Variable rate - 1.842%
125.0		August 2021	Variable rate – 1.717%
50.0		September 2021	Variable rate – 1.857%
22.0		May 2022	Variable rate – 1.668%
100.0		May 2022	Variable rate – 1.666%
10.0		June 2022	Variable rate – 1.931%
50.0		July 2022	Variable rate – 1.675%
50.0		July 2022	Variable rate – 1.693%
50.0		July 2022	Variable rate – 1.694%
50.0		August 2022	Variable rate – 1.702%
24.9		March 2023	Fixed rate – 2.160%
20.5		June 2025	Fixed rate – 2.940%
$	1,646.9

State laws generally give state insurance regulatory agencies broad authority to protect policyholders in their jurisdictions. Regulators have used this authority in the past to restrict the ability of our insurance subsidiaries to pay any dividends or other amounts without prior approval. We cannot be assured that the regulators will not seek to assert greater supervision and control over our insurance subsidiaries' businesses and financial affairs.

Our estimated consolidated statutory RBC ratio of 450 percent at September 30, 2017, reflects estimated consolidated statutory operating earnings of $257 million and dividends to the holding company of $286.8 million during the first nine months of 2017. Statutory earnings will often fluctuate on a quarterly basis due to the application of statutory accounting principles.

91

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

Our insurance subsidiaries transfer exposure to certain risk to others through reinsurance arrangements. When we obtain reinsurance, we are still liable for those transferred risks in the event the reinsurer defaults on its obligations. The failure, insolvency, inability or unwillingness of one or more of the Company's reinsurers to perform in accordance with the terms of its reinsurance agreement could negatively impact our earnings or financial position and our consolidated statutory RBC ratio.

Financial Strength Ratings of our Insurance Subsidiaries

Financial strength ratings provided by Fitch, S&P, A.M. Best and Moody's are the rating agency's opinions of the ability of our insurance subsidiaries to pay policyholder claims and obligations when due.

On August 15, 2017, Fitch affirmed its "BBB+" financial strength ratings of our primary insurance subsidiaries. The outlook for these ratings is stable. A "BBB" rating, in Fitch's opinion, indicates that there is currently a low expectation of ceased or interrupted payments. The capacity to meet policyholder and contract obligations on a timely basis is considered adequate, but adverse changes in circumstances and economic conditions are more likely to impact this capacity. Fitch ratings for the industry range from "AAA Exceptionally Strong" to "C Distressed" and some companies are not rated. Pluses and minuses show the relative standing within a category. Fitch has nineteen possible ratings. There are seven ratings above the "BBB+" rating of our primary insurance subsidiaries and eleven ratings that are below that rating.

On June 23, 2017, S&P affirmed the financial strength ratings of "BBB+" of our primary insurance subsidiaries and revised the outlook for these ratings to stable from negative. S&P financial strength ratings range from "AAA" to "R" and some companies are not rated.  An insurer rated "BBB" or higher is regarded as having financial security characteristics that outweigh any vulnerabilities, and is highly likely to have the ability to meet financial commitments. An insurer rated "BBB", in S&P's opinion, has good financial security characteristics, but is more likely to be affected by adverse business conditions than are higher-rated insurers.  Pluses and minuses show the relative standing within a category.  S&P has twenty-one possible ratings.  There are seven ratings above the "BBB+" rating of our primary insurance subsidiaries and thirteen ratings that are below that rating.

On February 8, 2017, A.M. Best affirmed the financial strength ratings of "A-" of our primary insurance subsidiaries and the outlook for these ratings is stable. The "A-" rating is assigned to companies that have an excellent ability, in A.M. Best's opinion, to meet their ongoing obligations to policyholders.  A.M. Best ratings for the industry currently range from "A++ (Superior)" to "F (In Liquidation)" and some companies are not rated.  An "A++" rating indicates a superior ability to meet ongoing obligations to policyholders.  A.M. Best has sixteen possible ratings.  There are three ratings above the "A-" rating of our primary insurance subsidiaries and twelve ratings that are below that rating.

On May 9, 2016, Moody's affirmed the financial strength ratings of "Baa1" of our primary insurance subsidiaries and the outlook for these ratings is stable. Moody’s financial strength ratings range from "Aaa" to "C".  These ratings may be supplemented with numbers "1", "2", or "3" to show relative standing within a category.  In Moody's view, an insurer rated "Baa" offers adequate financial security, however, certain protective elements may be lacking or may be characteristically unreliable over any great length of time. Moody's has twenty-one possible ratings.  There are seven ratings above the "Baa1" rating of our primary insurance subsidiaries and thirteen ratings that are below that rating.

Rating agencies have increased the frequency and scope of their credit reviews and requested additional information from the companies that they rate, including us.  They may also adjust upward the capital and other requirements employed in the rating agency models for maintenance of certain ratings levels.  We cannot predict what actions rating agencies may take, or what actions we may take in response.  Accordingly, downgrades and outlook revisions related to us or the life insurance industry may occur in the future at any time and without notice by any rating agency.  These could increase policy surrenders and withdrawals, adversely affect relationships with our distribution channels, reduce new sales, reduce our ability to borrow and increase our future borrowing costs.

92

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

Liquidity of the Holding Companies

Availability and Sources and Uses of Holding Company Liquidity; Limitations on Ability of Insurance Subsidiaries to Make Dividend and Surplus Debenture Interest Payments to the Holding Companies; Limitations on Holding Company Activities

At September 30, 2017, CNO, CDOC, Inc. ("CDOC", our wholly owned subsidiary and the immediate parent of Washington National and Conseco Life Insurance Company of Texas ("CLTX")) and our other non-insurance subsidiaries held: (i) unrestricted cash and cash equivalents of $180.5 million; (ii) fixed income investments of $96.1 million; and (iii) equity securities of $103.2 million.  CNO and CDOC are holding companies with no business operations of their own; they depend on their operating subsidiaries for cash to make principal and interest payments on debt, and to pay administrative expenses and income taxes.  CNO and CDOC receive cash from insurance subsidiaries, consisting of dividends and distributions, interest payments on surplus debentures and tax-sharing payments, as well as cash from non-insurance subsidiaries consisting of dividends, distributions, loans and advances.  The principal non-insurance subsidiaries that provide cash to CNO and CDOC are 40|86 Advisors, Inc. ("40|86 Advisors"), which receives fees from the insurance subsidiaries for investment services, and CNO Services, LLC which receives fees from the insurance subsidiaries for providing administrative services.  The agreements between our insurance subsidiaries and CNO Services, LLC and 40|86 Advisors, respectively, were previously approved by the domestic insurance regulator for each insurance company, and any payments thereunder do not require further regulatory approval.

The following summarizes the current ownership structure of CNO’s primary subsidiaries:

The ability of our insurance subsidiaries to pay dividends is subject to state insurance department regulations and is based on the financial statements of our insurance subsidiaries prepared in accordance with statutory accounting practices prescribed or permitted by regulatory authorities, which differ from GAAP.  These regulations generally permit dividends to be paid from statutory earned surplus of the insurance company without regulatory approval for any 12-month period in amounts equal to the greater of (or in some states, the lesser of):  (i) statutory net gain from operations or net income for the prior year; or (ii) 10 percent of statutory capital and surplus as of the end of the preceding year.  However, as each of the immediate insurance subsidiaries of CDOC has significant negative earned surplus, any dividend payments from the insurance subsidiaries require the prior approval of the director or commissioner of the applicable state insurance department.  In the first nine months of 2017, our insurance subsidiaries paid dividends to CDOC totaling $286.8 million.  We expect to receive regulatory approval for future dividends from our subsidiaries, but there can be no assurance that such payments will be approved or that the financial condition of our insurance subsidiaries will not change, making future approvals less likely.

CDOC holds surplus debentures from CLTX with an aggregate principal amount of $749.6 million.  Interest payments on those surplus debentures do not require additional approval provided the RBC ratio of CLTX exceeds 100 percent (but do require prior written notice to the Texas state insurance department).  The estimated RBC ratio of CLTX was 390 percent at September 30, 2017.  CDOC also holds a surplus debenture from Colonial Penn with a principal balance of $160.0 million. Interest payments on that surplus debenture require prior approval by the Pennsylvania state insurance department. Dividends and other payments from our non-insurance subsidiaries, including 40|86 Advisors and CNO Services, LLC, to CNO or CDOC do not require approval by any regulatory authority or other third party.  However, insurance regulators may prohibit payments

93

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

by our insurance subsidiaries to parent companies if they determine that such payments could be adverse to our policyholders or contractholders.

The insurance subsidiaries of CDOC receive funds to pay dividends primarily from:  (i) the earnings of their direct businesses; (ii) tax sharing payments received from subsidiaries (if applicable); and (iii) with respect to CLTX, dividends received from subsidiaries.  At September 30, 2017, the subsidiaries of CLTX had earned surplus (deficit) as summarized below (dollars in millions):

Subsidiaries of CLTX	Earned surplus (deficit)			Additional information
Bankers Life	$	567.4		(a)
Colonial Penn	(306.8		)	(b)

____________________

(a) Bankers Life paid dividends of $139.0 million to CLTX in the first nine months of 2017.

(b) The deficit is primarily due to transactions which occurred several years ago, including a tax planning transaction and the fee paid to recapture a block of business previously ceded to an unaffiliated insurer.

A significant deterioration in the financial condition, earnings or cash flow of the material subsidiaries of CNO or CDOC for any reason could hinder such subsidiaries' ability to pay cash dividends or other disbursements to CNO and/or CDOC, which, in turn, could limit CNO's ability to meet debt service requirements and satisfy other financial obligations.  In addition, we may choose to retain capital in our insurance subsidiaries or to contribute additional capital to our insurance subsidiaries to strengthen their surplus, and these decisions could limit the amount available at our top tier insurance subsidiaries to pay dividends to the holding companies.

On October 13, 2017, the Company entered into the Amendment Agreement with respect to its Revolving Credit Agreement. The Amendment Agreement, among other things, increases the total commitments available under the revolving credit facility from $150.0 million to $250.0 million, increases the aggregate amount of additional incremental loans the Company may incur from $50.0 million to $100.0 million and extends the maturity date of the revolving credit facility from May 19, 2019 to the earlier of October 13, 2022 and the date that is six months prior to the maturity date of the Company’s 4.50% senior notes due 2020, which is November 30, 2019. The amount drawn under the Amended Credit Agreement continues to be $100.0 million.

The interest rate applicable to loans under the Amended Credit Agreement continues to be calculated as the eurodollar rate or the base rate, at the Company’s option, plus a margin based on the Company’s unsecured debt rating. The margins under the Amended Credit Agreement range from 1.375% to 2.125%, in the case of loans at the eurodollar rate, and 0.375% to 1.125%, in the case of loans at the base rate. The commitment fee under the Amended Credit Agreement continues to be based on the Company’s unsecured debt rating.

Additionally, the Amended Credit Agreement revises the debt to total capitalization ratio that the Company is required to maintain from not more than 30.0 percent to not more than 35.0 percent. The Amended Credit Agreement continues to contain certain other restrictive covenants with which the Company must comply.

In the first nine months of 2017, we repurchased 6.7 million shares of common stock for $140.1 million under our securities repurchase program. In May 2017, the Company announced that its Board of Directors approved an additional $300.0 million to repurchase the Company's outstanding common stock. The Company has remaining repurchase authority of $412.6 million as of September 30, 2017. We currently anticipate repurchasing a total of approximately $175 million to $225 million of our common stock during 2017. The amount and timing of the securities repurchases (if any) will be based on business and market conditions and other factors including, but not limited to, the current price of our common stock, opportunities to invest in our business, acquisition transactions or ceding commissions related to reinsurance transactions.

In the first nine months of 2017, dividends declared on common stock totaled $44.7 million ($0.26 per common share). In May 2017, the Company increased its quarterly common stock dividend to $0.09 per share from $0.08 per share.

94

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

We have previously disclosed that our strategic priorities include a reduction of our relative long-term care exposure. To achieve this goal, it is likely that we will need to transfer the risks of a portion of this business through one or more reinsurance transactions. The comprehensive, nursing home and home health care long-term care business written before 2003 has negative margins. In order to meaningfully reduce the risk associated with our long-term care block, a substantial ceding commission would be paid by the Company to transfer long-term care risk through reinsurance. Such a reduction of our long-term care exposure would result in the recognition of a loss. Due to our current tax position, it is likely that a portion of the tax benefit recognized on the loss would not be realized and we may be required to increase our valuation allowance for deferred tax assets. Although we believe reducing our exposure to the risk of long-term care business would benefit the Company in the long term, such reduction could initially adversely impact certain aspects of our financial position, results of operations and/or cash flow, including the cash available to repurchase shares of our common stock.

On August 15, 2017, Fitch affirmed its “BB+” rating on our issuer credit and senior unsecured debt. The outlook for these ratings is stable. In Fitch's view, an obligation rated "BB" indicates an elevated vulnerability to default risk, particularly in the event of adverse changes in business or economic conditions over time; however, business or financial flexibility exists which supports the servicing of financial commitments. Pluses and minuses show the relative standing within a category. Fitch has a total of 21 possible ratings ranging from "AAA" to "D". There are ten ratings above CNO's "BB+" rating and ten ratings that are below its rating.

On June 23, 2017, S&P affirmed our issuer credit and unsecured debt ratings of "BB+" and revised the outlook for these ratings to stable from negative. In S&P's view, an obligation rated "BB" is less vulnerable to nonpayment than other speculative issues; however, it faces major ongoing uncertainties or exposure to adverse business, financial or economic conditions which could lead to the obligor's inadequate capacity to meet its financial commitment on the obligation. Pluses and minuses show the relative standing within a category. S&P has a total of 22 possible ratings ranging from "AAA (Extremely Strong)" to "D (Payment Default)". There are ten ratings above CNO's "BB+" rating and eleven ratings that are below its rating.

On February 8, 2017, A.M. Best affirmed our issuer credit and senior unsecured debt ratings of "bbb-" and the outlook for these ratings is stable. In A.M. Best's view, a company rated "bbb-" has an adequate ability to meet the terms of its obligations; however, the issuer is more susceptible to changes in economic or other conditions. Pluses and minuses show the relative standing within a category. A.M. Best has a total of 22 possible ratings ranging from "aaa (Exceptional)" to "d (In default)". There are nine ratings above CNO's "bbb-" rating and twelve ratings that are below its rating.

On May 9, 2016, Moody's affirmed our issuer credit and senior unsecured debt ratings of "Ba1" and the outlook for these ratings is stable. In Moody's view, obligations rated "Ba" are judged to have speculative elements and are subject to substantial credit risk. A rating is supplemented with numerical modifiers "1", "2" or "3" to show the relative standing within a category. Moody's has a total of 21 possible ratings ranging from "Aaa" to "C". There are ten ratings above CNO's "Ba1" rating and ten ratings that are below its rating.

We believe that the existing cash available to the holding company, the cash flows to be generated from operations and other transactions will be sufficient to allow us to meet our debt service obligations, pay corporate expenses and satisfy other financial obligations.  However, our cash flow is affected by a variety of factors, many of which are outside of our control, including insurance regulatory issues, competition, financial markets and other general business conditions.  We cannot provide assurance that we will possess sufficient income and liquidity to meet all of our debt service requirements and other holding company obligations.

95

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

INVESTMENTS

At September 30, 2017, the amortized cost, gross unrealized gains and losses and estimated fair value of fixed maturities, available for sale, were as follows (dollars in millions):

	Amortized cost		Gross unrealized gains		Gross unrealized losses			Estimated fair value
Investment grade (a):
Corporate securities	$	12,356.1	$	1,509.8	$	(20.3	)	$	13,845.6
United States Treasury securities and obligations of United States government corporations and agencies	145.4		26.9		—			172.3
States and political subdivisions	1,854.2		220.7		(.6		)	2,074.3
Debt securities issued by foreign governments	58.1		3.1		(.1		)	61.1
Asset-backed securities	1,203.2		43.8		(1.9		)	1,245.1
Collateralized debt obligations	236.5		1.4		—			237.9
Commercial mortgage-backed securities	1,261.0		36.6		(9.2		)	1,288.4
Mortgage pass-through securities	2.0		.2		—			2.2
Collateralized mortgage obligations	310.6		17.6		(.5		)	327.7
Total investment grade fixed maturities, available for sale	17,427.1		1,860.1		(32.6		)	19,254.6
Below-investment grade (a) (b):
Corporate securities	789.3		27.8		(12.7		)	804.4
States and political subdivisions	3.0		—		(.3		)	2.7
Asset-backed securities	1,405.4		136.8		(1.2		)	1,541.0
Commercial mortgage-backed securities	50.6		.8		(.9		)	50.5
Collateralized mortgage obligations	417.1		59.7		(.1		)	476.7
Total below-investment grade fixed maturities, available for sale	2,665.4		225.1		(15.2		)	2,875.3
Total fixed maturities, available for sale	$	20,092.5	$	2,085.2	$	(47.8	)	$	22,129.9

_______________

(a) Investment ratings – Investment ratings are assigned the second lowest rating by Nationally Recognized Statistical Rating Organizations ("NRSROs") (Moody's, S&P or Fitch), or if not rated by such firms, the rating assigned by the National Association of Insurance Commissioners (the "NAIC").  NAIC designations of "1" or "2" include fixed maturities generally rated investment grade (rated "Baa3" or higher by Moody's or rated "BBB-" or higher by S&P and Fitch).  NAIC designations of "3" through "6" are referred to as below-investment grade (which generally are rated "Ba1" or lower by Moody's or rated "BB+" or lower by S&P and Fitch).  References to investment grade or below-investment grade throughout our consolidated financial statements are determined as described above.

(b) Certain structured securities rated below-investment grade by NRSROs may be assigned a NAIC 1 or NAIC 2 designation based on the cost basis of the security relative to estimated recoverable amounts as determined by the NAIC. Refer to the table on the page which follows for a summary of our fixed maturity securities, available for sale, by NAIC designations.

96

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

The NAIC evaluates the fixed maturity investments of insurers for regulatory and capital assessment purposes and assigns securities to one of six credit quality categories called NAIC designations, which are used by insurers when preparing their annual statements based on statutory accounting principles. The NAIC designations are generally similar to the credit quality designations of the NRSROs for marketable fixed maturity securities, except for certain structured securities. However, certain structured securities rated below investment grade by the NRSROs can be assigned NAIC 1 or NAIC 2 designations depending on the cost basis of the holding relative to estimated recoverable amounts as determined by the NAIC. The following summarizes the NAIC designations and NRSRO equivalent ratings:

NAIC Designation	NRSRO Equivalent Rating
1	AAA/AA/A
2	BBB
3	BB
4	B
5	CCC and lower
6	In or near default

A summary of our fixed maturity securities, available for sale, by NAIC designations (or for fixed maturity securities held by non-regulated entities, based on NRSRO ratings) as of September 30, 2017 is as follows (dollars in millions):

NAIC designation	Amortized cost		Estimated fair value		Percentage of total estimated fair value
1	$	9,395.4	$	10,440.6	47.2	%
2	9,779.5		10,751.6		48.6
Total NAIC 1 and 2 (investment grade)	19,174.9		21,192.2		95.8
3	606.5		625.2		2.8
4	249.3		252.1		1.1
5	41.4		40.4		.2
6	20.4		20.0		.1
Total NAIC 3, 4, 5 and 6 (below-investment grade)	917.6		937.7		4.2
	$	20,092.5	$	22,129.9	100.0	%

97

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

Concentration of Fixed Maturity Securities, Available for Sale

The following table summarizes the carrying values and gross unrealized losses of our fixed maturity securities, available for sale, by category as of September 30, 2017 (dollars in millions):

	Carrying value		Percent of fixed maturities		Gross unrealized losses		Percent of gross unrealized losses
Asset-backed securities	$	2,786.1	12.6	%	$	3.1	6.2	%
States and political subdivisions	2,077.0		9.4		.9		1.9
Utilities	1,649.2		7.5		.3		.5
Healthcare/pharmaceuticals	1,636.9		7.4		1.7		3.5
Insurance	1,494.4		6.8		1.1		2.3
Energy	1,445.6		6.5		7.8		16.3
Commercial mortgage-backed securities	1,338.9		6.0		10.1		21.5
Banks	1,179.9		5.3		.2		.4
Food/beverage	982.4		4.4		.2		.4
Cable/media	811.0		3.7		5.6		11.8
Collateralized mortgage obligations	804.4		3.6		.6		1.2
Real estate/REITs	550.1		2.5		—		—
Capital goods	550.0		2.5		.3		.5
Chemicals	520.4		2.4		2.9		6.0
Transportation	475.9		2.2		.3		.7
Brokerage	441.6		2.0		1.2		2.6
Telecom	342.7		1.5		.4		.8
Technology	320.1		1.4		1.0		2.1
Aerospace/defense	295.9		1.3		.2		.3
Autos	287.2		1.3		.5		1.1
Business services	267.1		1.2		2.0		4.2
Paper	261.3		1.2		.1		.2
Collateralized debt obligations	237.9		1.1		—		—
Retail	227.9		1.0		.5		1.1
Other	1,146.0		5.2		6.8		14.4
Total fixed maturities, available for sale	$	22,129.9	100.0	%	$	47.8	100.0	%

Below-Investment Grade Securities

At September 30, 2017, the amortized cost of the Company's below-investment grade fixed maturity securities was $2,665.4 million, or 13 percent of the Company's fixed maturity portfolio. The estimated fair value of the below-investment grade portfolio was $2,875.3 million, or 108 percent of the amortized cost (refer to the table on page 96 for composition of the below-investment grade portfolio).

Below-investment grade corporate debt securities typically have different characteristics than investment grade corporate debt securities.  Based on historical performance, probability of default by the borrower is significantly greater for below-investment grade corporate debt securities and in many cases severity of loss is relatively greater as such securities are generally unsecured and often subordinated to other indebtedness of the issuer.  Also, issuers of below-investment grade corporate debt securities frequently have higher levels of debt relative to investment-grade issuers, hence, all other things being equal, are generally more sensitive to adverse economic conditions.  The Company attempts to reduce the overall risk related to

98

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

its investment in below-investment grade securities, as in all investments, through careful credit analysis, strict investment policy guidelines, and diversification by issuer and/or guarantor and by industry.

Net Realized Investment Gains (Losses)

The following table sets forth the net realized investment gains (losses) for the periods indicated (dollars in millions):

	Three months ended						Nine months ended
	September 30,						September 30,
	2017			2016			2017			2016
Fixed maturity securities, available for sale:
Gross realized gains on sale	$	32.3		$	7.3		$	60.4		$	127.1
Gross realized losses on sale	(8.5		)	(2.8		)	(16.4		)	(84.4		)
Impairments:
Total other-than-temporary impairment losses	(3.2		)	—			(10.0		)	(6.3		)
Other-than-temporary impairment losses recognized in accumulated other comprehensive income	—			—			(.9		)	—
Net impairment losses recognized	(3.2		)	—			(10.9		)	(6.3		)
Net realized investment gains from fixed maturities	20.6			4.5			33.1			36.4
Equity securities	7.7			17.2			9.6			21.3
Commercial mortgage loans	—			—			1.0			—
Impairments of other investments	(1.5		)	(1.2		)	(7.3		)	(18.5		)
Loss on dissolution of variable interest entities	(.6		)	—			(4.3		)	(7.3		)
Other (a)	3.0			(8.9		)	20.2			(8.6		)
Net realized investment gains	$	29.2		$	11.6		$	52.3		$	23.3

_________________

(a) Changes in the estimated fair value of trading securities that we have elected the fair value option (and are still held as of the end of the respective periods) were $13.0 million and $.8 million for the nine months ended September 30, 2017 and 2016, respectively.

During the first nine months of 2017, we recognized net realized investment gains of $52.3 million, which were comprised of: (i) $60.1 million of net gains from the sales of investments; (ii) $4.3 million of losses on the dissolution of VIEs; (iii) the increase in fair value of certain fixed maturity investments with embedded derivatives of $12.3 million; (iv) the increase in fair value of embedded derivatives related to a modified coinsurance agreement of $2.4 million; and (v) $18.2 million of writedowns of investments for other than temporary declines in fair value recognized through net income.

During the first nine months of 2016, we recognized net realized investment gains of $23.3 million, which were comprised of: (i) $48.1 million of net gains from the sales of investments; (ii) a $7.3 million loss on the dissolution of a VIE; (iii) the increase in fair value of certain fixed maturity investments with embedded derivatives of $.6 million; (iv) the increase in fair value of embedded derivatives related to a modified coinsurance agreement of $6.7 million; and (v) $24.8 million of writedowns of investments for other than temporary declines in fair value recognized through net income.

At September 30, 2017, there were three fixed maturity investments in default with both an amortized cost and carrying value of $2.1 million. At September 30, 2017, there was one mortgage loan in process of foreclosure with a carrying value of $10.6 million.

During the first nine months of 2017, the $16.4 million of gross realized losses on sales of $290.8 million of fixed maturity securities, available for sale included: (i) $9.7 million related to various corporate securities; (ii) $3.1 million related to commercial mortgage-backed securities; and (iii) $3.6 million related to various other investments. Securities are generally sold at a loss following unforeseen issue-specific events or conditions or shifts in perceived relative values.  These reasons

99

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

include but are not limited to:  (i) changes in the investment environment; (ii) expectation that the market value could deteriorate; (iii) our desire to reduce our exposure to an asset class, an issuer or an industry; (iv) prospective or actual changes in credit quality; or (v) changes in expected portfolio cash flows.

During the first nine months of 2016, the $84.4 million of gross realized losses on sales of $477.2 million of fixed maturity securities, available for sale, included: (i) $77.8 million related to various corporate securities (including $62.7 million related to sales of investments in the energy sector); (ii) $5.3 million related to commercial mortgage-backed securities; and (iii) $1.3 million related to various other investments.

Our fixed maturity investments are generally purchased in the context of various long-term strategies, including funding insurance liabilities, so we do not generally seek to generate short-term realized gains through the purchase and sale of such securities.  In certain circumstances, including those in which securities are selling at prices which exceed our view of their underlying economic value, or when it is possible to reinvest the proceeds to better meet our long-term asset-liability objectives, we may sell certain securities.

During the first nine months of 2017, we recognized $18.2 million of impairment losses recorded in earnings which included: (i) $5.7 million of writedowns on fixed maturities in the energy sector; (ii) $5.2 million of writedowns related to a mortgage loan; and (iii) $7.3 million of writedowns on other investments. Factors considered in determining the writedowns of investments in the first nine months of 2017 included changes in the estimated recoverable value of the assets related to each investment and the timing of and complexities related to the recovery process.

The following summarizes the investments sold at a loss during the first nine months of 2017 which had been continuously in an unrealized loss position exceeding 20 percent of the amortized cost basis prior to the sale for the period indicated (dollars in millions):

		At date of sale
	Number of issuers	Amortized cost		Fair value
Less than 6 months prior to sale	4	$	17.8	$	13.0
Greater than or equal to 6 months and less than 12 months prior to sale	1	2.7		1.9
Greater than 12 months prior to sale	1	.7		.5
	6	$	21.2	$	15.4

We regularly evaluate all of our investments with unrealized losses for possible impairment.  Our assessment of whether unrealized losses are "other than temporary" requires significant judgment.  Factors considered include:  (i) the extent to which fair value is less than the cost basis; (ii) the length of time that the fair value has been less than cost; (iii) whether the unrealized loss is event driven, credit-driven or a result of changes in market interest rates or risk premium; (iv) the near-term prospects for specific events, developments or circumstances likely to affect the value of the investment; (v) the investment's rating and whether the investment is investment-grade and/or has been downgraded since its purchase; (vi) whether the issuer is current on all payments in accordance with the contractual terms of the investment and is expected to meet all of its obligations under the terms of the investment; (vii) whether we intend to sell the investment or it is more likely than not that circumstances will require us to sell the investment before recovery occurs; (viii) the underlying current and prospective asset and enterprise values of the issuer and the extent to which the recoverability of the carrying value of our investment may be affected by changes in such values; (ix) projections of, and unfavorable changes in, cash flows on structured securities including mortgage-backed and asset-backed securities; (x) our best estimate of the value of any collateral; and (xi) other objective and subjective factors.

Future events may occur, or additional information may become available, which may necessitate future realized losses in our portfolio.  Significant losses could have a material adverse effect on our consolidated financial statements in future periods.

100

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

The following table sets forth the amortized cost and estimated fair value of those fixed maturities, available for sale, with unrealized losses at September 30, 2017, by contractual maturity.  Actual maturities will differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without penalties.  Structured securities frequently include provisions for periodic principal payments and permit periodic unscheduled payments.

	Amortized cost		Estimated fair value
	(Dollars in millions)
Due in one year or less	$	37.1	$	37.1
Due after one year through five years	136.5		135.4
Due after five years through ten years	135.1		132.0
Due after ten years	878.4		848.6
Subtotal	1,187.1		1,153.1
Structured securities	926.6		912.8
Total	$	2,113.7	$	2,065.9

At September 30, 2017 there were no investments in our portfolio rated below-investment grade which have been continuously in an unrealized loss position exceeding 20 percent of the cost basis.

101

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

The following table summarizes the gross unrealized losses of our fixed maturity securities, available for sale, by category and ratings category as of September 30, 2017 (dollars in millions):

	Investment grade				Below-investment grade
	AAA/AA/A		BBB		BB		B+ and below		Total gross unrealized losses
Commercial mortgage-backed securities	$	8.7	$	.5	$	.9	$	—	$	10.1
Energy	.1		4.1		1.9		1.7		7.8
Cable/media	—		5.4		.1		.1		5.6
Asset-backed securities	1.2		.7		.2		1.0		3.1
Chemicals	—		.7		2.2		—		2.9
Building materials	—		1.4		.9		—		2.3
Business services	—		—		2.0		—		2.0
Healthcare/pharmaceuticals	.1		.8		—		.8		1.7
Brokerage	.1		.5		—		.6		1.2
Insurance	—		1.1		—		—		1.1
Technology	—		1.0		—		—		1.0
States and political subdivisions	.3		.3		—		.3		.9
Entertainment/hotels	—		.6		—		.1		.7
Collateralized mortgage obligations	.5		—		—		.1		.6
Autos	—		.2		.3		—		.5
Metals and mining	—		—		.5		—		.5
Retail	—		.2		—		.3		.5
Telecom	—		.4		—		—		.4
Transportation	—		.3		—		—		.3
Capital goods	—		.2		.1		—		.3
Utilities	.2		—		—		.1		.3
Food/beverage	—		.1		—		.1		.2
Banks	.1		.1		—		—		.2
Aerospace/defense	.2		—		—		—		.2
Paper	—		.1		—		—		.1
Consumer products	—		—		—		.1		.1
Debt securities issued by foreign governments	—		.1		—		—		.1
Other	2.2		.1		.7		.1		3.1
Total fixed maturities, available for sale	$	13.7	$	18.9	$	9.8	$	5.4	$	47.8

Our investment strategy is to maximize, over a sustained period and within acceptable parameters of quality and risk, investment income and total investment return through active investment management.  Accordingly, we may sell securities at a gain or a loss to enhance the projected total return of the portfolio as market opportunities change, to reflect changing perceptions of risk, or to better match certain characteristics of our investment portfolio with the corresponding characteristics of our insurance liabilities.

102

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

The following table summarizes the gross unrealized losses and fair values of our investments with unrealized losses that are not deemed to be other-than-temporarily impaired, aggregated by investment category and length of time that such securities have been in a continuous unrealized loss position, at September 30, 2017 (dollars in millions):

	Less than 12 months					12 months or greater					Total
Description of securities	Fair value		Unrealized losses			Fair value		Unrealized losses			Fair value		Unrealized losses
United States Treasury securities and obligations of United States government corporations and agencies	$	20.3	$	—		$	.6	$	—		$	20.9	$	—
States and political subdivisions	35.1		(.6		)	19.3		(.3		)	54.4		(.9		)
Debt securities issued by foreign governments	10.5		(.1		)	—		—			10.5		(.1		)
Corporate securities	666.9		(7.8		)	400.4		(25.2		)	1,067.3		(33.0		)
Asset-backed securities	276.7		(1.3		)	79.6		(1.8		)	356.3		(3.1		)
Collateralized debt obligations	24.0		—			—		—			24.0		—
Commercial mortgage-backed securities	226.2		(1.3		)	221.9		(8.8		)	448.1		(10.1		)
Collateralized mortgage obligations	72.8		(.5		)	11.6		(.1		)	84.4		(.6		)
Total fixed maturities, available for sale	$	1,332.5	$	(11.6	)	$	733.4	$	(36.2	)	$	2,065.9	$	(47.8	)
Equity securities	$	37.4	$	(.8	)	$	89.7	$	(1.8	)	$	127.1	$	(2.6	)

Based on management's current assessment of investments with unrealized losses at September 30, 2017, the Company believes the issuers of the securities will continue to meet their obligations (or with respect to equity-type securities, the investment value will recover to its cost basis).  While we do not have the intent to sell securities with unrealized losses and it is not more likely than not that we will be required to sell securities with unrealized losses prior to their anticipated recovery, our intent on an individual security may change, based upon market or other unforeseen developments.  In such instances, if a loss is recognized from a sale subsequent to a balance sheet date due to these unexpected developments, the loss is recognized in the period in which we had the intent to sell the security before its anticipated recovery.

Structured Securities

At September 30, 2017, fixed maturity investments included structured securities with an estimated fair value of $5.2 billion (or 23 percent of all fixed maturity securities).  The yield characteristics of structured securities generally differ in some respects from those of traditional corporate fixed-income securities or government securities.  For example, interest and principal payments on structured securities may occur more frequently, often monthly.  In many instances, we are subject to variability in the amount and timing of principal and interest payments.  For example, in many cases, partial prepayments may occur at the option of the issuer and prepayment rates are influenced by a number of factors that cannot be predicted with certainty, including:  the relative sensitivity of prepayments on the underlying assets backing the security to changes in interest rates and asset values; the availability of alternative financing; a variety of economic, geographic and other factors; the timing, pace and proceeds of liquidations of defaulted collateral; and various security-specific structural considerations (for example, the repayment priority of a given security in a securitization structure).  In addition, the total amount of payments for non-agency structured securities may be affected by changes to cumulative default rates or loss severities of the related collateral.

103

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

The following table sets forth the par value, amortized cost and estimated fair value of structured securities, summarized by interest rates on the underlying collateral, at September 30, 2017 (dollars in millions):

	Par value		Amortized cost		Estimated fair value
Below 4 percent	$	1,755.8	$	1,591.9	$	1,669.1
4 percent – 5 percent	1,697.1		1,552.6		1,634.7
5 percent – 6 percent	1,419.5		1,278.4		1,372.6
6 percent – 7 percent	261.5		233.9		251.4
7 percent – 8 percent	58.9		59.7		69.3
8 percent and above	170.2		169.9		172.4
Total structured securities	$	5,363.0	$	4,886.4	$	5,169.5

The amortized cost and estimated fair value of structured securities at September 30, 2017, summarized by type of security, were as follows (dollars in millions):

			Estimated fair value
Type	Amortized cost		Amount		Percent of fixed maturities
Pass-throughs, sequential and equivalent securities	$	585.9	$	647.1	2.9	%
Planned amortization classes, target amortization classes and accretion-directed bonds	100.5		114.8		.5
Commercial mortgage-backed securities	1,311.6		1,338.9		6.1
Asset-backed securities	2,608.6		2,786.1		12.6
Collateralized debt obligations	236.5		237.9		1.1
Other	43.3		44.7		.2
Total structured securities	$	4,886.4	$	5,169.5	23.4	%

Pass-throughs, sequentials and equivalent securities have unique prepayment variability characteristics.  Pass-through securities typically return principal to the holders based on cash payments from the underlying mortgage obligations. Sequential securities return principal to tranche holders in a detailed hierarchy.  Planned amortization classes, targeted amortization classes and accretion-directed bonds adhere to fixed schedules of principal payments as long as the underlying mortgage loans experience prepayments within certain estimated ranges.  In most circumstances, changes in prepayment rates are first absorbed by support or companion classes insulating the timing of receipt of cash flows from the consequences of both faster prepayments (average life shortening) and slower prepayments (average life extension).

Commercial mortgage-backed securities are secured by commercial real estate mortgages, generally income producing properties that are managed for profit.  Property types include multi-family dwellings including apartments, retail centers, hotels, restaurants, hospitals, nursing homes, warehouses, and office buildings.  While most commercial mortgage-backed securities have call protection features whereby underlying borrowers may not prepay their mortgages for stated periods of time without incurring prepayment penalties, recoveries on defaulted collateral may result in involuntary prepayments.

104

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

Commercial Mortgage Loans

The following table provides the carrying value and estimated fair value of our outstanding mortgage loans and the underlying collateral as of September 30, 2017 (dollars in millions):

			Estimated fair value
Loan-to-value ratio (a)	Carrying value		Mortgage loans		Collateral
Less than 60%	$	983.5	$	1,007.0	$	2,463.3
60% to 70%	406.8		409.5		621.4
Greater than 70% to 80%	186.1		195.8		254.4
Greater than 80% to 90%	37.4		38.5		43.3
Greater than 90%	54.0		55.0		57.4
Total	$	1,667.8	$	1,705.8	$	3,439.8

________________

(a) Loan-to-value ratios are calculated as the ratio of:  (i) the carrying value of the commercial mortgage loans; to (ii) the estimated fair value of the underlying collateral.

INVESTMENTS IN VARIABLE INTEREST ENTITIES

The following table provides supplemental information about the revenues and expenses of the VIEs which have been consolidated in accordance with authoritative guidance, after giving effect to the elimination of our investment in the VIEs and investment management fees earned by a subsidiary of the Company (dollars in millions):

	Three months ended						Nine months ended
	September 30,						September 30,
	2017			2016			2017			2016
Revenues:
Net investment income – policyholder and other special-purpose portfolios	$	16.1		$	21.2		$	53.0		$	58.9
Fee revenue and other income	1.2			1.8			4.0			4.8
Total revenues	17.3			23.0			57.0			63.7
Expenses:
Interest expense	11.1			13.4			38.0			39.4
Other operating expenses	.4			.3			1.3			1.1
Total expenses	11.5			13.7			39.3			40.5
Income before net realized investment losses, loss on extinguishment of borrowings and income taxes	5.8			9.3			17.7			23.2
Net realized investment losses	(.7		)	(6.9		)	(2.5		)	(20.6		)
Loss on extinguishment of borrowings	(5.5		)	—			(5.5		)	—
Income before income taxes	$	(.4	)	$	2.4		$	9.7		$	2.6

During the first nine months of 2017, the VIEs recognized net realized investment losses of $2.5 million which were comprised of: (i) $2.2 million of net gains from the sales of fixed maturities; (ii) $4.3 million of losses on the dissolution of VIEs; and (iii) $.4 million of writedowns of investments for other than temporary declines in fair value recognized through net income. During the first nine months of 2016, the VIEs recognized net realized investment losses of $20.6 million, which were comprised of: (i) $12.1 million of net losses from the sales of fixed maturities; (ii) a $7.3 million loss on the dissolution of a

105

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

VIE; and (iii) $1.2 million of writedowns of investments for other than temporary declines in fair value recognized through net income.

Supplemental Information on Investments Held by VIEs

The following table summarizes the carrying values of the investments held by the VIEs by category as of September 30, 2017 (dollars in millions):

	Carrying value		Percent of fixed maturities		Gross unrealized losses		Percent of gross unrealized losses
Healthcare/pharmaceuticals	$	169.0	12.2	%	$	.1	1.8	%
Cable/media	155.0		11.2		1.7		21.6
Technology	147.3		10.6		.6		8.3
Food/beverage	96.2		6.9		.8		10.8
Capital goods	83.3		6.0		.3		3.3
Consumer products	67.4		4.9		.5		6.8
Paper	64.7		4.7		.1		1.3
Aerospace/defense	62.1		4.5		.3		4.0
Brokerage	61.0		4.4		.1		.7
Building materials	56.5		4.1		.1		.9
Retail	53.3		3.9		2.4		31.6
Chemicals	46.5		3.4		.1		.9
Utilities	39.5		2.9		—		.3
Autos	31.1		2.3		—		.1
Gaming	29.5		2.1		—		.5
Entertainment/hotels	27.9		2.0		.1		.6
Transportation	27.6		2.0		.1		1.8
Insurance	21.1		1.5		—		—
Banks	17.1		1.2		—		.3
Real estate/REITs	15.9		1.2		—		.1
Metals and mining	12.2		.9		—		—
Business services	8.5		.6		—		.3
Telecom	7.6		.5		—		.2
Energy	2.9		.2		—		—
Textiles	.8		.1		—		—
Other	78.5		5.7		.3		3.8
Total	$	1,382.5	100.0	%	$	7.6	100.0	%

106

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

The following table sets forth the amortized cost and estimated fair value of those investments held by the VIEs with unrealized losses at September 30, 2017, by contractual maturity.  Actual maturities will differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without penalties.

	Amortized cost		Estimated fair value
	(Dollars in millions)
Due in one year or less	$	1.7	$	1.7
Due after one year through five years	154.7		151.6
Due after five years through ten years	244.7		240.2
Total	$	401.1	$	393.5

The following summarizes the investments sold at a loss during the first nine months of 2017 which had been continuously in an unrealized loss position exceeding 20 percent of the amortized cost basis prior to the sale for the period indicated (dollars in millions):

		At date of sale
	Number of issuers	Amortized cost		Fair value
Less than 6 months prior to sale	2	$	2.8	$	1.8

The following summarizes the investments in our portfolio rated below-investment grade which have been continuously in an unrealized loss position exceeding 20 percent of the cost basis for the period indicated as of September 30, 2017 (dollars in millions):

	Number of issuers	Cost basis		Unrealized loss			Estimated fair value
Less than 6 months	1	$	5.4	$	(1.2	)	$	4.2

NEW ACCOUNTING STANDARDS

See "Recently Issued Accounting Standards" in the notes to consolidated financial statements for a discussion of recently issued accounting standards.

107

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

ITEM 3.  QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

Our market risks, and the ways we manage them, are summarized in "Management's Discussion and Analysis of Financial Condition and Results of Operations", included in our Annual Report on Form 10-K for the year ended December 31, 2016.  There have been no material changes in the first nine months of 2017 to such risks or our management of such risks.

ITEM 4. CONTROLS AND PROCEDURES.

Evaluation of Disclosure Controls and Procedures.  CNO's management, under the supervision and with the participation of the Chief Executive Officer and the Chief Financial Officer, evaluated the effectiveness of CNO's disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended).  Based on its evaluation, the Chief Executive Officer and Chief Financial Officer concluded that, as of September 30, 2017, CNO's disclosure controls and procedures were effective to ensure that information required to be disclosed by CNO in reports that it files or submits under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the SEC's rules and forms.  Disclosure controls and procedures are also designed to reasonably assure that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

Changes to Internal Control Over Financial Reporting.  There were no changes in the Company's internal control over financial reporting (as defined in Rule 13a-15(f) under the Securities Exchange Act of 1934) during the three months ended September 30, 2017, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

108

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

PART II - OTHER INFORMATION

ITEM 1.  LEGAL PROCEEDINGS.

Information required for Part II, Item 1 is incorporated by reference to the discussion under the heading "Litigation and Other Legal Proceedings" in the footnotes to our consolidated financial statements included in Part I, Item 1 of this Form 10-Q.

ITEM 1A.  RISK FACTORS.

CNO and its businesses are subject to a number of risks including general business and financial risk factors.  Any or all of such factors could have a material adverse effect on the business, financial condition or results of operations of CNO.  Refer to "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2016, for further discussion of such risk factors.  On September 27, 2017, President Trump announced a framework for tax reform including a reduction in the Federal corporate income tax rate from 35% to 20%. The following risk factor has been updated to summarize the impact the proposed rate reduction would have to CNO. If tax reform is enacted, there are likely to be other changes to the Code that would impact CNO. There have been no other material changes from such previously disclosed risk factors.

The value of our deferred tax assets may be reduced to the extent our future profits are less than we have projected or the current corporate income tax rate is reduced, and such reductions in value may have a material adverse effect on our results of operations and our financial condition.

As of September 30, 2017, we had net deferred tax assets of $573.9 million. Our income tax expense includes deferred income taxes arising from temporary differences between the financial reporting and tax basis of assets and liabilities, capital loss carryforwards and NOLs. We evaluate the realizability of our deferred tax assets and assess the need for a valuation allowance on an ongoing basis. In evaluating our deferred tax assets, we consider whether it is more likely than not that the deferred tax assets will be realized. The ultimate realization of our deferred tax assets depends upon generating sufficient future taxable income during the periods in which our temporary differences become deductible and before our capital loss carry-forwards and NOLs expire. Our assessment of the realizability of our deferred tax assets requires significant judgment. Failure to achieve our projections may result in an increase in the valuation allowance in a future period. Any future increase in the valuation allowance would result in additional income tax expense which could have a material adverse effect upon our earnings in the future, and reduce shareholders' equity.

The value of our net deferred tax assets as of September 30, 2017 reflects the current prescribed Federal corporate income tax rate of 35 percent. A reduction in the corporate income tax rate would cause a writedown of our net deferred tax assets, which may have a material adverse effect on our results of operations and financial condition. President Trump announced key proposals for tax reform on September 27, 2017, including a proposed reduction in the corporate income tax rate from the current 35 percent to 20 percent. A decrease in the corporate income tax rate to 20 percent would result in an immediate writedown of our deferred income tax assets of approximately $250 million based on the September 30, 2017 balances (or approximately $83 million reduction in the balance for each 5 percentage point decrease in the tax rate). The entire impact of the rate change would be recorded through net income (including the impact of a rate change on the taxes on accumulated other comprehensive income which has the impact of reducing the charge by approximately $220 million based on September 30, 2017 balances). A decrease in the corporate income tax rate to 20 percent would also result in a decrease to the statutory capital and surplus of our insurance subsidiaries of approximately $80 million due to a decrease in admissible deferred taxes based on September 30, 2017 balances. In addition, the risk charges that comprise RBC are tax effected, and an effective tax rate change to 20 percent could initially reduce our consolidated RBC ratio by approximately 85 percentage points (subject to changes being made to the formulas used to determine RBC by the NAIC). The decreases in statutory capital and the consolidated RBC ratio resulting from a corporate income tax rate change could result in the need to contribute additional capital to our insurance subsidiaries. A reduction in the corporate income tax rate would have no impact on the tax we pay on non-life income during the time our non-life net operating loss carryforwards remain available. However, a reduction in the corporate income tax rate will have a positive impact on the future cash flows of our insurance subsidiaries. During the period our non-life net operating loss carryforwards remain available and assuming a decrease in the corporate income tax rate to 20 percent, our insurance subsidiaries would pay tax at a rate of 13 percent compared to the current rate of 22.75 percent.

109

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

Issuer Purchases of Equity Securities

Period	Total number of shares (or units)	Average price paid per share (or unit)		Total number of shares (or units) purchased as part of publicly announced plans or programs	Maximum number (or approximate dollar value) of shares (or units) that may yet be purchased under the plans or programs (a)
					(dollars in millions)
July 1 through July 31	1,137	$	22.69	—	$	440.8
August 1 through August 31	391,512	22.36		391,400	432.0
September 1 through September 30	880,895	22.12		880,589	412.6
Total	1,273,544	22.19		1,271,989	412.6

_________________

(a) In May 2011, the Company announced a securities repurchase program of up to $100.0 million. In February 2012, June 2012, December 2012, December 2013, November 2014, November 2015 and May 2017, the Company's Board of Directors approved, in aggregate, an additional $1,900.0 million to repurchase the Company's outstanding securities.

ITEM 5. OTHER INFORMATION.

Effective October 31, 2017, the employment agreement with Christopher Nickele, the Company’s Executive Vice President and Chief Actuary, was amended to extend the term of the agreement until October 31, 2018. The amendment to Mr. Nickele’s employment agreement is attached hereto as Exhibit 10.7 and incorporated herein by reference.

110

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

ITEM 6. EXHIBITS.

10.1	Amendment dated as of August 11, 2017 to Employment Agreement between CNO Services, LLC and Bruce Baude.
10.2	Amendment dated as of August 14, 2017 to Employment Agreement between CNO Financial Group, Inc. and Edward Bonach.
10.3	Amendment dated as of August 17, 2017 to Employment Agreement between CNO Financial Group, Inc. and Erik Helding.
10.4	Amendment dated as of August 10, 2017 to Employment Agreement between 40|86 Advisors, Inc. and Eric Johnson.
10.5	Amendment dated as of August 17, 2017 to Employment Agreement between CNO Services, LLC and Christopher Nickele.
10.6	Amendment dated as of August 21, 2017 to Employment Agreement between CNO Services, LLC and Matthew Zimpfer.
10.7	Amendment dated as of October 31, 2017 to Employment Agreement between CNO Services, LLC and Christopher Nickele.
12.1	Computation of Ratio of Earnings to Fixed Charges.
31.1	Certification Pursuant to the Securities Exchange Act Rule 13a-14(a)/15d-14(a), as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2	Certification Pursuant to the Securities Exchange Act Rule 13a-14(a)/15d-14(a), as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1	Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2	Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS	XBRL Instance Document.
101.SCH	XBRL Taxonomy Extension Schema Document.
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB	XBRL Taxonomy Extension Label Linkbase Document.
101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document.

111

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

CNO FINANCIAL GROUP, INC.

Dated:  November 1, 2017

By:	/s/ John R. Kline
	John R. Kline
	Senior Vice President and Chief Accounting Officer
	(authorized officer and principal accounting officer)

112

EX-10.1

Exhibit 10.1

AMENDMENT TO EMPLOYMENT AGREEMENT

This AMENDMENT TO EMPLOYMENT AGREEMENT is entered into this 11th day of August, 2017, between CNO Services, LLC (the “Company”) and Bruce Baude (“Executive”).

Recitals

A.The Company and Executive entered into an Amended and Restated Employment Agreement dated as of January 6, 2015 and an Amendment thereto effective July 30, 2015 (collectively, the “Agreement”).

B.The Company and Executive desire to further amend the Agreement as set forth herein.

NOW, THEREFORE, in consideration of the foregoing and the mutual covenants contained herein, the receipt and sufficiency of which are hereby acknowledged:

1. The first two sentences of Section 10(c) of the Agreement are hereby amended in their entirety to read as follows:

Executive’s employment may be terminated in a Control Termination. A “Control Termination” shall mean any termination by the Company (or its successor), of Executive’s employment for any reason, or by Executive With Reason as so defined, within six months in anticipation of or within two years following a Change in Control.

All other provisions of Section 10(c) of the Agreement shall remain unchanged.

2. The first sentence of Section 11(d) of the Agreement is hereby amended in its entirety to read as follows:

In the event that Executive is terminated by the Company (or its successor) in a Control Termination as so defined, or if Executive terminates his employment With Reason in a Control Termination, then the Company shall pay Executive within 30 days of the Termination Date the Accrued Amounts.

All other provisions of Section 11(d) of the Agreement shall remain unchanged.

All provisions of the Agreement not amended hereby shall remain in full force and effect.

IN WITNESS WHEREOF, the parties have executed this Amendment to Employment Agreement as of the date first above written.

CNO SERVICES, LLC

By:	/s/ Edward J. Bonach
	Edward J. Bonach
	Chief Executive Officer

/s/ Bruce Baude

Bruce Baude

2

EX-10.2

Exhibit 10.2

AMENDMENT TO EMPLOYMENT AGREEMENT

This AMENDMENT TO EMPLOYMENT AGREEMENT is entered into this 14th day of August, 2017, between CNO Financial Group, Inc. (the “Company”) and Edward J. Bonach (“Executive”).

Recitals

A.The Company and Executive entered into an Amended and Restated Employment Agreement dated as of December 18, 2014 and an Amendment thereto dated as of May 16, 2017 (collectively, the “Agreement”).

B.The Company and Executive desire to further amend the Agreement as set forth herein.

NOW, THEREFORE, in consideration of the foregoing and the mutual covenants contained herein, the receipt and sufficiency of which are hereby acknowledged:

1. The first two sentences of Section 10(c) of the Agreement are hereby amended in their entirety to read as follows:

Executive’s employment may be terminated in a Control Termination. A “Control Termination” shall mean any termination by the Company (or its successor), of Executive’s employment for any reason, or by Executive With Reason as so defined, within six months in anticipation of or within two years following a Change in Control.

All other provisions of Section 10(c) of the Agreement shall remain unchanged.

2. The first sentence of Section 11(d) of the Agreement is hereby amended in its entirety to read as follows:

In the event that Executive is terminated by the Company (or its successor) in a Control Termination as so defined, or if Executive terminates his employment With Reason in a Control Termination, then the Company shall pay Executive within 30 days of the Termination Date the Accrued Amounts.

All other provisions of Section 11(d) of the Agreement shall remain unchanged.

All provisions of the Agreement not amended hereby shall remain in full force and effect.

IN WITNESS WHEREOF, the parties have executed this Amendment to Employment Agreement as of the date first above written.

CNO FINANCIAL GROUP, INC.

By:	/s/ Susan L. Menzel
	Susan L. Menzel, Executive Vice
	President, Human Resources

/s/ Edward J. Bonach

Edward J. Bonach

2

EX-10.3

Exhibit 10.3

AMENDMENT TO EMPLOYMENT AGREEMENT

This AMENDMENT TO EMPLOYMENT AGREEMENT is entered into this 17th day of August, 2017, between CNO Financial Group, Inc. (the “Company”) and Erik M. Helding (“Executive”).

Recitals

A.The Company and Executive entered into an Employment Agreement dated as of April 8, 2016 (the “Agreement”).

B.The Company and Executive desire to amend the Agreement as set forth herein.

NOW, THEREFORE, in consideration of the foregoing and the mutual covenants contained herein, the receipt and sufficiency of which are hereby acknowledged:

1. The first two sentences of Section 10(c) of the Agreement are hereby amended in their entirety to read as follows:

Executive’s employment may be terminated in a Control Termination. A “Control Termination” shall mean any termination by the Company (or its successor), of Executive’s employment for any reason, or by Executive With Reason as so defined, within six months in anticipation of or within two years following a Change in Control.

All other provisions of Section 10(c) of the Agreement shall remain unchanged.

2. The first sentence of Section 11(d) of the Agreement is hereby amended in its entirety to read as follows:

In the event that Executive is terminated by the Company (or its successor) in a Control Termination as so defined, or if Executive terminates his employment With Reason in a Control Termination, then the Company shall pay Executive within 30 days of the Termination Date the Accrued Amounts.

All other provisions of Section 11(d) of the Agreement shall remain unchanged.

All provisions of the Agreement not amended hereby shall remain in full force and effect.

IN WITNESS WHEREOF, the parties have executed this Amendment to Employment Agreement as of the date first above written.

CNO FINANCIAL GROUP, INC.

By:	/s/ Edward J. Bonach
	Edward J. Bonach
	Chief Executive Officer

/s/ Erik M. Helding

Erik M. Helding

2

EX-10.4

Exhibit 10.4

AMENDMENT TO EMPLOYMENT AGREEMENT

This AMENDMENT TO EMPLOYMENT AGREEMENT is entered into this 10th day of August, 2017, between 40|86 Advisors, Inc. (the “Company”) and Eric R. Johnson (“Executive”).

Recitals

A.The Company and Executive entered into an Amended and Restated Employment Agreement dated as of September 30, 2016 (the “Agreement”).

B.The Company and Executive desire to amend the Agreement as set forth herein.

NOW, THEREFORE, in consideration of the foregoing and the mutual covenants contained herein, the receipt and sufficiency of which are hereby acknowledged:

1. The first two sentences of Section 10(c) of the Agreement are hereby amended in their entirety to read as follows:

Executive’s employment may be terminated in a Control Termination. A “Control Termination” shall mean any termination by the Company (or its successor), of Executive’s employment for any reason, or by Executive With Reason as so defined, within six months in anticipation of or within two years following a Change in Control.

All other provisions of Section 10(c) of the Agreement shall remain unchanged.

2. The first sentence of Section 11(d) of the Agreement is hereby amended in its entirety to read as follows:

In the event that Executive is terminated by the Company (or its successor) in a Control Termination as so defined, or if Executive terminates his employment With Reason in a Control Termination, then the Company shall pay Executive within 30 days of the Termination Date the Accrued Amounts.

All other provisions of Section 11(d) of the Agreement shall remain unchanged.

All provisions of the Agreement not amended hereby shall remain in full force and effect.

IN WITNESS WHEREOF, the parties have executed this Amendment to Employment Agreement as of the date first above written.

40|86 ADVISORS, INC.

By:	/s/ Karl W. Kindig
	Karl W. Kindig
	Assistant Secretary

/s/ Eric R. Johnson

Eric R. Johnson

2

EX-10.5

Exhibit 10.5

AMENDMENT TO EMPLOYMENT AGREEMENT

This AMENDMENT TO EMPLOYMENT AGREEMENT is entered into this 17th day of August, 2017, between CNO Services, LLC (the “Company”) and Christopher J. Nickele (“Executive”).

Recitals

A.The Company and Executive entered into an Amended and Restated Employment Agreement dated as of December 18, 2014 (the “Agreement”).

B.The Company and Executive desire to amend the Agreement as set forth herein.

NOW, THEREFORE, in consideration of the foregoing and the mutual covenants contained herein, the receipt and sufficiency of which are hereby acknowledged:

1. The first two sentences of Section 10(c) of the Agreement are hereby amended in their entirety to read as follows:

Executive’s employment may be terminated in a Control Termination. A “Control Termination” shall mean any termination by the Company (or its successor), of Executive’s employment for any reason, or by Executive With Reason as so defined, within six months in anticipation of or within two years following a Change in Control.

All other provisions of Section 10(c) of the Agreement shall remain unchanged.

2. The first sentence of Section 11(d) of the Agreement is hereby amended in its entirety to read as follows:

In the event that Executive is terminated by the Company (or its successor) in a Control Termination as so defined, or if Executive terminates his employment With Reason in a Control Termination, then the Company shall pay Executive within 30 days of the Termination Date the Accrued Amounts.

All other provisions of Section 11(d) of the Agreement shall remain unchanged.

All provisions of the Agreement not amended hereby shall remain in full force and effect.

IN WITNESS WHEREOF, the parties have executed this Amendment to Employment Agreement as of the date first above written.

CNO SERVICES, LLC

By:	/s/ Edward J. Bonach
	Edward J. Bonach
	Chief Executive Officer

/s/ Christopher J. Nickele

Christopher J. Nickele

2

EX-10.6

Exhibit 10.6

AMENDMENT TO EMPLOYMENT AGREEMENT

This AMENDMENT TO EMPLOYMENT AGREEMENT is entered into this 21st day of August, 2017, between CNO Services, LLC (the “Company”) and Matthew J. Zimpfer (“Executive”).

Recitals

A.The Company and Executive entered into an Amended and Restated Employment Agreement dated as of January 12, 2015 (the “Agreement”).

B.The Company and Executive desire to amend the Agreement as set forth herein.

NOW, THEREFORE, in consideration of the foregoing and the mutual covenants contained herein, the receipt and sufficiency of which are hereby acknowledged:

1. Section 2 of the Agreement is hereby amended solely to change the ending date of the Term from June 30, 2017 to June 30, 2020. All other provisions of Section 2 of the Agreement shall remain unchanged.

2. The third sentence of Section 5(b) of the Agreement is hereby amended solely to change “2017 bonus” to “2020 bonus.” All other provisions of Section 5(b) of the Agreement shall remain unchanged.

3. The first two sentences of Section 10(c) of the Agreement are hereby amended in their entirety to read as follows:

Executive’s employment may be terminated in a Control Termination. A “Control Termination” shall mean any termination by the Company (or its successor), of Executive’s employment for any reason, or by Executive With Reason as so defined, within six months in anticipation of or within two years following a Change in Control.

All other provisions of Section 10(c) of the Agreement shall remain unchanged.

4. The first sentence of Section 11(d) of the Agreement is hereby amended in its entirety to read as follows:

In the event that Executive is terminated by the Company (or its successor) in a Control Termination as so defined, or if Executive

terminates his employment With Reason in a Control Termination, then the Company shall pay Executive within 30 days of the Termination Date the Accrued Amounts.

All other provisions of Section 11(d) of the Agreement shall remain unchanged.

All provisions of the Agreement not amended hereby shall remain in full force and effect.

IN WITNESS WHEREOF, the parties have executed this Amendment to Employment Agreement as of the date first above written.

CNO SERVICES, LLC

By:	/s/ Edward J. Bonach
	Edward J. Bonach
	Chief Executive Officer

/s/ Matthew J. Zimpfer

Matthew J. Zimpfer

2

EX-10.7

Exhibit 10.7

AMENDMENT TO EMPLOYMENT AGREEMENT

This AMENDMENT TO EMPLOYMENT AGREEMENT is entered into this 31^st day of October, 2017, between CNO Services, LLC (the “Company”) and Christopher J. Nickele (“Executive”).

Recitals

A.The Company and Executive entered into an Amended and Restated Employment Agreement dated as of December 18, 2014 and an Amendment to Employment Agreement dated as of August 17, 2017 (collectively, the “Agreement”).

B.The Company and Executive desire to further amend the Agreement to extend its Term (as defined in the Agreement) and to make the other changes set forth herein.

NOW, THEREFORE, in consideration of the foregoing and the mutual covenants contained herein, the receipt and sufficiency of which are hereby acknowledged:

1. Section 2 of the Agreement is hereby amended solely to change the ending date of the Term from October 31, 2017 to October 31, 2018. All other provisions of Section 2 of the Agreement shall remain unchanged.

2. Section 5(b) of the Agreement is hereby amended solely to change “2017 bonus” in the penultimate sentence to “2018 bonus.” All other provisions of Section 5(b) of the Agreement shall remain unchanged.

3. All provisions of the Agreement not amended hereby shall remain in full force and effect.

IN WITNESS WHEREOF, the parties have executed this Amendment to Employment Agreement as of the date first above written.

CNO SERVICES, LLC

By:	/s/ Gary C. Bhojwani
	Gary C. Bhojwani
	President

/s/ Christopher J. Nickele

Christopher J. Nickele

EX-12.1

Exhibit 12.1

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Computation of Ratio of Earnings to Fixed Charges

(Dollars in millions)

	Nine months
	ended		Year ended
	September 30,		December 31,
	2017		2016
Pretax income from operations:
Net income	$	246.5	$	358.2
Add income tax expense (benefit)	108.6		(5.0		)
Pretax income from operations	355.1		353.2
Add fixed charges:
Interest expense on corporate debt	34.8		45.8
Interest expense on investment borrowings and borrowings related to variable interest entities	57.5		70.6
Interest added to policyholder account balances	79.6		112.9
Portion of rental (a)	13.5		17.2
Fixed charges	185.4		246.5
Adjusted earnings	$	540.5	$	599.7
Ratio of earnings to fixed charges	2.92X		2.43X

____________________

(a) Interest portion of rental is estimated to be 33 percent.

EX-31.1

Exhibit 31.1

CERTIFICATION

I, Edward J. Bonach, certify that:

1. I have reviewed this quarterly report on Form 10-Q of CNO Financial Group, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date:  November 1, 2017

/s/ Edward J. Bonach

Edward J. Bonach

Chief Executive Officer

EX-31.2

Exhibit 31.2

CERTIFICATION

I, Erik M. Helding, certify that:

1. I have reviewed this quarterly report on Form 10-Q of CNO Financial Group, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: November 1, 2017

/s/ Erik M. Helding

Erik M. Helding

Executive Vice President

and Chief Financial Officer

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of CNO Financial Group, Inc. (the "Company") on Form 10-Q for the period ending September 30, 2017 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Edward J. Bonach, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my actual knowledge:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Edward J. Bonach

Edward J. Bonach

Chief Executive Officer

November 1, 2017

A signed original of this written statement required by Section 906 has been provided to CNO Financial Group, Inc. and will be retained by CNO Financial Group, Inc. and furnished to the Securities and Exchange Commission upon request.

EX-32.2

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of CNO Financial Group, Inc. (the "Company") on Form 10-Q for the period ending September 30, 2017 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Erik M. Helding, Executive Vice President and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my actual knowledge:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Erik M. Helding

Erik M. Helding

Executive Vice President

and Chief Financial Officer

November 1, 2017

A signed original of this written statement required by Section 906 has been provided to CNO Financial Group, Inc. and will be retained by CNO Financial Group, Inc. and furnished to the Securities and Exchange Commission upon request.

XML

DOCUMENT AND ENTITY INFORMATION - shares	9 Months Ended
	Sep. 30, 2017	Oct. 19, 2017
Document and Entity Information [Abstract]
Entity Registrant Name	CNO Financial Group, Inc.
Entity Central Index Key	0001224608
Document Type	10-Q
Document Period End Date	Sep. 30, 2017
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2017
Document Fiscal Period Focus	Q3
Entity Filer Category	Large Accelerated Filer
Amendment Flag	false
Entity Common Stock, Shares Outstanding		167,762,323

XML

CONSOLIDATED BALANCE SHEET (unaudited) - USD ($) $ in Millions	Sep. 30, 2017	Dec. 31, 2016
Investments:
Fixed maturities, available for sale, at fair value (amortized cost: September 30, 2017 - $20,092.5; December 31, 2016 - $19,803.1)	$ 22,129.9	$ 21,096.2
Equity securities at fair value (cost: September 30, 2017 - $688.7; December 31, 2016 - $580.7)	713.3	584.2
Mortgage loans	1,667.8	1,768.0
Policy loans	114.6	112.0
Trading securities	294.4	363.4
Investments held by variable interest entities	1,382.5	1,724.3
Other invested assets	752.1	589.5
Total investments	27,054.6	26,237.6
Cash and cash equivalents - unrestricted	765.9	478.9
Cash and cash equivalents held by variable interest entities	105.9	189.3
Accrued investment income	268.0	239.6
Present value of future profits	368.5	401.8
Deferred acquisition costs	1,023.8	1,044.7
Reinsurance receivables	2,195.5	2,260.4
Income tax assets, net	567.4	789.7
Assets held in separate accounts	4.8	4.7
Other assets	350.2	328.5
Total assets	32,704.6	31,975.2
Liabilities for insurance products:
Policyholder account balances	11,113.5	10,912.7
Future policy benefits	11,374.1	10,953.3
Liability for policy and contract claims	519.5	500.6
Unearned and advanced premiums	262.4	282.5
Liabilities related to separate accounts	4.8	4.7
Other liabilities	789.1	611.4
Investment borrowings	1,646.9	1,647.4
Borrowings related to variable interest entities	1,198.2	1,662.8
Notes payable – direct corporate obligations	914.4	912.9
Total liabilities	27,822.9	27,488.3
Commitments and Contingencies
Shareholders' equity:
Common stock ($0.01 par value, 8,000,000,000 shares authorized, shares issued and outstanding: September 30, 2017 – 167,762,323; December 31, 2016 – 173,753,614)	1.7	1.7
Additional paid-in capital	3,094.5	3,212.1
Accumulated other comprehensive income	933.6	622.4
Retained earnings	851.9	650.7
Total shareholders' equity	4,881.7	4,486.9
Total liabilities and shareholders' equity	$ 32,704.6	$ 31,975.2

XML

CONSOLIDATED BALANCE SHEET (unaudited) (Parenthetical) - USD ($) $ in Millions	Sep. 30, 2017	Dec. 31, 2016
Investments:
Fixed maturities, available for sale, amortized cost	$ 20,092.5	$ 19,803.1
Equity securities cost	$ 688.7	$ 580.7
Shareholders' equity:
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	8,000,000,000	8,000,000,000
Common stock, shares issued (in shares)	167,762,323	173,753,614
Common stock, shares outstanding (in shares)	167,762,323	173,753,614

XML

CONSOLIDATED STATEMENT OF OPERATIONS (unaudited) - USD ($) shares in Thousands, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Revenues:
Insurance policy income	$ 659.3	$ 649.0	$ 1,987.2	$ 1,947.0
Net investment income:
General account assets	325.9	301.7	960.3	888.5
Policyholder and other special-purpose portfolios	52.7	43.1	171.8	82.7
Realized investment gains (losses):
Net realized investment gains (losses), excluding impairment losses	34.5	12.8	74.8	55.4
Other-than-temporary impairments:
Total other-than-temporary impairment losses	(4.7)	(1.2)	(17.3)	(24.8)
Portion of other-than-temporary impairment losses recognized in accumulated other comprehensive income	0.0	0.0	(0.9)	0.0
Net impairment losses recognized	(4.7)	(1.2)	(18.2)	(24.8)
Loss on dissolution of variable interest entities	(0.6)	0.0	(4.3)	(7.3)
Total realized gains	29.2	11.6	52.3	23.3
Fee revenue and other income	12.2	10.5	35.5	38.7
Total revenues	1,079.3	1,015.9	3,207.1	2,980.2
Benefits and expenses:
Insurance policy benefits	638.1	609.8	1,941.6	1,861.2
Loss on reinsurance transaction	0.0	75.4	0.0	75.4
Interest expense	30.1	29.4	92.3	86.0
Amortization	58.2	64.7	181.3	181.6
Loss on extinguishment of borrowings related to a variable interest entity	5.5	0.0	5.5	0.0
Other operating costs and expenses	217.5	187.3	631.3	603.5
Total benefits and expenses	949.4	966.6	2,852.0	2,807.7
Income before income taxes	129.9	49.3	355.1	172.5
Income tax expense (benefit):
Tax expense on period income	44.1	16.9	123.6	61.7
Valuation allowance for deferred tax assets and other tax items	(15.0)	13.8	(15.0)	(13.2)
Net income	$ 100.8	$ 18.6	$ 246.5	$ 124.0
Basic:
Weighted average shares outstanding (in shares)	168,684	174,247	170,890	177,640
Net income (loss) (in dollars per share)	$ 0.60	$ 0.11	$ 1.44	$ 0.70
Diluted:
Weighted average shares outstanding (in shares)	170,982	175,723	172,800	179,373
Net income (loss) (in dollars per share)	$ 0.59	$ 0.11	$ 1.43	$ 0.69

XML

CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME (unaudited) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Statement of Comprehensive Income [Abstract]
Net income	$ 100.8	$ 18.6	$ 246.5	$ 124.0
Other comprehensive income, before tax:
Unrealized gains for the period	120.9	228.3	794.5	1,329.2
Adjustment to present value of future profits and deferred acquisition costs	(1.8)	(11.3)	(25.3)	(119.6)
Amount related to premium deficiencies assuming the net unrealized gains (losses) had been realized	(31.0)	(82.8)	(243.0)	(493.4)
Reclassification adjustments:
For net realized investment (gains) losses included in net income	(27.7)	(14.6)	(44.0)	(24.2)
For amortization of the present value of future profits and deferred acquisition costs related to net realized investment gains (losses) included in net income	0.7	0.2	1.0	0.9
Unrealized gains on investments	61.1	119.8	483.2	692.9
Change related to deferred compensation plan	0.0	0.0	0.0	8.6
Other comprehensive income before tax	61.1	119.8	483.2	701.5
Income tax expense related to items of accumulated other comprehensive income	(22.0)	(42.1)	(172.0)	(248.8)
Other comprehensive income, net of tax	39.1	77.7	311.2	452.7
Comprehensive income	$ 139.9	$ 96.3	$ 557.7	$ 576.7

XML

CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY (unaudited) - USD ($) $ in Millions	Total	Common stock and additional paid-in capital	Accumulated other comprehensive income	Retained earnings
Balance, beginning of period at Dec. 31, 2015	$ 4,138.5	$ 3,388.6	$ 402.8	$ 347.1
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	124.0			124.0
Change in unrealized appreciation (depreciation) of investments and other (net of applicable income tax expense)	451.5		451.5
Change in noncredit component of impairment losses on fixed maturities, available for sale (net of applicable income tax expense)	1.2		1.2
Cost of common stock repurchased	(203.0)	(203.0)
Dividends on common stock	(40.8)			(40.8)
Stock options, restricted stock and performance units	22.4	22.4
Balance, end of period at Sep. 30, 2016	4,493.8	3,208.0	855.5	430.3
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cumulative effect of accounting change	0.3	0.9		(0.6)
Balance, beginning of period at Dec. 31, 2016	4,486.9	3,213.8	622.4	650.7
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	246.5			246.5
Change in unrealized appreciation (depreciation) of investments and other (net of applicable income tax expense)	309.1		309.1
Change in noncredit component of impairment losses on fixed maturities, available for sale (net of applicable income tax expense)	2.1		2.1
Cost of common stock repurchased	(140.1)	(140.1)
Dividends on common stock	(44.7)			(44.7)
Stock options, restricted stock and performance units	21.6	21.6
Balance, end of period at Sep. 30, 2017	$ 4,881.7	$ 3,096.2	$ 933.6	$ 851.9

XML

CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY (unaudited) (Parenthetical) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Statement of Stockholders' Equity [Abstract]
Change in unrealized appreciation (depreciation) of investments, applicable income tax expense (benefit)	$ 170.9	$ 248.1
Change in noncredit component of impairment losses on fixed maturities, available for sale, applicable income tax expense (benefit)	$ 1.1	$ 0.7

XML

CONSOLIDATED STATEMENT OF CASH FLOWS (unaudited) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Cash flows from operating activities:
Insurance policy income	$ 1,859.4	$ 1,837.9
Net investment income	898.9	877.7
Fee revenue and other income	35.5	38.7
Cash and cash equivalents received upon recapture of reinsurance	0.0	73.6
Insurance policy benefits	(1,491.7)	(1,439.6)
Interest expense	(81.0)	(66.5)
Deferrable policy acquisition costs	(183.4)	(179.4)
Other operating costs	(546.0)	(552.1)
Income taxes	(58.0)	(5.5)
Net cash from operating activities	433.7	584.8
Cash flows from investing activities:
Sales of investments	1,742.5	2,225.7
Maturities and redemptions of investments	2,543.0	1,529.5
Purchases of investments	(4,076.8)	(4,196.7)
Net sales (purchases) of trading securities	94.8	(31.0)
Change in cash and cash equivalents held by variable interest entities	83.4	216.7
Other	(23.6)	(17.8)
Net cash provided (used) by investing activities	363.3	(273.6)
Cash flows from financing activities:
Issuance of common stock	6.0	6.9
Payments to repurchase common stock	(142.3)	(210.0)
Common stock dividends paid	(44.5)	(40.9)
Amounts received for deposit products	1,067.2	992.1
Withdrawals from deposit products	(920.8)	(891.5)
Issuance of investment borrowings:
Federal Home Loan Bank	332.0	432.7
Related to variable interest entities	387.3	477.1
Payments on investment borrowings:
Federal Home Loan Bank	(332.6)	(333.3)
Related to variable interest entities	(862.3)	(470.6)
Net cash used by financing activities	(510.0)	(37.5)
Net increase in cash and cash equivalents	287.0	273.7
Cash and cash equivalents, beginning of period	478.9	432.3
Cash and cash equivalents, end of period	$ 765.9	$ 706.0

XML

BUSINESS AND BASIS OF PRESENTATION

9 Months Ended

Sep. 30, 2017

Organization, Consolidation and Presentation of Financial Statements [Abstract]

BUSINESS AND BASIS OF PRESENTATION

BUSINESS AND BASIS OF PRESENTATION

The following notes should be read together with the notes to the consolidated financial statements included in our 2016 Annual Report on Form 10-K.

CNO Financial Group, Inc., a Delaware corporation ("CNO"), is a holding company for a group of insurance companies operating throughout the United States that develop, market and administer health insurance, annuity, individual life insurance and other insurance products.  The terms "CNO Financial Group, Inc.", "CNO", the "Company", "we", "us", and "our" as used in these financial statements refer to CNO and its subsidiaries.  Such terms, when used to describe insurance business and products, refer to the insurance business and products of CNO's insurance subsidiaries.

We focus on serving middle-income pre-retiree and retired Americans, which we believe are attractive, underserved, high growth markets.  We sell our products through three distribution channels: career agents, independent producers (some of whom sell one or more of our product lines exclusively) and direct marketing.

Our unaudited consolidated financial statements reflect normal recurring adjustments that, in the opinion of management, are necessary for a fair statement of our financial position, results of operations and cash flows for the periods presented.  As permitted by rules and regulations of the Securities and Exchange Commission (the "SEC") applicable to quarterly reports on Form 10-Q, we have condensed or omitted certain information and disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP").  We have reclassified certain amounts from the prior periods to conform to the 2017 presentation.  These reclassifications have no effect on net income or shareholders' equity.  Results for interim periods are not necessarily indicative of the results that may be expected for a full year.

The balance sheet at December 31, 2016, presented herein, has been derived from the audited financial statements at that date but does not include all of the information and footnotes required by GAAP for complete financial statements.

When we prepare financial statements in conformity with GAAP, we are required to make estimates and assumptions that significantly affect reported amounts of various assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the reporting periods.  For example, we use significant estimates and assumptions to calculate values for deferred acquisition costs, the present value of future profits, fair value measurements of certain investments (including derivatives), other-than-temporary impairments of investments, assets and liabilities related to income taxes, liabilities for insurance products, liabilities related to litigation and guaranty fund assessment accruals.  If our future experience differs from these estimates and assumptions, our financial statements would be materially affected.

The accompanying financial statements include the accounts of the Company and its subsidiaries. Our consolidated financial statements exclude transactions between us and our consolidated affiliates, or among our consolidated affiliates.

XML

INVESTMENTS

9 Months Ended

Sep. 30, 2017

Investments, Debt and Equity Securities [Abstract]

INVESTMENTS

INVESTMENTS

We classify our fixed maturity securities into one of two categories: (i) "available for sale" (which we carry at estimated fair value with any unrealized gain or loss, net of tax and related adjustments, recorded as a component of shareholders' equity); or (ii) "trading" (which we carry at estimated fair value with changes in such value recognized as net investment income (classified as investment income from policyholder and other special-purpose portfolios)).

Ourtrading securities include: (i) investments purchased with the intent of selling in the near term to generate income; (ii) investments supporting certain insurance liabilities (including investments backing the market strategies of our multibucket annuity products); and (iii) certain fixed maturity securities containing embedded derivatives for which we have elected the fair value option.  The change in fair value of the income generating investments and investments supporting insurance liabilities is recognized in income from policyholder and other special-purpose portfolios (a component of net investment income). The change in fair value of securities with embedded derivatives is recognized in realized investment gains (losses). Investment income related to investments supporting certain insurance liabilities is substantially offset by the change in insurance policy benefits related to certain products.

Accumulated other comprehensive income is primarily comprised of the net effect of unrealized appreciation (depreciation) on our investments.  These amounts, included in shareholders' equity as of September 30, 2017 and December 31, 2016, were as follows (dollars in millions):

	September 30, 2017			December 31, 2016
Net unrealized appreciation (depreciation) on fixed maturity securities, available for sale, on which an other-than-temporary impairment loss has been recognized	$	2.4		$	(1.1	)
Net unrealized gains on all other investments	2,058.9			1,311.9
Adjustment to present value of future profits (a)	(98.1		)	(106.2		)
Adjustment to deferred acquisition costs	(287.9		)	(223.5		)
Adjustment to insurance liabilities	(224.5		)	(13.5		)
Deferred income tax liabilities	(517.2		)	(345.2		)
Accumulated other comprehensive income	$	933.6		$	622.4

________

(a) The present value of future profits is the value assigned to the right to receive future cash flows from contracts existing at September 10, 2003, the date Conseco, Inc., an Indiana corporation, emerged from bankruptcy.

At September 30, 2017, adjustments to the present value of future profits, deferred acquisition costs, insurance liabilities and deferred tax assets included $(86.7) million, $(135.8) million, $(224.5) million and $159.1 million, respectively, for premium deficiencies that would exist on certain blocks of business (primarily long-term care products) if unrealized gains on the assets backing such products had been realized and the proceeds from the sales of such assets were invested at then current yields.

At September 30, 2017, the amortized cost, gross unrealized gains and losses, estimated fair value, other-than-temporary impairments in accumulated other comprehensive income of fixed maturities, available for sale, and equity securities were as follows (dollars in millions):

	Amortized cost		Gross unrealized gains		Gross unrealized losses			Estimated fair value		Other-than-temporary impairments included in accumulated other comprehensive income
Corporate securities	$	13,145.4	$	1,537.6	$	(33.0	)	$	14,650.0	$	(3.6	)
United States Treasury securities and obligations of United States government corporations and agencies	145.4		26.9		—			172.3		—
States and political subdivisions	1,857.2		220.7		(.9		)	2,077.0		—
Debt securities issued by foreign governments	58.1		3.1		(.1		)	61.1		—
Asset-backed securities	2,608.6		180.6		(3.1		)	2,786.1		—
Collateralized debt obligations	236.5		1.4		—			237.9		—
Commercial mortgage-backed securities	1,311.6		37.4		(10.1		)	1,338.9		—
Mortgage pass-through securities	2.0		.2		—			2.2		—
Collateralized mortgage obligations	727.7		77.3		(.6		)	804.4		(1.1		)
Total fixed maturities, available for sale	$	20,092.5	$	2,085.2	$	(47.8	)	$	22,129.9	$	(4.7	)
Equity securities	$	688.7	$	27.2	$	(2.6	)	$	713.3

At December 31, 2016, the amortized cost, gross unrealized gains and losses, estimated fair value, other-than-temporary impairments in accumulated other comprehensive income of fixed maturities, available for sale, and equity securities were as follows (dollars in millions):

	Amortized cost		Gross unrealized gains		Gross unrealized losses			Estimated fair value		Other-than-temporary impairments included in accumulated other comprehensive income
Corporate securities	$	12,549.9	$	1,100.0	$	(139.0	)	$	13,510.9	$	(3.6	)
United States Treasury securities and obligations of United States government corporations and agencies	143.8		20.5		—			164.3		—
States and political subdivisions	1,811.8		186.7		(9.6		)	1,988.9		(3.0		)
Debt securities issued by foreign governments	37.1		.2		(.4		)	36.9		—
Asset-backed securities	2,641.5		84.3		(15.5		)	2,710.3		—
Collateralized debt obligations	230.0		1.0		(.3		)	230.7		—
Commercial mortgage-backed securities	1,531.0		33.1		(27.9		)	1,536.2		—
Mortgage pass-through securities	2.3		.2		—			2.5		—
Collateralized mortgage obligations	855.7		61.4		(1.6		)	915.5		(1.4		)
Total fixed maturities, available for sale	$	19,803.1	$	1,487.4	$	(194.3	)	$	21,096.2	$	(8.0	)
Equity securities	$	580.7	$	11.5	$	(8.0	)	$	584.2

The following table sets forth the amortized cost and estimated fair value of fixed maturities, available for sale, at September 30, 2017, by contractual maturity.  Actual maturities will differ from contractual maturities because certain borrowers may have the right to call or prepay obligations with or without penalties.  Structured securities (such as asset-backed securities, collateralized debt obligations, commercial mortgage-backed securities, mortgage pass-through securities and collateralized mortgage obligations, collectively referred to as "structured securities") frequently include provisions for periodic principal payments and permit periodic unscheduled payments.

	Amortized cost		Estimated fair value
	(Dollars in millions)
Due in one year or less	$	398.1	$	406.1
Due after one year through five years	2,004.8		2,131.7
Due after five years through ten years	1,562.8		1,671.1
Due after ten years	11,240.4		12,751.5
Subtotal	15,206.1		16,960.4
Structured securities	4,886.4		5,169.5
Total fixed maturities, available for sale	$	20,092.5	$	22,129.9

The following table sets forth the amortized cost and estimated fair value of fixed maturities, available for sale, at December 31, 2016, by contractual maturity.

	Amortized cost		Estimated fair value
	(Dollars in millions)
Due in one year or less	$	354.7	$	359.8
Due after one year through five years	2,243.8		2,399.5
Due after five years through ten years	1,549.1		1,620.8
Due after ten years	10,395.0		11,320.9
Subtotal	14,542.6		15,701.0
Structured securities	5,260.5		5,395.2
Total fixed maturities, available for sale	$	19,803.1	$	21,096.2

Net Realized Investment Gains (Losses)

The following table sets forth the net realized investment gains (losses) for the periods indicated (dollars in millions):

	Three months ended						Nine months ended
	September 30,						September 30,
	2017			2016			2017			2016
Fixed maturity securities, available for sale:
Gross realized gains on sale	$	32.3		$	7.3		$	60.4		$	127.1
Gross realized losses on sale	(8.5		)	(2.8		)	(16.4		)	(84.4		)
Impairments:
Total other-than-temporary impairment losses	(3.2		)	—			(10.0		)	(6.3		)
Other-than-temporary impairment losses recognized in accumulated other comprehensive income	—			—			(.9		)	—
Net impairment losses recognized	(3.2		)	—			(10.9		)	(6.3		)
Net realized investment gains from fixed maturities	20.6			4.5			33.1			36.4
Equity securities	7.7			17.2			9.6			21.3
Commercial mortgage loans	—			—			1.0			—
Impairments of other investments	(1.5		)	(1.2		)	(7.3		)	(18.5		)
Loss on dissolution of variable interest entities	(.6		)	—			(4.3		)	(7.3		)
Other (a)	3.0			(8.9		)	20.2			(8.6		)
Net realized investment gains	$	29.2		$	11.6		$	52.3		$	23.3

_________________

(a) Changes in the estimated fair value of trading securities that we have elected the fair value option (and are still held as of the end of the respective periods) were $13.0 million and $.8 million for the nine months ended September 30, 2017 and 2016, respectively.

During the first nine months of 2017, we recognized net realized investment gains of $52.3 million, which were comprised of: (i) $60.1 million of net gains from the sales of investments; (ii) $4.3 million of losses on the dissolution of variable interest entities ("VIEs"); (iii) the increase in fair value of certain fixed maturity investments with embedded derivatives of $12.3 million; (iv) the increase in fair value of embedded derivatives related to a modified coinsurance agreement of $2.4 million; and (v) $18.2 million of writedowns of investments for other than temporary declines in fair value recognized through net income.

During the first nine months of 2016, we recognized net realized investment gains of $23.3 million, which were comprised of: (i) $48.1 million of net gains from the sales of investments; (ii) a $7.3 million loss on the dissolution of a VIE; (iii) the increase in fair value of certain fixed maturity investments with embedded derivatives of $.6 million; (iv) the increase in fair value of embedded derivatives related to a modified coinsurance agreement of $6.7 million; and (v) $24.8 million of writedowns of investments for other than temporary declines in fair value recognized through net income.

During the first nine months of 2017 and 2016, certain VIEs that were required to be consolidated were dissolved. We recognized a loss of $4.3 million and $7.3 million during the first nine months of 2017 and 2016, respectively, representing the difference between the carrying value of the investment borrowings of such VIEs and the contractual distributions required following the liquidation of the underlying assets.

Our fixed maturity investments are generally purchased in the context of various long-term strategies, including funding insurance liabilities, so we do not generally seek to generate short-term realized gains through the purchase and sale of such securities.  In certain circumstances, including those in which securities are selling at prices which exceed our view of their underlying economic value, or when it is possible to reinvest the proceeds to better meet our long-term asset-liability objectives, we may sell certain securities.

During the first nine months of 2017, the $16.4 million of gross realized losses on sales of $290.8 million of fixed maturity securities, available for sale included: (i) $9.7 million related to various corporate securities; (ii) $3.1 million related to commercial mortgage-backed securities; and (iii) $3.6 million related to various other investments. Securities are generally sold at a loss following unforeseen issue-specific events or conditions or shifts in perceived relative values.  These reasons include but are not limited to:  (i) changes in the investment environment; (ii) expectation that the market value could deteriorate; (iii) our desire to reduce our exposure to an asset class, an issuer or an industry; (iv) prospective or actual changes in credit quality; or (v) changes in expected portfolio cash flows.

During the first nine months of 2017, we recognized $18.2 million of impairment losses recorded in earnings which included: (i) $5.7 million of writedowns on fixed maturities in the energy sector; (ii) $5.2 million of writedowns related to a mortgage loan; and (iii) $7.3 million of writedowns on other investments. Factors considered in determining the writedowns of investments in the first nine months of 2017 included changes in the estimated recoverable value of the assets related to each investment and the timing of and complexities related to the recovery process.

During the first nine months of 2016, we recognized $24.8 million of impairment losses recorded in earnings which included: (i) $6.3 million of writedowns on fixed maturities of a single issuer in the energy sector; (ii) $3.7 million of writedowns on a direct loan due to borrower specific events; (iii) $12.7 million of writedowns on a privately placed preferred stock of an entity formed to construct and operate a chemical plant; (iv) $.9 million of writedowns related to a real estate investment; and (v) $1.2 million of writedowns of investments held by VIEs due to other-than-temporary declines in value.

We regularly evaluate all of our investments with unrealized losses for possible impairment.  Our assessment of whether unrealized losses are "other than temporary" requires significant judgment.  Factors considered include:  (i) the extent to which fair value is less than the cost basis; (ii) the length of time that the fair value has been less than cost; (iii) whether the unrealized loss is event driven, credit-driven or a result of changes in market interest rates or risk premium; (iv) the near-term prospects for specific events, developments or circumstances likely to affect the value of the investment; (v) the investment's rating and whether the investment is investment-grade and/or has been downgraded since its purchase; (vi) whether the issuer is current on all payments in accordance with the contractual terms of the investment and is expected to meet all of its obligations under the terms of the investment; (vii) whether we intend to sell the investment or it is more likely than not that circumstances will require us to sell the investment before recovery occurs; (viii) the underlying current and prospective asset and enterprise values of the issuer and the extent to which the recoverability of the carrying value of our investment may be affected by changes in such values; (ix) projections of, and unfavorable changes in, cash flows on structured securities including mortgage-backed and asset-backed securities; (x) our best estimate of the value of any collateral; and (xi) other objective and subjective factors.

Future events may occur, or additional information may become available, which may necessitate future realized losses in our portfolio.  Significant losses could have a material adverse effect on our consolidated financial statements in future periods.

Impairment losses on equity securities are recognized in net income.  The manner in which impairment losses on fixed maturity securities, available for sale, are recognized in the financial statements is dependent on the facts and circumstances related to the specific security.  If we intend to sell a security or it is more likely than not that we would be required to sell a security before the recovery of its amortized cost, the security is other-than-temporarily impaired and the full amount of the impairment is recognized as a loss through earnings.  If we do not expect to recover the amortized cost basis, we do not plan to sell the security, and if it is not more likely than not that we would be required to sell a security before the recovery of its amortized cost, less any current period credit loss, the recognition of the other-than-temporary impairment is bifurcated.  We recognize the credit loss portion in net income and the noncredit loss portion in accumulated other comprehensive income.

We estimate the amount of the credit loss component of a fixed maturity security impairment as the difference between amortized cost and the present value of the expected cash flows of the security.  The present value is determined using the best estimate of future cash flows discounted at the effective interest rate implicit to the security at the date of purchase or the current yield to accrete an asset-backed or floating-rate security.  The methodology and assumptions for establishing the best estimate of future cash flows vary depending on the type of security.

For most structured securities, cash flow estimates are based on bond-specific facts and circumstances that may include collateral characteristics, expectations of delinquency and default rates, loss severity, prepayment speeds and structural support, including excess spread, subordination and guarantees.  For corporate bonds, cash flow estimates are derived from scenario-based outcomes of expected corporate restructurings or the disposition of assets using bond specific facts and circumstances. The previous amortized cost basis less the impairment recognized in net income becomes the security's new cost basis.  We accrete the new cost basis to the estimated future cash flows over the expected remaining life of the security, except when the security is in default or considered nonperforming.

The remaining noncredit impairment, which is recorded in accumulated other comprehensive income, is the difference between the security's estimated fair value and our best estimate of future cash flows discounted at the effective interest rate prior to impairment.  The remaining noncredit impairment typically represents changes in the market interest rates, current market liquidity and risk premiums.  As of September 30, 2017, other-than-temporary impairments included in accumulated other comprehensive income totaled $4.7 million (before taxes and related amortization).

The following table summarizes the amount of credit losses recognized in earnings on fixed maturity securities, available for sale, held at the beginning of the period, for which a portion of the other-than-temporary impairment was also recognized in accumulated other comprehensive income for the three and nine months ended September 30, 2017 and 2016 (dollars in millions):

	Three months ended						Nine months ended
	September 30,						September 30,
	2017			2016			2017			2016
Credit losses on fixed maturity securities, available for sale, beginning of period	$	(4.9	)	$	(2.6	)	$	(5.5	)	$	(2.6	)
Add: credit losses on other-than-temporary impairments not previously recognized	—			—			—			—
Less: credit losses on securities sold	—			.1			1.6			.1
Less: credit losses on securities impaired due to intent to sell (a)	—			—			—			—
Add: credit losses on previously impaired securities	—			—			(1.0		)	—
Less: increases in cash flows expected on previously impaired securities	—			—			—			—
Credit losses on fixed maturity securities, available for sale, end of period	$	(4.9	)	$	(2.5	)	$	(4.9	)	$	(2.5	)

__________

(a) Represents securities for which the amount previously recognized in accumulated other comprehensive income was recognized in earnings because we intend to sell the security or we more likely than not will be required to sell the security before recovery of its amortized cost basis.

Gross Unrealized Investment Losses

Our investment strategy is to maximize, over a sustained period and within acceptable parameters of quality and risk, investment income and total investment return through active investment management. Accordingly, we may sell securities at a gain or a loss to enhance the projected total return of the portfolio as market opportunities change, to reflect changing perceptions of risk, or to better match certain characteristics of our investment portfolio with the corresponding characteristics of our insurance liabilities.

The following table summarizes the gross unrealized losses and fair values of our investments with unrealized losses that are not deemed to be other-than-temporarily impaired, aggregated by investment category and length of time that such securities have been in a continuous unrealized loss position, at September 30, 2017 (dollars in millions):

	Less than 12 months					12 months or greater					Total
Description of securities	Fair value		Unrealized losses			Fair value		Unrealized losses			Fair value		Unrealized losses
United States Treasury securities and obligations of United States government corporations and agencies	$	20.3	$	—		$	.6	$	—		$	20.9	$	—
States and political subdivisions	35.1		(.6		)	19.3		(.3		)	54.4		(.9		)
Debt securities issued by foreign governments	10.5		(.1		)	—		—			10.5		(.1		)
Corporate securities	666.9		(7.8		)	400.4		(25.2		)	1,067.3		(33.0		)
Asset-backed securities	276.7		(1.3		)	79.6		(1.8		)	356.3		(3.1		)
Collateralized debt obligations	24.0		—			—		—			24.0		—
Commercial mortgage-backed securities	226.2		(1.3		)	221.9		(8.8		)	448.1		(10.1		)
Collateralized mortgage obligations	72.8		(.5		)	11.6		(.1		)	84.4		(.6		)
Total fixed maturities, available for sale	$	1,332.5	$	(11.6	)	$	733.4	$	(36.2	)	$	2,065.9	$	(47.8	)
Equity securities	$	37.4	$	(.8	)	$	89.7	$	(1.8	)	$	127.1	$	(2.6	)

The following table summarizes the gross unrealized losses and fair values of our investments with unrealized losses that are not deemed to be other-than-temporarily impaired, aggregated by investment category and length of time that such securities have been in a continuous unrealized loss position, at December 31, 2016 (dollars in millions):

	Less than 12 months					12 months or greater					Total
Description of securities	Fair value		Unrealized losses			Fair value		Unrealized losses			Fair value		Unrealized losses
United States Treasury securities and obligations of United States government corporations and agencies	$	8.0	$	—		$	—	$	—		$	8.0	$	—
States and political subdivisions	176.3		(7.8		)	18.3		(1.8		)	194.6		(9.6		)
Debt securities issued by foreign governments	18.9		(.4		)	—		—			18.9		(.4		)
Corporate securities	1,907.6		(75.5		)	559.6		(63.5		)	2,467.2		(139.0		)
Asset-backed securities	692.9		(8.5		)	262.5		(7.0		)	955.4		(15.5		)
Collateralized debt obligations	38.3		(.1		)	30.8		(.2		)	69.1		(.3		)
Commercial mortgage-backed securities	525.2		(16.6		)	154.0		(11.3		)	679.2		(27.9		)
Collateralized mortgage obligations	73.6		(.6		)	34.6		(1.0		)	108.2		(1.6		)
Total fixed maturities, available for sale	$	3,440.8	$	(109.5	)	$	1,059.8	$	(84.8	)	$	4,500.6	$	(194.3	)
Equity securities	$	239.4	$	(8.0	)	$	—	$	—		$	239.4	$	(8.0	)

Based on management's current assessment of investments with unrealized losses at September 30, 2017, the Company believes the issuers of the securities will continue to meet their obligations (or with respect to equity-type securities, the investment value will recover to its cost basis).  While we do not have the intent to sell securities with unrealized losses and it is not more likely than not that we will be required to sell securities with unrealized losses prior to their anticipated recovery, our intent on an individual security may change, based upon market or other unforeseen developments.  In such instances, if a loss is recognized from a sale subsequent to a balance sheet date due to these unexpected developments, the loss is recognized in the period in which we had the intent to sell the security before its anticipated recovery.

XML

EARNINGS PER SHARE

9 Months Ended

Sep. 30, 2017

Earnings Per Share [Abstract]

EARNINGS PER SHARE

EARNINGS PER SHARE

A reconciliation of net income and shares used to calculate basic and diluted earnings per share is as follows (dollars in millions and shares in thousands):

	Three months ended				Nine months ended
	September 30,				September 30,
	2017		2016		2017		2016
Net income for basic and diluted earnings per share	$	100.8	$	18.6	$	246.5	$	124.0
Shares:
Weighted average shares outstanding for basic earnings per share	168,684		174,247		170,890		177,640
Effect of dilutive securities on weighted average shares:
Stock options, restricted stock and performance units	2,298		1,476		1,910		1,733
Weighted average shares outstanding for diluted earnings per share	170,982		175,723		172,800		179,373

Basic earnings per common share is computed by dividing net income by the weighted average number of common shares outstanding for the period.  Restricted shares (including our performance units) are not included in basic earnings per share until vested.  Diluted earnings per share reflect the potential dilution that could occur if outstanding stock options were exercised and restricted stock was vested.  The dilution from options and restricted shares is calculated using the treasury stock method.  Under this method, we assume the proceeds from the exercise of the options (or the unrecognized compensation expense with respect to restricted stock and performance units) will be used to purchase shares of our common stock at the average market price during the period, reducing the dilutive effect of the exercise of the options (or the vesting of the restricted stock and performance units).

XML

BUSINESS SEGMENTS

9 Months Ended

Sep. 30, 2017

Segment Reporting [Abstract]

BUSINESS SEGMENTS

BUSINESS SEGMENTS

The Company manages its business through the following operating segments: Bankers Life, Washington National and Colonial Penn, which are defined on the basis of product distribution; and corporate operations, comprised of holding company activities and certain noninsurance company businesses. In the fourth quarter of 2016, we began reporting the long-term care block recaptured from Beechwood Re Ltd ("BRe") effective September 30, 2016, as an additional business segment.

We measure segment performance by excluding net realized investment gains (losses), fair value changes in embedded derivative liabilities (net of related amortization), fair value changes and an amendment to the agent deferred compensation plan, loss on reinsurance transaction, income taxes and other non-operating items consisting primarily of earnings attributable to VIEs ("pre-tax operating earnings") because we believe that this performance measure is a better indicator of the ongoing business and trends in our business.  Our primary investment focus is on investment income to support our liabilities for insurance products as opposed to the generation of net realized investment gains (losses), and a long-term focus is necessary to maintain profitability over the life of the business.

The net realized investment gains (losses), fair value changes in embedded derivative liabilities (net of related amortization), fair value changes and an amendment to the agent deferred compensation plan, loss on reinsurance transaction and other non-operating items consisting primarily of earnings attributable to VIEs depend on market conditions or represent unusual items that do not necessarily relate to the underlying business of our segments.  Net realized investment gains (losses) and fair value changes in embedded derivative liabilities (net of related amortization) may affect future earnings levels since our underlying business is long-term in nature and changes in our investment portfolio may impact our ability to earn the assumed interest rates needed to maintain the profitability of our business.

Operating information by segment was as follows (dollars in millions):

	Three months ended				Nine months ended
	September 30,				September 30,
	2017		2016		2017		2016
Revenues:
Bankers Life:
Insurance policy income:
Annuities	$	3.7	$	6.8	$	15.5	$	17.4
Health	307.2		310.3		926.9		933.3
Life	103.7		96.6		310.4		295.8
Net investment income (a)	270.6		244.7		800.4		686.8
Fee revenue and other income (a)	11.3		9.6		32.5		23.5
Total Bankers Life revenues	696.5		668.0		2,085.7		1,956.8
Washington National:
Insurance policy income:
Annuities	.5		1.2		1.6		2.3
Health	160.4		156.9		480.3		469.1
Life	6.5		6.3		20.1		18.6
Net investment income (a)	68.0		67.1		201.9		191.3
Fee revenue and other income (a)	.3		.4		.8		1.0
Total Washington National revenues	235.7		231.9		704.7		682.3
Colonial Penn:
Insurance policy income:
Health	.5		.6		1.6		2.0
Life	72.6		70.3		217.5		208.5
Net investment income (a)	11.0		11.1		33.1		33.0
Fee revenue and other income (a)	.3		.2		.9		.8
Total Colonial Penn revenues	84.4		82.2		253.1		244.3
Long-term care in run-off:
Insurance policy income - health	4.2		—		13.3		—
Net investment income (a)	6.8		—		26.5		—
Total Long-term care in run-off revenues	11.0		—		39.8		—
Corporate operations:
Net investment income	7.0		6.7		24.8		16.6
Fee and other income	1.8		2.5		6.5		7.6
Total corporate revenues	8.8		9.2		31.3		24.2
Total revenues	$	1,036.4	$	991.3	$	3,114.6	$	2,907.6

(continued on next page)

(continued from previous page)

	Three months ended						Nine months ended
	September 30,						September 30,
	2017			2016			2017			2016
Expenses:
Bankers Life:
Insurance policy benefits	$	437.2		$	427.1		$	1,307.7		$	1,240.9
Amortization	38.7			43.8			126.3			135.3
Interest expense on investment borrowings	5.3			3.5			14.3			9.4
Other operating costs and expenses	108.4			105.5			328.2			312.2
Total Bankers Life expenses	589.6			579.9			1,776.5			1,697.8
Washington National:
Insurance policy benefits	144.7			144.5			436.7			422.0
Amortization	14.3			14.3			43.9			44.5
Interest expense on investment borrowings	1.7			.9			4.5			2.5
Other operating costs and expenses	47.5			47.0			145.0			140.3
Total Washington National expenses	208.2			206.7			630.1			609.3
Colonial Penn:
Insurance policy benefits	47.7			50.3			150.8			151.3
Amortization	3.9			3.7			11.9			11.3
Interest expense on investment borrowings	.3			.1			.7			.4
Other operating costs and expenses	23.5			27.2			73.0			84.2
Total Colonial Penn expenses	75.4			81.3			236.4			247.2
Long-term care in run-off:
Insurance policy benefits	11.4			—			36.6			—
Other operating costs and expenses	.6			—			2.1			—
Total Long-term care in run-off expenses	12.0			—			38.7			—
Corporate operations:
Interest expense on corporate debt	11.7			11.5			34.8			34.3
Other operating costs and expenses	23.7			13.6			68.3			43.7
Total corporate expenses	35.4			25.1			103.1			78.0
Total expenses	920.6			893.0			2,784.8			2,632.3
Pre-tax operating earnings by segment:
Bankers Life	106.9			88.1			309.2			259.0
Washington National	27.5			25.2			74.6			73.0
Colonial Penn	9.0			.9			16.7			(2.9		)
Long-term care in run-off	(1.0		)	—			1.1			—
Corporate operations	(26.6		)	(15.9		)	(71.8		)	(53.8		)
Pre-tax operating earnings	$	115.8		$	98.3		$	329.8		$	275.3

___________________

(a) It is not practicable to provide additional components of revenue by product or services.

A reconciliation of segment revenues and expenses to consolidated revenues and expenses and net income (loss) is as follows (dollars in millions):

	Three months ended						Nine months ended
	September 30,						September 30,
	2017			2016			2017			2016
Total segment revenues	$	1,036.4		$	991.3		$	3,114.6		$	2,907.6
Net realized investment gains	29.2			11.6			52.3			23.3
Revenues related to VIEs	13.7			13.0			40.2			39.3
Fee revenue related to transition and support services agreements	—			—			—			10.0
Consolidated revenues	1,079.3			1,015.9			3,207.1			2,980.2
Total segment expenses	920.6			893.0			2,784.8			2,632.3
Insurance policy benefits - fair value changes in embedded derivative liabilities	(2.9		)	(12.1		)	9.8			47.0
Amortization related to fair value changes in embedded derivative liabilities	.6			2.7			(1.8		)	(10.4		)
Amortization related to net realized investment gains	.7			.2			1.0			.9
Expenses related to VIEs	17.0			13.7			44.8			40.5
Fair value changes and amendment related to agent deferred compensation plan	13.4			(6.3		)	13.4			12.0
Loss on reinsurance transaction	—			75.4			—			75.4
Expenses related to transition and support services agreements	—			—			—			10.0
Consolidated expenses	949.4			966.6			2,852.0			2,807.7
Income before tax	129.9			49.3			355.1			172.5
Income tax expense (benefit):
Tax expense on period income	44.1			16.9			123.6			61.7
Valuation allowance for deferred tax assets and other tax items	(15.0		)	13.8			(15.0		)	(13.2		)
Net income	$	100.8		$	18.6		$	246.5		$	124.0

XML

ACCOUNTING FOR DERIVATIVES

9 Months Ended

Sep. 30, 2017

Derivative Instruments and Hedging Activities Disclosure [Abstract]

ACCOUNTING FOR DERIVATIVES

ACCOUNTING FOR DERIVATIVES

Our freestanding and embedded derivatives, which are not designated as hedging instruments, are held at fair value and are summarized as follows (dollars in millions):

	Fair value
	September 30, 2017			December 31, 2016
Assets:
Other invested assets:
Fixed index call options	$	142.2		$	111.9
Reinsurance receivables	(1.8		)	(4.2		)
Total assets	$	140.4		$	107.7
Liabilities:
Future policy benefits:
Fixed index products	$	1,249.3		$	1,092.3
Total liabilities	$	1,249.3		$	1,092.3

Our fixed index annuity products provide a guaranteed minimum rate of return and a higher potential return that is based on a percentage (the "participation rate") of the amount of increase in the value of a particular index, such as the Standard & Poor's 500 Index, over a specified period.  Typically, on each policy anniversary date, a new index period begins.  We are generally able to change the participation rate at the beginning of each index period during a policy year, subject to contractual minimums.  The Company accounts for the options attributed to the policyholder for the estimated life of the contract as embedded derivatives. These accounting requirements often create volatility in the earnings from these products. We typically buy call options (including call spreads) referenced to the applicable indices in an effort to offset or hedge potential increases to policyholder benefits resulting from increases in the particular index to which the policy's return is linked.  The notional amount of these options was $2.9 billion and $2.5 billion at September 30, 2017 and December 31, 2016, respectively.

From time to time, we utilize United States Treasury interest rate futures primarily to hedge interest rate risk related to anticipated mortgage loan transactions.

We are required to establish an embedded derivative related to a modified coinsurance agreement pursuant to which we assume the risks of a block of health insurance business. The embedded derivative represents the mark-to-market adjustment for approximately $125 million in underlying investments held by the ceding reinsurer.

We purchase certain fixed maturity securities that contain embedded derivatives that are required to be held at fair value on the consolidated balance sheet. We have elected the fair value option to carry the entire security at fair value with changes in fair value recognized in net income.

The following table provides the pre-tax gains (losses) recognized in net income for derivative instruments, which are not designated as hedges for the periods indicated (dollars in millions):

	Three months ended				Nine months ended
	September 30,				September 30,
	2017		2016		2017		2016
Net investment income from policyholder and other special-purpose portfolios:
Fixed index call options	$	30.6	$	17.0	$	95.4	$	10.9
Net realized gains (losses):
Interest rate futures	—		—		—		(1.1		)
Embedded derivative related to modified coinsurance agreement	.3		.1		2.4		6.7
Total	.3		.1		2.4		5.6
Insurance policy benefits:
Embedded derivative related to fixed index annuities	—		18.3		—		(33.3		)
Total	$	30.9	$	35.4	$	97.8	$	(16.8	)

Derivative Counterparty Risk

If the counterparties to the call options fail to meet their obligations, we may recognize a loss.  We limit our exposure to such a loss by diversifying among several counterparties believed to be strong and creditworthy.  At September 30, 2017, all of our counterparties were rated "A-" or higher by S&P Global Ratings ("S&P").

We also enter into exchange-traded interest rate future contracts. The contracts are marked to market and margined on a daily basis. The Company has minimal exposure to credit-related losses in the event of nonperformance.

The Company and its subsidiaries are parties to master netting arrangements with its counterparties related to entering into various derivative contracts. Exchange-traded derivatives require margin accounts which we offset.

The following table summarizes information related to derivatives with master netting arrangements or collateral as of September 30, 2017 and December 31, 2016 (dollars in millions):

								Gross amounts not offset in the balance sheet
		Gross amounts recognized		Gross amounts offset in the balance sheet		Net amounts of assets presented in the balance sheet		Financial instruments		Cash collateral received		Net amount
September 30, 2017:
	Fixed index call options	$	142.2	$	—	$	142.2	$	—	$	—	$	142.2
December 31, 2016:
	Fixed index call options	111.9		—		111.9		—		—		111.9

XML

REINSURANCE

9 Months Ended

Sep. 30, 2017

Reinsurance Disclosures [Abstract]

REINSURANCE

REINSURANCE

The cost of reinsurance ceded totaled $27.1 million and $32.2 million in the third quarters of 2017 and 2016, respectively, and $79.9 million and $97.3 million in the first nine months of 2017 and 2016, respectively.  We deduct this cost from insurance policy income.  Reinsurance recoveries netted against insurance policy benefits totaled $22.6 million and $31.7 million in the third quarters of 2017 and 2016, respectively, and $69.1 million and $113.3 million in the first nine months of 2017 and 2016, respectively.

From time to time, we assume insurance from other companies.  Any costs associated with the assumption of insurance are amortized consistent with the method used to amortize deferred acquisition costs.  Reinsurance premiums assumed totaled $7.4 million and $8.3 million in the third quarters of 2017 and 2016, respectively, and $23.1 million and $25.8 million in the first nine months of 2017 and 2016, respectively.

XML

INCOME TAXES

9 Months Ended

Sep. 30, 2017

Income Tax Disclosure [Abstract]

INCOME TAXES

INCOME TAXES

The Company's interim tax expense is based upon the estimated annual effective tax rate for the respective period. Under authoritative guidance, certain items are required to be excluded from the estimated annual effective tax rate calculation. Such items include changes in judgment about the realizability of deferred tax assets resulting from changes in projections of income expected to be available in future years, and items deemed to be unusual, infrequent, or that can not be reliably estimated. In these cases, the actual tax expense or benefit applicable to that item is treated discretely and is reported in the same period as the related item. The components of income tax expense are as follows (dollars in millions):

	Three months ended						Nine months ended
	September 30,						September 30,
	2017			2016			2017			2016
Current tax expense	$	25.9		$	46.8		$	68.5		$	51.6
Deferred tax expense (benefit)	18.2			(29.9		)	55.1			10.1
Valuation allowance applicable to current year income	(2.2		)	(10.5		)	(2.2		)	(10.5		)
Income tax expense calculated based on estimated annual effective tax rate	41.9			6.4			121.4			51.2
Income tax expense on discrete items:
Change in valuation allowance	(12.8		)	16.0			(12.8		)	(11.0		)
Other items	—			8.3			—			8.3
Total income tax expense	$	29.1		$	30.7		$	108.6		$	48.5

A reconciliation of the U.S. statutory corporate tax rate to the estimated annual effective rate, before discrete items, reflected in the consolidated statement of operations is as follows:

	Nine months ended
	September 30,
	2017		2016
U.S. statutory corporate rate	35.0	%	35.0	%
Valuation allowance	(.6	)	(6.1	)
Non-taxable income and nondeductible benefits, net	(1.5	)	(1.0	)
State taxes	1.3		1.8
Estimated annual effective tax rate	34.2	%	29.7	%

The effective tax rate for the nine months ended September 30, 2017 and 2016 included reductions in the deferred tax valuation allowance of $2.2 million and $10.5 million, respectively, reflecting higher current year expected taxable income than previously reflected in our deferred tax valuation allowance model in each year.

Our total tax expense for the nine months ended September 30, 2017, includes $12.8 million of reductions to the deferred tax valuation allowance primarily related to the recognition of capital gains. Our total tax expense for the nine months ended September 30, 2016, includes $11.0 million of reductions to the deferred tax valuation allowance related to adjustments to future expected taxable income reflected in our deferred tax valuation allowance model and $8.3 million of increased tax expense primarily related to IRS exam adjustments. The reduction to the deferred tax valuation allowance primarily relates to higher expected non-life income consistent with our current investment strategies, the impacts of the recapture of certain reinsurance agreements and IRS examination adjustments.

Effective January 1, 2017, the Company adopted new authoritative guidance related to several aspects of the accounting for share-based payment transactions, including the income tax consequences. Under the new guidance, any excess tax benefits are recognized as an income tax benefit in the income statement. The new guidance is applied on a modified retrospective basis through a cumulative-effect adjustment to retained earnings for all tax benefits that were not previously recognized because the related tax deduction had not reduced taxes payable. The Company had NOL carryforwards of $15.7 million related to deductions for stock options and restricted stock on the date of adoption. However, a corresponding valuation allowance of $15.7 million was recognized as a result of adopting this guidance. Therefore, there was no impact to our consolidated financial statements related to the initial adoption of this provision of the new guidance.

The components of the Company's income tax assets and liabilities are summarized below (dollars in millions):

	September 30, 2017			December 31, 2016
Deferred tax assets:
Net federal operating loss carryforwards	$	841.8		$	882.9
Net state operating loss carryforwards	12.2			12.3
Investments	13.7			17.8
Insurance liabilities	678.9			668.4
Other	60.1			66.3
Gross deferred tax assets	1,606.7			1,647.7
Deferred tax liabilities:
Present value of future profits and deferred acquisition costs	(275.0		)	(277.8		)
Accumulated other comprehensive income	(516.9		)	(344.1		)
Gross deferred tax liabilities	(791.9		)	(621.9		)
Net deferred tax assets before valuation allowance	814.8			1,025.8
Valuation allowance	(240.9		)	(240.2		)
Net deferred tax assets	573.9			785.6
Current income taxes prepaid (accrued)	(6.5		)	4.1
Income tax assets, net	$	567.4		$	789.7

Our income tax expense includes deferred income taxes arising from temporary differences between the financial reporting and tax bases of assets and liabilities and net operating loss carryforwards ("NOLs"). Deferred tax assets and liabilities are measured using enacted tax rates expected to apply in the years in which temporary differences are expected to be recovered or paid.  The effect of a change in tax rates on deferred tax assets and liabilities is recognized in earnings in the period when the changes are enacted.

A reduction of the net carrying amount of deferred tax assets by establishing a valuation allowance is required if, based on the available evidence, it is more likely than not that such assets will not be realized. In assessing the need for a valuation allowance, all available evidence, both positive and negative, shall be considered to determine whether, based on the weight of that evidence, a valuation allowance for deferred tax assets is needed. This assessment requires significant judgment and considers, among other matters, the nature, frequency and severity of current and cumulative losses, forecasts of future profitability, the duration of carryforward periods, our experience with operating loss and tax credit carryforwards expiring unused, and tax planning strategies. We evaluate the need to establish a valuation allowance for our deferred income tax assets on an ongoing basis. The realization of our deferred tax assets depends upon generating sufficient future taxable income of the appropriate type during the periods in which our temporary differences become deductible and before our NOLs expire.

Based on our assessment, it appears more likely than not that $573.9 million of our net deferred tax assets of $814.8 million will be realized through future taxable earnings. Accordingly, we have established a deferred tax valuation allowance of $240.9 million at September 30, 2017 ($230.9 million of which relates to our net federal operating loss carryforwards and $10.0 million relates to state operating loss carryforwards). We will continue to assess the need for a valuation allowance in the future. If future results are less than projected, an increase to the valuation allowance may be required to reduce the deferred tax asset, which could have a material impact on our results of operations in the period in which it is recorded.

We use a deferred tax valuation model to assess the need for a valuation allowance. Our model is adjusted to reflect changes in our projections of future taxable income including changes resulting from investment strategies, the impact of the sale or reinsurance of business and the recapture of business previously ceded. Our estimates of future taxable income are based on evidence we consider to be objective and verifiable.

Our projection of future taxable income for purposes of determining the valuation allowance is based on our adjusted average annual taxable income which is assumed to increase by 3 percent for the next five years, and level taxable income is assumed thereafter. In the projections used for our analysis, our adjusted average taxable income of approximately $335 million consisted of $85 million of non-life taxable income and $250 million of life taxable income.

Recovery of our deferred tax asset is dependent on achieving the level of future taxable income projected in our deferred tax valuation model and failure to do so could result in an increase in the valuation allowance in a future period.  Any future increase in the valuation allowance may result in additional income tax expense and reduce shareholders' equity, and such an increase could have a significant impact upon our earnings in the future.

The Internal Revenue Code (the "Code") limits the extent to which losses realized by a non-life entity (or entities) may offset income from a life insurance company (or companies) to the lesser of:  (i) 35 percent of the income of the life insurance company; or (ii) 35 percent of the total loss of the non-life entities (including NOLs of the non-life entities).  There is no similar limitation on the extent to which losses realized by a life insurance entity (or entities) may offset income from a non-life entity (or entities). This limitation is the primary reason a valuation allowance for NOLs is required.

Section 382 of the Code imposes limitations on a corporation's ability to use its NOLs when the company undergoes an ownership change.  Future transactions and the timing of such transactions could cause an ownership change for Section 382 income tax purposes.  Such transactions may include, but are not limited to, additional repurchases under our securities repurchase program, issuances of common stock and acquisitions or sales of shares of CNO stock by certain holders of our shares, including persons who have held, currently hold or may accumulate in the future five percent or more of our outstanding common stock for their own account.  Many of these transactions are beyond our control.  If an additional ownership change were to occur for purposes of Section 382, we would be required to calculate an annual restriction on the use of our NOLs to offset future taxable income.  The annual restriction would be calculated based upon the value of CNO's equity at the time of such ownership change, multiplied by a federal long-term tax exempt rate (1.93 percent at September 30, 2017), and the annual restriction could limit our ability to use a substantial portion of our NOLs to offset future taxable income.  We regularly monitor ownership change (as calculated for purposes of Section 382) and, as of September 30, 2017, we were below the 50 percent ownership change level that would trigger further impairment of our ability to utilize our NOLs.

As of September 30, 2017, we had $2.4 billion of federal NOLs (all of which were non-life NOLs). The following table summarizes the expiration dates of our loss carryforwards (dollars in millions):

	Net operating loss
Year of expiration	carryforwards
2023	$	1,818.5
2025	85.2
2026	149.9
2027	10.8
2028	80.3
2029	213.2
2030	.3
2031	.2
2032	44.4
2033	.6
2034	.9
2035	.8
Total federal NOLs	$	2,405.1

We also had deferred tax assets related to NOLs for state income taxes of $12.2 million and $12.3 million at September 30, 2017 and December 31, 2016, respectively.  The related state NOLs are available to offset future state taxable income in certain states through 2025.

All of the life NOLs were utilized by December 31, 2016. Accordingly, we began making estimated federal tax payments equal to the prescribed federal tax rate applied to 65 percent of our life insurance company taxable income due to the limitations on the extent to which we can use non-life NOLs to offset life insurance company taxable income. Under current law, we will continue to pay tax on 65 percent of our life insurance company taxable income until all non-life NOLs are utilized or expire.

The Internal Revenue Service ("IRS") is conducting an examination of 2013 through 2014. In connection with this exam, we have agreed to extend the statute of limitation for 2013 through September 30, 2018. The Company’s various state income tax returns are generally open for tax years beginning in 2014, based on individual state statutes of limitation. Generally, for tax years which generate NOLs, capital losses or tax credit carryforwards, the statute remains open until the expiration of the statute of limitations for the tax year in which such carryforwards are utilized. The outcome of the tax audit cannot be predicted with certainty. If the Company’s tax audit is not resolved in a manner consistent with management’s expectations, the Company may be required to adjust its provision for income taxes.

XML

NOTES PAYABLE - DIRECT CORPORATE OBLIGATIONS

9 Months Ended

Sep. 30, 2017

Debt Disclosure [Abstract]

NOTES PAYABLE - DIRECT CORPORATE OBLIGATIONS

NOTES PAYABLE - DIRECT CORPORATE OBLIGATIONS

The following notes payable were direct corporate obligations of the Company as of September 30, 2017 and December 31, 2016 (dollars in millions):

	September 30, 2017			December 31, 2016
4.500% Senior Notes due May 2020	$	325.0		$	325.0
5.250% Senior Notes due May 2025	500.0			500.0
Revolving Credit Agreement (as defined below)	100.0			100.0
Unamortized debt issue costs	(10.6		)	(12.1		)
Direct corporate obligations	$	914.4		$	912.9

Revolving Credit Agreement

On May 19, 2015, the Company entered into a revolving credit agreement with KeyBank National Association, as administrative agent (the "Agent"), and the lenders from time to time party thereto (the "Revolving Credit Agreement"). On May 19, 2015, the Company made an initial drawing of $100.0 million under the Revolving Credit Agreement, resulting in $50.0 million available for additional borrowings.

The interest rates with respect to loans under the Revolving Credit Agreement are based on, at the Company's option, a floating base rate (defined as a per annum rate equal to the highest of: (i) the federal funds rate plus 0.50%; (ii) the "prime rate" of the Agent; and (iii) the eurodollar rate for a one-month interest period plus an applicable margin of initially 1.00% per annum), or a eurodollar rate plus an applicable margin of initially 2.00% per annum. At September 30, 2017, the interest rate on the amounts outstanding under the Revolving Credit Agreement was 3.24 percent. In addition, the daily average undrawn portion of the Revolving Credit Agreement accrues a commitment fee payable quarterly in arrears. The applicable margin for, and the commitment fee applicable to, the Revolving Credit Agreement, will be adjusted from time to time pursuant to a ratings based pricing grid.

The Revolving Credit Agreement requires the Company to maintain (each as calculated in accordance with the Revolving Credit Agreement): (i) a debt to total capitalization ratio of not more than 30.0 percent (such ratio was 19.2 percent at September 30, 2017); (ii) an aggregate ratio of total adjusted capital to company action level risk-based capital for the Company's insurance subsidiaries of not less than 250 percent (such ratio was estimated to be 450 percent at September 30, 2017); and (iii) a minimum consolidated net worth of not less than the sum of (x) $2,674 million plus (y) 50.0% of the net equity proceeds received by the Company from the issuance and sale of equity interests in the Company (the Company's consolidated net worth was $3,948.1 million at September 30, 2017 compared to the minimum requirement of $2,683.8 million).

As further described in the note to the consolidated financial statements entitled "Subsequent Event", the Revolving Credit Agreement was amended and restated in October 2017.

Scheduled Repayment of our Direct Corporate Obligations

The scheduled repayment of our direct corporate obligations was as follows at September 30, 2017 (dollars in millions):

Year ending September 30,
2018	$	—
2019	100.0
2020	325.0
2021	—
2022	—
Thereafter	500.0
	$	925.0

XML

INVESTMENT BORROWINGS

9 Months Ended

Sep. 30, 2017

Investment Borrowings [Abstract]

INVESTMENT BORROWINGS

INVESTMENT BORROWINGS

Three of the Company's insurance subsidiaries (Washington National Insurance Company ("Washington National"), Bankers Life and Casualty Company ("Bankers Life") and Colonial Penn Life Insurance Company ("Colonial Penn")) are members of the Federal Home Loan Bank ("FHLB").  As members of the FHLB, our insurance subsidiaries have the ability to borrow on a collateralized basis from the FHLB. We are required to hold certain minimum amounts of FHLB common stock as a condition of membership in the FHLB, and additional amounts based on the amount of the borrowings.  At September 30, 2017, the carrying value of the FHLB common stock was $71.2 million.  As of September 30, 2017, collateralized borrowings from the FHLB totaled $1.6 billion and the proceeds were used to purchase fixed maturity securities.  The borrowings are classified as investment borrowings in the accompanying consolidated balance sheet.  The borrowings are collateralized by investments with an estimated fair value of $2.0 billion at September 30, 2017, which are maintained in a custodial account for the benefit of the FHLB.  Substantially all of such investments are classified as fixed maturities, available for sale, in our consolidated balance sheet.  

The following summarizes the terms of the borrowings from the FHLB by our insurance subsidiaries (dollars in millions):

Amount		Maturity	Interest rate at
borrowed		date	September 30, 2017
$	50.0	February 2018	Variable rate – 1.404%
50.0		August 2018	Variable rate – 1.435%
50.0		January 2019	Variable rate – 1.724%
50.0		February 2019	Variable rate – 1.404%
100.0		March 2019	Variable rate – 1.714%
21.8		July 2019	Variable rate – 1.727%
15.0		October 2019	Variable rate – 1.830%
50.0		May 2020	Variable rate – 1.754%
21.8		June 2020	Fixed rate – 1.960%
25.0		September 2020	Variable rate – 1.953%
100.0		September 2020	Variable rate – 1.897%
50.0		September 2020	Variable rate – 1.894%
75.0		September 2020	Variable rate – 1.453%
100.0		October 2020	Variable rate – 1.409%
50.0		December 2020	Variable rate – 1.932%
100.0		July 2021	Variable rate – 1.854%
100.0		July 2021	Variable rate – 1.824%
28.2		August 2021	Fixed rate – 2.550%
57.7		August 2021	Variable rate - 1.842%
125.0		August 2021	Variable rate – 1.717%
50.0		September 2021	Variable rate – 1.857%
22.0		May 2022	Variable rate – 1.668%
100.0		May 2022	Variable rate – 1.666%
10.0		June 2022	Variable rate – 1.931%
50.0		July 2022	Variable rate – 1.675%
50.0		July 2022	Variable rate – 1.693%
50.0		July 2022	Variable rate – 1.694%
50.0		August 2022	Variable rate – 1.702%
24.9		March 2023	Fixed rate – 2.160%
20.5		June 2025	Fixed rate – 2.940%
$	1,646.9

The variable rate borrowings are pre-payable on each interest reset date without penalty.  The fixed rate borrowings are pre-payable subject to payment of a yield maintenance fee based on prevailing market interest rates.  At September 30, 2017, the aggregate yield maintenance fee to prepay all fixed rate borrowings was $3.2 million.

Interest expense of $19.5 million and $12.3 million in the first nine months of 2017 and 2016, respectively, was recognized related to total borrowings from the FHLB.

XML

CHANGES IN COMMON STOCK

9 Months Ended

Sep. 30, 2017

Stockholders' Equity Note [Abstract]

CHANGES IN COMMON STOCK

CHANGES IN COMMON STOCK

Changes in the number of shares of common stock outstanding were as follows (shares in thousands):

Balance, December 31, 2016	173,754
Treasury stock purchased and retired	(6,701	)
Stock options exercised	524
Restricted and performance stock vested	185		(a)
Balance, September 30, 2017	167,762

____________________

(a) Such amount was reduced by 103 thousand shares which were tendered to the Company for the payment of required federal and state tax withholdings owed on the vesting of restricted and performance stock.

In the first nine months of 2017, we repurchased 6.7 million shares of common stock for $140.1 million under our securities repurchase program. In May 2017, the Company announced that its Board of Directors approved an additional $300.0 million to repurchase the Company's outstanding common stock. The Company had remaining repurchase authority of $412.6 million as of September 30, 2017.

In the first nine months of 2017, dividends declared on common stock totaled $44.7 million ($0.26 per common share). In May 2017, the Company increased its quarterly common stock dividend to $0.09 per share from $0.08 per share.

XML

SALES INDUCEMENTS

9 Months Ended

Sep. 30, 2017

Deferred Sales Inducements [Abstract]

SALES INDUCEMENTS

SALES INDUCEMENTS

Certain of our annuity products offer sales inducements to contract holders in the form of enhanced crediting rates or bonus payments in the initial period of the contract.  Certain of our life insurance products offer persistency bonuses credited to the contract holder's balance after the policy has been outstanding for a specified period of time.  These enhanced rates and persistency bonuses are considered sales inducements in accordance with GAAP.  Such amounts are deferred and amortized in the same manner as deferred acquisition costs.  Sales inducements deferred totaled $1.5 million and $2.8 million during the nine months ended September 30, 2017 and 2016, respectively.  Amounts amortized totaled $6.6 million and $7.1 million during the nine months ended September 30, 2017 and 2016, respectively.  The unamortized balance of deferred sales inducements was $44.3 million and $49.4 million at September 30, 2017 and December 31, 2016, respectively.  The balance of insurance liabilities for persistency bonus benefits was $.4 million and $.5 million at September 30, 2017 and December 31, 2016, respectively.

XML

OUT-OF-PERIOD ADJUSTMENTS

9 Months Ended

Sep. 30, 2017

Other Liabilities Disclosure [Abstract]

OUT-OF-PERIOD ADJUSTMENTS

OUT-OF-PERIOD ADJUSTMENTS

In the third quarter of 2017, we recorded the net effect of an out-of-period adjustment related to the calculation of certain life insurance liabilities in our Colonial Penn segment which decreased insurance policy benefits by $2.5 million, increased tax expense by $.9 million and increased our net income by $1.6 million (or 1 cent per diluted share). In the second quarter of 2017, we recorded the net effect of an out-of-period adjustment related to the calculation of certain long-term care insurance liabilities in our Bankers Life segment which decreased insurance policy benefits by $1.7 million, increased tax expense by $.6 million and increased our net income by $1.1 million (or 1 cent per diluted share). We evaluated these adjustments taking into account both qualitative and quantitative factors and considered the impact of these adjustments in relation to each period, as well as the periods in which they originated. The impact of recognizing these adjustments in prior years was not significant to any individual period. Management believes these adjustments are immaterial to the consolidated financial statements and all previously issued financial statements.

XML

RECENTLY ISSUED ACCOUNTING STANDARDS

9 Months Ended

Sep. 30, 2017

New Accounting Pronouncements and Changes in Accounting Principles [Abstract]

RECENTLY ISSUED ACCOUNTING STANDARDS

RECENTLY ISSUED ACCOUNTING STANDARDS

Pending Accounting Standards

In May 2014, the Financial Accounting Standards Board (the "FASB") issued authoritative guidance for recognizing revenue from contracts with customers. Certain contracts with customers are specifically excluded from this guidance, including insurance contracts. The core principle of the new guidance is that an entity should recognize revenue when it transfers promised goods or services in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The guidance also requires additional disclosures about the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. The guidance will be effective for the Company on January 1, 2018 and permits two methods of transition upon adoption; full retrospective and modified retrospective. Under the full retrospective method, prior periods would be restated under the new revenue standard, providing for comparability in all periods presented. Under the modified retrospective method, prior periods would not be restated. Instead, revenues and other disclosures for pre-2018 periods would be provided in the notes to the financial statements as previously reported under the current revenue standard. The new guidance will impact our accounting for various distribution and marketing agreements with other insurance companies pursuant to which Bankers Life's career agents distribute third party products including prescription drug and Medicare Advantage plans. The revenue associated with these distribution agreements has been less than 1 percent of our total revenue. Our annual fee income earned during a calendar year will not change, but the amount recognized during each quarterly period will vary based on the sales of such products in each period. Accordingly, the adoption of this guidance is not expected to have a material impact on our consolidated financial statements. The Company expects to adopt the new guidance using the modified retrospective method.

In January 2016, the FASB issued authoritative guidance related to the recognition and measurement of financial assets and financial liabilities which made targeted improvements to GAAP as follows:

(i) Require equity investments (except those accounted for under the equity method of accounting or those that result in consolidation of the investee) to be measured at fair value with changes in fair value recognized in net income. However, an entity may choose to measure equity investments that do not have readily determinable fair values at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer.

(ii) Simplify the impairment assessment of equity investments without readily determinable fair values by requiring a qualitative assessment to identify impairment. When a qualitative assessment indicates that impairment exists, an entity is required to measure the investment at fair value.

(iii) Eliminate the requirement for public business entities to disclose the method(s) and significant assumptions used to estimate the fair value that is required to be disclosed for financial instruments measured at amortized cost on the balance sheet.

(iv) Require public business entities to use the exit price notion when measuring the fair value of financial instruments for disclosure purposes.

(v) Require an entity to present separately in other comprehensive income the portion of the total change in the fair value of a liability resulting from a change in the instrument-specific credit risk when the entity has elected to measure the liability at fair value in accordance with the fair value option for financial instruments.

(vi) Require separate presentation of financial assets and financial liabilities by measurement category and form of financial asset (that is, securities or loans and receivables) on the balance sheet or the accompanying notes to the financial statements.

(vii) Clarify that an entity should evaluate the need for a valuation allowance on a deferred tax asset related to available-for-sale securities in combination with the entity's other deferred tax assets.

An entity should apply this guidance by means of a cumulative-effect adjustment to the balance sheet as of the beginning of the fiscal year of adoption. The amendments related to equity securities without readily determinable fair values (including disclosure requirements) should be applied prospectively to equity investments that exist as of the date of adoption of the guidance. The guidance will be effective for the Company for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. Early adoption of the guidance is not permitted; except that item (v) above is permitted to be adopted early as of the beginning of the fiscal year of adoption. The Company currently holds equity securities classified as available for sale securities that are measured at fair value with changes in fair value recognized through accumulated other comprehensive income. Upon adoption of this guidance, changes in fair value of such equity securities will be recognized through net income. Based upon the equity securities held at September 30, 2017, the estimated impact of the new guidance, assuming it was adopted on October 1, 2017, would be a cumulative effect adjustment that would increase retained earnings by approximately $15 million with a corresponding decrease to accumulated other comprehensive income of approximately $15 million. The Company may experience an increase in volatility in the income statement due to the requirement to measure equity investments at fair value with changes in fair value recognized in income. In addition, the Company will be required to modify certain disclosures upon adoption.

In February 2016, the FASB issued authoritative guidance related to accounting for leases, requiring lessees to report most leases on their balance sheets, regardless of whether the lease is classified as a finance lease or an operating lease. For lessees, the initial lease liability is equal to the present value of future lease payments, and a corresponding asset, adjusted for certain items, is also recorded. Expense recognition for lessees will remain similar to current accounting requirements for capital and operating leases. The accounting applied by a lessor is largely unchanged from that applied under previous GAAP. In transition, lessees and lessors are required to recognize and measure leases at the beginning of the earliest period presented using a modified retrospective approach. The guidance will be effective for the Company for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Early adoption is permitted. The Company has not yet determined the expected impact of adoption of this guidance on its consolidated financial position, results of operations or cash flows.

In June 2016, the FASB issued authoritative guidance related to the measurement of credit losses on financial instruments. The new guidance replaces the incurred loss impairment methodology with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to form credit loss estimates. The guidance will be effective for the Company for fiscal years beginning in 2020, including interim periods within the fiscal year. Early adoption is permitted as of the fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. The Company has not yet determined the expected impact of adoption of this guidance on its consolidated financial position, results of operations or cash flows.

In August 2016, the FASB issued authoritative guidance related to how certain cash receipts and cash payments are presented and classified in the statement of cash flows. The guidance addresses eight specific cash flow issues including debt prepayment or debt extinguishment costs, proceeds from the settlement of corporate-owned life insurance policies, distributions received from equity method investees, and others. The guidance will be effective for the Company for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years. Early adoption is permitted. The adoption of this guidance will result in reclassifications to certain cash receipts and payments within our consolidated statement of cash flows, but will have no impact on our consolidated financial position, results of operations or cash flows.

In November 2016, the FASB issued authoritative guidance to address the diversity in practice that currently exists regarding the classification and presentation of changes in restricted cash on the statement of cash flows. The new guidance requires that a statement of cash flows explain the change during the period in the total of cash, cash equivalents and amounts generally described as restricted cash or restricted cash equivalents. Therefore, amounts generally described as restricted cash and restricted cash equivalents should be included with cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown on the statement of cash flows. Entities will also be required to disclose information about the nature of their restricted cash and restricted cash equivalents. Additionally, if cash, cash equivalents, restricted cash and restricted cash equivalents are presented in more than one line item in the statement of financial position, entities will be required to present a reconciliation, either on the face of the statement of cash flows or disclosed in the notes, of the totals in the statement of cash flows to the related line item captions in the statement of financial position. The guidance will be effective for the Company for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years. Early adoption is permitted, including adoption in an interim period. The adoption of this guidance will impact the presentation of our consolidated statement of cash flows and related cash flow disclosures, but will have no impact on our consolidated financial position, results of operations or cash flows.

In January 2017, the FASB issued authoritative guidance that removes Step 2 of the goodwill impairment test under current guidance, which requires a hypothetical purchase price allocation. The new guidance requires an impairment charge to be recognized for the amount by which the carrying amount exceeds the reported unit's fair value. Upon adoption, the guidance is to be applied prospectively. The guidance will be effective for the Company on January 1, 2020, with early adoption permitted. The adoption of this guidance is not expected to have a material impact on the Company's consolidated financial position, results of operations or cash flows.

In March 2017, the FASB issued authoritative guidance related to the premium amortization on purchased callable debt securities. The guidance shortens the amortization period for certain callable debt securities held at a premium. Specifically, the new guidance requires the premium to be amortized to the earliest call date. The guidance does not require an accounting change for securities held at a discount; the discount continues to be amortized to maturity. The guidance will be effective for the Company for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. Early adoption is permitted, including adoption in an interim period. If an entity early adopts the guidance in an interim period, any adjustments should be reflected as of the beginning of the fiscal year that includes that interim period. The guidance should be applied on a modified retrospective basis through a cumulative-effect adjustment directly to retained earnings as of the beginning of the period of adoption. The Company has not yet determined the expected impact of adoption of this guidance on our consolidated financial position, results of operations or cash flows.

In May 2017, the FASB issued authoritative guidance related to which changes to the terms or conditions of a share-based award require an entity to apply modification accounting. The guidance will be effective for the Company in 2018. The guidance is to be applied prospectively to an award modified on or after the adoption date. The adoption of this guidance is not expected to have a material impact to the Company's consolidated financial position, results of operations or cash flows.

In August 2017, the FASB issued authoritative guidance related to derivatives and hedging. The new guidance expands and refines hedge accounting for both nonfinancial and financial risk components and aligns the recognition and presentation of the effects of the hedging instruments and the hedged item in the financial statements. The new guidance also includes certain targeted improvements to ease the application of current guidance related to the assessment of hedge effectiveness. The guidance will be effective for the Company for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. Early adoption is permitted, including adoption in an interim period. The Company has not yet determined the expected impact of adoption of this guidance on its consolidated financial position, results of operations or cash flows.

Adopted Accounting Standards

In March 2016, the FASB issued authoritative guidance that clarifies the requirements for assessing whether contingent call (put) options that can accelerate the payment of principal on debt instruments are clearly and closely related to their debt hosts. An entity performing the assessment under this guidance is required to assess the embedded call (put) options solely in accordance with a four-step decision sequence. The guidance is effective for the Company on January 1, 2017. The adoption of this guidance had no effect on our consolidated financial statements.

In March 2016, the FASB issued authoritative guidance related to several aspects of the accounting for share-based payment transactions, including the income tax consequences, accounting policy for forfeiture rate assumptions, classification of awards as either equity or liabilities and classification on the statement of cash flows. The new guidance requires all income tax effects of stock-based compensation awards to be recognized in the income statement when the awards vest or are settled. The new guidance also allows an employer to withhold shares upon settlement of an award to satisfy the employer's tax withholding requirements up to the highest marginal tax rate applicable to employees, without resulting in liability classification of the award. Current guidance strictly limits the withholding to the employer's minimum statutory tax withholding requirement. The guidance was effective for the Company on January 1, 2017. The impact of adoption was as follows (dollars in millions):

	January 1, 2017
				Effect of Adoption of Authoritative Guidance
	Amounts prior to effect of adoption of authoritative guidance			Election to account for forfeitures as they occur			Recognition of excess tax benefits			As adjusted
Income tax assets	$	1,029.9		$	.3		$	15.7		$	1,045.9
Valuation allowance for deferred income tax assets	(240.2		)	—			(15.7		)	(255.9		)
Income tax assets, net	789.7			.3			—			790.0
Total assets	31,975.2			.3			—			31,975.5
Additional paid-in capital	3,212.1			.9			—			3,213.0
Retained earnings	650.7			(.6		)	—			650.1
Total shareholders' equity	4,486.9			.3			—			4,487.2
Total liabilities and shareholders' equity	31,975.2			.3			—			31,975.5

	Nine months ended
	September 30, 2016
	Amounts prior to effect of adoption of authoritative guidance			Effect of adoption of authoritative guidance			As adjusted
Cash flows from operating activities:
Other operating costs	$	(555.4	)	$	3.3		$	(552.1	)
Net cash flow from operating activities	581.5			3.3			584.8
Cash flows from financing activities:
Payments to repurchase common stock	(206.7		)	(3.3		)	(210.0		)
Net cash used by financing activities	(34.2		)	(3.3		)	(37.5		)
Net increase in cash and cash equivalents	273.7			—			273.7

In October 2016, the FASB issued authoritative guidance to amend the consolidation guidance on how a reporting entity that is the single decision maker of a VIE should treat indirect interests in the entity held through related parties that are under common control with the reporting entity when determining whether it is the primary beneficiary of that VIE. The guidance is effective for the Company on January 1, 2017. The adoption of this guidance had no impact on our consolidated financial statements.

XML

LITIGATION AND OTHER LEGAL PROCEEDINGS

9 Months Ended

Sep. 30, 2017

Commitments and Contingencies Disclosure [Abstract]

LITIGATION AND OTHER LEGAL PROCEEDINGS

LITIGATION AND OTHER LEGAL PROCEEDINGS

Legal Proceedings

The Company and its subsidiaries are involved in various legal actions in the normal course of business, in which claims for compensatory and punitive damages are asserted, some for substantial amounts.  We recognize an estimated loss from these loss contingencies when we believe it is probable that a loss has been incurred and the amount of the loss can be reasonably estimated. Some of the pending matters have been filed as purported class actions and some actions have been filed in certain jurisdictions that permit punitive damage awards that are disproportionate to the actual damages incurred.  The amounts sought in certain of these actions are often large or indeterminate and the ultimate outcome of certain actions is difficult to predict.  In the event of an adverse outcome in one or more of these matters, there is a possibility that the ultimate liability may be in excess of the liabilities we have established and could have a material adverse effect on our business, financial condition, results of operations and cash flows.  In addition, the resolution of pending or future litigation may involve modifications to the terms of outstanding insurance policies or could impact the timing and amount of rate increases, which could adversely affect the future profitability of the related insurance policies.  Based upon information presently available, and in light of legal, factual and other defenses available to the Company and its subsidiaries, the Company does not believe that it is probable that the ultimate liability from either pending or threatened legal actions, after consideration of existing loss provisions, will have a material adverse effect on the Company's consolidated financial condition, operating results or cash flows. However, given the inherent difficulty in predicting the outcome of legal proceedings, there exists the possibility that such legal actions could have a material adverse effect on the Company's consolidated financial condition, operating results or cash flows.

In addition to the inherent difficulty of predicting litigation outcomes, particularly those that will be decided by a jury, some matters purport to seek substantial or an unspecified amount of damages for unsubstantiated conduct spanning several years based on complex legal theories and damages models. The alleged damages typically are indeterminate or not factually supported in the complaint, and, in any event, the Company's experience indicates that monetary demands for damages often bear little relation to the ultimate loss. In some cases, plaintiffs are seeking to certify classes in the litigation and class certification either has been denied or is pending and we have filed oppositions to class certification or sought to decertify a prior class certification. In addition, for many of these cases: (i) there is uncertainty as to the outcome of pending appeals or motions; (ii) there are significant factual issues to be resolved; and/or (iii) there are novel legal issues presented. Accordingly, the Company cannot reasonably estimate the possible loss or range of loss in excess of amounts accrued, if any, or predict the timing of the eventual resolution of these matters.  The Company reviews these matters on an ongoing basis.  When assessing reasonably possible and probable outcomes, the Company bases its assessment on the expected ultimate outcome following all appeals.

On September 29, 2016, Washington National and Bankers Conseco Life Insurance Company ("BCLIC") commenced an arbitration proceeding seeking compensatory, consequential and punitive damages against BRe based upon BRe’s incurable material breaches of the long-term care reinsurance agreements, conversion, fraud, and breaches of fiduciary duties and the obligation to deal honestly and in good faith. BRe filed a counterclaim against Washington National and BCLIC in the arbitration alleging damages relating to the reinsurance agreements and their termination. In addition, on September 29, 2016, a complaint was filed by BCLIC and Washington National in the United States District Court for the Southern District of New York, Bankers Conseco Life Insurance Company and Washington National Insurance Company v. Moshe M. Feuer, Scott Taylor and David Levy, Case No. 16-cv-7646, alleging, among other claims, fraud/fraudulent concealment, and violation of the Racketeer Influenced and Corrupt Organizations Act. These allegations relate to the long-term care reinsurance agreements between BRe and Washington National and BCLIC, respectively, and emanate from the undisclosed relationships between and among the defendants (who were the principal owners and officers of BRe) and Platinum Partners, LP ("Platinum") and its affiliates. On April 27, 2017, an amended complaint was filed adding Beechwood Capital Group, LLC as a defendant. Feuer, Taylor and Levy have moved to compel arbitration of Washington National's and BCLIC's claims. Washington National and BCLIC intend to vigorously pursue their claims for damages and other remedies in the arbitration and the litigation described above.

By public notice dated July 26, 2017, the Cayman Islands Monetary Authority advised that, effective July 25, 2017, two individuals (the "Controllers") had been appointed pursuant to Section 24(2)(h) of the Cayman Islands Insurance Law to assume control of the affairs of BRe.  According to the public notice, effective with their appointment, the Controllers assumed immediate control of the affairs of BRe and have all the powers necessary to administer the affairs of BRe including power to terminate its insurance business.  The Controllers are responsible for assessing the financial position of BRe and submitting a report to the Cayman Islands Monetary Authority by a date to be specified.  We are in the process of assessing the potential impact of this action on the proceedings described in the foregoing paragraph.

On July 20, 2007, a complaint was filed in the Hamilton County, Indiana Circuit Court, Signature Estates of Indiana, Inc. d/b/a Gordon Marketing, Stephens-Matthews Marketing, Inc., Shields Brokerage, Inc. and Edwin A. Hildebrand d/b/a Hildebrand Insurance Services v. Conseco Medical Insurance Company, Conseco Medical Insurance Company a/k/a Washington National Insurance Company and Washington National Insurance Company, Cause No. 29D02- 0707-PL-790.  The Plaintiffs are independent insurance marketing organizations which previously marketed Conseco Medical Insurance Company ("CMIC") individual major medical products and which are claiming damages for allegedly fraudulent conduct by CMIC in withdrawing from this business in 2002.  The Plaintiffs contend that they relied on CMIC’s alleged representations that its major medical business was profitable and that CMIC was committed to it.  The Plaintiffs further allege that when CMIC exited the market, it caused agents that were previously writing business through their organizations to cease doing business with them, thereby causing irreparable damage.  CMIC merged into Washington National, effective July 1, 2003.  On December 16, 2016, following a jury trial, verdicts were entered in favor of the plaintiffs, and compensatory damages aggregating $4.7 million and punitive damages aggregating $6.0 million were awarded to the plaintiffs.  Washington National filed post-trial motions requesting the court correct errors, grant a new trial, find that punitive damages were improper, and reduce both compensatory and punitive damages.  Plaintiffs filed motions requesting pre-judgment interest and attorney fees.  On June 19, 2017, the court reduced punitive damages by $1.5 million and denied plaintiffs' motions for pre-judgment interest and attorney fees. Both sides have filed a Notice of Appeal. We believe the case is without merit and intend to defend it vigorously.

Regulatory Examinations and Fines

Insurance companies face significant risks related to regulatory investigations and actions.  Regulatory investigations generally result from matters related to sales or underwriting practices, payment of contingent or other sales commissions, claim payments and procedures, product design, product disclosure, additional premium charges for premiums paid on a periodic basis, denial or delay of benefits, charging excessive or impermissible fees on products, procedures related to canceling policies, changing the way cost of insurance charges are calculated for certain life insurance products or recommending unsuitable products to customers.  We are, in the ordinary course of our business, subject to various examinations, inquiries and information requests from state, federal and other authorities.  The ultimate outcome of these regulatory actions (including the costs of complying with information requests and policy reviews) cannot be predicted with certainty.  In the event of an unfavorable outcome in one or more of these matters, the ultimate liability may be in excess of liabilities we have established and we could suffer significant reputational harm as a result of these matters, which could also have a material adverse effect on our business, financial condition, results of operations or cash flows.

In August 2011, we were notified of an examination to be done on behalf of a number of states for the purpose of determining compliance with unclaimed property laws by the Company and its subsidiaries.  Such examination has included inquiries related to the use of data available on the U.S. Social Security Administration's Death Master File to identify instances where benefits under life insurance policies, annuities and retained asset accounts are payable. We are continuing to provide information to the examiners in response to their requests. A total of 38 states and the District of Columbia are currently participating in this examination.

XML

CONSOLIDATED STATEMENT OF CASH FLOWS

9 Months Ended

Sep. 30, 2017

Supplemental Cash Flow Elements [Abstract]

CONSOLIDATED STATEMENT OF CASH FLOWS

CONSOLIDATED STATEMENT OF CASH FLOWS

The following disclosures supplement our consolidated statement of cash flows.

The following reconciles net income to net cash from operating activities (dollars in millions):

	Nine months ended
	September 30,
	2017			2016
Cash flows from operating activities:
Net income	$	246.5		$	124.0
Adjustments to reconcile net income to net cash from operating activities:
Amortization and depreciation	200.8			199.1
Income taxes	50.6			43.0
Insurance liabilities	321.5			310.2
Accrual and amortization of investment income	(233.2		)	(93.4		)
Deferral of policy acquisition costs	(183.4		)	(179.4		)
Net realized investment gains	(52.3		)	(23.3		)
Loss on reinsurance transaction	—			75.4
Cash and cash equivalents received upon recapture of reinsurance	—			73.6
Loss on extinguishment of borrowings related to a variable interest entity	5.5			—
Other	77.7			55.6
Net cash from operating activities	$	433.7		$	584.8

Other non-cash items not reflected in the investing and financing activities sections of the consolidated statement of cash flows (dollars in millions):

	Nine months ended
	September 30,
	2017		2016
Stock options, restricted stock and performance units	$	17.8	$	18.9
Market value of investments recaptured in connection with the termination of reinsurance agreements with BRe	—		431.1

XML

INVESTMENTS IN VARIABLE INTEREST ENTITIES

9 Months Ended

Sep. 30, 2017

Investments in Variable Interest Entities [Abstract]

INVESTMENTS IN VARIABLE INTEREST ENTITIES

INVESTMENTS IN VARIABLE INTEREST ENTITIES

We have concluded that we are the primary beneficiary with respect to certain VIEs, which are consolidated in our financial statements.  In consolidating the VIEs, we consistently use the financial information most recently distributed to investors in the VIE.

All of the VIEs are collateralized loan trusts that were established to issue securities to finance the purchase of corporate loans and other permitted investments.  The assets held by the trusts are legally isolated and not available to the Company.  The liabilities of the VIEs are expected to be satisfied from the cash flows generated by the underlying loans held by the trusts, not from the assets of the Company.  The Company has no financial obligation to the VIEs beyond its investment in each VIE.

Certain of our insurance subsidiaries are noteholders of the VIEs.  Another subsidiary of the Company is the investment manager for the VIEs.  As such, it has the power to direct the most significant activities of the VIEs which materially impacts the economic performance of the VIEs.

The following tables provide supplemental information about the assets and liabilities of the VIEs which have been consolidated in accordance with authoritative guidance (dollars in millions):

	September 30, 2017
	VIEs			Eliminations			Net effect on consolidated balance sheet
Assets:
Investments held by variable interest entities	$	1,382.5		$	—		$	1,382.5
Notes receivable of VIEs held by insurance subsidiaries	—			(159.9		)	(159.9		)
Cash and cash equivalents held by variable interest entities	105.9			—			105.9
Accrued investment income	2.0			(.1		)	1.9
Income tax assets, net	(.6		)	—			(.6		)
Other assets	13.3			(1.4		)	11.9
Total assets	$	1,503.1		$	(161.4	)	$	1,341.7
Liabilities:
Other liabilities	$	145.9		$	(3.5	)	$	142.4
Borrowings related to variable interest entities	1,198.2			—			1,198.2
Notes payable of VIEs held by insurance subsidiaries	172.9			(172.9		)	—
Total liabilities	$	1,517.0		$	(176.4	)	$	1,340.6

	December 31, 2016
	VIEs		Eliminations			Net effect on consolidated balance sheet
Assets:
Investments held by variable interest entities	$	1,724.3	$	—		$	1,724.3
Notes receivable of VIEs held by insurance subsidiaries	—		(204.2		)	(204.2		)
Cash and cash equivalents held by variable interest entities	189.3		—			189.3
Accrued investment income	3.0		(.1		)	2.9
Income tax assets, net	6.4		(1.3		)	5.1
Other assets	13.1		(1.8		)	11.3
Total assets	$	1,936.1	$	(207.4	)	$	1,728.7
Liabilities:
Other liabilities	$	81.8	$	(6.4	)	$	75.4
Borrowings related to variable interest entities	1,662.8		—			1,662.8
Notes payable of VIEs held by insurance subsidiaries	203.3		(203.3		)	—
Total liabilities	$	1,947.9	$	(209.7	)	$	1,738.2

The investment portfolios held by the VIEs are primarily comprised of commercial bank loans to corporate obligors which are almost entirely rated below-investment grade.  At September 30, 2017, such loans had an amortized cost of $1,381.7 million; gross unrealized gains of $8.4 million; gross unrealized losses of $7.6 million; and an estimated fair value of $1,382.5 million.

The following table sets forth the amortized cost and estimated fair value of the investments held by the VIEs at September 30, 2017, by contractual maturity.  Actual maturities will differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without penalties.

	Amortized cost		Estimated fair value
	(Dollars in millions)
Due in one year or less	$	5.9	$	5.9
Due after one year through five years	499.4		500.1
Due after five years through ten years	876.4		876.5
Total	$	1,381.7	$	1,382.5

During the first nine months of 2017, the VIEs recognized net realized investment losses of $2.5 million, which were comprised of: (i) $2.2 million of net gains from the sales of investments; (ii) $4.3 million of losses on the dissolution of VIEs; and (iii) $.4 million of writedowns of investments for other than temporary declines in fair value recognized through net income. During the first nine months of 2016, the VIEs recognized net realized investment losses of $20.6 million, which were comprised of: (i) $12.1 million of net losses from the sales of fixed maturities; (ii) a $7.3 million loss on the dissolution of a VIE; and (iii) $1.2 million of writedowns of investments for other than temporary declines in fair value recognized through net income.

At September 30, 2017, there were no investments held by the VIEs that were in default or considered nonperforming.

During the first nine months of 2017, $2.2 million of net gains from the sale of investments included sales of $86.0 million which resulted in gross investment losses (before income taxes) of $2.0 million. During the first nine months of 2016, $186.6 million of investments held by the VIEs were sold which resulted in gross investment losses (before income taxes) of $20.3 million.

At September 30, 2017, the VIEs held:  (i) investments with a fair value of $382.5 million and gross unrealized losses of $7.1 million that had been in an unrealized loss position for less than twelve months; and (ii) investments with a fair value of $11.0 million and gross unrealized losses of $.5 million that had been in an unrealized loss position for greater than twelve months.

At December 31, 2016, the VIEs held: (i) investments with a fair value of $93.8 million and gross unrealized losses of $.9 million that had been in an unrealized loss position for less than twelve months; and (ii) investments with a fair value of $143.9 million and gross unrealized losses of $2.9 million that had been in an unrealized loss position for greater than twelve months.

The investments held by the VIEs are evaluated for other-than-temporary declines in fair value in a manner that is consistent with the Company's fixed maturities, available for sale.

In addition, the Company, in the normal course of business, makes passive investments in structured securities issued by VIEs for which the Company is not the investment manager.  These structured securities include asset-backed securities, collateralized debt obligations, commercial mortgage-backed securities, residential mortgage-backed securities and collateralized mortgage obligations.  Our maximum exposure to loss on these securities is limited to our cost basis in the investment.  We have determined that we are not the primary beneficiary of these structured securities due to the relative size of our investment in comparison to the total principal amount of the individual structured securities and the level of credit subordination which reduces our obligation to absorb gains or losses.

At September 30, 2017, we held investments in various limited partnerships, in which we are not the primary beneficiary, totaling $315.1 million (classified as other invested assets).  At September 30, 2017, we had unfunded commitments to these partnerships and other investments of $266.2 million.  Our maximum exposure to loss on these investments is limited to the amount of our investment.

XML

FAIR VALUE MEASUREMENTS

9 Months Ended

Sep. 30, 2017

Fair Value Disclosures [Abstract]

FAIR VALUE MEASUREMENTS

FAIR VALUE MEASUREMENTS

Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date and, therefore, represents an exit price, not an entry price.  We carry certain assets and liabilities at fair value on a recurring basis, including fixed maturities, equity securities, trading securities, investments held by VIEs, derivatives, separate account assets and embedded derivatives.  We carry our company-owned life insurance policy, which is invested in a series of mutual funds, at its cash surrender value which approximates fair value. In addition, we disclose fair value for certain financial instruments, including mortgage loans, policy loans, cash and cash equivalents, insurance liabilities for interest-sensitive products, investment borrowings, notes payable and borrowings related to VIEs.

The degree of judgment utilized in measuring the fair value of financial instruments is largely dependent on the level to which pricing is based on observable inputs.  Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect our view of market assumptions in the absence of observable market information.  Financial instruments with readily available active quoted prices would be considered to have fair values based on the highest level of observable inputs, and little judgment would be utilized in measuring fair value.  Financial instruments that rarely trade would often have fair value based on a lower level of observable inputs, and more judgment would be utilized in measuring fair value.

Valuation Hierarchy

There is a three-level hierarchy for valuing assets or liabilities at fair value based on whether inputs are observable or unobservable.

• Level 1 – includes assets and liabilities valued using inputs that are unadjusted quoted prices in active markets for identical assets or liabilities.  Our Level 1 assets primarily include cash and cash equivalents and exchange traded securities.

• Level 2 – includes assets and liabilities valued using inputs that are quoted prices for similar assets in an active market, quoted prices for identical or similar assets in a market that is not active, observable inputs, or observable inputs that can be corroborated by market data.  Level 2 assets and liabilities include those financial instruments that are valued by independent pricing services using models or other valuation methodologies.  These models consider various inputs such as credit rating, maturity, corporate credit spreads, reported trades and other inputs that are observable or derived from observable information in the marketplace or are supported by transactions executed in the marketplace. Financial assets in this category primarily include:  certain publicly registered and privately placed corporate fixed maturity securities; certain government or agency securities; certain mortgage and asset-backed securities; certain equity securities; most investments held by our consolidated VIEs; certain mutual fund investments; most short-term investments; and non-exchange-traded derivatives such as call options. Financial liabilities in this category include investment borrowings, notes payable and borrowings related to VIEs.

• Level 3 – includes assets and liabilities valued using unobservable inputs that are used in model-based valuations that contain management assumptions.  Level 3 assets and liabilities include those financial instruments whose fair value is estimated based on broker/dealer quotes, pricing services or internally developed models or methodologies utilizing significant inputs not based on, or corroborated by, readily available market information.  Financial assets in this category include certain corporate securities (primarily certain below-investment grade privately placed securities), certain structured securities, mortgage loans, and other less liquid securities.  Financial liabilities in this category include our insurance liabilities for interest-sensitive products, which includes embedded derivatives (including embedded derivatives related to our fixed index annuity products and to a modified coinsurance arrangement) since their values include significant unobservable inputs including actuarial assumptions.

At each reporting date, we classify assets and liabilities into the three input levels based on the lowest level of input that is significant to the measurement of fair value for each asset and liability reported at fair value.  This classification is impacted by a number of factors, including the type of financial instrument, whether the financial instrument is new to the market and not yet established, the characteristics specific to the transaction and overall market conditions.  Our assessment of the significance of a particular input to the fair value measurement and the ultimate classification of each asset and liability requires judgment and is subject to change from period to period based on the observability of the valuation inputs. Any transfers between levels are reported as having occurred at the beginning of the period. There were no transfers between Level 1 and Level 2 in both the first nine months of 2017 and 2016.

The vast majority of our fixed maturity and equity securities, including those held in trading portfolios and those held by consolidated VIEs, short-term and separate account assets use Level 2 inputs for the determination of fair value.  These fair values are obtained primarily from independent pricing services, which use Level 2 inputs for the determination of fair value.  Our Level 2 assets are valued as follows:

•Fixed maturities available for sale, equity securities and trading securities

Corporate securities are generally priced using market and income approaches. Inputs generally consist of trades of identical or similar securities, quoted prices in inactive markets, issuer rating, benchmark yields, maturity, and credit spreads.

U.S. Treasuries and obligations of U.S. Government corporations and agencies are generally priced using the market approach. Inputs generally consist of trades of identical or similar securities, quoted prices in inactive markets and maturity.

States and political subdivisions are generally priced using the market approach. Inputs generally consist of trades of identical or similar securities, quoted prices in inactive markets, new issuances and credit spreads.

Asset-backed securities, collateralized debt obligations, commercial mortgage-backed securities, mortgage pass-through securities and collateralized mortgage obligations are generally priced using market and income approaches. Inputs generally consist of quoted prices in inactive markets, spreads on actively traded securities, expected prepayments, expected default rates, expected recovery rates, and issue specific information including, but not limited to, collateral type, seniority and vintage.

Equity securities (primarily comprised of non-redeemable preferred stock) are generally priced using the market approach. Inputs generally consist of trades of identical or similar securities, quoted prices in inactive markets, issuer rating, benchmark yields, maturity, and credit spreads.

• Investments held by VIEs

Corporate securities are generally priced using market and income approaches using pricing vendors. Inputs generally consist of issuer rating, benchmark yields, maturity, and credit spreads.

• Other invested assets - derivatives

The fair value measurements for derivative instruments, including embedded derivatives requiring bifurcation, are determined based on the consideration of several inputs including closing exchange or over-the-counter market price quotes; time value and volatility factors underlying options; market interest rates; and non-performance risk.

Third party pricing services normally derive security prices through recently reported trades for identical or similar securities making adjustments through the reporting date based upon available market observable information.  If there are no recently reported trades, the third party pricing services may use matrix or model processes to develop a security price where future cash flow expectations are discounted at an estimated risk-adjusted market rate.  The number of prices obtained for a given security is dependent on the Company's analysis of such prices as further described below.

As the Company is responsible for the determination of fair value, we have control processes designed to ensure that the fair values received from third-party pricing sources are reasonable and the valuation techniques and assumptions used appear reasonable and consistent with prevailing market conditions. Additionally, when inputs are provided by third-party pricing sources, we have controls in place to review those inputs for reasonableness. As part of these controls, we perform monthly quantitative and qualitative analysis on the prices received from third parties to determine whether the prices are reasonable estimates of fair value.  The Company's analysis includes:  (i) a review of the methodology used by third party pricing services; (ii) where available, a comparison of multiple pricing services' valuations for the same security; (iii) a review of month to month price fluctuations; (iv) a review to ensure valuations are not unreasonably dated; and (v) back testing to compare actual purchase and sale transactions with valuations received from third parties.  As a result of such procedures, the Company may conclude the prices received from third parties are not reflective of current market conditions.  In those instances, we may request additional pricing quotes or apply internally developed valuations.  However, the number of such instances is insignificant and the aggregate change in value of such investments is not materially different from the original prices received.

The categorization of the fair value measurements of our investments priced by independent pricing services was based upon the Company's judgment of the inputs or methodologies used by the independent pricing services to value different asset classes.  Such inputs typically include:  benchmark yields, reported trades, broker dealer quotes, issuer spreads, benchmark securities, bids, offers and other relevant data.  The Company categorizes such fair value measurements based upon asset classes and the underlying observable or unobservable inputs used to value such investments.

For securities that are not priced by pricing services and may not be reliably priced using pricing models, we obtain broker quotes.  These broker quotes are non-binding andrepresent an exit price, but assumptions used to establish the fair value may not be observable and therefore represent Level 3 inputs.  Approximately 45 percent of our Level 3 fixed maturity securities were valued using unadjusted broker quotes or broker-provided valuation inputs.  The remaining Level 3 fixed maturity investments do not have readily determinable market prices and/or observable inputs.  For these securities, we use internally developed valuations.  Key assumptions used to determine fair value for these securities may include risk premiums, projected performance of underlying collateral and other factors involving significant assumptions which may not be reflective of an active market.  For certain investments, we use a matrix or model process to develop a security price where future cash flow expectations are discounted at an estimated market rate.  The pricing matrix incorporates term interest rates as well as a spread level based on the issuer's credit rating, other factors relating to the issuer, and the security's maturity.  In some instances issuer-specific spread adjustments, which can be positive or negative, are made based upon internal analysis of security specifics such as liquidity, deal size, and time to maturity.

For certain embedded derivatives, we use actuarial assumptions in the determination of fair value which we consider to be Level 3 inputs.

The categorization of fair value measurements, by input level, for our financial instruments carried at fair value on a recurring basis at September 30, 2017 is as follows (dollars in millions):

	Quoted prices in active markets for identical assets or liabilities (Level 1)		Significant other observable inputs (Level 2)		Significant unobservable inputs  (Level 3)		Total
Assets:
Fixed maturities, available for sale:
Corporate securities	$	—	$	14,394.3	$	255.7	$	14,650.0
United States Treasury securities and obligations of United States government corporations and agencies	—		172.3		—		172.3
States and political subdivisions	—		2,077.0		—		2,077.0
Debt securities issued by foreign governments	—		57.1		4.0		61.1
Asset-backed securities	—		2,726.2		59.9		2,786.1
Collateralized debt obligations	—		237.9		—		237.9
Commercial mortgage-backed securities	—		1,338.9		—		1,338.9
Mortgage pass-through securities	—		2.2		—		2.2
Collateralized mortgage obligations	—		804.4		—		804.4
Total fixed maturities, available for sale	—		21,810.3		319.6		22,129.9
Equity securities - corporate securities	477.8		213.9		21.6		713.3
Trading securities:
Corporate securities	—		21.1		—		21.1
United States Treasury securities and obligations of United States government corporations and agencies	—		.5		—		.5
Asset-backed securities	—		101.2		—		101.2
Collateralized debt obligations	—		2.7		—		2.7
Commercial mortgage-backed securities	—		93.3		—		93.3
Collateralized mortgage obligations	—		72.5		—		72.5
Equity securities	3.1		—		—		3.1
Total trading securities	3.1		291.3		—		294.4
Investments held by variable interest entities - corporate securities	—		1,377.5		5.0		1,382.5
Other invested assets - derivatives	—		142.2		—		142.2
Assets held in separate accounts	—		4.8		—		4.8
Total assets carried at fair value by category	$	480.9	$	23,840.0	$	346.2	$	24,667.1
Liabilities:
Future policy benefits - embedded derivatives associated with fixed index annuity products	$	—	$	—	$	1,249.3	$	1,249.3

The categorization of fair value measurements, by input level, for our financial instruments carried at fair value on a recurring basis at December 31, 2016 is as follows (dollars in millions):

	Quoted prices in active markets  for identical assets or liabilities (Level 1)		Significant other observable inputs  (Level 2)		Significant unobservable inputs  (Level 3)		Total
Assets:
Fixed maturities, available for sale:
Corporate securities	$	—	$	13,252.4	$	258.5	$	13,510.9
United States Treasury securities and obligations of United States government corporations and agencies	—		164.3		—		164.3
States and political subdivisions	—		1,988.9		—		1,988.9
Debt securities issued by foreign governments	—		33.0		3.9		36.9
Asset-backed securities	—		2,649.9		60.4		2,710.3
Collateralized debt obligations	—		225.3		5.4		230.7
Commercial mortgage-backed securities	—		1,504.2		32.0		1,536.2
Mortgage pass-through securities	—		2.5		—		2.5
Collateralized mortgage obligations	—		915.5		—		915.5
Total fixed maturities, available for sale	—		20,736.0		360.2		21,096.2
Equity securities - corporate securities	359.9		199.1		25.2		584.2
Trading securities:
Corporate securities	—		19.0		—		19.0
United States Treasury securities and obligations of United States government corporations and agencies	—		.5		—		.5
Asset-backed securities	—		94.3		—		94.3
Collateralized debt obligations	—		2.4		—		2.4
Commercial mortgage-backed securities	—		163.9		—		163.9
Collateralized mortgage obligations	—		78.4		—		78.4
Equity securities	4.9		—		—		4.9
Total trading securities	4.9		358.5		—		363.4
Investments held by variable interest entities - corporate securities	—		1,724.3		—		1,724.3
Other invested assets - derivatives	—		111.9		—		111.9
Assets held in separate accounts	—		4.7		—		4.7
Total assets carried at fair value by category	$	364.8	$	23,134.5	$	385.4	$	23,884.7
Liabilities:
Future policy benefits - embedded derivatives associated with fixed index annuity products	$	—	$	—	$	1,092.3	$	1,092.3

For those financial instruments disclosed at fair value, we use the following methods and assumptions to determine the estimated fair values:

Mortgage loans and policy loans.  We discount future expected cash flows based on interest rates currently being offered for similar loans with similar risk characteristics.  We aggregate loans with similar characteristics in our calculations.  The fair value of policy loans approximates their carrying value.

Company-owned life insurance is backed by a series of mutual funds and is carried at cash surrender value which approximates estimated fair value.

Cash and cash equivalents include commercial paper, invested cash and other investments purchased with original maturities of less than three months. We carry them at amortized cost, which approximates estimated fair value.

Liabilities for policyholder account balances.  The estimated fair value of insurance liabilities for policyholder account balances was approximately equal to its carrying value as interest rates credited on the vast majority of account balances approximate current rates paid on similar products and because these rates are not generally guaranteed beyond one year.

Investment borrowings, notes payable and borrowings related to variable interest entities.  For publicly traded debt, we use current fair values.  For other notes, we use discounted cash flow analyses based on our current incremental borrowing rates for similar types of borrowing arrangements.

The fair value measurements for our financial instruments disclosed at fair value on a recurring basis are as follows (dollars in millions):

	September 30, 2017
	Quoted prices in active markets for identical assets or liabilities (Level 1)		Significant other observable inputs  (Level 2)		Significant unobservable inputs  (Level 3)		Total estimated fair value		Total carrying amount
Assets:
Mortgage loans	$	—	$	—	$	1,705.8	$	1,705.8	$	1,667.8
Policy loans	—		—		114.6		114.6		114.6
Other invested assets:
Company-owned life insurance	—		178.8		—		178.8		178.8
Cash and cash equivalents:
Unrestricted	765.9		—		—		765.9		765.9
Held by variable interest entities	105.9		—		—		105.9		105.9
Liabilities:
Policyholder account balances	—		—		11,113.5		11,113.5		11,113.5
Investment borrowings	—		1,650.1		—		1,650.1		1,646.9
Borrowings related to variable interest entities	—		1,215.1		—		1,215.1		1,198.2
Notes payable – direct corporate obligations	—		970.5		—		970.5		914.4

	December 31, 2016
	Quoted prices in active markets for identical assets or liabilities (Level 1)		Significant other observable inputs  (Level 2)		Significant unobservable inputs  (Level 3)		Total estimated fair value		Total carrying amount
Assets:
Mortgage loans	$	—	$	—	$	1,800.1	$	1,800.1	$	1,768.0
Policy loans	—		—		112.0		112.0		112.0
Other invested assets:
Company-owned life insurance	—		165.0		—		165.0		165.0
Cash and cash equivalents:
Unrestricted	473.6		5.3		—		478.9		478.9
Held by variable interest entities	189.3		—		—		189.3		189.3
Liabilities:
Policyholder account balances	—		—		10,912.7		10,912.7		10,912.7
Investment borrowings	—		1,650.0		—		1,650.0		1,647.4
Borrowings related to variable interest entities	—		1,675.2		—		1,675.2		1,662.8
Notes payable – direct corporate obligations	—		931.9		—		931.9		912.9

The following table presents additional information about assets and liabilities measured at fair value on a recurring basis and for which we have utilized significant unobservable (Level 3) inputs to determine fair value for the three months ended September 30, 2017 (dollars in millions):

	September 30, 2017
	Beginning balance as of June 30, 2017			Purchases, sales, issuances and settlements, net (b)			Total realized and unrealized gains (losses) included in net income		Total realized and unrealized gains (losses) included in accumulated other comprehensive income (loss)			Transfers into Level 3 (a)		Transfers out of Level 3 (a)			Ending balance as of September 30, 2017			Amount of total gains (losses) for the three months ended September 30, 2017 included in our net income relating to assets and liabilities still held as of the reporting date
Assets:
Fixed maturities, available for sale:
Corporate securities	$	263.3		$	(44.8	)	$	1.7	$	1.3		$	34.2	$	—		$	255.7		$	(3.2	)
Debt securities issued by foreign governments	3.9			—			—		.1			—		—			4.0			—
Asset-backed securities	59.6			(1.3		)	—		.7			7.1		(6.2		)	59.9			—
Collateralized debt obligations	2.5			(2.5		)	—		—			—		—			—			—
Collateralized mortgage obligations	.2			—			—		(.2		)	—		—			—			—
Total fixed maturities, available for sale	329.5			(48.6		)	1.7		1.9			41.3		(6.2		)	319.6			(3.2		)
Equity securities - corporate securities	24.6			(8.3		)	6.4		(1.1		)	—		—			21.6			(.5		)
Investments held by variable interest entities - corporate securities	—			—			—		—			5.0		—			5.0			—
Liabilities:
Future policy benefits - embedded derivatives associated with fixed index annuity products	(1,205.4		)	(56.3		)	12.4		—			—		—			(1,249.3		)	12.4

_________

(a) Transfers into Level 3 are the result of unobservable inputs utilized within valuation methodologies for assets that were previously valued using observable inputs. Transfers out of Level 3 are due to the use of observable inputs in valuation methodologies as well as the utilization of pricing service information for certain assets that the Company is able to validate.

(b) Purchases, sales, issuances and settlements, net, represent the activity that occurred during the period that results in a change of the asset or liability but does not represent changes in fair value for the instruments held at the beginning of the period.  Such activity primarily consists of purchases and sales of fixed maturity and equity securities and changes to embedded derivative instruments related to insurance products resulting from the issuance of new contracts, or changes to existing contracts.  The following summarizes such activity for the three months ended September 30, 2017 (dollars in millions):

	Purchases			Sales			Issuances			Settlements		Purchases, sales, issuances and settlements, net
Assets:
Fixed maturities, available for sale:
Corporate securities	$	15.3		$	(60.1	)	$	—		$	—	$	(44.8	)
Asset-backed securities	9.9			(11.2		)	—			—		(1.3		)
Collateralized debt obligations	—			(2.5		)	—			—		(2.5		)
Total fixed maturities, available for sale	25.2			(73.8		)	—			—		(48.6		)
Equity securities - corporate securities	—			(8.3		)	—			—		(8.3		)
Liabilities:
Future policy benefits - embedded derivatives associated with fixed index annuity products	(41.0		)	1.8			(31.4		)	14.3		(56.3		)

The following table presents additional information about assets and liabilities measured at fair value on a recurring basis and for which we have utilized significant unobservable (Level 3) inputs to determine fair value for the nine months ended September 30, 2017 (dollars in millions):

	September 30, 2017
	Beginning balance as of December 31, 2016			Purchases, sales, issuances and settlements, net (b)			Total realized and unrealized gains (losses) included in net income		Total realized and unrealized gains (losses) included in accumulated other comprehensive income (loss)			Transfers into Level 3 (a)		Transfers out of Level 3 (a)			Ending balance as of September 30, 2017			Amount of total gains (losses) for the nine months ended September 30, 2017 included in our net income relating to assets and liabilities still held as of the reporting date
Assets:
Fixed maturities, available for sale:
Corporate securities	$	258.5		$	(44.1	)	$	9.5	$	.6		$	31.2	$	—		$	255.7		$	(6.5	)
Debt securities issued by foreign governments	3.9			—			—		.1			—		—			4.0			—
Asset-backed securities	60.4			3.8			—		2.3			4.2		(10.8		)	59.9			—
Collateralized debt obligations	5.4			(2.5		)	—		—			—		(2.9		)	—			—
Commercial mortgage-backed securities	32.0			—			—		—			—		(32.0		)	—			—
Total fixed maturities, available for sale	360.2			(42.8		)	9.5		3.0			35.4		(45.7		)	319.6			(6.5		)
Equity securities - corporate securities	25.2			(8.5		)	6.3		(1.4		)	—		—			21.6			(.5		)
Investments held by variable interest entities - corporate securities	—			5.0			—		—			—		—			5.0			—
Liabilities:
Future policy benefits - embedded derivatives associated with fixed index annuity products	(1,092.3		)	(174.2		)	17.2		—			—		—			(1,249.3		)	17.2

_________

(a) Transfers into Level 3 are the result of unobservable inputs utilized within valuation methodologies for assets that were previously valued using observable inputs. Transfers out of Level 3 are due to the use of observable inputs in valuation methodologies as well as the utilization of pricing service information for certain assets that the Company is able to validate.

(b) Purchases, sales, issuances and settlements, net, represent the activity that occurred during the period that results in a change of the asset or liability but does not represent changes in fair value for the instruments held at the beginning of the period.  Such activity primarily consists of purchases and sales of fixed maturity and equity securities and changes to embedded derivative instruments related to insurance products resulting from the issuance of new contracts, or changes to existing contracts.  The following summarizes such activity for the nine months ended September 30, 2017 (dollars in millions):

	Purchases			Sales			Issuances			Settlements		Purchases, sales, issuances and settlements, net
Assets:
Fixed maturities, available for sale:
Corporate securities	$	64.3		$	(108.4	)	$	—		$	—	$	(44.1	)
Asset-backed securities	21.9			(18.1		)	—			—		3.8
Collateralized debt obligations	—			(2.5		)	—			—		(2.5		)
Total fixed maturities, available for sale	86.2			(129.0		)	—			—		(42.8		)
Equity securities - corporate securities	—			(8.5		)	—			—		(8.5		)
Investments held by variable interest entities - corporate securities	5.0			—			—			—		5.0
Liabilities:
Future policy benefits - embedded derivatives associated with fixed index annuity products	(130.1		)	5.3			(95.7		)	46.3		(174.2		)

The following table presents additional information about assets and liabilities measured at fair value on a recurring basis and for which we have utilized significant unobservable (Level 3) inputs to determine fair value for the three months ended September 30, 2016 (dollars in millions):

	September 30, 2016
	Beginning balance as of June 30, 2016			Purchases, sales, issuances and settlements, net (b)			Total realized and unrealized gains (losses) included in net income		Total realized and unrealized gains (losses) included in accumulated other comprehensive income (loss)			Transfers into Level 3 (a)		Transfers out of Level 3 (a)			Ending balance as of September 30, 2016			Amount of total gains (losses) for the three months ended September 30, 2016 included in our net income relating to assets and liabilities still held as of the reporting date
Assets:
Fixed maturities, available for sale:
Corporate securities	$	174.6		$	118.8		$	—	$	(4.9	)	$	—	$	—		$	288.5		$	—
Debt securities issued by foreign governments	4.1			—			—		—			—		—			4.1			—
Asset-backed securities	39.1			5.7			—		2.1			24.6		(15.0		)	56.5			—
Collateralized debt obligations	—			2.5			—		—			—		—			2.5			—
Commercial mortgage-backed securities	1.1			17.0			—		(.1		)	14.4		—			32.4			—
Collateralized mortgage obligations	—			12.0			—		—			—		—			12.0			—
Total fixed maturities, available for sale	218.9			156.0			—		(2.9		)	39.0		(15.0		)	396.0			—
Equity securities - corporate securities	21.4			3.3			—		(.8		)	—		—			23.9			—
Trading securities - commercial mortgage-backed securities	—			—			—		(1.7		)	10.0		—			8.3			(1.7		)
Liabilities:
Future policy benefits - embedded derivatives associated with fixed index annuity products	(1,127.0		)	(37.0		)	18.3		—			—		—			(1,145.7		)	18.3

____________

(a) Transfers into Level 3 are the result of unobservable inputs utilized within valuation methodologies for assets that were previously valued using observable inputs. Transfers out of Level 3 are due to the use of observable inputs in valuation methodologies as well as the utilization of pricing service information for certain assets that the Company is able to validate.

(b) Purchases, sales, issuances and settlements, net, represent the activity that occurred during the period that results in a change of the asset or liability but does not represent changes in fair value for the instruments held at the beginning of the period.  Such activity primarily consists of purchases and sales of fixed maturity and equity securities and changes to embedded derivative instruments related to insurance products resulting from the issuance of new contracts, or changes to existing contracts.  In addition, such activity includes the investments received upon the recapture of reinsurance agreements with BRe on September 29, 2016. The following summarizes such activity for the three months ended September 30, 2016 (dollars in millions):

	Purchases			Received in reinsurance recapture		Sales			Issuances			Settlements		Purchases, sales, issuances and settlements, net
Assets:
Fixed maturities, available for sale:
Corporate securities	$	1.1		$	118.6	$	(.9	)	$	—		$	—	$	118.8
Asset-backed securities	7.0			—		(1.3		)	—			—		5.7
Collateralized debt obligations	2.5			—		—			—			—		2.5
Commercial mortgage-backed securities	17.0			—		—			—			—		17.0
Collateralized mortgage obligations	—			12.0		—			—			—		12.0
Total fixed maturities, available for sale	27.6			130.6		(2.2		)	—			—		156.0
Equity securities - corporate securities	1.1			2.2		—			—			—		3.3
Liabilities:
Future policy benefits - embedded derivatives associated with fixed index annuity products	(38.5		)	—		3.1			(14.6		)	13.0		(37.0		)

The following table presents additional information about assets and liabilities measured at fair value on a recurring basis and for which we have utilized significant unobservable (Level 3) inputs to determine fair value for the nine months ended September 30, 2016 (dollars in millions):

	September 30, 2016
	Beginning balance as of December 31, 2015			Purchases, sales, issuances and settlements, net (b)			Total realized and unrealized gains (losses) included in net income			Total realized and unrealized gains (losses) included in accumulated other comprehensive income (loss)			Transfers into Level 3 (a)		Transfers out of Level 3 (a)			Ending balance as of September 30, 2016			Amount of total gains (losses) for the nine months ended September 30, 2016 included in our net income relating to assets and liabilities still held as of the reporting date
Assets:
Fixed maturities, available for sale:
Corporate securities	$	170.4		$	104.4		$	(7.0	)	$	7.4		$	20.3	$	(7.0	)	$	288.5		$	(5.6	)
Debt securities issued by foreign governments	—			4.0			—			.1			—		—			4.1			—
Asset-backed securities	35.9			1.7			—			4.0			28.6		(13.7		)	56.5			—
Collateralized debt obligations	—			2.5			—			—			—		—			2.5			—
Commercial mortgage-backed securities	1.1			17.0			—			.4			13.9		—			32.4			—
Mortgage pass-through securities	.1			(.1		)	—			—			—		—			—			—
Collateralized mortgage obligations	—			12.0			—			—			—		—			12.0			—
Total fixed maturities, available for sale	207.5			141.5			(7.0		)	11.9			62.8		(20.7		)	396.0			(5.6		)
Equity securities - corporate securities	32.0			5.5			(12.8		)	(.8		)	—		—			23.9			(12.8		)
Trading securities - commercial mortgage-backed securities	39.9			—			—			(1.4		)	—		(30.2		)	8.3			(1.4		)
Liabilities:
Future policy benefits - embedded derivatives associated with fixed index annuity products	(1,057.1		)	(55.3		)	(33.3		)	—			—		—			(1,145.7		)	(33.3		)

____________

(a) Transfers into Level 3 are the result of unobservable inputs utilized within valuation methodologies for assets that were previously valued using observable inputs. Transfers out of Level 3 are due to the use of observable inputs in valuation methodologies as well as the utilization of pricing service information for certain assets that the Company is able to validate.

(b) Purchases, sales, issuances and settlements, net, represent the activity that occurred during the period that results in a change of the asset or liability but does not represent changes in fair value for the instruments held at the beginning of the period.  Such activity primarily consists of purchases and sales of fixed maturity and equity securities and changes to embedded derivative instruments related to insurance products resulting from the issuance of new contracts, or changes to existing contracts.  In addition, such activity includes the investments received upon the recapture of reinsurance agreements with BRe on September 29, 2016. The following summarizes such activity for the nine months ended September 30, 2016 (dollars in millions):

	Purchases			Received in reinsurance recapture		Sales			Issuances			Settlements		Purchases, sales, issuances and settlements, net
Assets:
Fixed maturities, available for sale:
Corporate securities	$	1.1		$	118.6	$	(15.3	)	$	—		$	—	$	104.4
Debt securities issued by foreign governments	4.0			—		—			—			—		4.0
Asset-backed securities	7.0			—		(5.3		)	—			—		1.7
Collateralized debt obligations	2.5			—		—			—			—		2.5
Commercial mortgage-backed securities	17.0			—		—			—			—		17.0
Mortgage pass-through securities	—			—		(.1		)	—			—		(.1		)
Collateralized mortgage obligations	—			12.0		—			—			—		12.0
Total fixed maturities, available for sale	31.6			130.6		(20.7		)	—			—		141.5
Equity securities - corporate securities	3.3			2.2		—			—			—		5.5
Liabilities:
Future policy benefits - embedded derivatives associated with fixed index annuity products	(101.9		)	—		19.2			(17.5		)	44.9		(55.3		)

At September 30, 2017, 55 percent of our Level 3 fixed maturities, available for sale, were investment grade and 80 percent of our Level 3 fixed maturities, available for sale, consisted of corporate securities.

Realized and unrealized investment gains and losses presented in the preceding tables represent gains and losses during the time the applicable financial instruments were classified as Level 3.

Realized and unrealized gains (losses) on Level 3 assets are primarily reported in either net investment income for policyholder and other special-purpose portfolios, net realized investment gains (losses) or insurance policy benefits within the consolidated statement of operations or accumulated other comprehensive income within shareholders' equity based on the appropriate accounting treatment for the instrument.

The amount presented for gains (losses) included in our net loss for assets and liabilities still held as of the reporting date primarily represents impairments for fixed maturities, available for sale, changes in fair value of trading securities and certain derivatives and changes in fair value of embedded derivative instruments included in liabilities for insurance products that exist as of the reporting date.

The following table provides additional information about the significant unobservable (Level 3) inputs developed internally by the Company to determine fair value for certain assets and liabilities carried at fair value at September 30, 2017 (dollars in millions):

	Fair value at September 30, 2017		Valuation techniques	Unobservable inputs	Range (weighted average)
Assets:
Corporate securities (a)	$	138.4	Discounted cash flow analysis	Discount margins	1.50% - 61.70% (9.10%)
Corporate securities (b)	3.1		Recovery method	Percent of recovery expected	5% - 38% (17.76%)
Asset-backed securities (c)	24.9		Discounted cash flow analysis	Discount margins	1.77% - 3.36% (2.54%)
Equity securities (d)	21.6		Market comparables	EBITDA multiples	0.5X - 6.2X (5.9X)
Other assets categorized as Level 3 (e)	158.2		Unadjusted third-party price source	Not applicable	Not applicable
Total	346.2
Liabilities:
Future policy benefits (f)	1,249.3		Discounted projected embedded derivatives	Projected portfolio yields	5.15% - 5.61% (5.59%)
				Discount rates	0.44% - 2.80% (1.94%)
				Surrender rates	0.94% - 46.48% (13.52%)

________________________________

(a) Corporate securities - The significant unobservable input used in the fair value measurement of our corporate securities is discount margin added to a riskless market yield. Significant increases (decreases) in discount margin in isolation would result in a significantly lower (higher) fair value measurement.

(b) Corporate securities - The significant unobservable input used in the fair value measurement of these corporate securities is percentage of recovery expected.  Significant increases (decreases) in percentage of recovery expected in isolation would result in a significantly higher (lower) fair value measurement.

(c) Asset-backed securities - The significant unobservable input used in the fair value measurement of these asset-backed securities is discount margin added to a riskless market yield. Significant increases (decreases) in discount margin in isolation would result in a significantly lower (higher) fair value measurement.

(d) Equity securities - The significant unobservable input used in the fair value measurement of these equity securities is multiples of earnings before interest, taxes, depreciation and amortization ("EBITDA"). Generally, increases (decreases) in the EBITDA multiples would result in higher (lower) fair value measurements.

(e) Other assets categorized as Level 3 - For these assets, there were no adjustments to quoted market prices obtained from third-party pricing sources.

(f) Future policy benefits - The significant unobservable inputs used in the fair value measurement of our embedded derivatives associated with fixed index annuity products are projected portfolio yields, discount rates and surrender rates. Increases (decreases) in projected portfolio yields in isolation would lead to a higher (lower) fair value measurement. The discount rate is based on the Treasury rate adjusted by a margin. Increases (decreases) in the discount rates would lead to a lower (higher) fair value measurement. Assumed surrender rates are used to project how long the contracts remain in force. Generally, the longer the contracts are assumed to be in force the higher the fair value of the embedded derivative.

The following table provides additional information about the significant unobservable (Level 3) inputs developed internally by the Company to determine fair value for certain assets and liabilities carried at fair value at December 31, 2016 (dollars in millions):

	Fair value at December 31, 2016		Valuation techniques	Unobservable inputs	Range (weighted average)
Assets:
Corporate securities (a)	$	148.5	Discounted cash flow analysis	Discount margins	1.35% - 27.71% (13.52%)
Corporate securities (b)	14.8		Recovery method	Percent of recovery expected	5% - 69% (55%)
Asset-backed securities (c)	24.0		Discounted cash flow analysis	Discount margins	2.06% - 3.64% (2.76%)
Equity securities (d)	25.2		Market comparables	EBITDA multiples	0.4X - 6.2X (5.9X)
Other assets categorized as Level 3 (e)	172.9		Unadjusted third-party price source	Not applicable	Not applicable
Total	385.4
Liabilities:
Future policy benefits (f)	1,092.3		Discounted projected embedded derivatives	Projected portfolio yields	5.15% - 5.61% (5.59%)
				Discount rates	0.18% - 3.06% (2.07%)
				Surrender rates	0.94% - 46.48% (13.52%)

________________________________

(a) Corporate securities - The significant unobservable input used in the fair value measurement of our corporate securities is discount margin added to a riskless market yield. Significant increases (decreases) in discount margin in isolation would result in a significantly lower (higher) fair value measurement.

(b) Corporate securities - The significant unobservable input used in the fair value measurement of our corporate securities is percentage of recovery expected.  Significant increases (decreases) in percentage of recovery expected in isolation would result in a significantly higher (lower) fair value measurement.

(c) Asset-backed securities - The significant unobservable input used in the fair value measurement of these asset-backed securities is discount margin added to a riskless market yield. Significant increases (decreases) in discount margin in isolation would result in a significantly lower (higher) fair value measurement.

(d) Equity securities - The significant unobservable input used in the fair value measurement of these equity securities is EBITDA multiples. Generally, increases (decreases) in the EBITDA multiples would result in higher (lower) fair value measurements.

(e) Other assets categorized as Level 3 - For these assets, there were no adjustments to quoted market prices obtained from third-party pricing sources.

(f) Future policy benefits - The significant unobservable inputs used in the fair value measurement of our embedded derivatives associated with fixed index annuity products are projected portfolio yields, discount rates and surrender rates. Increases (decreases) in projected portfolio yields in isolation would lead to a higher (lower) fair value measurement. The discount rate is based on the Treasury rate adjusted by a margin. Increases (decreases) in the discount rates would lead to a lower (higher) fair value measurement. Assumed surrender rates are used to project how long the contracts remain in force. Generally, the longer the contracts are assumed to be in force the higher the fair value of the embedded derivative.

XML

SUBSEQUENT EVENT

9 Months Ended

Sep. 30, 2017

Subsequent Events [Abstract]

Subsequent Event

SUBSEQUENT EVENT

On October 13, 2017, the Company entered into an amendment and restatement agreement (the "Amendment Agreement") with respect to its Revolving Credit Agreement (as amended by the Amendment Agreement, the "Amended Credit Agreement"). The Amendment Agreement, among other things, increases the total commitments available under the revolving credit facility from $150.0 million to $250.0 million, increases the aggregate amount of additional incremental loans the Company may incur from $50.0 million to $100.0 million and extends the maturity date of the revolving credit facility from May 19, 2019 to the earlier of October 13, 2022 and the date that is six months prior to the maturity date of the Company’s 4.50% senior notes due 2020, which is November 30, 2019. The amount drawn under the Amended Credit Agreement continues to be $100.0 million.

The interest rate applicable to loans under the Amended Credit Agreement continues to be calculated as the eurodollar rate or the base rate, at the Company’s option, plus a margin based on the Company’s unsecured debt rating. The margins under the Amended Credit Agreement range from 1.375% to 2.125%, in the case of loans at the eurodollar rate, and 0.375% to 1.125%, in the case of loans at the base rate. The commitment fee under the Amended Credit Agreement continues to be based on the Company’s unsecured debt rating.

Additionally, the Amended Credit Agreement revises the debt to total capitalization ratio that the Company is required to maintain from not more than 30.0 percent to not more than 35.0 percent. The Amended Credit Agreement continues to contain certain other restrictive covenants with which the Company must comply.

XML

RECENTLY ISSUED ACCOUNTING STANDARDS (Policies)

9 Months Ended

Sep. 30, 2017

New Accounting Pronouncements and Changes in Accounting Principles [Abstract]

Investments

We regularly evaluate all of our investments with unrealized losses for possible impairment.  Our assessment of whether unrealized losses are "other than temporary" requires significant judgment.  Factors considered include:  (i) the extent to which fair value is less than the cost basis; (ii) the length of time that the fair value has been less than cost; (iii) whether the unrealized loss is event driven, credit-driven or a result of changes in market interest rates or risk premium; (iv) the near-term prospects for specific events, developments or circumstances likely to affect the value of the investment; (v) the investment's rating and whether the investment is investment-grade and/or has been downgraded since its purchase; (vi) whether the issuer is current on all payments in accordance with the contractual terms of the investment and is expected to meet all of its obligations under the terms of the investment; (vii) whether we intend to sell the investment or it is more likely than not that circumstances will require us to sell the investment before recovery occurs; (viii) the underlying current and prospective asset and enterprise values of the issuer and the extent to which the recoverability of the carrying value of our investment may be affected by changes in such values; (ix) projections of, and unfavorable changes in, cash flows on structured securities including mortgage-backed and asset-backed securities; (x) our best estimate of the value of any collateral; and (xi) other objective and subjective factors.

Future events may occur, or additional information may become available, which may necessitate future realized losses in our portfolio.  Significant losses could have a material adverse effect on our consolidated financial statements in future periods.

Impairment losses on equity securities are recognized in net income.  The manner in which impairment losses on fixed maturity securities, available for sale, are recognized in the financial statements is dependent on the facts and circumstances related to the specific security.  If we intend to sell a security or it is more likely than not that we would be required to sell a security before the recovery of its amortized cost, the security is other-than-temporarily impaired and the full amount of the impairment is recognized as a loss through earnings.  If we do not expect to recover the amortized cost basis, we do not plan to sell the security, and if it is not more likely than not that we would be required to sell a security before the recovery of its amortized cost, less any current period credit loss, the recognition of the other-than-temporary impairment is bifurcated.  We recognize the credit loss portion in net income and the noncredit loss portion in accumulated other comprehensive income.

We estimate the amount of the credit loss component of a fixed maturity security impairment as the difference between amortized cost and the present value of the expected cash flows of the security.  The present value is determined using the best estimate of future cash flows discounted at the effective interest rate implicit to the security at the date of purchase or the current yield to accrete an asset-backed or floating-rate security.  The methodology and assumptions for establishing the best estimate of future cash flows vary depending on the type of security.

For most structured securities, cash flow estimates are based on bond-specific facts and circumstances that may include collateral characteristics, expectations of delinquency and default rates, loss severity, prepayment speeds and structural support, including excess spread, subordination and guarantees.  For corporate bonds, cash flow estimates are derived from scenario-based outcomes of expected corporate restructurings or the disposition of assets using bond specific facts and circumstances. The previous amortized cost basis less the impairment recognized in net income becomes the security's new cost basis.  We accrete the new cost basis to the estimated future cash flows over the expected remaining life of the security, except when the security is in default or considered nonperforming.

The remaining noncredit impairment, which is recorded in accumulated other comprehensive income, is the difference between the security's estimated fair value and our best estimate of future cash flows discounted at the effective interest rate prior to impairment.  The remaining noncredit impairment typically represents changes in the market interest rates, current market liquidity and risk premiums.

We classify our fixed maturity securities into one of two categories: (i) "available for sale" (which we carry at estimated fair value with any unrealized gain or loss, net of tax and related adjustments, recorded as a component of shareholders' equity); or (ii) "trading" (which we carry at estimated fair value with changes in such value recognized as net investment income (classified as investment income from policyholder and other special-purpose portfolios)).

Ourtrading securities include: (i) investments purchased with the intent of selling in the near term to generate income; (ii) investments supporting certain insurance liabilities (including investments backing the market strategies of our multibucket annuity products); and (iii) certain fixed maturity securities containing embedded derivatives for which we have elected the fair value option.  The change in fair value of the income generating investments and investments supporting insurance liabilities is recognized in income from policyholder and other special-purpose portfolios (a component of net investment income). The change in fair value of securities with embedded derivatives is recognized in realized investment gains (losses). Investment income related to investments supporting certain insurance liabilities is substantially offset by the change in insurance policy benefits related to certain products.

Earnings Per Share

Basic earnings per common share is computed by dividing net income by the weighted average number of common shares outstanding for the period.  Restricted shares (including our performance units) are not included in basic earnings per share until vested.  Diluted earnings per share reflect the potential dilution that could occur if outstanding stock options were exercised and restricted stock was vested.  The dilution from options and restricted shares is calculated using the treasury stock method.  Under this method, we assume the proceeds from the exercise of the options (or the unrecognized compensation expense with respect to restricted stock and performance units) will be used to purchase shares of our common stock at the average market price during the period, reducing the dilutive effect of the exercise of the options (or the vesting of the restricted stock and performance units).

Segment Reporting

The Company manages its business through the following operating segments: Bankers Life, Washington National and Colonial Penn, which are defined on the basis of product distribution; and corporate operations, comprised of holding company activities and certain noninsurance company businesses. In the fourth quarter of 2016, we began reporting the long-term care block recaptured from Beechwood Re Ltd ("BRe") effective September 30, 2016, as an additional business segment.

We measure segment performance by excluding net realized investment gains (losses), fair value changes in embedded derivative liabilities (net of related amortization), fair value changes and an amendment to the agent deferred compensation plan, loss on reinsurance transaction, income taxes and other non-operating items consisting primarily of earnings attributable to VIEs ("pre-tax operating earnings") because we believe that this performance measure is a better indicator of the ongoing business and trends in our business.  Our primary investment focus is on investment income to support our liabilities for insurance products as opposed to the generation of net realized investment gains (losses), and a long-term focus is necessary to maintain profitability over the life of the business.

The net realized investment gains (losses), fair value changes in embedded derivative liabilities (net of related amortization), fair value changes and an amendment to the agent deferred compensation plan, loss on reinsurance transaction and other non-operating items consisting primarily of earnings attributable to VIEs depend on market conditions or represent unusual items that do not necessarily relate to the underlying business of our segments.  Net realized investment gains (losses) and fair value changes in embedded derivative liabilities (net of related amortization) may affect future earnings levels since our underlying business is long-term in nature and changes in our investment portfolio may impact our ability to earn the assumed interest rates needed to maintain the profitability of our business.

Recently Issued Accounting Standards

RECENTLY ISSUED ACCOUNTING STANDARDS

Pending Accounting Standards

In May 2014, the Financial Accounting Standards Board (the "FASB") issued authoritative guidance for recognizing revenue from contracts with customers. Certain contracts with customers are specifically excluded from this guidance, including insurance contracts. The core principle of the new guidance is that an entity should recognize revenue when it transfers promised goods or services in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The guidance also requires additional disclosures about the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. The guidance will be effective for the Company on January 1, 2018 and permits two methods of transition upon adoption; full retrospective and modified retrospective. Under the full retrospective method, prior periods would be restated under the new revenue standard, providing for comparability in all periods presented. Under the modified retrospective method, prior periods would not be restated. Instead, revenues and other disclosures for pre-2018 periods would be provided in the notes to the financial statements as previously reported under the current revenue standard. The new guidance will impact our accounting for various distribution and marketing agreements with other insurance companies pursuant to which Bankers Life's career agents distribute third party products including prescription drug and Medicare Advantage plans. The revenue associated with these distribution agreements has been less than 1 percent of our total revenue. Our annual fee income earned during a calendar year will not change, but the amount recognized during each quarterly period will vary based on the sales of such products in each period. Accordingly, the adoption of this guidance is not expected to have a material impact on our consolidated financial statements. The Company expects to adopt the new guidance using the modified retrospective method.

In January 2016, the FASB issued authoritative guidance related to the recognition and measurement of financial assets and financial liabilities which made targeted improvements to GAAP as follows:

(i) Require equity investments (except those accounted for under the equity method of accounting or those that result in consolidation of the investee) to be measured at fair value with changes in fair value recognized in net income. However, an entity may choose to measure equity investments that do not have readily determinable fair values at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer.

(ii) Simplify the impairment assessment of equity investments without readily determinable fair values by requiring a qualitative assessment to identify impairment. When a qualitative assessment indicates that impairment exists, an entity is required to measure the investment at fair value.

(iii) Eliminate the requirement for public business entities to disclose the method(s) and significant assumptions used to estimate the fair value that is required to be disclosed for financial instruments measured at amortized cost on the balance sheet.

(iv) Require public business entities to use the exit price notion when measuring the fair value of financial instruments for disclosure purposes.

(v) Require an entity to present separately in other comprehensive income the portion of the total change in the fair value of a liability resulting from a change in the instrument-specific credit risk when the entity has elected to measure the liability at fair value in accordance with the fair value option for financial instruments.

(vi) Require separate presentation of financial assets and financial liabilities by measurement category and form of financial asset (that is, securities or loans and receivables) on the balance sheet or the accompanying notes to the financial statements.

(vii) Clarify that an entity should evaluate the need for a valuation allowance on a deferred tax asset related to available-for-sale securities in combination with the entity's other deferred tax assets.

An entity should apply this guidance by means of a cumulative-effect adjustment to the balance sheet as of the beginning of the fiscal year of adoption. The amendments related to equity securities without readily determinable fair values (including disclosure requirements) should be applied prospectively to equity investments that exist as of the date of adoption of the guidance. The guidance will be effective for the Company for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. Early adoption of the guidance is not permitted; except that item (v) above is permitted to be adopted early as of the beginning of the fiscal year of adoption. The Company currently holds equity securities classified as available for sale securities that are measured at fair value with changes in fair value recognized through accumulated other comprehensive income. Upon adoption of this guidance, changes in fair value of such equity securities will be recognized through net income. Based upon the equity securities held at September 30, 2017, the estimated impact of the new guidance, assuming it was adopted on October 1, 2017, would be a cumulative effect adjustment that would increase retained earnings by approximately $15 million with a corresponding decrease to accumulated other comprehensive income of approximately $15 million. The Company may experience an increase in volatility in the income statement due to the requirement to measure equity investments at fair value with changes in fair value recognized in income. In addition, the Company will be required to modify certain disclosures upon adoption.

In February 2016, the FASB issued authoritative guidance related to accounting for leases, requiring lessees to report most leases on their balance sheets, regardless of whether the lease is classified as a finance lease or an operating lease. For lessees, the initial lease liability is equal to the present value of future lease payments, and a corresponding asset, adjusted for certain items, is also recorded. Expense recognition for lessees will remain similar to current accounting requirements for capital and operating leases. The accounting applied by a lessor is largely unchanged from that applied under previous GAAP. In transition, lessees and lessors are required to recognize and measure leases at the beginning of the earliest period presented using a modified retrospective approach. The guidance will be effective for the Company for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Early adoption is permitted. The Company has not yet determined the expected impact of adoption of this guidance on its consolidated financial position, results of operations or cash flows.

In June 2016, the FASB issued authoritative guidance related to the measurement of credit losses on financial instruments. The new guidance replaces the incurred loss impairment methodology with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to form credit loss estimates. The guidance will be effective for the Company for fiscal years beginning in 2020, including interim periods within the fiscal year. Early adoption is permitted as of the fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. The Company has not yet determined the expected impact of adoption of this guidance on its consolidated financial position, results of operations or cash flows.

In August 2016, the FASB issued authoritative guidance related to how certain cash receipts and cash payments are presented and classified in the statement of cash flows. The guidance addresses eight specific cash flow issues including debt prepayment or debt extinguishment costs, proceeds from the settlement of corporate-owned life insurance policies, distributions received from equity method investees, and others. The guidance will be effective for the Company for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years. Early adoption is permitted. The adoption of this guidance will result in reclassifications to certain cash receipts and payments within our consolidated statement of cash flows, but will have no impact on our consolidated financial position, results of operations or cash flows.

In November 2016, the FASB issued authoritative guidance to address the diversity in practice that currently exists regarding the classification and presentation of changes in restricted cash on the statement of cash flows. The new guidance requires that a statement of cash flows explain the change during the period in the total of cash, cash equivalents and amounts generally described as restricted cash or restricted cash equivalents. Therefore, amounts generally described as restricted cash and restricted cash equivalents should be included with cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown on the statement of cash flows. Entities will also be required to disclose information about the nature of their restricted cash and restricted cash equivalents. Additionally, if cash, cash equivalents, restricted cash and restricted cash equivalents are presented in more than one line item in the statement of financial position, entities will be required to present a reconciliation, either on the face of the statement of cash flows or disclosed in the notes, of the totals in the statement of cash flows to the related line item captions in the statement of financial position. The guidance will be effective for the Company for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years. Early adoption is permitted, including adoption in an interim period. The adoption of this guidance will impact the presentation of our consolidated statement of cash flows and related cash flow disclosures, but will have no impact on our consolidated financial position, results of operations or cash flows.

In January 2017, the FASB issued authoritative guidance that removes Step 2 of the goodwill impairment test under current guidance, which requires a hypothetical purchase price allocation. The new guidance requires an impairment charge to be recognized for the amount by which the carrying amount exceeds the reported unit's fair value. Upon adoption, the guidance is to be applied prospectively. The guidance will be effective for the Company on January 1, 2020, with early adoption permitted. The adoption of this guidance is not expected to have a material impact on the Company's consolidated financial position, results of operations or cash flows.

In March 2017, the FASB issued authoritative guidance related to the premium amortization on purchased callable debt securities. The guidance shortens the amortization period for certain callable debt securities held at a premium. Specifically, the new guidance requires the premium to be amortized to the earliest call date. The guidance does not require an accounting change for securities held at a discount; the discount continues to be amortized to maturity. The guidance will be effective for the Company for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. Early adoption is permitted, including adoption in an interim period. If an entity early adopts the guidance in an interim period, any adjustments should be reflected as of the beginning of the fiscal year that includes that interim period. The guidance should be applied on a modified retrospective basis through a cumulative-effect adjustment directly to retained earnings as of the beginning of the period of adoption. The Company has not yet determined the expected impact of adoption of this guidance on our consolidated financial position, results of operations or cash flows.

In May 2017, the FASB issued authoritative guidance related to which changes to the terms or conditions of a share-based award require an entity to apply modification accounting. The guidance will be effective for the Company in 2018. The guidance is to be applied prospectively to an award modified on or after the adoption date. The adoption of this guidance is not expected to have a material impact to the Company's consolidated financial position, results of operations or cash flows.

In August 2017, the FASB issued authoritative guidance related to derivatives and hedging. The new guidance expands and refines hedge accounting for both nonfinancial and financial risk components and aligns the recognition and presentation of the effects of the hedging instruments and the hedged item in the financial statements. The new guidance also includes certain targeted improvements to ease the application of current guidance related to the assessment of hedge effectiveness. The guidance will be effective for the Company for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. Early adoption is permitted, including adoption in an interim period. The Company has not yet determined the expected impact of adoption of this guidance on its consolidated financial position, results of operations or cash flows.

Adopted Accounting Standards

In March 2016, the FASB issued authoritative guidance that clarifies the requirements for assessing whether contingent call (put) options that can accelerate the payment of principal on debt instruments are clearly and closely related to their debt hosts. An entity performing the assessment under this guidance is required to assess the embedded call (put) options solely in accordance with a four-step decision sequence. The guidance is effective for the Company on January 1, 2017. The adoption of this guidance had no effect on our consolidated financial statements.

In March 2016, the FASB issued authoritative guidance related to several aspects of the accounting for share-based payment transactions, including the income tax consequences, accounting policy for forfeiture rate assumptions, classification of awards as either equity or liabilities and classification on the statement of cash flows. The new guidance requires all income tax effects of stock-based compensation awards to be recognized in the income statement when the awards vest or are settled. The new guidance also allows an employer to withhold shares upon settlement of an award to satisfy the employer's tax withholding requirements up to the highest marginal tax rate applicable to employees, without resulting in liability classification of the award. Current guidance strictly limits the withholding to the employer's minimum statutory tax withholding requirement. The guidance was effective for the Company on January 1, 2017. The impact of adoption was as follows (dollars in millions):

	January 1, 2017
				Effect of Adoption of Authoritative Guidance
	Amounts prior to effect of adoption of authoritative guidance			Election to account for forfeitures as they occur			Recognition of excess tax benefits			As adjusted
Income tax assets	$	1,029.9		$	.3		$	15.7		$	1,045.9
Valuation allowance for deferred income tax assets	(240.2		)	—			(15.7		)	(255.9		)
Income tax assets, net	789.7			.3			—			790.0
Total assets	31,975.2			.3			—			31,975.5
Additional paid-in capital	3,212.1			.9			—			3,213.0
Retained earnings	650.7			(.6		)	—			650.1
Total shareholders' equity	4,486.9			.3			—			4,487.2
Total liabilities and shareholders' equity	31,975.2			.3			—			31,975.5

	Nine months ended
	September 30, 2016
	Amounts prior to effect of adoption of authoritative guidance			Effect of adoption of authoritative guidance			As adjusted
Cash flows from operating activities:
Other operating costs	$	(555.4	)	$	3.3		$	(552.1	)
Net cash flow from operating activities	581.5			3.3			584.8
Cash flows from financing activities:
Payments to repurchase common stock	(206.7		)	(3.3		)	(210.0		)
Net cash used by financing activities	(34.2		)	(3.3		)	(37.5		)
Net increase in cash and cash equivalents	273.7			—			273.7

In October 2016, the FASB issued authoritative guidance to amend the consolidation guidance on how a reporting entity that is the single decision maker of a VIE should treat indirect interests in the entity held through related parties that are under common control with the reporting entity when determining whether it is the primary beneficiary of that VIE. The guidance is effective for the Company on January 1, 2017. The adoption of this guidance had no impact on our consolidated financial statements.

Fair Value Measurements

For those financial instruments disclosed at fair value, we use the following methods and assumptions to determine the estimated fair values:

Mortgage loans and policy loans.  We discount future expected cash flows based on interest rates currently being offered for similar loans with similar risk characteristics.  We aggregate loans with similar characteristics in our calculations.  The fair value of policy loans approximates their carrying value.

Company-owned life insurance is backed by a series of mutual funds and is carried at cash surrender value which approximates estimated fair value.

Cash and cash equivalents include commercial paper, invested cash and other investments purchased with original maturities of less than three months. We carry them at amortized cost, which approximates estimated fair value.

Liabilities for policyholder account balances.  The estimated fair value of insurance liabilities for policyholder account balances was approximately equal to its carrying value as interest rates credited on the vast majority of account balances approximate current rates paid on similar products and because these rates are not generally guaranteed beyond one year.

Investment borrowings, notes payable and borrowings related to variable interest entities.  For publicly traded debt, we use current fair values.  For other notes, we use discounted cash flow analyses based on our current incremental borrowing rates for similar types of borrowing arrangements.

Realized and unrealized investment gains and losses presented in the preceding tables represent gains and losses during the time the applicable financial instruments were classified as Level 3.

Realized and unrealized gains (losses) on Level 3 assets are primarily reported in either net investment income for policyholder and other special-purpose portfolios, net realized investment gains (losses) or insurance policy benefits within the consolidated statement of operations or accumulated other comprehensive income within shareholders' equity based on the appropriate accounting treatment for the instrument.

The amount presented for gains (losses) included in our net loss for assets and liabilities still held as of the reporting date primarily represents impairments for fixed maturities, available for sale, changes in fair value of trading securities and certain derivatives and changes in fair value of embedded derivative instruments included in liabilities for insurance products that exist as of the reporting date.

FAIR VALUE MEASUREMENTS

Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date and, therefore, represents an exit price, not an entry price.  We carry certain assets and liabilities at fair value on a recurring basis, including fixed maturities, equity securities, trading securities, investments held by VIEs, derivatives, separate account assets and embedded derivatives.  We carry our company-owned life insurance policy, which is invested in a series of mutual funds, at its cash surrender value which approximates fair value. In addition, we disclose fair value for certain financial instruments, including mortgage loans, policy loans, cash and cash equivalents, insurance liabilities for interest-sensitive products, investment borrowings, notes payable and borrowings related to VIEs.

The degree of judgment utilized in measuring the fair value of financial instruments is largely dependent on the level to which pricing is based on observable inputs.  Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect our view of market assumptions in the absence of observable market information.  Financial instruments with readily available active quoted prices would be considered to have fair values based on the highest level of observable inputs, and little judgment would be utilized in measuring fair value.  Financial instruments that rarely trade would often have fair value based on a lower level of observable inputs, and more judgment would be utilized in measuring fair value.

Valuation Hierarchy

There is a three-level hierarchy for valuing assets or liabilities at fair value based on whether inputs are observable or unobservable.

• Level 1 – includes assets and liabilities valued using inputs that are unadjusted quoted prices in active markets for identical assets or liabilities.  Our Level 1 assets primarily include cash and cash equivalents and exchange traded securities.

• Level 2 – includes assets and liabilities valued using inputs that are quoted prices for similar assets in an active market, quoted prices for identical or similar assets in a market that is not active, observable inputs, or observable inputs that can be corroborated by market data.  Level 2 assets and liabilities include those financial instruments that are valued by independent pricing services using models or other valuation methodologies.  These models consider various inputs such as credit rating, maturity, corporate credit spreads, reported trades and other inputs that are observable or derived from observable information in the marketplace or are supported by transactions executed in the marketplace. Financial assets in this category primarily include:  certain publicly registered and privately placed corporate fixed maturity securities; certain government or agency securities; certain mortgage and asset-backed securities; certain equity securities; most investments held by our consolidated VIEs; certain mutual fund investments; most short-term investments; and non-exchange-traded derivatives such as call options. Financial liabilities in this category include investment borrowings, notes payable and borrowings related to VIEs.

• Level 3 – includes assets and liabilities valued using unobservable inputs that are used in model-based valuations that contain management assumptions.  Level 3 assets and liabilities include those financial instruments whose fair value is estimated based on broker/dealer quotes, pricing services or internally developed models or methodologies utilizing significant inputs not based on, or corroborated by, readily available market information.  Financial assets in this category include certain corporate securities (primarily certain below-investment grade privately placed securities), certain structured securities, mortgage loans, and other less liquid securities.  Financial liabilities in this category include our insurance liabilities for interest-sensitive products, which includes embedded derivatives (including embedded derivatives related to our fixed index annuity products and to a modified coinsurance arrangement) since their values include significant unobservable inputs including actuarial assumptions.

At each reporting date, we classify assets and liabilities into the three input levels based on the lowest level of input that is significant to the measurement of fair value for each asset and liability reported at fair value.  This classification is impacted by a number of factors, including the type of financial instrument, whether the financial instrument is new to the market and not yet established, the characteristics specific to the transaction and overall market conditions.  Our assessment of the significance of a particular input to the fair value measurement and the ultimate classification of each asset and liability requires judgment and is subject to change from period to period based on the observability of the valuation inputs. Any transfers between levels are reported as having occurred at the beginning of the period. There were no transfers between Level 1 and Level 2 in both the first nine months of 2017 and 2016.

The vast majority of our fixed maturity and equity securities, including those held in trading portfolios and those held by consolidated VIEs, short-term and separate account assets use Level 2 inputs for the determination of fair value.  These fair values are obtained primarily from independent pricing services, which use Level 2 inputs for the determination of fair value.  Our Level 2 assets are valued as follows:

•Fixed maturities available for sale, equity securities and trading securities

Corporate securities are generally priced using market and income approaches. Inputs generally consist of trades of identical or similar securities, quoted prices in inactive markets, issuer rating, benchmark yields, maturity, and credit spreads.

U.S. Treasuries and obligations of U.S. Government corporations and agencies are generally priced using the market approach. Inputs generally consist of trades of identical or similar securities, quoted prices in inactive markets and maturity.

States and political subdivisions are generally priced using the market approach. Inputs generally consist of trades of identical or similar securities, quoted prices in inactive markets, new issuances and credit spreads.

Asset-backed securities, collateralized debt obligations, commercial mortgage-backed securities, mortgage pass-through securities and collateralized mortgage obligations are generally priced using market and income approaches. Inputs generally consist of quoted prices in inactive markets, spreads on actively traded securities, expected prepayments, expected default rates, expected recovery rates, and issue specific information including, but not limited to, collateral type, seniority and vintage.

Equity securities (primarily comprised of non-redeemable preferred stock) are generally priced using the market approach. Inputs generally consist of trades of identical or similar securities, quoted prices in inactive markets, issuer rating, benchmark yields, maturity, and credit spreads.

• Investments held by VIEs

Corporate securities are generally priced using market and income approaches using pricing vendors. Inputs generally consist of issuer rating, benchmark yields, maturity, and credit spreads.

• Other invested assets - derivatives

The fair value measurements for derivative instruments, including embedded derivatives requiring bifurcation, are determined based on the consideration of several inputs including closing exchange or over-the-counter market price quotes; time value and volatility factors underlying options; market interest rates; and non-performance risk.

Third party pricing services normally derive security prices through recently reported trades for identical or similar securities making adjustments through the reporting date based upon available market observable information.  If there are no recently reported trades, the third party pricing services may use matrix or model processes to develop a security price where future cash flow expectations are discounted at an estimated risk-adjusted market rate.  The number of prices obtained for a given security is dependent on the Company's analysis of such prices as further described below.

As the Company is responsible for the determination of fair value, we have control processes designed to ensure that the fair values received from third-party pricing sources are reasonable and the valuation techniques and assumptions used appear reasonable and consistent with prevailing market conditions. Additionally, when inputs are provided by third-party pricing sources, we have controls in place to review those inputs for reasonableness. As part of these controls, we perform monthly quantitative and qualitative analysis on the prices received from third parties to determine whether the prices are reasonable estimates of fair value.  The Company's analysis includes:  (i) a review of the methodology used by third party pricing services; (ii) where available, a comparison of multiple pricing services' valuations for the same security; (iii) a review of month to month price fluctuations; (iv) a review to ensure valuations are not unreasonably dated; and (v) back testing to compare actual purchase and sale transactions with valuations received from third parties.  As a result of such procedures, the Company may conclude the prices received from third parties are not reflective of current market conditions.  In those instances, we may request additional pricing quotes or apply internally developed valuations.  However, the number of such instances is insignificant and the aggregate change in value of such investments is not materially different from the original prices received.

The categorization of the fair value measurements of our investments priced by independent pricing services was based upon the Company's judgment of the inputs or methodologies used by the independent pricing services to value different asset classes.  Such inputs typically include:  benchmark yields, reported trades, broker dealer quotes, issuer spreads, benchmark securities, bids, offers and other relevant data.  The Company categorizes such fair value measurements based upon asset classes and the underlying observable or unobservable inputs used to value such investments.

For securities that are not priced by pricing services and may not be reliably priced using pricing models, we obtain broker quotes.  These broker quotes are non-binding andrepresent an exit price, but assumptions used to establish the fair value may not be observable and therefore represent Level 3 inputs.  Approximately 45 percent of our Level 3 fixed maturity securities were valued using unadjusted broker quotes or broker-provided valuation inputs.  The remaining Level 3 fixed maturity investments do not have readily determinable market prices and/or observable inputs.  For these securities, we use internally developed valuations.  Key assumptions used to determine fair value for these securities may include risk premiums, projected performance of underlying collateral and other factors involving significant assumptions which may not be reflective of an active market.  For certain investments, we use a matrix or model process to develop a security price where future cash flow expectations are discounted at an estimated market rate.  The pricing matrix incorporates term interest rates as well as a spread level based on the issuer's credit rating, other factors relating to the issuer, and the security's maturity.  In some instances issuer-specific spread adjustments, which can be positive or negative, are made based upon internal analysis of security specifics such as liquidity, deal size, and time to maturity.

For certain embedded derivatives, we use actuarial assumptions in the determination of fair value which we consider to be Level 3 inputs.

XML

INVESTMENTS (Tables)

9 Months Ended

Sep. 30, 2017

Investments, Debt and Equity Securities [Abstract]

Schedule of accumulated other comprehensive income (loss)

Accumulated other comprehensive income is primarily comprised of the net effect of unrealized appreciation (depreciation) on our investments.  These amounts, included in shareholders' equity as of September 30, 2017 and December 31, 2016, were as follows (dollars in millions):

	September 30, 2017			December 31, 2016
Net unrealized appreciation (depreciation) on fixed maturity securities, available for sale, on which an other-than-temporary impairment loss has been recognized	$	2.4		$	(1.1	)
Net unrealized gains on all other investments	2,058.9			1,311.9
Adjustment to present value of future profits (a)	(98.1		)	(106.2		)
Adjustment to deferred acquisition costs	(287.9		)	(223.5		)
Adjustment to insurance liabilities	(224.5		)	(13.5		)
Deferred income tax liabilities	(517.2		)	(345.2		)
Accumulated other comprehensive income	$	933.6		$	622.4

________

(a) The present value of future profits is the value assigned to the right to receive future cash flows from contracts existing at September 10, 2003, the date Conseco, Inc., an Indiana corporation, emerged from bankruptcy.

Schedule of fixed maturities for available for sale and equity securities

At September 30, 2017, the amortized cost, gross unrealized gains and losses, estimated fair value, other-than-temporary impairments in accumulated other comprehensive income of fixed maturities, available for sale, and equity securities were as follows (dollars in millions):

	Amortized cost		Gross unrealized gains		Gross unrealized losses			Estimated fair value		Other-than-temporary impairments included in accumulated other comprehensive income
Corporate securities	$	13,145.4	$	1,537.6	$	(33.0	)	$	14,650.0	$	(3.6	)
United States Treasury securities and obligations of United States government corporations and agencies	145.4		26.9		—			172.3		—
States and political subdivisions	1,857.2		220.7		(.9		)	2,077.0		—
Debt securities issued by foreign governments	58.1		3.1		(.1		)	61.1		—
Asset-backed securities	2,608.6		180.6		(3.1		)	2,786.1		—
Collateralized debt obligations	236.5		1.4		—			237.9		—
Commercial mortgage-backed securities	1,311.6		37.4		(10.1		)	1,338.9		—
Mortgage pass-through securities	2.0		.2		—			2.2		—
Collateralized mortgage obligations	727.7		77.3		(.6		)	804.4		(1.1		)
Total fixed maturities, available for sale	$	20,092.5	$	2,085.2	$	(47.8	)	$	22,129.9	$	(4.7	)
Equity securities	$	688.7	$	27.2	$	(2.6	)	$	713.3

At December 31, 2016, the amortized cost, gross unrealized gains and losses, estimated fair value, other-than-temporary impairments in accumulated other comprehensive income of fixed maturities, available for sale, and equity securities were as follows (dollars in millions):

	Amortized cost		Gross unrealized gains		Gross unrealized losses			Estimated fair value		Other-than-temporary impairments included in accumulated other comprehensive income
Corporate securities	$	12,549.9	$	1,100.0	$	(139.0	)	$	13,510.9	$	(3.6	)
United States Treasury securities and obligations of United States government corporations and agencies	143.8		20.5		—			164.3		—
States and political subdivisions	1,811.8		186.7		(9.6		)	1,988.9		(3.0		)
Debt securities issued by foreign governments	37.1		.2		(.4		)	36.9		—
Asset-backed securities	2,641.5		84.3		(15.5		)	2,710.3		—
Collateralized debt obligations	230.0		1.0		(.3		)	230.7		—
Commercial mortgage-backed securities	1,531.0		33.1		(27.9		)	1,536.2		—
Mortgage pass-through securities	2.3		.2		—			2.5		—
Collateralized mortgage obligations	855.7		61.4		(1.6		)	915.5		(1.4		)
Total fixed maturities, available for sale	$	19,803.1	$	1,487.4	$	(194.3	)	$	21,096.2	$	(8.0	)
Equity securities	$	580.7	$	11.5	$	(8.0	)	$	584.2

Schedule of investments classified by contractual maturity date

The following table sets forth the amortized cost and estimated fair value of fixed maturities, available for sale, at September 30, 2017, by contractual maturity.  Actual maturities will differ from contractual maturities because certain borrowers may have the right to call or prepay obligations with or without penalties.  Structured securities (such as asset-backed securities, collateralized debt obligations, commercial mortgage-backed securities, mortgage pass-through securities and collateralized mortgage obligations, collectively referred to as "structured securities") frequently include provisions for periodic principal payments and permit periodic unscheduled payments.

	Amortized cost		Estimated fair value
	(Dollars in millions)
Due in one year or less	$	398.1	$	406.1
Due after one year through five years	2,004.8		2,131.7
Due after five years through ten years	1,562.8		1,671.1
Due after ten years	11,240.4		12,751.5
Subtotal	15,206.1		16,960.4
Structured securities	4,886.4		5,169.5
Total fixed maturities, available for sale	$	20,092.5	$	22,129.9

The following table sets forth the amortized cost and estimated fair value of fixed maturities, available for sale, at December 31, 2016, by contractual maturity.

	Amortized cost		Estimated fair value
	(Dollars in millions)
Due in one year or less	$	354.7	$	359.8
Due after one year through five years	2,243.8		2,399.5
Due after five years through ten years	1,549.1		1,620.8
Due after ten years	10,395.0		11,320.9
Subtotal	14,542.6		15,701.0
Structured securities	5,260.5		5,395.2
Total fixed maturities, available for sale	$	19,803.1	$	21,096.2

Schedule of realized gain (loss) on investments

The following table sets forth the net realized investment gains (losses) for the periods indicated (dollars in millions):

	Three months ended						Nine months ended
	September 30,						September 30,
	2017			2016			2017			2016
Fixed maturity securities, available for sale:
Gross realized gains on sale	$	32.3		$	7.3		$	60.4		$	127.1
Gross realized losses on sale	(8.5		)	(2.8		)	(16.4		)	(84.4		)
Impairments:
Total other-than-temporary impairment losses	(3.2		)	—			(10.0		)	(6.3		)
Other-than-temporary impairment losses recognized in accumulated other comprehensive income	—			—			(.9		)	—
Net impairment losses recognized	(3.2		)	—			(10.9		)	(6.3		)
Net realized investment gains from fixed maturities	20.6			4.5			33.1			36.4
Equity securities	7.7			17.2			9.6			21.3
Commercial mortgage loans	—			—			1.0			—
Impairments of other investments	(1.5		)	(1.2		)	(7.3		)	(18.5		)
Loss on dissolution of variable interest entities	(.6		)	—			(4.3		)	(7.3		)
Other (a)	3.0			(8.9		)	20.2			(8.6		)
Net realized investment gains	$	29.2		$	11.6		$	52.3		$	23.3

_________________

(a) Changes in the estimated fair value of trading securities that we have elected the fair value option (and are still held as of the end of the respective periods) were $13.0 million and $.8 million for the nine months ended September 30, 2017 and 2016, respectively.

Schedule of credit losses recognized in earnings

The following table summarizes the amount of credit losses recognized in earnings on fixed maturity securities, available for sale, held at the beginning of the period, for which a portion of the other-than-temporary impairment was also recognized in accumulated other comprehensive income for the three and nine months ended September 30, 2017 and 2016 (dollars in millions):

	Three months ended						Nine months ended
	September 30,						September 30,
	2017			2016			2017			2016
Credit losses on fixed maturity securities, available for sale, beginning of period	$	(4.9	)	$	(2.6	)	$	(5.5	)	$	(2.6	)
Add: credit losses on other-than-temporary impairments not previously recognized	—			—			—			—
Less: credit losses on securities sold	—			.1			1.6			.1
Less: credit losses on securities impaired due to intent to sell (a)	—			—			—			—
Add: credit losses on previously impaired securities	—			—			(1.0		)	—
Less: increases in cash flows expected on previously impaired securities	—			—			—			—
Credit losses on fixed maturity securities, available for sale, end of period	$	(4.9	)	$	(2.5	)	$	(4.9	)	$	(2.5	)

__________

(a) Represents securities for which the amount previously recognized in accumulated other comprehensive income was recognized in earnings because we intend to sell the security or we more likely than not will be required to sell the security before recovery of its amortized cost basis.

Schedule of unrealized loss on investments

The following table summarizes the gross unrealized losses and fair values of our investments with unrealized losses that are not deemed to be other-than-temporarily impaired, aggregated by investment category and length of time that such securities have been in a continuous unrealized loss position, at September 30, 2017 (dollars in millions):

	Less than 12 months					12 months or greater					Total
Description of securities	Fair value		Unrealized losses			Fair value		Unrealized losses			Fair value		Unrealized losses
United States Treasury securities and obligations of United States government corporations and agencies	$	20.3	$	—		$	.6	$	—		$	20.9	$	—
States and political subdivisions	35.1		(.6		)	19.3		(.3		)	54.4		(.9		)
Debt securities issued by foreign governments	10.5		(.1		)	—		—			10.5		(.1		)
Corporate securities	666.9		(7.8		)	400.4		(25.2		)	1,067.3		(33.0		)
Asset-backed securities	276.7		(1.3		)	79.6		(1.8		)	356.3		(3.1		)
Collateralized debt obligations	24.0		—			—		—			24.0		—
Commercial mortgage-backed securities	226.2		(1.3		)	221.9		(8.8		)	448.1		(10.1		)
Collateralized mortgage obligations	72.8		(.5		)	11.6		(.1		)	84.4		(.6		)
Total fixed maturities, available for sale	$	1,332.5	$	(11.6	)	$	733.4	$	(36.2	)	$	2,065.9	$	(47.8	)
Equity securities	$	37.4	$	(.8	)	$	89.7	$	(1.8	)	$	127.1	$	(2.6	)

The following table summarizes the gross unrealized losses and fair values of our investments with unrealized losses that are not deemed to be other-than-temporarily impaired, aggregated by investment category and length of time that such securities have been in a continuous unrealized loss position, at December 31, 2016 (dollars in millions):

	Less than 12 months					12 months or greater					Total
Description of securities	Fair value		Unrealized losses			Fair value		Unrealized losses			Fair value		Unrealized losses
United States Treasury securities and obligations of United States government corporations and agencies	$	8.0	$	—		$	—	$	—		$	8.0	$	—
States and political subdivisions	176.3		(7.8		)	18.3		(1.8		)	194.6		(9.6		)
Debt securities issued by foreign governments	18.9		(.4		)	—		—			18.9		(.4		)
Corporate securities	1,907.6		(75.5		)	559.6		(63.5		)	2,467.2		(139.0		)
Asset-backed securities	692.9		(8.5		)	262.5		(7.0		)	955.4		(15.5		)
Collateralized debt obligations	38.3		(.1		)	30.8		(.2		)	69.1		(.3		)
Commercial mortgage-backed securities	525.2		(16.6		)	154.0		(11.3		)	679.2		(27.9		)
Collateralized mortgage obligations	73.6		(.6		)	34.6		(1.0		)	108.2		(1.6		)
Total fixed maturities, available for sale	$	3,440.8	$	(109.5	)	$	1,059.8	$	(84.8	)	$	4,500.6	$	(194.3	)
Equity securities	$	239.4	$	(8.0	)	$	—	$	—		$	239.4	$	(8.0	)

XML

EARNINGS PER SHARE (Tables)

9 Months Ended

Sep. 30, 2017

Earnings Per Share [Abstract]

Schedule of earnings per share reconciliation

A reconciliation of net income and shares used to calculate basic and diluted earnings per share is as follows (dollars in millions and shares in thousands):

	Three months ended				Nine months ended
	September 30,				September 30,
	2017		2016		2017		2016
Net income for basic and diluted earnings per share	$	100.8	$	18.6	$	246.5	$	124.0
Shares:
Weighted average shares outstanding for basic earnings per share	168,684		174,247		170,890		177,640
Effect of dilutive securities on weighted average shares:
Stock options, restricted stock and performance units	2,298		1,476		1,910		1,733
Weighted average shares outstanding for diluted earnings per share	170,982		175,723		172,800		179,373

XML

BUSINESS SEGMENTS (Tables)

9 Months Ended

Sep. 30, 2017

Segment Reporting [Abstract]

Schedule of segment reporting information by segment

Operating information by segment was as follows (dollars in millions):

	Three months ended				Nine months ended
	September 30,				September 30,
	2017		2016		2017		2016
Revenues:
Bankers Life:
Insurance policy income:
Annuities	$	3.7	$	6.8	$	15.5	$	17.4
Health	307.2		310.3		926.9		933.3
Life	103.7		96.6		310.4		295.8
Net investment income (a)	270.6		244.7		800.4		686.8
Fee revenue and other income (a)	11.3		9.6		32.5		23.5
Total Bankers Life revenues	696.5		668.0		2,085.7		1,956.8
Washington National:
Insurance policy income:
Annuities	.5		1.2		1.6		2.3
Health	160.4		156.9		480.3		469.1
Life	6.5		6.3		20.1		18.6
Net investment income (a)	68.0		67.1		201.9		191.3
Fee revenue and other income (a)	.3		.4		.8		1.0
Total Washington National revenues	235.7		231.9		704.7		682.3
Colonial Penn:
Insurance policy income:
Health	.5		.6		1.6		2.0
Life	72.6		70.3		217.5		208.5
Net investment income (a)	11.0		11.1		33.1		33.0
Fee revenue and other income (a)	.3		.2		.9		.8
Total Colonial Penn revenues	84.4		82.2		253.1		244.3
Long-term care in run-off:
Insurance policy income - health	4.2		—		13.3		—
Net investment income (a)	6.8		—		26.5		—
Total Long-term care in run-off revenues	11.0		—		39.8		—
Corporate operations:
Net investment income	7.0		6.7		24.8		16.6
Fee and other income	1.8		2.5		6.5		7.6
Total corporate revenues	8.8		9.2		31.3		24.2
Total revenues	$	1,036.4	$	991.3	$	3,114.6	$	2,907.6

(continued on next page)

(continued from previous page)

	Three months ended						Nine months ended
	September 30,						September 30,
	2017			2016			2017			2016
Expenses:
Bankers Life:
Insurance policy benefits	$	437.2		$	427.1		$	1,307.7		$	1,240.9
Amortization	38.7			43.8			126.3			135.3
Interest expense on investment borrowings	5.3			3.5			14.3			9.4
Other operating costs and expenses	108.4			105.5			328.2			312.2
Total Bankers Life expenses	589.6			579.9			1,776.5			1,697.8
Washington National:
Insurance policy benefits	144.7			144.5			436.7			422.0
Amortization	14.3			14.3			43.9			44.5
Interest expense on investment borrowings	1.7			.9			4.5			2.5
Other operating costs and expenses	47.5			47.0			145.0			140.3
Total Washington National expenses	208.2			206.7			630.1			609.3
Colonial Penn:
Insurance policy benefits	47.7			50.3			150.8			151.3
Amortization	3.9			3.7			11.9			11.3
Interest expense on investment borrowings	.3			.1			.7			.4
Other operating costs and expenses	23.5			27.2			73.0			84.2
Total Colonial Penn expenses	75.4			81.3			236.4			247.2
Long-term care in run-off:
Insurance policy benefits	11.4			—			36.6			—
Other operating costs and expenses	.6			—			2.1			—
Total Long-term care in run-off expenses	12.0			—			38.7			—
Corporate operations:
Interest expense on corporate debt	11.7			11.5			34.8			34.3
Other operating costs and expenses	23.7			13.6			68.3			43.7
Total corporate expenses	35.4			25.1			103.1			78.0
Total expenses	920.6			893.0			2,784.8			2,632.3
Pre-tax operating earnings by segment:
Bankers Life	106.9			88.1			309.2			259.0
Washington National	27.5			25.2			74.6			73.0
Colonial Penn	9.0			.9			16.7			(2.9		)
Long-term care in run-off	(1.0		)	—			1.1			—
Corporate operations	(26.6		)	(15.9		)	(71.8		)	(53.8		)
Pre-tax operating earnings	$	115.8		$	98.3		$	329.8		$	275.3

___________________

(a) It is not practicable to provide additional components of revenue by product or services.

Reconciliation of operating profit (loss) from segments to consolidated

A reconciliation of segment revenues and expenses to consolidated revenues and expenses and net income (loss) is as follows (dollars in millions):

	Three months ended						Nine months ended
	September 30,						September 30,
	2017			2016			2017			2016
Total segment revenues	$	1,036.4		$	991.3		$	3,114.6		$	2,907.6
Net realized investment gains	29.2			11.6			52.3			23.3
Revenues related to VIEs	13.7			13.0			40.2			39.3
Fee revenue related to transition and support services agreements	—			—			—			10.0
Consolidated revenues	1,079.3			1,015.9			3,207.1			2,980.2
Total segment expenses	920.6			893.0			2,784.8			2,632.3
Insurance policy benefits - fair value changes in embedded derivative liabilities	(2.9		)	(12.1		)	9.8			47.0
Amortization related to fair value changes in embedded derivative liabilities	.6			2.7			(1.8		)	(10.4		)
Amortization related to net realized investment gains	.7			.2			1.0			.9
Expenses related to VIEs	17.0			13.7			44.8			40.5
Fair value changes and amendment related to agent deferred compensation plan	13.4			(6.3		)	13.4			12.0
Loss on reinsurance transaction	—			75.4			—			75.4
Expenses related to transition and support services agreements	—			—			—			10.0
Consolidated expenses	949.4			966.6			2,852.0			2,807.7
Income before tax	129.9			49.3			355.1			172.5
Income tax expense (benefit):
Tax expense on period income	44.1			16.9			123.6			61.7
Valuation allowance for deferred tax assets and other tax items	(15.0		)	13.8			(15.0		)	(13.2		)
Net income	$	100.8		$	18.6		$	246.5		$	124.0

XML

ACCOUNTING FOR DERIVATIVES (Tables)

9 Months Ended

Sep. 30, 2017

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Fair value by balance sheet location

Our freestanding and embedded derivatives, which are not designated as hedging instruments, are held at fair value and are summarized as follows (dollars in millions):

	Fair value
	September 30, 2017			December 31, 2016
Assets:
Other invested assets:
Fixed index call options	$	142.2		$	111.9
Reinsurance receivables	(1.8		)	(4.2		)
Total assets	$	140.4		$	107.7
Liabilities:
Future policy benefits:
Fixed index products	$	1,249.3		$	1,092.3
Total liabilities	$	1,249.3		$	1,092.3

Schedule pre-tax gains (losses) recognized in net income for derivative instruments

The following table provides the pre-tax gains (losses) recognized in net income for derivative instruments, which are not designated as hedges for the periods indicated (dollars in millions):

	Three months ended				Nine months ended
	September 30,				September 30,
	2017		2016		2017		2016
Net investment income from policyholder and other special-purpose portfolios:
Fixed index call options	$	30.6	$	17.0	$	95.4	$	10.9
Net realized gains (losses):
Interest rate futures	—		—		—		(1.1		)
Embedded derivative related to modified coinsurance agreement	.3		.1		2.4		6.7
Total	.3		.1		2.4		5.6
Insurance policy benefits:
Embedded derivative related to fixed index annuities	—		18.3		—		(33.3		)
Total	$	30.9	$	35.4	$	97.8	$	(16.8	)

Derivatives with master netting arrangements

The following table summarizes information related to derivatives with master netting arrangements or collateral as of September 30, 2017 and December 31, 2016 (dollars in millions):

								Gross amounts not offset in the balance sheet
		Gross amounts recognized		Gross amounts offset in the balance sheet		Net amounts of assets presented in the balance sheet		Financial instruments		Cash collateral received		Net amount
September 30, 2017:
	Fixed index call options	$	142.2	$	—	$	142.2	$	—	$	—	$	142.2
December 31, 2016:
	Fixed index call options	111.9		—		111.9		—		—		111.9

XML

INCOME TAXES (Tables)

9 Months Ended

Sep. 30, 2017

Income Tax Disclosure [Abstract]

Schedule of components of income tax expense

The components of income tax expense are as follows (dollars in millions):

	Three months ended						Nine months ended
	September 30,						September 30,
	2017			2016			2017			2016
Current tax expense	$	25.9		$	46.8		$	68.5		$	51.6
Deferred tax expense (benefit)	18.2			(29.9		)	55.1			10.1
Valuation allowance applicable to current year income	(2.2		)	(10.5		)	(2.2		)	(10.5		)
Income tax expense calculated based on estimated annual effective tax rate	41.9			6.4			121.4			51.2
Income tax expense on discrete items:
Change in valuation allowance	(12.8		)	16.0			(12.8		)	(11.0		)
Other items	—			8.3			—			8.3
Total income tax expense	$	29.1		$	30.7		$	108.6		$	48.5

Schedule of effective income tax rate reconciliation

A reconciliation of the U.S. statutory corporate tax rate to the estimated annual effective rate, before discrete items, reflected in the consolidated statement of operations is as follows:

	Nine months ended
	September 30,
	2017		2016
U.S. statutory corporate rate	35.0	%	35.0	%
Valuation allowance	(.6	)	(6.1	)
Non-taxable income and nondeductible benefits, net	(1.5	)	(1.0	)
State taxes	1.3		1.8
Estimated annual effective tax rate	34.2	%	29.7	%

Schedule of deferred tax assets and liabilities

The components of the Company's income tax assets and liabilities are summarized below (dollars in millions):

	September 30, 2017			December 31, 2016
Deferred tax assets:
Net federal operating loss carryforwards	$	841.8		$	882.9
Net state operating loss carryforwards	12.2			12.3
Investments	13.7			17.8
Insurance liabilities	678.9			668.4
Other	60.1			66.3
Gross deferred tax assets	1,606.7			1,647.7
Deferred tax liabilities:
Present value of future profits and deferred acquisition costs	(275.0		)	(277.8		)
Accumulated other comprehensive income	(516.9		)	(344.1		)
Gross deferred tax liabilities	(791.9		)	(621.9		)
Net deferred tax assets before valuation allowance	814.8			1,025.8
Valuation allowance	(240.9		)	(240.2		)
Net deferred tax assets	573.9			785.6
Current income taxes prepaid (accrued)	(6.5		)	4.1
Income tax assets, net	$	567.4		$	789.7

Summary of operating loss carryforwards

The following table summarizes the expiration dates of our loss carryforwards (dollars in millions):

	Net operating loss
Year of expiration	carryforwards
2023	$	1,818.5
2025	85.2
2026	149.9
2027	10.8
2028	80.3
2029	213.2
2030	.3
2031	.2
2032	44.4
2033	.6
2034	.9
2035	.8
Total federal NOLs	$	2,405.1

XML

NOTES PAYABLE - DIRECT CORPORATE OBLIGATIONS (Tables)

9 Months Ended

Sep. 30, 2017

Debt Disclosure [Abstract]

Schedule of long-term debt instruments

The following notes payable were direct corporate obligations of the Company as of September 30, 2017 and December 31, 2016 (dollars in millions):

	September 30, 2017			December 31, 2016
4.500% Senior Notes due May 2020	$	325.0		$	325.0
5.250% Senior Notes due May 2025	500.0			500.0
Revolving Credit Agreement (as defined below)	100.0			100.0
Unamortized debt issue costs	(10.6		)	(12.1		)
Direct corporate obligations	$	914.4		$	912.9

Schedule of maturities of long-term debt

The scheduled repayment of our direct corporate obligations was as follows at September 30, 2017 (dollars in millions):

Year ending September 30,
2018	$	—
2019	100.0
2020	325.0
2021	—
2022	—
Thereafter	500.0
	$	925.0

XML

INVESTMENT BORROWINGS (Tables)

9 Months Ended

Sep. 30, 2017

Investment Borrowings [Abstract]

Schedule of terms of federal home loan bank borrowing

The following summarizes the terms of the borrowings from the FHLB by our insurance subsidiaries (dollars in millions):

Amount		Maturity	Interest rate at
borrowed		date	September 30, 2017
$	50.0	February 2018	Variable rate – 1.404%
50.0		August 2018	Variable rate – 1.435%
50.0		January 2019	Variable rate – 1.724%
50.0		February 2019	Variable rate – 1.404%
100.0		March 2019	Variable rate – 1.714%
21.8		July 2019	Variable rate – 1.727%
15.0		October 2019	Variable rate – 1.830%
50.0		May 2020	Variable rate – 1.754%
21.8		June 2020	Fixed rate – 1.960%
25.0		September 2020	Variable rate – 1.953%
100.0		September 2020	Variable rate – 1.897%
50.0		September 2020	Variable rate – 1.894%
75.0		September 2020	Variable rate – 1.453%
100.0		October 2020	Variable rate – 1.409%
50.0		December 2020	Variable rate – 1.932%
100.0		July 2021	Variable rate – 1.854%
100.0		July 2021	Variable rate – 1.824%
28.2		August 2021	Fixed rate – 2.550%
57.7		August 2021	Variable rate - 1.842%
125.0		August 2021	Variable rate – 1.717%
50.0		September 2021	Variable rate – 1.857%
22.0		May 2022	Variable rate – 1.668%
100.0		May 2022	Variable rate – 1.666%
10.0		June 2022	Variable rate – 1.931%
50.0		July 2022	Variable rate – 1.675%
50.0		July 2022	Variable rate – 1.693%
50.0		July 2022	Variable rate – 1.694%
50.0		August 2022	Variable rate – 1.702%
24.9		March 2023	Fixed rate – 2.160%
20.5		June 2025	Fixed rate – 2.940%
$	1,646.9

XML

CHANGES IN COMMON STOCK (Tables)

9 Months Ended

Sep. 30, 2017

Stockholders' Equity Note [Abstract]

Schedule of options activity

Changes in the number of shares of common stock outstanding were as follows (shares in thousands):

Balance, December 31, 2016	173,754
Treasury stock purchased and retired	(6,701	)
Stock options exercised	524
Restricted and performance stock vested	185		(a)
Balance, September 30, 2017	167,762

____________________

(a) Such amount was reduced by 103 thousand shares which were tendered to the Company for the payment of required federal and state tax withholdings owed on the vesting of restricted and performance stock.

XML

RECENTLY ISSUED ACCOUNTING STANDARDS (Tables)

9 Months Ended

Sep. 30, 2017

New Accounting Pronouncements and Changes in Accounting Principles [Abstract]

Schedule of New Accounting Pronouncements and Changes in Accounting Principles

The impact of adoption was as follows (dollars in millions):

	January 1, 2017
				Effect of Adoption of Authoritative Guidance
	Amounts prior to effect of adoption of authoritative guidance			Election to account for forfeitures as they occur			Recognition of excess tax benefits			As adjusted
Income tax assets	$	1,029.9		$	.3		$	15.7		$	1,045.9
Valuation allowance for deferred income tax assets	(240.2		)	—			(15.7		)	(255.9		)
Income tax assets, net	789.7			.3			—			790.0
Total assets	31,975.2			.3			—			31,975.5
Additional paid-in capital	3,212.1			.9			—			3,213.0
Retained earnings	650.7			(.6		)	—			650.1
Total shareholders' equity	4,486.9			.3			—			4,487.2
Total liabilities and shareholders' equity	31,975.2			.3			—			31,975.5

	Nine months ended
	September 30, 2016
	Amounts prior to effect of adoption of authoritative guidance			Effect of adoption of authoritative guidance			As adjusted
Cash flows from operating activities:
Other operating costs	$	(555.4	)	$	3.3		$	(552.1	)
Net cash flow from operating activities	581.5			3.3			584.8
Cash flows from financing activities:
Payments to repurchase common stock	(206.7		)	(3.3		)	(210.0		)
Net cash used by financing activities	(34.2		)	(3.3		)	(37.5		)
Net increase in cash and cash equivalents	273.7			—			273.7

XML

CONSOLIDATED STATEMENT OF CASH FLOWS (Tables)

9 Months Ended

Sep. 30, 2017

Supplemental Cash Flow Elements [Abstract]

Schedule of the reconciliation for net income provided by operating activities

The following reconciles net income to net cash from operating activities (dollars in millions):

	Nine months ended
	September 30,
	2017			2016
Cash flows from operating activities:
Net income	$	246.5		$	124.0
Adjustments to reconcile net income to net cash from operating activities:
Amortization and depreciation	200.8			199.1
Income taxes	50.6			43.0
Insurance liabilities	321.5			310.2
Accrual and amortization of investment income	(233.2		)	(93.4		)
Deferral of policy acquisition costs	(183.4		)	(179.4		)
Net realized investment gains	(52.3		)	(23.3		)
Loss on reinsurance transaction	—			75.4
Cash and cash equivalents received upon recapture of reinsurance	—			73.6
Loss on extinguishment of borrowings related to a variable interest entity	5.5			—
Other	77.7			55.6
Net cash from operating activities	$	433.7		$	584.8

Schedule of other significant noncash transactions

Other non-cash items not reflected in the investing and financing activities sections of the consolidated statement of cash flows (dollars in millions):

	Nine months ended
	September 30,
	2017		2016
Stock options, restricted stock and performance units	$	17.8	$	18.9
Market value of investments recaptured in connection with the termination of reinsurance agreements with BRe	—		431.1

XML

INVESTMENTS IN VARIABLE INTEREST ENTITIES (Tables)

9 Months Ended

Sep. 30, 2017

Investments in Variable Interest Entities [Abstract]

Schedule of impact on balance sheet of consolidating variable interest entities

The following tables provide supplemental information about the assets and liabilities of the VIEs which have been consolidated in accordance with authoritative guidance (dollars in millions):

	September 30, 2017
	VIEs			Eliminations			Net effect on consolidated balance sheet
Assets:
Investments held by variable interest entities	$	1,382.5		$	—		$	1,382.5
Notes receivable of VIEs held by insurance subsidiaries	—			(159.9		)	(159.9		)
Cash and cash equivalents held by variable interest entities	105.9			—			105.9
Accrued investment income	2.0			(.1		)	1.9
Income tax assets, net	(.6		)	—			(.6		)
Other assets	13.3			(1.4		)	11.9
Total assets	$	1,503.1		$	(161.4	)	$	1,341.7
Liabilities:
Other liabilities	$	145.9		$	(3.5	)	$	142.4
Borrowings related to variable interest entities	1,198.2			—			1,198.2
Notes payable of VIEs held by insurance subsidiaries	172.9			(172.9		)	—
Total liabilities	$	1,517.0		$	(176.4	)	$	1,340.6

	December 31, 2016
	VIEs		Eliminations			Net effect on consolidated balance sheet
Assets:
Investments held by variable interest entities	$	1,724.3	$	—		$	1,724.3
Notes receivable of VIEs held by insurance subsidiaries	—		(204.2		)	(204.2		)
Cash and cash equivalents held by variable interest entities	189.3		—			189.3
Accrued investment income	3.0		(.1		)	2.9
Income tax assets, net	6.4		(1.3		)	5.1
Other assets	13.1		(1.8		)	11.3
Total assets	$	1,936.1	$	(207.4	)	$	1,728.7
Liabilities:
Other liabilities	$	81.8	$	(6.4	)	$	75.4
Borrowings related to variable interest entities	1,662.8		—			1,662.8
Notes payable of VIEs held by insurance subsidiaries	203.3		(203.3		)	—
Total liabilities	$	1,947.9	$	(209.7	)	$	1,738.2

Summary of variable interest entities by contractual maturity

The following table sets forth the amortized cost and estimated fair value of the investments held by the VIEs at September 30, 2017, by contractual maturity.  Actual maturities will differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without penalties.

	Amortized cost		Estimated fair value
	(Dollars in millions)
Due in one year or less	$	5.9	$	5.9
Due after one year through five years	499.4		500.1
Due after five years through ten years	876.4		876.5
Total	$	1,381.7	$	1,382.5

XML

FAIR VALUE MEASUREMENTS (Tables)

9 Months Ended

Sep. 30, 2017

Fair Value Disclosures [Abstract]

Schedule of financial instruments carried at fair value categorized by input level

The categorization of fair value measurements, by input level, for our financial instruments carried at fair value on a recurring basis at September 30, 2017 is as follows (dollars in millions):

	Quoted prices in active markets for identical assets or liabilities (Level 1)		Significant other observable inputs (Level 2)		Significant unobservable inputs  (Level 3)		Total
Assets:
Fixed maturities, available for sale:
Corporate securities	$	—	$	14,394.3	$	255.7	$	14,650.0
United States Treasury securities and obligations of United States government corporations and agencies	—		172.3		—		172.3
States and political subdivisions	—		2,077.0		—		2,077.0
Debt securities issued by foreign governments	—		57.1		4.0		61.1
Asset-backed securities	—		2,726.2		59.9		2,786.1
Collateralized debt obligations	—		237.9		—		237.9
Commercial mortgage-backed securities	—		1,338.9		—		1,338.9
Mortgage pass-through securities	—		2.2		—		2.2
Collateralized mortgage obligations	—		804.4		—		804.4
Total fixed maturities, available for sale	—		21,810.3		319.6		22,129.9
Equity securities - corporate securities	477.8		213.9		21.6		713.3
Trading securities:
Corporate securities	—		21.1		—		21.1
United States Treasury securities and obligations of United States government corporations and agencies	—		.5		—		.5
Asset-backed securities	—		101.2		—		101.2
Collateralized debt obligations	—		2.7		—		2.7
Commercial mortgage-backed securities	—		93.3		—		93.3
Collateralized mortgage obligations	—		72.5		—		72.5
Equity securities	3.1		—		—		3.1
Total trading securities	3.1		291.3		—		294.4
Investments held by variable interest entities - corporate securities	—		1,377.5		5.0		1,382.5
Other invested assets - derivatives	—		142.2		—		142.2
Assets held in separate accounts	—		4.8		—		4.8
Total assets carried at fair value by category	$	480.9	$	23,840.0	$	346.2	$	24,667.1
Liabilities:
Future policy benefits - embedded derivatives associated with fixed index annuity products	$	—	$	—	$	1,249.3	$	1,249.3

The categorization of fair value measurements, by input level, for our financial instruments carried at fair value on a recurring basis at December 31, 2016 is as follows (dollars in millions):

	Quoted prices in active markets  for identical assets or liabilities (Level 1)		Significant other observable inputs  (Level 2)		Significant unobservable inputs  (Level 3)		Total
Assets:
Fixed maturities, available for sale:
Corporate securities	$	—	$	13,252.4	$	258.5	$	13,510.9
United States Treasury securities and obligations of United States government corporations and agencies	—		164.3		—		164.3
States and political subdivisions	—		1,988.9		—		1,988.9
Debt securities issued by foreign governments	—		33.0		3.9		36.9
Asset-backed securities	—		2,649.9		60.4		2,710.3
Collateralized debt obligations	—		225.3		5.4		230.7
Commercial mortgage-backed securities	—		1,504.2		32.0		1,536.2
Mortgage pass-through securities	—		2.5		—		2.5
Collateralized mortgage obligations	—		915.5		—		915.5
Total fixed maturities, available for sale	—		20,736.0		360.2		21,096.2
Equity securities - corporate securities	359.9		199.1		25.2		584.2
Trading securities:
Corporate securities	—		19.0		—		19.0
United States Treasury securities and obligations of United States government corporations and agencies	—		.5		—		.5
Asset-backed securities	—		94.3		—		94.3
Collateralized debt obligations	—		2.4		—		2.4
Commercial mortgage-backed securities	—		163.9		—		163.9
Collateralized mortgage obligations	—		78.4		—		78.4
Equity securities	4.9		—		—		4.9
Total trading securities	4.9		358.5		—		363.4
Investments held by variable interest entities - corporate securities	—		1,724.3		—		1,724.3
Other invested assets - derivatives	—		111.9		—		111.9
Assets held in separate accounts	—		4.7		—		4.7
Total assets carried at fair value by category	$	364.8	$	23,134.5	$	385.4	$	23,884.7
Liabilities:
Future policy benefits - embedded derivatives associated with fixed index annuity products	$	—	$	—	$	1,092.3	$	1,092.3

Schedule of assets and liabilities measured on a recurring fair value basis

The fair value measurements for our financial instruments disclosed at fair value on a recurring basis are as follows (dollars in millions):

	September 30, 2017
	Quoted prices in active markets for identical assets or liabilities (Level 1)		Significant other observable inputs  (Level 2)		Significant unobservable inputs  (Level 3)		Total estimated fair value		Total carrying amount
Assets:
Mortgage loans	$	—	$	—	$	1,705.8	$	1,705.8	$	1,667.8
Policy loans	—		—		114.6		114.6		114.6
Other invested assets:
Company-owned life insurance	—		178.8		—		178.8		178.8
Cash and cash equivalents:
Unrestricted	765.9		—		—		765.9		765.9
Held by variable interest entities	105.9		—		—		105.9		105.9
Liabilities:
Policyholder account balances	—		—		11,113.5		11,113.5		11,113.5
Investment borrowings	—		1,650.1		—		1,650.1		1,646.9
Borrowings related to variable interest entities	—		1,215.1		—		1,215.1		1,198.2
Notes payable – direct corporate obligations	—		970.5		—		970.5		914.4

	December 31, 2016
	Quoted prices in active markets for identical assets or liabilities (Level 1)		Significant other observable inputs  (Level 2)		Significant unobservable inputs  (Level 3)		Total estimated fair value		Total carrying amount
Assets:
Mortgage loans	$	—	$	—	$	1,800.1	$	1,800.1	$	1,768.0
Policy loans	—		—		112.0		112.0		112.0
Other invested assets:
Company-owned life insurance	—		165.0		—		165.0		165.0
Cash and cash equivalents:
Unrestricted	473.6		5.3		—		478.9		478.9
Held by variable interest entities	189.3		—		—		189.3		189.3
Liabilities:
Policyholder account balances	—		—		10,912.7		10,912.7		10,912.7
Investment borrowings	—		1,650.0		—		1,650.0		1,647.4
Borrowings related to variable interest entities	—		1,675.2		—		1,675.2		1,662.8
Notes payable – direct corporate obligations	—		931.9		—		931.9		912.9

The following table presents additional information about assets and liabilities measured at fair value on a recurring basis and for which we have utilized significant unobservable (Level 3) inputs to determine fair value for the three months ended September 30, 2017 (dollars in millions):

	September 30, 2017
	Beginning balance as of June 30, 2017			Purchases, sales, issuances and settlements, net (b)			Total realized and unrealized gains (losses) included in net income		Total realized and unrealized gains (losses) included in accumulated other comprehensive income (loss)			Transfers into Level 3 (a)		Transfers out of Level 3 (a)			Ending balance as of September 30, 2017			Amount of total gains (losses) for the three months ended September 30, 2017 included in our net income relating to assets and liabilities still held as of the reporting date
Assets:
Fixed maturities, available for sale:
Corporate securities	$	263.3		$	(44.8	)	$	1.7	$	1.3		$	34.2	$	—		$	255.7		$	(3.2	)
Debt securities issued by foreign governments	3.9			—			—		.1			—		—			4.0			—
Asset-backed securities	59.6			(1.3		)	—		.7			7.1		(6.2		)	59.9			—
Collateralized debt obligations	2.5			(2.5		)	—		—			—		—			—			—
Collateralized mortgage obligations	.2			—			—		(.2		)	—		—			—			—
Total fixed maturities, available for sale	329.5			(48.6		)	1.7		1.9			41.3		(6.2		)	319.6			(3.2		)
Equity securities - corporate securities	24.6			(8.3		)	6.4		(1.1		)	—		—			21.6			(.5		)
Investments held by variable interest entities - corporate securities	—			—			—		—			5.0		—			5.0			—
Liabilities:
Future policy benefits - embedded derivatives associated with fixed index annuity products	(1,205.4		)	(56.3		)	12.4		—			—		—			(1,249.3		)	12.4

_________

(a) Transfers into Level 3 are the result of unobservable inputs utilized within valuation methodologies for assets that were previously valued using observable inputs. Transfers out of Level 3 are due to the use of observable inputs in valuation methodologies as well as the utilization of pricing service information for certain assets that the Company is able to validate.

(b) Purchases, sales, issuances and settlements, net, represent the activity that occurred during the period that results in a change of the asset or liability but does not represent changes in fair value for the instruments held at the beginning of the period.  Such activity primarily consists of purchases and sales of fixed maturity and equity securities and changes to embedded derivative instruments related to insurance products resulting from the issuance of new contracts, or changes to existing contracts.  The following summarizes such activity for the three months ended September 30, 2017 (dollars in millions):

	Purchases			Sales			Issuances			Settlements		Purchases, sales, issuances and settlements, net
Assets:
Fixed maturities, available for sale:
Corporate securities	$	15.3		$	(60.1	)	$	—		$	—	$	(44.8	)
Asset-backed securities	9.9			(11.2		)	—			—		(1.3		)
Collateralized debt obligations	—			(2.5		)	—			—		(2.5		)
Total fixed maturities, available for sale	25.2			(73.8		)	—			—		(48.6		)
Equity securities - corporate securities	—			(8.3		)	—			—		(8.3		)
Liabilities:
Future policy benefits - embedded derivatives associated with fixed index annuity products	(41.0		)	1.8			(31.4		)	14.3		(56.3		)

The following table presents additional information about assets and liabilities measured at fair value on a recurring basis and for which we have utilized significant unobservable (Level 3) inputs to determine fair value for the nine months ended September 30, 2017 (dollars in millions):

	September 30, 2017
	Beginning balance as of December 31, 2016			Purchases, sales, issuances and settlements, net (b)			Total realized and unrealized gains (losses) included in net income		Total realized and unrealized gains (losses) included in accumulated other comprehensive income (loss)			Transfers into Level 3 (a)		Transfers out of Level 3 (a)			Ending balance as of September 30, 2017			Amount of total gains (losses) for the nine months ended September 30, 2017 included in our net income relating to assets and liabilities still held as of the reporting date
Assets:
Fixed maturities, available for sale:
Corporate securities	$	258.5		$	(44.1	)	$	9.5	$	.6		$	31.2	$	—		$	255.7		$	(6.5	)
Debt securities issued by foreign governments	3.9			—			—		.1			—		—			4.0			—
Asset-backed securities	60.4			3.8			—		2.3			4.2		(10.8		)	59.9			—
Collateralized debt obligations	5.4			(2.5		)	—		—			—		(2.9		)	—			—
Commercial mortgage-backed securities	32.0			—			—		—			—		(32.0		)	—			—
Total fixed maturities, available for sale	360.2			(42.8		)	9.5		3.0			35.4		(45.7		)	319.6			(6.5		)
Equity securities - corporate securities	25.2			(8.5		)	6.3		(1.4		)	—		—			21.6			(.5		)
Investments held by variable interest entities - corporate securities	—			5.0			—		—			—		—			5.0			—
Liabilities:
Future policy benefits - embedded derivatives associated with fixed index annuity products	(1,092.3		)	(174.2		)	17.2		—			—		—			(1,249.3		)	17.2

_________

(a) Transfers into Level 3 are the result of unobservable inputs utilized within valuation methodologies for assets that were previously valued using observable inputs. Transfers out of Level 3 are due to the use of observable inputs in valuation methodologies as well as the utilization of pricing service information for certain assets that the Company is able to validate.

(b) Purchases, sales, issuances and settlements, net, represent the activity that occurred during the period that results in a change of the asset or liability but does not represent changes in fair value for the instruments held at the beginning of the period.  Such activity primarily consists of purchases and sales of fixed maturity and equity securities and changes to embedded derivative instruments related to insurance products resulting from the issuance of new contracts, or changes to existing contracts.  The following summarizes such activity for the nine months ended September 30, 2017 (dollars in millions):

	Purchases			Sales			Issuances			Settlements		Purchases, sales, issuances and settlements, net
Assets:
Fixed maturities, available for sale:
Corporate securities	$	64.3		$	(108.4	)	$	—		$	—	$	(44.1	)
Asset-backed securities	21.9			(18.1		)	—			—		3.8
Collateralized debt obligations	—			(2.5		)	—			—		(2.5		)
Total fixed maturities, available for sale	86.2			(129.0		)	—			—		(42.8		)
Equity securities - corporate securities	—			(8.5		)	—			—		(8.5		)
Investments held by variable interest entities - corporate securities	5.0			—			—			—		5.0
Liabilities:
Future policy benefits - embedded derivatives associated with fixed index annuity products	(130.1		)	5.3			(95.7		)	46.3		(174.2		)

The following table presents additional information about assets and liabilities measured at fair value on a recurring basis and for which we have utilized significant unobservable (Level 3) inputs to determine fair value for the three months ended September 30, 2016 (dollars in millions):

	September 30, 2016
	Beginning balance as of June 30, 2016			Purchases, sales, issuances and settlements, net (b)			Total realized and unrealized gains (losses) included in net income		Total realized and unrealized gains (losses) included in accumulated other comprehensive income (loss)			Transfers into Level 3 (a)		Transfers out of Level 3 (a)			Ending balance as of September 30, 2016			Amount of total gains (losses) for the three months ended September 30, 2016 included in our net income relating to assets and liabilities still held as of the reporting date
Assets:
Fixed maturities, available for sale:
Corporate securities	$	174.6		$	118.8		$	—	$	(4.9	)	$	—	$	—		$	288.5		$	—
Debt securities issued by foreign governments	4.1			—			—		—			—		—			4.1			—
Asset-backed securities	39.1			5.7			—		2.1			24.6		(15.0		)	56.5			—
Collateralized debt obligations	—			2.5			—		—			—		—			2.5			—
Commercial mortgage-backed securities	1.1			17.0			—		(.1		)	14.4		—			32.4			—
Collateralized mortgage obligations	—			12.0			—		—			—		—			12.0			—
Total fixed maturities, available for sale	218.9			156.0			—		(2.9		)	39.0		(15.0		)	396.0			—
Equity securities - corporate securities	21.4			3.3			—		(.8		)	—		—			23.9			—
Trading securities - commercial mortgage-backed securities	—			—			—		(1.7		)	10.0		—			8.3			(1.7		)
Liabilities:
Future policy benefits - embedded derivatives associated with fixed index annuity products	(1,127.0		)	(37.0		)	18.3		—			—		—			(1,145.7		)	18.3

____________

(a) Transfers into Level 3 are the result of unobservable inputs utilized within valuation methodologies for assets that were previously valued using observable inputs. Transfers out of Level 3 are due to the use of observable inputs in valuation methodologies as well as the utilization of pricing service information for certain assets that the Company is able to validate.

(b) Purchases, sales, issuances and settlements, net, represent the activity that occurred during the period that results in a change of the asset or liability but does not represent changes in fair value for the instruments held at the beginning of the period.  Such activity primarily consists of purchases and sales of fixed maturity and equity securities and changes to embedded derivative instruments related to insurance products resulting from the issuance of new contracts, or changes to existing contracts.  In addition, such activity includes the investments received upon the recapture of reinsurance agreements with BRe on September 29, 2016. The following summarizes such activity for the three months ended September 30, 2016 (dollars in millions):

	Purchases			Received in reinsurance recapture		Sales			Issuances			Settlements		Purchases, sales, issuances and settlements, net
Assets:
Fixed maturities, available for sale:
Corporate securities	$	1.1		$	118.6	$	(.9	)	$	—		$	—	$	118.8
Asset-backed securities	7.0			—		(1.3		)	—			—		5.7
Collateralized debt obligations	2.5			—		—			—			—		2.5
Commercial mortgage-backed securities	17.0			—		—			—			—		17.0
Collateralized mortgage obligations	—			12.0		—			—			—		12.0
Total fixed maturities, available for sale	27.6			130.6		(2.2		)	—			—		156.0
Equity securities - corporate securities	1.1			2.2		—			—			—		3.3
Liabilities:
Future policy benefits - embedded derivatives associated with fixed index annuity products	(38.5		)	—		3.1			(14.6		)	13.0		(37.0		)

The following table presents additional information about assets and liabilities measured at fair value on a recurring basis and for which we have utilized significant unobservable (Level 3) inputs to determine fair value for the nine months ended September 30, 2016 (dollars in millions):

	September 30, 2016
	Beginning balance as of December 31, 2015			Purchases, sales, issuances and settlements, net (b)			Total realized and unrealized gains (losses) included in net income			Total realized and unrealized gains (losses) included in accumulated other comprehensive income (loss)			Transfers into Level 3 (a)		Transfers out of Level 3 (a)			Ending balance as of September 30, 2016			Amount of total gains (losses) for the nine months ended September 30, 2016 included in our net income relating to assets and liabilities still held as of the reporting date
Assets:
Fixed maturities, available for sale:
Corporate securities	$	170.4		$	104.4		$	(7.0	)	$	7.4		$	20.3	$	(7.0	)	$	288.5		$	(5.6	)
Debt securities issued by foreign governments	—			4.0			—			.1			—		—			4.1			—
Asset-backed securities	35.9			1.7			—			4.0			28.6		(13.7		)	56.5			—
Collateralized debt obligations	—			2.5			—			—			—		—			2.5			—
Commercial mortgage-backed securities	1.1			17.0			—			.4			13.9		—			32.4			—
Mortgage pass-through securities	.1			(.1		)	—			—			—		—			—			—
Collateralized mortgage obligations	—			12.0			—			—			—		—			12.0			—
Total fixed maturities, available for sale	207.5			141.5			(7.0		)	11.9			62.8		(20.7		)	396.0			(5.6		)
Equity securities - corporate securities	32.0			5.5			(12.8		)	(.8		)	—		—			23.9			(12.8		)
Trading securities - commercial mortgage-backed securities	39.9			—			—			(1.4		)	—		(30.2		)	8.3			(1.4		)
Liabilities:
Future policy benefits - embedded derivatives associated with fixed index annuity products	(1,057.1		)	(55.3		)	(33.3		)	—			—		—			(1,145.7		)	(33.3		)

____________

(a) Transfers into Level 3 are the result of unobservable inputs utilized within valuation methodologies for assets that were previously valued using observable inputs. Transfers out of Level 3 are due to the use of observable inputs in valuation methodologies as well as the utilization of pricing service information for certain assets that the Company is able to validate.

(b) Purchases, sales, issuances and settlements, net, represent the activity that occurred during the period that results in a change of the asset or liability but does not represent changes in fair value for the instruments held at the beginning of the period.  Such activity primarily consists of purchases and sales of fixed maturity and equity securities and changes to embedded derivative instruments related to insurance products resulting from the issuance of new contracts, or changes to existing contracts.  In addition, such activity includes the investments received upon the recapture of reinsurance agreements with BRe on September 29, 2016. The following summarizes such activity for the nine months ended September 30, 2016 (dollars in millions):

	Purchases			Received in reinsurance recapture		Sales			Issuances			Settlements		Purchases, sales, issuances and settlements, net
Assets:
Fixed maturities, available for sale:
Corporate securities	$	1.1		$	118.6	$	(15.3	)	$	—		$	—	$	104.4
Debt securities issued by foreign governments	4.0			—		—			—			—		4.0
Asset-backed securities	7.0			—		(5.3		)	—			—		1.7
Collateralized debt obligations	2.5			—		—			—			—		2.5
Commercial mortgage-backed securities	17.0			—		—			—			—		17.0
Mortgage pass-through securities	—			—		(.1		)	—			—		(.1		)
Collateralized mortgage obligations	—			12.0		—			—			—		12.0
Total fixed maturities, available for sale	31.6			130.6		(20.7		)	—			—		141.5
Equity securities - corporate securities	3.3			2.2		—			—			—		5.5
Liabilities:
Future policy benefits - embedded derivatives associated with fixed index annuity products	(101.9		)	—		19.2			(17.5		)	44.9		(55.3		)

Schedule of fair value measurement inputs

The following table provides additional information about the significant unobservable (Level 3) inputs developed internally by the Company to determine fair value for certain assets and liabilities carried at fair value at September 30, 2017 (dollars in millions):

	Fair value at September 30, 2017		Valuation techniques	Unobservable inputs	Range (weighted average)
Assets:
Corporate securities (a)	$	138.4	Discounted cash flow analysis	Discount margins	1.50% - 61.70% (9.10%)
Corporate securities (b)	3.1		Recovery method	Percent of recovery expected	5% - 38% (17.76%)
Asset-backed securities (c)	24.9		Discounted cash flow analysis	Discount margins	1.77% - 3.36% (2.54%)
Equity securities (d)	21.6		Market comparables	EBITDA multiples	0.5X - 6.2X (5.9X)
Other assets categorized as Level 3 (e)	158.2		Unadjusted third-party price source	Not applicable	Not applicable
Total	346.2
Liabilities:
Future policy benefits (f)	1,249.3		Discounted projected embedded derivatives	Projected portfolio yields	5.15% - 5.61% (5.59%)
				Discount rates	0.44% - 2.80% (1.94%)
				Surrender rates	0.94% - 46.48% (13.52%)

________________________________

(a) Corporate securities - The significant unobservable input used in the fair value measurement of our corporate securities is discount margin added to a riskless market yield. Significant increases (decreases) in discount margin in isolation would result in a significantly lower (higher) fair value measurement.

(b) Corporate securities - The significant unobservable input used in the fair value measurement of these corporate securities is percentage of recovery expected.  Significant increases (decreases) in percentage of recovery expected in isolation would result in a significantly higher (lower) fair value measurement.

(c) Asset-backed securities - The significant unobservable input used in the fair value measurement of these asset-backed securities is discount margin added to a riskless market yield. Significant increases (decreases) in discount margin in isolation would result in a significantly lower (higher) fair value measurement.

(d) Equity securities - The significant unobservable input used in the fair value measurement of these equity securities is multiples of earnings before interest, taxes, depreciation and amortization ("EBITDA"). Generally, increases (decreases) in the EBITDA multiples would result in higher (lower) fair value measurements.

(e) Other assets categorized as Level 3 - For these assets, there were no adjustments to quoted market prices obtained from third-party pricing sources.

(f) Future policy benefits - The significant unobservable inputs used in the fair value measurement of our embedded derivatives associated with fixed index annuity products are projected portfolio yields, discount rates and surrender rates. Increases (decreases) in projected portfolio yields in isolation would lead to a higher (lower) fair value measurement. The discount rate is based on the Treasury rate adjusted by a margin. Increases (decreases) in the discount rates would lead to a lower (higher) fair value measurement. Assumed surrender rates are used to project how long the contracts remain in force. Generally, the longer the contracts are assumed to be in force the higher the fair value of the embedded derivative.

The following table provides additional information about the significant unobservable (Level 3) inputs developed internally by the Company to determine fair value for certain assets and liabilities carried at fair value at December 31, 2016 (dollars in millions):

	Fair value at December 31, 2016		Valuation techniques	Unobservable inputs	Range (weighted average)
Assets:
Corporate securities (a)	$	148.5	Discounted cash flow analysis	Discount margins	1.35% - 27.71% (13.52%)
Corporate securities (b)	14.8		Recovery method	Percent of recovery expected	5% - 69% (55%)
Asset-backed securities (c)	24.0		Discounted cash flow analysis	Discount margins	2.06% - 3.64% (2.76%)
Equity securities (d)	25.2		Market comparables	EBITDA multiples	0.4X - 6.2X (5.9X)
Other assets categorized as Level 3 (e)	172.9		Unadjusted third-party price source	Not applicable	Not applicable
Total	385.4
Liabilities:
Future policy benefits (f)	1,092.3		Discounted projected embedded derivatives	Projected portfolio yields	5.15% - 5.61% (5.59%)
				Discount rates	0.18% - 3.06% (2.07%)
				Surrender rates	0.94% - 46.48% (13.52%)

________________________________

(a) Corporate securities - The significant unobservable input used in the fair value measurement of our corporate securities is discount margin added to a riskless market yield. Significant increases (decreases) in discount margin in isolation would result in a significantly lower (higher) fair value measurement.

(b) Corporate securities - The significant unobservable input used in the fair value measurement of our corporate securities is percentage of recovery expected.  Significant increases (decreases) in percentage of recovery expected in isolation would result in a significantly higher (lower) fair value measurement.

(c) Asset-backed securities - The significant unobservable input used in the fair value measurement of these asset-backed securities is discount margin added to a riskless market yield. Significant increases (decreases) in discount margin in isolation would result in a significantly lower (higher) fair value measurement.

(d) Equity securities - The significant unobservable input used in the fair value measurement of these equity securities is EBITDA multiples. Generally, increases (decreases) in the EBITDA multiples would result in higher (lower) fair value measurements.

(e) Other assets categorized as Level 3 - For these assets, there were no adjustments to quoted market prices obtained from third-party pricing sources.

(f) Future policy benefits - The significant unobservable inputs used in the fair value measurement of our embedded derivatives associated with fixed index annuity products are projected portfolio yields, discount rates and surrender rates. Increases (decreases) in projected portfolio yields in isolation would lead to a higher (lower) fair value measurement. The discount rate is based on the Treasury rate adjusted by a margin. Increases (decreases) in the discount rates would lead to a lower (higher) fair value measurement. Assumed surrender rates are used to project how long the contracts remain in force. Generally, the longer the contracts are assumed to be in force the higher the fair value of the embedded derivative.

XML

BUSINESS AND BASIS OF PRESENTATION (Details)	9 Months Ended
	Sep. 30, 2017 distribution_channel
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of distribution channels	3

XML

INVESTMENTS - SCHEDULE OF UNREALIZED APPRECIATION (DEPRECIATION) ON INVESTMENTS INCLUDED IN ACCUMULATED OTHER COMPREHENSIVE INCOME (Details) - USD ($) $ in Millions	Sep. 30, 2017	Dec. 31, 2016
Investments, Debt and Equity Securities [Abstract]
Net unrealized appreciation (depreciation) on fixed maturity securities, available for sale, on which an other-than-temporary impairment loss has been recognized	$ 2.4	$ (1.1)
Net unrealized gains on all other investments	2,058.9	1,311.9
Adjustment to present value of future profits	(98.1)	(106.2)
Adjustment to deferred acquisition costs	(287.9)	(223.5)
Adjustment to insurance liabilities	(224.5)	(13.5)
Deferred income tax liabilities	(517.2)	(345.2)
Accumulated other comprehensive income	$ 933.6	$ 622.4

XML

INVESTMENTS - NARRATIVE (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016	Dec. 31, 2016
Schedule of Available-for-sale Securities [Line Items]
Premium deficiencies adjustments to present value of future profits	$ (86.7)		$ (86.7)
Reduction to deferred acquisition costs due to unrealized gains that would result in premium deficiency if unrealized gains were realized	(135.8)		(135.8)
Adjustment to insurance liabilities	224.5		224.5		$ 13.5
Increase to deferred tax assets due to unrealized gains that would result in premium deficiency if unrealized gains were realized	159.1		159.1
Net realized investment gains (losses)	29.2	$ 11.6	52.3	$ 23.3
Net realized investment gains (losses), excluding impairment losses	34.5	12.8	74.8	55.4
Loss on dissolution of variable interest entities	0.6	0.0	4.3	7.3
Net impairment losses recognized	(4.7)	(1.2)	(18.2)	(24.8)
Value of available for sale securities sold			290.8
Other than temporary impairment losses, losses on other investments following unforeseen events			7.3	0.9
Other-than-temporary impairments included in accumulated other comprehensive income			4.7
Embedded Derivative Related to Reinsurance Contract
Schedule of Available-for-sale Securities [Line Items]
Increase in fair value of embedded derivative			12.3	0.6
Coinsurance | Embedded Derivative Related to Reinsurance Contract
Schedule of Available-for-sale Securities [Line Items]
Increase in fair value of embedded derivative			2.4	6.7
Marketable securities
Schedule of Available-for-sale Securities [Line Items]
Net realized investment gains (losses), excluding impairment losses			60.1	48.1
Total fixed maturities, available for sale
Schedule of Available-for-sale Securities [Line Items]
Net realized investment gains (losses)	20.6	4.5	33.1	36.4
Gross realized losses on sale	$ 8.5	$ 2.8	16.4	84.4
Corporate securities
Schedule of Available-for-sale Securities [Line Items]
Gross realized losses on sale			9.7
Commercial mortgage-backed securities
Schedule of Available-for-sale Securities [Line Items]
Gross realized losses on sale			3.1
Various other investments
Schedule of Available-for-sale Securities [Line Items]
Gross realized losses on sale			3.6
Fixed income investments | Energy Sector
Schedule of Available-for-sale Securities [Line Items]
Net impairment losses recognized			(5.7)	(6.3)
Real estate investment
Schedule of Available-for-sale Securities [Line Items]
Net impairment losses recognized			$ (5.2)
Direct loan
Schedule of Available-for-sale Securities [Line Items]
Net impairment losses recognized				(3.7)
Preferred Stock
Schedule of Available-for-sale Securities [Line Items]
Net impairment losses recognized				(12.7)
Variable Interest Entity, Primary Beneficiary
Schedule of Available-for-sale Securities [Line Items]
Net impairment losses recognized				$ (1.2)

XML

INVESTMENTS - SCHEDULE OF AMORTIZED COST, GROSS UNREALIZED GAINS AND LOSSES, ESTIMATED FAIR VALUE, AND OTHER-THAN-TEMPORARY IMPAIRMENTS (Details) - USD ($) $ in Millions	9 Months Ended	12 Months Ended
	Sep. 30, 2017	Dec. 31, 2016
Schedule of Available-for-sale Securities [Line Items]
Amortized cost	$ 20,092.5	$ 19,803.1
Other-than-temporary impairments included in accumulated other comprehensive income	(4.7)
Corporate securities
Schedule of Available-for-sale Securities [Line Items]
Amortized cost	13,145.4	12,549.9
Gross unrealized gains	1,537.6	1,100.0
Gross unrealized losses	(33.0)	(139.0)
Estimated fair value	14,650.0	13,510.9
Other-than-temporary impairments included in accumulated other comprehensive income	(3.6)	(3.6)
United States Treasury securities and obligations of United States government corporations and agencies
Schedule of Available-for-sale Securities [Line Items]
Amortized cost	145.4	143.8
Gross unrealized gains	26.9	20.5
Gross unrealized losses	0.0	0.0
Estimated fair value	172.3	164.3
Other-than-temporary impairments included in accumulated other comprehensive income	0.0	0.0
States and political subdivisions
Schedule of Available-for-sale Securities [Line Items]
Amortized cost	1,857.2	1,811.8
Gross unrealized gains	220.7	186.7
Gross unrealized losses	(0.9)	(9.6)
Estimated fair value	2,077.0	1,988.9
Other-than-temporary impairments included in accumulated other comprehensive income	0.0	(3.0)
Debt securities issued by foreign governments
Schedule of Available-for-sale Securities [Line Items]
Amortized cost	58.1	37.1
Gross unrealized gains	3.1	0.2
Gross unrealized losses	(0.1)	(0.4)
Estimated fair value	61.1	36.9
Other-than-temporary impairments included in accumulated other comprehensive income	0.0	0.0
Asset-backed securities
Schedule of Available-for-sale Securities [Line Items]
Amortized cost	2,608.6	2,641.5
Gross unrealized gains	180.6	84.3
Gross unrealized losses	(3.1)	(15.5)
Estimated fair value	2,786.1	2,710.3
Other-than-temporary impairments included in accumulated other comprehensive income	0.0	0.0
Collateralized debt obligations
Schedule of Available-for-sale Securities [Line Items]
Amortized cost	236.5	230.0
Gross unrealized gains	1.4	1.0
Gross unrealized losses	0.0	(0.3)
Estimated fair value	237.9	230.7
Other-than-temporary impairments included in accumulated other comprehensive income	0.0	0.0
Commercial mortgage-backed securities
Schedule of Available-for-sale Securities [Line Items]
Amortized cost	1,311.6	1,531.0
Gross unrealized gains	37.4	33.1
Gross unrealized losses	(10.1)	(27.9)
Estimated fair value	1,338.9	1,536.2
Other-than-temporary impairments included in accumulated other comprehensive income	0.0	0.0
Mortgage pass-through securities
Schedule of Available-for-sale Securities [Line Items]
Amortized cost	2.0	2.3
Gross unrealized gains	0.2	0.2
Gross unrealized losses	0.0	0.0
Estimated fair value	2.2	2.5
Other-than-temporary impairments included in accumulated other comprehensive income	0.0	0.0
Collateralized mortgage obligations
Schedule of Available-for-sale Securities [Line Items]
Amortized cost	727.7	855.7
Gross unrealized gains	77.3	61.4
Gross unrealized losses	(0.6)	(1.6)
Estimated fair value	804.4	915.5
Other-than-temporary impairments included in accumulated other comprehensive income	(1.1)	(1.4)
Total fixed maturities, available for sale
Schedule of Available-for-sale Securities [Line Items]
Amortized cost	20,092.5	19,803.1
Gross unrealized gains	2,085.2	1,487.4
Gross unrealized losses	(47.8)	(194.3)
Estimated fair value	22,129.9	21,096.2
Other-than-temporary impairments included in accumulated other comprehensive income	(4.7)	(8.0)
Equity securities
Schedule of Available-for-sale Securities [Line Items]
Amortized cost	688.7	580.7
Gross unrealized gains	27.2	11.5
Gross unrealized losses	(2.6)	(8.0)
Estimated fair value	$ 713.3	$ 584.2

XML

INVESTMENTS - SUMMARY OF INVESTMENTS BY CONTRACTUAL MATURITY (Details) - USD ($) $ in Millions	Sep. 30, 2017	Dec. 31, 2016
Amortized cost
Due in one year or less	$ 398.1	$ 354.7
Due after one year through five years	2,004.8	2,243.8
Due after five years through ten years	1,562.8	1,549.1
Due after ten years	11,240.4	10,395.0
Subtotal	15,206.1	14,542.6
Structured securities	4,886.4	5,260.5
Amortized cost	20,092.5	19,803.1
Estimated fair value
Due in one year or less	406.1	359.8
Due after one year through five years	2,131.7	2,399.5
Due after five years through ten years	1,671.1	1,620.8
Due after ten years	12,751.5	11,320.9
Subtotal	16,960.4	15,701.0
Structured securities	5,169.5	5,395.2
Total fixed maturities, available for sale	$ 22,129.9	$ 21,096.2

XML

INVESTMENTS - NET REALIZED INVESTMENT GAINS (LOSSES) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Gain (Loss) on Investments [Line Items]
Total other-than-temporary impairment losses	$ (4.7)	$ (1.2)	$ (17.3)	$ (24.8)
Other-than-temporary impairment losses recognized in accumulated other comprehensive income	0.0	0.0	(0.9)	0.0
Total realized gains	29.2	11.6	52.3	23.3
Loss on dissolution of variable interest entities	(0.6)	0.0	(4.3)	(7.3)
Investments
Gain (Loss) on Investments [Line Items]
Change in estimated fair value of trading securities			13.0	0.8
Total fixed maturities, available for sale
Gain (Loss) on Investments [Line Items]
Gross realized gains on sale	32.3	7.3	60.4	127.1
Gross realized losses on sale	(8.5)	(2.8)	(16.4)	(84.4)
Total other-than-temporary impairment losses	(3.2)	0.0	(10.0)	(6.3)
Other-than-temporary impairment losses recognized in accumulated other comprehensive income	0.0	0.0	(0.9)	0.0
Net impairment losses recognized	(3.2)	0.0	(10.9)	(6.3)
Total realized gains	20.6	4.5	33.1	36.4
Equity securities
Gain (Loss) on Investments [Line Items]
Total realized gains	7.7	17.2	9.6	21.3
Commercial mortgage loans
Gain (Loss) on Investments [Line Items]
Total realized gains	0.0	0.0	1.0	0.0
Impairments of other investments
Gain (Loss) on Investments [Line Items]
Total realized gains	(1.5)	(1.2)	(7.3)	(18.5)
Other
Gain (Loss) on Investments [Line Items]
Total realized gains	3.0	(8.9)	20.2	(8.6)
VIEs
Gain (Loss) on Investments [Line Items]
Loss on dissolution of variable interest entities	$ (0.6)	$ 0.0	$ (4.3)	$ (7.3)

XML

INVESTMENTS - SCHEDULE OF OTHER THAN TEMPORARY IMPAIRMENT (Details) - Available-for-sale Securities - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Other than Temporary Impairment, Credit Losses Recognized in Earnings [Roll Forward]
Credit losses on fixed maturity securities, available for sale, beginning of period	$ (4.9)	$ (2.6)	$ (5.5)	$ (2.6)
Add: credit losses on other-than-temporary impairments not previously recognized	0.0	0.0	0.0	0.0
Less: credit losses on securities sold	0.0	0.1	1.6	0.1
Less: credit losses on securities impaired due to intent to sell	0.0	0.0	0.0	0.0
Add: credit losses on previously impaired securities	0.0	0.0	(1.0)	0.0
Less: increases in cash flows expected on previously impaired securities	0.0	0.0	0.0	0.0
Credit losses on fixed maturity securities, available for sale, end of period	$ (4.9)	$ (2.5)	$ (4.9)	$ (2.5)

XML

INVESTMENTS - SUMMARY OF INVESTMENTS WITH UNREALIZED LOSSES BY INVESTMENT CATEGORY (Details) - USD ($) $ in Millions	Sep. 30, 2017	Dec. 31, 2016
Schedule of Available-for-sale Securities [Line Items]
Fair value, less than 12 months	$ 1,332.5	$ 3,440.8
Unrealized losses, less than 12 months	(11.6)	(109.5)
Fair value, 12 months or greater	733.4	1,059.8
Unrealized losses, 12 months or greater	(36.2)	(84.8)
Fair value, total	2,065.9	4,500.6
Unrealized losses, total	(47.8)	(194.3)
United States Treasury securities and obligations of United States government corporations and agencies
Schedule of Available-for-sale Securities [Line Items]
Fair value, less than 12 months	20.3	8.0
Unrealized losses, less than 12 months	0.0	0.0
Fair value, 12 months or greater	0.6	0.0
Unrealized losses, 12 months or greater	0.0	0.0
Fair value, total	20.9	8.0
Unrealized losses, total	0.0	0.0
States and political subdivisions
Schedule of Available-for-sale Securities [Line Items]
Fair value, less than 12 months	35.1	176.3
Unrealized losses, less than 12 months	(0.6)	(7.8)
Fair value, 12 months or greater	19.3	18.3
Unrealized losses, 12 months or greater	(0.3)	(1.8)
Fair value, total	54.4	194.6
Unrealized losses, total	(0.9)	(9.6)
Debt securities issued by foreign governments
Schedule of Available-for-sale Securities [Line Items]
Fair value, less than 12 months	10.5	18.9
Unrealized losses, less than 12 months	(0.1)	(0.4)
Fair value, 12 months or greater	0.0	0.0
Unrealized losses, 12 months or greater	0.0	0.0
Fair value, total	10.5	18.9
Unrealized losses, total	(0.1)	(0.4)
Corporate securities
Schedule of Available-for-sale Securities [Line Items]
Fair value, less than 12 months	666.9	1,907.6
Unrealized losses, less than 12 months	(7.8)	(75.5)
Fair value, 12 months or greater	400.4	559.6
Unrealized losses, 12 months or greater	(25.2)	(63.5)
Fair value, total	1,067.3	2,467.2
Unrealized losses, total	(33.0)	(139.0)
Asset-backed securities
Schedule of Available-for-sale Securities [Line Items]
Fair value, less than 12 months	276.7	692.9
Unrealized losses, less than 12 months	(1.3)	(8.5)
Fair value, 12 months or greater	79.6	262.5
Unrealized losses, 12 months or greater	(1.8)	(7.0)
Fair value, total	356.3	955.4
Unrealized losses, total	(3.1)	(15.5)
Collateralized debt obligations
Schedule of Available-for-sale Securities [Line Items]
Fair value, less than 12 months	24.0	38.3
Unrealized losses, less than 12 months	0.0	(0.1)
Fair value, 12 months or greater	0.0	30.8
Unrealized losses, 12 months or greater	0.0	(0.2)
Fair value, total	24.0	69.1
Unrealized losses, total	0.0	(0.3)
Commercial mortgage-backed securities
Schedule of Available-for-sale Securities [Line Items]
Fair value, less than 12 months	226.2	525.2
Unrealized losses, less than 12 months	(1.3)	(16.6)
Fair value, 12 months or greater	221.9	154.0
Unrealized losses, 12 months or greater	(8.8)	(11.3)
Fair value, total	448.1	679.2
Unrealized losses, total	(10.1)	(27.9)
Collateralized mortgage obligations
Schedule of Available-for-sale Securities [Line Items]
Fair value, less than 12 months	72.8	73.6
Unrealized losses, less than 12 months	(0.5)	(0.6)
Fair value, 12 months or greater	11.6	34.6
Unrealized losses, 12 months or greater	(0.1)	(1.0)
Fair value, total	84.4	108.2
Unrealized losses, total	(0.6)	(1.6)
Equity securities
Schedule of Available-for-sale Securities [Line Items]
Fair value, less than 12 months	37.4	239.4
Unrealized losses, less than 12 months	(0.8)	(8.0)
Fair value, 12 months or greater	89.7	0.0
Unrealized losses, 12 months or greater	(1.8)	0.0
Fair value, total	127.1	239.4
Unrealized losses, total	$ (2.6)	$ (8.0)

XML

EARNINGS PER SHARE (Details) - USD ($) shares in Thousands, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Dilutive Securities, Effect on Basic Earnings Per Share [Abstract]
Net income	$ 100.8	$ 18.6	$ 246.5	$ 124.0
Shares:
Weighted average shares outstanding for basic earnings per share (in shares)	168,684	174,247	170,890	177,640
Effect of dilutive securities on weighted average shares:
Stock options, restricted stock and performance units (in shares)	2,298	1,476	1,910	1,733
Weighted average shares outstanding for diluted earnings per share (in shares)	170,982	175,723	172,800	179,373

XML

BUSINESS SEGMENTS (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Revenues:
Fee revenue and other income	$ 12.2	$ 10.5	$ 35.5	$ 38.7
Total revenues	1,036.4	991.3	3,114.6	2,907.6
Expenses:
Insurance policy benefits	638.1	609.8	1,941.6	1,861.2
Other operating costs and expenses	217.5	187.3	631.3	603.5
Total expenses	920.6	893.0	2,784.8	2,632.3
Pre-tax operating earnings	115.8	98.3	329.8	275.3
Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]
Total segment revenues	1,036.4	991.3	3,114.6	2,907.6
Net realized investment gains	29.2	11.6	52.3	23.3
Revenues related to VIEs	13.7	13.0	40.2	39.3
Fee revenue related to transition and support services agreements	0.0	0.0	0.0	10.0
Total revenues	1,079.3	1,015.9	3,207.1	2,980.2
Total segment expenses	920.6	893.0	2,784.8	2,632.3
Insurance policy benefits - fair value changes in embedded derivative liabilities	(2.9)	(12.1)	9.8	47.0
Amortization related to fair value changes in embedded derivative liabilities	0.6	2.7	(1.8)	(10.4)
Amortization related to net realized investment gains	0.7	0.2	1.0	0.9
Expenses related to VIEs	17.0	13.7	44.8	40.5
Fair value changes and amendment related to agent deferred compensation plan	13.4	(6.3)	13.4	12.0
Loss on reinsurance transaction	0.0	75.4	0.0	75.4
Expenses related to transition and support services agreements	0.0	0.0	0.0	10.0
Total benefits and expenses	949.4	966.6	2,852.0	2,807.7
Income before income taxes	129.9	49.3	355.1	172.5
Tax expense on period income	44.1	16.9	123.6	61.7
Valuation allowance for deferred tax assets and other tax items	(15.0)	13.8	(15.0)	(13.2)
Net income	100.8	18.6	246.5	124.0
Operating segments | Bankers Life:
Revenues:
Annuities	3.7	6.8	15.5	17.4
Health	307.2	310.3	926.9	933.3
Life	103.7	96.6	310.4	295.8
Net investment income	270.6	244.7	800.4	686.8
Fee revenue and other income	11.3	9.6	32.5	23.5
Total revenues	696.5	668.0	2,085.7	1,956.8
Expenses:
Insurance policy benefits	437.2	427.1	1,307.7	1,240.9
Amortization	38.7	43.8	126.3	135.3
Interest expense on investment borrowings	5.3	3.5	14.3	9.4
Other operating costs and expenses	108.4	105.5	328.2	312.2
Total expenses	589.6	579.9	1,776.5	1,697.8
Pre-tax operating earnings	106.9	88.1	309.2	259.0
Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]
Total segment revenues	696.5	668.0	2,085.7	1,956.8
Total segment expenses	589.6	579.9	1,776.5	1,697.8
Operating segments | Washington National:
Revenues:
Annuities	0.5	1.2	1.6	2.3
Health	160.4	156.9	480.3	469.1
Life	6.5	6.3	20.1	18.6
Net investment income	68.0	67.1	201.9	191.3
Fee revenue and other income	0.3	0.4	0.8	1.0
Total revenues	235.7	231.9	704.7	682.3
Expenses:
Insurance policy benefits	144.7	144.5	436.7	422.0
Amortization	14.3	14.3	43.9	44.5
Interest expense on investment borrowings	1.7	0.9	4.5	2.5
Other operating costs and expenses	47.5	47.0	145.0	140.3
Total expenses	208.2	206.7	630.1	609.3
Pre-tax operating earnings	27.5	25.2	74.6	73.0
Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]
Total segment revenues	235.7	231.9	704.7	682.3
Total segment expenses	208.2	206.7	630.1	609.3
Operating segments | Colonial Penn:
Revenues:
Health	0.5	0.6	1.6	2.0
Life	72.6	70.3	217.5	208.5
Net investment income	11.0	11.1	33.1	33.0
Fee revenue and other income	0.3	0.2	0.9	0.8
Total revenues	84.4	82.2	253.1	244.3
Expenses:
Insurance policy benefits	47.7	50.3	150.8	151.3
Amortization	3.9	3.7	11.9	11.3
Interest expense on investment borrowings	0.3	0.1	0.7	0.4
Other operating costs and expenses	23.5	27.2	73.0	84.2
Total expenses	75.4	81.3	236.4	247.2
Pre-tax operating earnings	9.0	0.9	16.7	(2.9)
Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]
Total segment revenues	84.4	82.2	253.1	244.3
Total segment expenses	75.4	81.3	236.4	247.2
Operating segments | Long-term care in run-off:
Revenues:
Health	4.2	0.0	13.3	0.0
Net investment income	6.8	0.0	26.5	0.0
Total revenues	11.0	0.0	39.8	0.0
Expenses:
Insurance policy benefits	11.4	0.0	36.6	0.0
Other operating costs and expenses	0.6	0.0	2.1	0.0
Total expenses	12.0	0.0	38.7	0.0
Pre-tax operating earnings	(1.0)	0.0	1.1	0.0
Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]
Total segment revenues	11.0	0.0	39.8	0.0
Total segment expenses	12.0	0.0	38.7	0.0
Corporate
Revenues:
Net investment income	7.0	6.7	24.8	16.6
Fee revenue and other income	1.8	2.5	6.5	7.6
Total revenues	8.8	9.2	31.3	24.2
Expenses:
Interest expense on corporate debt	11.7	11.5	34.8	34.3
Other operating costs and expenses	23.7	13.6	68.3	43.7
Total expenses	35.4	25.1	103.1	78.0
Pre-tax operating earnings	(26.6)	(15.9)	(71.8)	(53.8)
Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]
Total segment revenues	8.8	9.2	31.3	24.2
Total segment expenses	$ 35.4	$ 25.1	$ 103.1	$ 78.0

XML

ACCOUNTING FOR DERIVATIVES - FAIR VALUE BY BALANCE SHEET LOCATION (Details) - USD ($) $ in Millions	Sep. 30, 2017	Dec. 31, 2016
Fixed index call options
Derivatives, Fair Value [Line Items]
Assets	$ 142.2	$ 111.9
Not Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Assets	140.4	107.7
Liabilities	1,249.3	1,092.3
Not Designated as Hedging Instrument | Fixed index call options | Other invested assets:
Derivatives, Fair Value [Line Items]
Assets	142.2	111.9
Not Designated as Hedging Instrument | Reinsurance receivables | Other invested assets:
Derivatives, Fair Value [Line Items]
Assets	(1.8)	(4.2)
Not Designated as Hedging Instrument | Fixed index products | Future policy benefits:
Derivatives, Fair Value [Line Items]
Liabilities	$ 1,249.3	$ 1,092.3

XML

ACCOUNTING FOR DERIVATIVES (Details) - USD ($) $ in Millions	Sep. 30, 2017	Dec. 31, 2016
Embedded Derivative Associated With Modified Coinsurance Agreement
Derivative [Line Items]
Embedded derivative	$ 125
Fixed index call options
Derivative [Line Items]
Notional amount	$ 2,900	$ 2,500

XML

ACCOUNTING FOR DERIVATIVES - SCHEDULE PRE-TAX GAINS (LOSSES) RECOGNIZED IN NET INCOME FOR DERIVATIVE INSTRUMENTS (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Derivative [Line Items]
Gains (losses) on derivatives not designated as hedging instruments	$ 30.9	$ 35.4	$ 97.8	$ (16.8)
Investment Income | Fixed index call options
Derivative [Line Items]
Gains (losses) on derivatives not designated as hedging instruments	30.6	17.0	95.4	10.9
Gain (Loss) on Investments
Derivative [Line Items]
Gains (losses) on derivatives not designated as hedging instruments	0.3	0.1	2.4	5.6
Gain (Loss) on Investments | Interest rate futures
Derivative [Line Items]
Gains (losses) on derivatives not designated as hedging instruments	0.0	0.0	0.0	(1.1)
Gain (Loss) on Investments | Embedded Derivative | Coinsurance
Derivative [Line Items]
Gains (losses) on derivatives not designated as hedging instruments	0.3	0.1	2.4	6.7
Insurance Policy Benefits | Embedded Derivative | Fixed Index Annuity
Derivative [Line Items]
Gains (losses) on derivatives not designated as hedging instruments	$ 0.0	$ 18.3	$ 0.0	$ (33.3)

XML

ACCOUNTING FOR DERIVATIVES - DERIVATIVES WITH MASTER NETTING ARRANGEMENTS (Details) - Fixed index call options - USD ($) $ in Millions	Sep. 30, 2017	Dec. 31, 2016
Derivative [Line Items]
Gross amounts recognized	$ 142.2	$ 111.9
Gross amounts offset in the balance sheet	0.0	0.0
Net amounts of assets presented in the balance sheet	142.2	111.9
Financial instruments	0.0	0.0
Cash collateral received	0.0	0.0
Net amount	$ 142.2	$ 111.9

XML

REINSURANCE (Narrative) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Reinsurance Disclosures [Abstract]
Ceded premiums written	$ 27.1	$ 32.2	$ 79.9	$ 97.3
Ceded insurance policy benefits	22.6	31.7	69.1	113.3
Assumed premiums written	$ 7.4	$ 8.3	$ 23.1	$ 25.8

XML

INCOME TAXES - COMPONENTS OF TAX EXPENSE (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Income Tax Disclosure [Abstract]
Current tax expense	$ 25.9	$ 46.8	$ 68.5	$ 51.6
Deferred tax expense (benefit)	18.2	(29.9)	55.1	10.1
Valuation allowance applicable to current year income	(2.2)	(10.5)	(2.2)	(10.5)
Income tax expense calculated based on estimated annual effective tax rate	41.9	6.4	121.4	51.2
Change in valuation allowance	(12.8)	16.0	(12.8)	(11.0)
Other items	0.0	8.3	0.0	8.3
Total income tax expense	$ 29.1	$ 30.7	$ 108.6	$ 48.5

XML

INCOME TAXES - RECONCILIATION OF CORPORATE TAX RATE (Details)	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Income Tax Disclosure [Abstract]
U.S. statutory corporate rate	35.00%	35.00%
Valuation allowance	(0.60%)	(6.10%)
Non-taxable income and nondeductible benefits, net	(1.50%)	(1.00%)
State taxes	1.30%	1.80%
Estimated annual effective tax rate	34.20%	29.70%

XML

INCOME TAXES - NARRATIVE (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016	Jan. 01, 2017	Dec. 31, 2016
Operating Loss Carryforwards [Line Items]
Valuation allowance applicable to current year income	$ 2.2	$ 10.5	$ 2.2	$ 10.5
Change in valuation allowance	12.8	(16.0)	12.8	11.0
Other items	0.0	$ 8.3	0.0	$ 8.3
Income tax assets	1,606.7		1,606.7		$ 1,045.9	$ 1,647.7
Valuation allowance	(240.9)		(240.9)		(255.9)	(240.2)
Deferred tax assets more likely than not to be realized through future taxable earnings	573.9		573.9			785.6
Net deferred tax assets	$ 814.8		$ 814.8			1,025.8
Deferred tax valuation analysis, growth rate for the next five years	3.00%		3.00%
Valuation allowance model, forecast period of Model			5 years
Estimated normalized annual taxable income for the current year			$ 335.0
Adjusted average non-life taxable income			85.0
Adjusted average life taxable income			$ 250.0
Loss limitation based on income of life insurance company, percent	35.00%		35.00%
Loss limitation based on loss of non-life entities, percent	35.00%		35.00%
Federal long-term tax exempt rate	1.93%		1.93%
Ownership change threshold restricting NOL usage	50.00%		50.00%
Net operating loss carryforwards	$ 2,405.1		$ 2,405.1
Net state operating loss carryforwards	12.2		$ 12.2			$ 12.3
Future cash tax payments based on income of life insurance company, percent			65.00%
Federal
Operating Loss Carryforwards [Line Items]
Valuation allowance	(230.9)		$ (230.9)
Net operating loss carryforwards	2,405.1		2,405.1
State
Operating Loss Carryforwards [Line Items]
Valuation allowance	$ (10.0)		$ (10.0)
Recognition of excess tax benefits
Operating Loss Carryforwards [Line Items]
Income tax assets					15.7
Valuation allowance					$ (15.7)

XML

INCOME TAXES - DEFERRED ASSETS AND LIABILITIES (Details) - USD ($) $ in Millions	Sep. 30, 2017	Jan. 01, 2017	Dec. 31, 2016
Deferred tax assets:
Net federal operating loss carryforwards	$ 841.8		$ 882.9
Net state operating loss carryforwards	12.2		12.3
Investments	13.7		17.8
Insurance liabilities	678.9		668.4
Other	60.1		66.3
Gross deferred tax assets	1,606.7	$ 1,045.9	1,647.7
Deferred tax liabilities:
Present value of future profits and deferred acquisition costs	(275.0)		(277.8)
Accumulated other comprehensive income	(516.9)		(344.1)
Gross deferred tax liabilities	(791.9)		(621.9)
Net deferred tax assets before valuation allowance	814.8		1,025.8
Valuation allowance	(240.9)	$ (255.9)	(240.2)
Net deferred tax assets	573.9		785.6
Current income taxes prepaid (accrued)	(6.5)		4.1
Income tax assets, net	$ 567.4		$ 789.7

XML

INCOME TAXES - NET OPERATING LOSSES (Details) $ in Millions	9 Months Ended
	Sep. 30, 2017 USD ($)
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	$ 2,405.1
Carryforward Expiration 2023
Operating Loss Carryforwards [Line Items]
Year of expiration	Dec. 31, 2023
Net operating loss carryforwards	$ 1,818.5
Carryforward Expiration 2025
Operating Loss Carryforwards [Line Items]
Year of expiration	Dec. 31, 2025
Net operating loss carryforwards	$ 85.2
Carryforward Expiration 2026
Operating Loss Carryforwards [Line Items]
Year of expiration	Dec. 31, 2026
Net operating loss carryforwards	$ 149.9
Carryforward Expiration 2027
Operating Loss Carryforwards [Line Items]
Year of expiration	Dec. 31, 2027
Net operating loss carryforwards	$ 10.8
Carryforward Expiration 2028
Operating Loss Carryforwards [Line Items]
Year of expiration	Dec. 31, 2028
Net operating loss carryforwards	$ 80.3
Carryforward Expiration 2029
Operating Loss Carryforwards [Line Items]
Year of expiration	Dec. 31, 2029
Net operating loss carryforwards	$ 213.2
Carryforward Expiration 2030
Operating Loss Carryforwards [Line Items]
Year of expiration	Dec. 31, 2030
Net operating loss carryforwards	$ 0.3
Carryforward Expiration 2031
Operating Loss Carryforwards [Line Items]
Year of expiration	Dec. 31, 2031
Net operating loss carryforwards	$ 0.2
Carryforward Expiration 2032
Operating Loss Carryforwards [Line Items]
Year of expiration	Dec. 31, 2032
Net operating loss carryforwards	$ 44.4
Carryforward Expiration 2033
Operating Loss Carryforwards [Line Items]
Year of expiration	Dec. 31, 2033
Net operating loss carryforwards	$ 0.6
Carryforward Expiration 2034
Operating Loss Carryforwards [Line Items]
Year of expiration	Dec. 31, 2034
Net operating loss carryforwards	$ 0.9
Carryforward Expiration 2035
Operating Loss Carryforwards [Line Items]
Year of expiration	Dec. 31, 2035
Net operating loss carryforwards	$ 0.8

XML

NOTES PAYABLE - DIRECT CORPORATE OBLIGATIONS - SCHEDULE OF LONG-TERM DEBT INSTRUMENTS (Details) - USD ($) $ in Millions	Sep. 30, 2017	Dec. 31, 2016	May 19, 2015
Debt Instruments [Abstract]
Direct corporate obligations	$ 914.4	$ 912.9
Unamortized debt issue costs	(10.6)	(12.1)
Senior notes | 4.500% Senior Notes due May 2020
Debt Instruments [Abstract]
Direct corporate obligations	$ 325.0	325.0
Interest rate	4.50%
Senior notes | 5.250% Senior Notes due May 2025
Debt Instruments [Abstract]
Direct corporate obligations	$ 500.0	500.0
Interest rate	5.25%
Line of credit | Revolving credit agreement
Debt Instruments [Abstract]
Direct corporate obligations	$ 100.0	$ 100.0	$ 100.0

XML

NOTES PAYABLE - DIRECT CORPORATE OBLIGATIONS - REVOLVING CREDIT AGREEMENT (Details) - USD ($) $ in Millions	May 19, 2015	Sep. 30, 2017	Dec. 31, 2016
Debt Instrument [Line Items]
Initial drawing amount		$ 914.4	$ 912.9
Revolving credit agreement | Line of credit
Debt Instrument [Line Items]
Initial drawing amount	$ 100.0	$ 100.0	$ 100.0
Remaining borrowing capacity	$ 50.0
Interest rate on amounts outstanding at period end		3.24%
Debt covenant, required minimum debt to total capitalization ratio	30.00%
Debt covenant, actual debt to total capitalization ratio at period end		19.20%
Debt covenant, minimum required aggregate total adjusted capital to company action level risk-based capital ratio	250.00%
Debt covenant, actual aggregate total adjusted capital to company action level risk-based capital ratio at period end		450.00%
Debt covenant, minimum required consolidated net worth, component one, amount	$ 2,674.0
Debt covenant, minimum required consolidated net worth, component two, as a percent of net equity proceeds received from issuance and sale of equity interests	50.00%
Debt covenant, actual consolidated net worth at period end		$ 3,948.1
Debt covenant, required minimum consolidated net worth, amount		$ 2,683.8
Revolving credit agreement | Line of credit | Federal Funds Rate
Debt Instrument [Line Items]
Basis spread on variable rate	0.50%
Revolving credit agreement | Line of credit | One-Month Eurodollar
Debt Instrument [Line Items]
Basis spread on variable rate	1.00%
Revolving credit agreement | Line of credit | Eurodollar
Debt Instrument [Line Items]
Basis spread on variable rate	2.00%

XML

NOTES PAYABLE - DIRECT CORPORATE OBLIGATIONS NOTES PAYABLE - DIRECT CORPORATE OBLIGATIONS - SCHEDULED REPAYMENT (Details) $ in Millions	Sep. 30, 2017 USD ($)
Debt Disclosure [Abstract]
2018	$ 0.0
2019	100.0
2020	325.0
2021	0.0
2022	0.0
Thereafter	500.0
Long-term Debt	$ 925.0

XML

INVESTMENT BORROWINGS (Details) $ in Millions	9 Months Ended
	Sep. 30, 2017 USD ($) subsidiary	Sep. 30, 2016 USD ($)	Dec. 31, 2016 USD ($)
Schedule of Trading Securities and Other Trading Assets [Line Items]
Number of insurance subsidiaries that are members of the FHLB | subsidiary	3
Investment borrowings	$ 1,646.9		$ 1,647.4
Federal Home Loan Bank advances
Schedule of Trading Securities and Other Trading Assets [Line Items]
Federal Home Loan Bank stock	71.2
Investment borrowings	1,646.9
Federal Home Loan Bank, advances, collateral pledged	2,000.0
Aggregate fee to prepay all fixed rate FHLB borrowings	3.2
Interest expense on FHLB borrowings	19.5	$ 12.3
Federal Home Loan Bank advances | Borrowings due February 2018
Schedule of Trading Securities and Other Trading Assets [Line Items]
Investment borrowings	$ 50.0
Maturity date	Feb. 28, 2018
Interest rate	1.404%
Federal Home Loan Bank advances | Borrowings due August 2018
Schedule of Trading Securities and Other Trading Assets [Line Items]
Investment borrowings	$ 50.0
Maturity date	Aug. 31, 2018
Interest rate	1.435%
Federal Home Loan Bank advances | Borrowings due January 2019
Schedule of Trading Securities and Other Trading Assets [Line Items]
Investment borrowings	$ 50.0
Maturity date	Jan. 31, 2019
Interest rate	1.724%
Federal Home Loan Bank advances | Borrowings due February 2019
Schedule of Trading Securities and Other Trading Assets [Line Items]
Investment borrowings	$ 50.0
Maturity date	Feb. 28, 2019
Interest rate	1.404%
Federal Home Loan Bank advances | Borrowings due March 2019
Schedule of Trading Securities and Other Trading Assets [Line Items]
Investment borrowings	$ 100.0
Maturity date	Mar. 31, 2019
Interest rate	1.714%
Federal Home Loan Bank advances | Borrowings due July 2019
Schedule of Trading Securities and Other Trading Assets [Line Items]
Investment borrowings	$ 21.8
Maturity date	Jul. 31, 2019
Interest rate	1.727%
Federal Home Loan Bank advances | Borrowings due October 2019
Schedule of Trading Securities and Other Trading Assets [Line Items]
Investment borrowings	$ 15.0
Maturity date	Oct. 31, 2019
Interest rate	1.83%
Federal Home Loan Bank advances | Borrowing due May 2020
Schedule of Trading Securities and Other Trading Assets [Line Items]
Investment borrowings	$ 50.0
Maturity date	May 31, 2020
Interest rate	1.754%
Federal Home Loan Bank advances | Borrowings due June 2020
Schedule of Trading Securities and Other Trading Assets [Line Items]
Investment borrowings	$ 21.8
Maturity date	Jun. 30, 2020
Interest rate	1.96%
Federal Home Loan Bank advances | Borrowings due September 2020
Schedule of Trading Securities and Other Trading Assets [Line Items]
Investment borrowings	$ 25.0
Maturity date	Sep. 30, 2020
Interest rate	1.953%
Federal Home Loan Bank advances | Borrowings due September 2020 rate two
Schedule of Trading Securities and Other Trading Assets [Line Items]
Investment borrowings	$ 100.0
Maturity date	Sep. 30, 2020
Interest rate	1.897%
Federal Home Loan Bank advances | Borrowings due September 2020 rate three
Schedule of Trading Securities and Other Trading Assets [Line Items]
Investment borrowings	$ 50.0
Maturity date	Sep. 30, 2020
Interest rate	1.894%
Federal Home Loan Bank advances | Borrowings due September 2020 rate four
Schedule of Trading Securities and Other Trading Assets [Line Items]
Investment borrowings	$ 75.0
Maturity date	Sep. 30, 2020
Interest rate	1.453%
Federal Home Loan Bank advances | Borrowings due October 2020
Schedule of Trading Securities and Other Trading Assets [Line Items]
Investment borrowings	$ 100.0
Maturity date	Oct. 31, 2020
Interest rate	1.409%
Federal Home Loan Bank advances | Borrowings due December 2020
Schedule of Trading Securities and Other Trading Assets [Line Items]
Investment borrowings	$ 50.0
Maturity date	Dec. 31, 2020
Interest rate	1.932%
Federal Home Loan Bank advances | Borrowings due July 2021
Schedule of Trading Securities and Other Trading Assets [Line Items]
Investment borrowings	$ 100.0
Maturity date	Jul. 31, 2021
Interest rate	1.854%
Federal Home Loan Bank advances | Borrowings due July 2021 rate two
Schedule of Trading Securities and Other Trading Assets [Line Items]
Investment borrowings	$ 100.0
Maturity date	Jul. 31, 2021
Interest rate	1.824%
Federal Home Loan Bank advances | Borrowings due August 2021
Schedule of Trading Securities and Other Trading Assets [Line Items]
Investment borrowings	$ 28.2
Maturity date	Aug. 31, 2021
Interest rate	2.55%
Federal Home Loan Bank advances | Borrowings due August 2021 rate two
Schedule of Trading Securities and Other Trading Assets [Line Items]
Investment borrowings	$ 57.7
Maturity date	Aug. 31, 2021
Interest rate	1.842%
Federal Home Loan Bank advances | Borrowings due August 2021 Rate Three
Schedule of Trading Securities and Other Trading Assets [Line Items]
Investment borrowings	$ 125.0
Maturity date	Aug. 31, 2021
Interest rate	1.717%
Federal Home Loan Bank advances | Borrowings due September 2021
Schedule of Trading Securities and Other Trading Assets [Line Items]
Investment borrowings	$ 50.0
Maturity date	Sep. 30, 2021
Interest rate	1.857%
Federal Home Loan Bank advances | Borrowings due May 2022, Rate One
Schedule of Trading Securities and Other Trading Assets [Line Items]
Investment borrowings	$ 22.0
Maturity date	May 31, 2022
Interest rate	1.668%
Federal Home Loan Bank advances | Borrowings due May 2022, Rate Two
Schedule of Trading Securities and Other Trading Assets [Line Items]
Investment borrowings	$ 100.0
Maturity date	May 31, 2022
Interest rate	1.666%
Federal Home Loan Bank advances | Borrowings due June 2022
Schedule of Trading Securities and Other Trading Assets [Line Items]
Investment borrowings	$ 10.0
Maturity date	Jun. 30, 2022
Interest rate	1.931%
Federal Home Loan Bank advances | Borrowings due July 2022 rate one
Schedule of Trading Securities and Other Trading Assets [Line Items]
Investment borrowings	$ 50.0
Maturity date	Jul. 31, 2022
Interest rate	1.675%
Federal Home Loan Bank advances | Borrowings due July 2022 rate two
Schedule of Trading Securities and Other Trading Assets [Line Items]
Investment borrowings	$ 50.0
Maturity date	Jul. 31, 2022
Interest rate	1.693%
Federal Home Loan Bank advances | Borrowings due July 2022 rate three
Schedule of Trading Securities and Other Trading Assets [Line Items]
Investment borrowings	$ 50.0
Maturity date	Jul. 31, 2022
Interest rate	1.694%
Federal Home Loan Bank advances | Borrowings due August 2022
Schedule of Trading Securities and Other Trading Assets [Line Items]
Investment borrowings	$ 50.0
Maturity date	Aug. 31, 2022
Interest rate	1.702%
Federal Home Loan Bank advances | Borrowings due March 2023
Schedule of Trading Securities and Other Trading Assets [Line Items]
Investment borrowings	$ 24.9
Maturity date	Mar. 31, 2023
Interest rate	2.16%
Federal Home Loan Bank advances | Borrowings due June 2025
Schedule of Trading Securities and Other Trading Assets [Line Items]
Investment borrowings	$ 20.5
Maturity date	Jun. 30, 2025
Interest rate	2.94%

XML

CHANGES IN COMMON STOCK (Details) - USD ($) $ / shares in Units, $ in Millions	1 Months Ended	4 Months Ended	5 Months Ended	9 Months Ended
	May 31, 2017	Apr. 30, 2017	Sep. 30, 2017	Sep. 30, 2017	Sep. 30, 2016
Number of common shares outstanding
Balance, beginning of year (in shares)		173,753,614		173,753,614
Balance, end of year (in shares)			167,762,323	167,762,323
Number of stock tendered for payment of federal and state taxes owed (in shares)				103,000
Payments to repurchase common stock				$ 142.3	$ 210.0
Stock repurchase program, increase in authorized amount	$ 300.0
Stock repurchase program, remaining repurchase authorized amount			$ 412.6	412.6
Common stock dividends declared				$ 44.7	$ 40.8
Dividends (in dollars per share)		$ 0.08	$ 0.09	$ 0.26
Common stock
Number of common shares outstanding
Balance, beginning of year (in shares)		173,754,000		173,754,000
Treasury stock purchased and retired (in shares)				(6,701,000)
Balance, end of year (in shares)			167,762,000	167,762,000
Common stock | Stock options
Number of common shares outstanding
Shares issued under employee benefit compensation plans (in shares)				524,000
Common stock | Restricted and Performance Stock
Number of common shares outstanding
Shares issued under employee benefit compensation plans (in shares)				185,000
Common stock
Number of common shares outstanding
Payments to repurchase common stock				$ 140.1

XML

SALES INDUCEMENTS (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Dec. 31, 2016
Deferred Sales Inducements [Abstract]
Deferred sales inducements	$ 1.5	$ 2.8
Deferred sales inducements, amortization expense	6.6	$ 7.1
Unamortized deferred sales inducements	44.3		$ 49.4
Insurance liabilities for persistency bonus benefits	$ 0.4		$ 0.5

XML

OUT-OF-PERIOD ADJUSTMENTS (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended			9 Months Ended
	Sep. 30, 2017	Jun. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Decrease of insurance policy benefits	$ (638.1)		$ (609.8)	$ (1,941.6)	$ (1,861.2)
Increase on tax expense	29.1		30.7	108.6	48.5
Increase on net income	100.8		$ 18.6	$ 246.5	$ 124.0
Restatement Adjustment | Bankers Life | Long-term Care Insurance Benefits
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Decrease of insurance policy benefits	2.5	$ 1.7
Increase on tax expense	0.9	0.6
Increase on net income	$ 1.6	$ 1.1
Adjustment to net income per diluted share (in dollars per share)	$ 0.01	$ 0.01

XML

RECENTLY ISSUED ACCOUNTING STANDARDS (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Jan. 01, 2017	Dec. 31, 2016	Dec. 31, 2015
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Cumulative effect of accounting change				$ 0.3
Income tax assets	$ 1,606.7		$ 1,045.9	1,647.7
Valuation allowance for deferred income tax assets	(240.9)		(255.9)	(240.2)
Income tax assets, net			790.0
Total assets	32,704.6		31,975.5	31,975.2
Additional paid-in capital	3,094.5		3,213.0	3,212.1
Retained earnings	851.9		650.1	650.7
Total shareholders' equity	4,881.7	$ 4,493.8	4,487.2	4,486.9	$ 4,138.5
Total liabilities and shareholders' equity	32,704.6		31,975.5	31,975.2
Other operating costs	(546.0)	(552.1)
Net cash flow from operating activities	433.7	584.8
Payments to repurchase common stock	(142.3)	(210.0)
Net cash used by financing activities	(510.0)	(37.5)
Net increase in cash and cash equivalents	287.0	273.7
Election to account for forfeitures as they occur
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Income tax assets			0.3
Valuation allowance for deferred income tax assets			0.0
Income tax assets, net			0.3
Total assets			0.3
Additional paid-in capital			0.9
Retained earnings			(0.6)
Total shareholders' equity			0.3
Total liabilities and shareholders' equity			0.3
Recognition of excess tax benefits
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Income tax assets			15.7
Valuation allowance for deferred income tax assets			(15.7)
Income tax assets, net			0.0
Total assets			0.0
Additional paid-in capital			0.0
Retained earnings			0.0
Total shareholders' equity			0.0
Total liabilities and shareholders' equity			0.0
Effect of adoption of authoritative guidance
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Other operating costs		3.3
Net cash flow from operating activities		3.3
Payments to repurchase common stock		(3.3)
Net cash used by financing activities		(3.3)
Net increase in cash and cash equivalents		0.0
Amounts prior to effect of adoption of authoritative guidance
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Income tax assets			1,029.9
Valuation allowance for deferred income tax assets			(240.2)
Income tax assets, net			789.7
Total assets			31,975.2
Additional paid-in capital			3,212.1
Retained earnings			650.7
Total shareholders' equity			4,486.9
Total liabilities and shareholders' equity			$ 31,975.2
Other operating costs		(555.4)
Net cash flow from operating activities		581.5
Payments to repurchase common stock		(206.7)
Net cash used by financing activities		(34.2)
Net increase in cash and cash equivalents		273.7
Retained earnings
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Cumulative effect of accounting change				(0.6)
Total shareholders' equity	851.9	430.3		650.7	347.1
Retained earnings | Pro Forma | Accounting Standards Update 2016-01
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Cumulative effect of accounting change	15.0
Accumulated other comprehensive income
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total shareholders' equity	933.6	$ 855.5		$ 622.4	$ 402.8
Accumulated other comprehensive income | Pro Forma | Accounting Standards Update 2016-01
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Cumulative effect of accounting change	$ 15.0
Revenue | Accounting Standards Update 2014-09
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Concentration risk, percentage	1.00%

XML

LITIGATION AND OTHER LEGAL PROCEEDINGS (Details) $ in Millions			9 Months Ended
	Jun. 19, 2017 USD ($)	Dec. 16, 2016 USD ($)	Sep. 30, 2017 state	Jul. 26, 2017 individual
Loss Contingencies [Line Items]
Number of individuals appointed to assume immediate control and power over affairs | individual				2
Number of states participating in examination of compliance with unclaimed property laws | state			38
Compensatory damages
Loss Contingencies [Line Items]
Damages awarded to plaintiffs		$ 4.7
Punitive Damages
Loss Contingencies [Line Items]
Damages awarded to plaintiffs		$ 6.0
Damages reduced	$ 1.5

XML

CONSOLIDATED STATEMENT OF CASH FLOWS (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Cash flows from operating activities:
Net income	$ 100.8	$ 18.6	$ 246.5	$ 124.0
Adjustments to reconcile net income to net cash from operating activities:
Amortization and depreciation			200.8	199.1
Income taxes			50.6	43.0
Insurance liabilities			321.5	310.2
Accrual and amortization of investment income			(233.2)	(93.4)
Deferral of policy acquisition costs			(183.4)	(179.4)
Net realized investment gains			(52.3)	(23.3)
Loss on reinsurance transaction	0.0	75.4	0.0	75.4
Cash and cash equivalents received upon recapture of reinsurance			0.0	73.6
Loss on extinguishment of borrowings related to a variable interest entity	$ 5.5	$ 0.0	5.5	0.0
Other			77.7	55.6
Net cash from operating activities			433.7	584.8
Stock options, restricted stock and performance units			17.8	18.9
Market value of investments recaptured in connection with the termination of reinsurance agreements with BRe			$ 0.0	$ 431.1

XML

INVESTMENTS IN VARIABLE INTEREST ENTITIES - BALANCE SHEET ITEMS (Details) - USD ($) $ in Millions	Sep. 30, 2017	Dec. 31, 2016
Assets:
Investments held by variable interest entities	$ 1,382.5	$ 1,724.3
Cash and cash equivalents held by variable interest entities	105.9	189.3
Liabilities:
Borrowings related to variable interest entities	1,198.2	1,662.8
VIEs
Assets:
Investments held by variable interest entities	1,382.5	1,724.3
Notes receivable of VIEs held by insurance subsidiaries	0.0	0.0
Cash and cash equivalents held by variable interest entities	105.9	189.3
Accrued investment income	2.0	3.0
Income tax assets, net	(0.6)	6.4
Other assets	13.3	13.1
Total assets	1,503.1	1,936.1
Liabilities:
Other liabilities	145.9	81.8
Borrowings related to variable interest entities	1,198.2	1,662.8
Notes payable of VIEs held by insurance subsidiaries	172.9	203.3
Total liabilities	1,517.0	1,947.9
Eliminations
Assets:
Investments held by variable interest entities	0.0	0.0
Notes receivable of VIEs held by insurance subsidiaries	(159.9)	(204.2)
Cash and cash equivalents held by variable interest entities	0.0	0.0
Accrued investment income	(0.1)	(0.1)
Income tax assets, net	0.0	(1.3)
Other assets	(1.4)	(1.8)
Total assets	(161.4)	(207.4)
Liabilities:
Other liabilities	(3.5)	(6.4)
Borrowings related to variable interest entities	0.0	0.0
Notes payable of VIEs held by insurance subsidiaries	(172.9)	(203.3)
Total liabilities	(176.4)	(209.7)
Net effect on consolidated balance sheet
Assets:
Investments held by variable interest entities	1,382.5	1,724.3
Notes receivable of VIEs held by insurance subsidiaries	(159.9)	(204.2)
Cash and cash equivalents held by variable interest entities	105.9	189.3
Accrued investment income	1.9	2.9
Income tax assets, net	(0.6)	5.1
Other assets	11.9	11.3
Total assets	1,341.7	1,728.7
Liabilities:
Other liabilities	142.4	75.4
Borrowings related to variable interest entities	1,198.2	1,662.8
Notes payable of VIEs held by insurance subsidiaries	0.0	0.0
Total liabilities	$ 1,340.6	$ 1,738.2

XML

INVESTMENTS IN VARIABLE INTEREST ENTITIES - NARRATIVE (Details) $ in Millions	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2017 USD ($) investment	Sep. 30, 2016 USD ($)	Sep. 30, 2017 USD ($) investment	Sep. 30, 2016 USD ($)	Dec. 31, 2016 USD ($)
Variable Interest Entity [Line Items]
Variable interest entity amortized cost securities held	$ 1,381.7		$ 1,381.7
Variable interest entity, gross unrealized gains fixed maturity securities	8.4		8.4
Variable interest entity gross unrealized losses fixed maturity securities	7.6		7.6
Estimated fair value of fixed maturity securities	1,382.5		1,382.5
Variable interest entities net realized gain (loss) on investments			(2.5)	$ (20.6)
Net gain (loss) from sale of fixed maturities			2.2	(12.1)
Loss on dissolution of variable interest entities	$ (0.6)	$ 0.0	(4.3)	(7.3)
Writedowns of investments for other than temporary declines in fair value recognized through net income			$ 0.4	1.2
Number of investments held by VIE, in default | investment	0		0
Variable interest entities, investments sold			$ 86.0	186.6
Variable interest entity, gross investment losses from sale			2.0	$ 20.3
Investments held in limited partnerships	$ 315.1		315.1
Unfunded commitments to limited partnerships	266.2		266.2
Less than twelve months
Variable Interest Entity [Line Items]
Fair value investments held by variable interest entity that had been in an unrealized loss position	382.5		382.5		$ 93.8
Gross unrealized losses for a period			7.1		0.9
Greater than twelve months
Variable Interest Entity [Line Items]
Fair value investments held by variable interest entity that had been in an unrealized loss position	$ 11.0		11.0		143.9
Gross unrealized losses for a period			$ 0.5		$ 2.9

XML

INVESTMENTS IN VARIABLE INTEREST ENTITIES - SCHEDULE OF VIEs (Details) $ in Millions	Sep. 30, 2017 USD ($)
Investment Holdings [Line Items]
Total amortized cost	$ 1,381.7
Total fair value	1,382.5
Amortized cost
Investment Holdings [Line Items]
Due in one year or less	5.9
Due after one year through five years	499.4
Due after five years through ten years	876.4
Total amortized cost	1,381.7
Estimated fair value
Investment Holdings [Line Items]
Due in one year or less	5.9
Due after one year through five years	500.1
Due after five years through ten years	876.5
Total fair value	$ 1,382.5

XML

FAIR VALUE MEASUREMENTS - NARRATIVE (Details)	9 Months Ended
	Sep. 30, 2017
Fair Value Disclosures [Abstract]
Fair value of level 3 fixed maturity securities valued using broker quotes, percentage	45.00%
Available for sale fixed maturities classified as level 3, investment grade, percent	55.00%
Available for sale fixed maturities classified as Level 3 and corporate securities	80.00%

XML

FAIR VALUE MEASUREMENTS - MEASUREMENTS BY INPUT LEVEL (Details) - USD ($) $ in Millions	Sep. 30, 2017	Dec. 31, 2016
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total fixed maturities, available for sale	$ 22,129.9	$ 21,096.2
Trading securities	294.4	363.4
Investments held by variable interest entities	1,382.5	1,724.3
Assets held in separate accounts	4.8	4.7
Fair Value, Measurements, Recurring
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Trading securities	294.4	363.4
Investments held by variable interest entities	1,382.5	1,724.3
Assets held in separate accounts	4.8	4.7
Total assets carried at fair value by category	24,667.1	23,884.7
Fair Value, Measurements, Recurring | Embedded derivatives associated with fixed index annuity products
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Future policy benefits - embedded derivatives associated with fixed index annuity products	1,249.3	1,092.3
Fair Value, Measurements, Recurring | Derivatives
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Other invested assets - derivatives	142.2	111.9
Fair Value, Measurements, Recurring | Corporate securities
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total fixed maturities, available for sale	14,650.0	13,510.9
Equity securities - corporate securities	713.3	584.2
Trading securities	21.1	19.0
Fair Value, Measurements, Recurring | United States Treasury securities and obligations of United States government corporations and agencies
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total fixed maturities, available for sale	172.3	164.3
Trading securities	0.5	0.5
Fair Value, Measurements, Recurring | States and political subdivisions
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total fixed maturities, available for sale	2,077.0	1,988.9
Fair Value, Measurements, Recurring | Debt securities issued by foreign governments
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total fixed maturities, available for sale	61.1	36.9
Fair Value, Measurements, Recurring | Asset-backed securities
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total fixed maturities, available for sale	2,786.1	2,710.3
Trading securities	101.2	94.3
Fair Value, Measurements, Recurring | Collateralized debt obligations
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total fixed maturities, available for sale	237.9	230.7
Trading securities	2.7	2.4
Fair Value, Measurements, Recurring | Commercial mortgage-backed securities
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total fixed maturities, available for sale	1,338.9	1,536.2
Trading securities	93.3	163.9
Fair Value, Measurements, Recurring | Mortgage pass-through securities
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total fixed maturities, available for sale	2.2	2.5
Fair Value, Measurements, Recurring | Collateralized mortgage obligations
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total fixed maturities, available for sale	804.4	915.5
Trading securities	72.5	78.4
Fair Value, Measurements, Recurring | Total fixed maturities, available for sale
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total fixed maturities, available for sale	22,129.9	21,096.2
Fair Value, Measurements, Recurring | Equity securities
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Trading securities	3.1	4.9
Fair Value, Measurements, Recurring | Quoted prices in active markets for identical assets or liabilities (Level 1)
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Trading securities	3.1	4.9
Investments held by variable interest entities	0.0	0.0
Assets held in separate accounts	0.0	0.0
Total assets carried at fair value by category	480.9	364.8
Fair Value, Measurements, Recurring | Quoted prices in active markets for identical assets or liabilities (Level 1) | Embedded derivatives associated with fixed index annuity products
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Future policy benefits - embedded derivatives associated with fixed index annuity products	0.0	0.0
Fair Value, Measurements, Recurring | Quoted prices in active markets for identical assets or liabilities (Level 1) | Derivatives
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Other invested assets - derivatives	0.0	0.0
Fair Value, Measurements, Recurring | Quoted prices in active markets for identical assets or liabilities (Level 1) | Corporate securities
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total fixed maturities, available for sale	0.0	0.0
Equity securities - corporate securities	477.8	359.9
Trading securities	0.0	0.0
Fair Value, Measurements, Recurring | Quoted prices in active markets for identical assets or liabilities (Level 1) | United States Treasury securities and obligations of United States government corporations and agencies
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total fixed maturities, available for sale	0.0	0.0
Trading securities	0.0	0.0
Fair Value, Measurements, Recurring | Quoted prices in active markets for identical assets or liabilities (Level 1) | States and political subdivisions
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total fixed maturities, available for sale	0.0	0.0
Fair Value, Measurements, Recurring | Quoted prices in active markets for identical assets or liabilities (Level 1) | Debt securities issued by foreign governments
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total fixed maturities, available for sale	0.0	0.0
Fair Value, Measurements, Recurring | Quoted prices in active markets for identical assets or liabilities (Level 1) | Asset-backed securities
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total fixed maturities, available for sale	0.0	0.0
Trading securities	0.0	0.0
Fair Value, Measurements, Recurring | Quoted prices in active markets for identical assets or liabilities (Level 1) | Collateralized debt obligations
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total fixed maturities, available for sale	0.0	0.0
Trading securities	0.0	0.0
Fair Value, Measurements, Recurring | Quoted prices in active markets for identical assets or liabilities (Level 1) | Commercial mortgage-backed securities
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total fixed maturities, available for sale	0.0	0.0
Trading securities	0.0	0.0
Fair Value, Measurements, Recurring | Quoted prices in active markets for identical assets or liabilities (Level 1) | Mortgage pass-through securities
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total fixed maturities, available for sale	0.0	0.0
Fair Value, Measurements, Recurring | Quoted prices in active markets for identical assets or liabilities (Level 1) | Collateralized mortgage obligations
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total fixed maturities, available for sale	0.0	0.0
Trading securities	0.0	0.0
Fair Value, Measurements, Recurring | Quoted prices in active markets for identical assets or liabilities (Level 1) | Total fixed maturities, available for sale
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total fixed maturities, available for sale	0.0	0.0
Fair Value, Measurements, Recurring | Quoted prices in active markets for identical assets or liabilities (Level 1) | Equity securities
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Trading securities	3.1	4.9
Fair Value, Measurements, Recurring | Significant other observable inputs (Level 2)
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Trading securities	291.3	358.5
Investments held by variable interest entities	1,377.5	1,724.3
Assets held in separate accounts	4.8	4.7
Total assets carried at fair value by category	23,840.0	23,134.5
Fair Value, Measurements, Recurring | Significant other observable inputs (Level 2) | Embedded derivatives associated with fixed index annuity products
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Future policy benefits - embedded derivatives associated with fixed index annuity products	0.0	0.0
Fair Value, Measurements, Recurring | Significant other observable inputs (Level 2) | Derivatives
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Other invested assets - derivatives	142.2	111.9
Fair Value, Measurements, Recurring | Significant other observable inputs (Level 2) | Corporate securities
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total fixed maturities, available for sale	14,394.3	13,252.4
Equity securities - corporate securities	213.9	199.1
Trading securities	21.1	19.0
Fair Value, Measurements, Recurring | Significant other observable inputs (Level 2) | United States Treasury securities and obligations of United States government corporations and agencies
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total fixed maturities, available for sale	172.3	164.3
Trading securities	0.5	0.5
Fair Value, Measurements, Recurring | Significant other observable inputs (Level 2) | States and political subdivisions
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total fixed maturities, available for sale	2,077.0	1,988.9
Fair Value, Measurements, Recurring | Significant other observable inputs (Level 2) | Debt securities issued by foreign governments
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total fixed maturities, available for sale	57.1	33.0
Fair Value, Measurements, Recurring | Significant other observable inputs (Level 2) | Asset-backed securities
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total fixed maturities, available for sale	2,726.2	2,649.9
Trading securities	101.2	94.3
Fair Value, Measurements, Recurring | Significant other observable inputs (Level 2) | Collateralized debt obligations
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total fixed maturities, available for sale	237.9	225.3
Trading securities	2.7	2.4
Fair Value, Measurements, Recurring | Significant other observable inputs (Level 2) | Commercial mortgage-backed securities
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total fixed maturities, available for sale	1,338.9	1,504.2
Trading securities	93.3	163.9
Fair Value, Measurements, Recurring | Significant other observable inputs (Level 2) | Mortgage pass-through securities
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total fixed maturities, available for sale	2.2	2.5
Fair Value, Measurements, Recurring | Significant other observable inputs (Level 2) | Collateralized mortgage obligations
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total fixed maturities, available for sale	804.4	915.5
Trading securities	72.5	78.4
Fair Value, Measurements, Recurring | Significant other observable inputs (Level 2) | Total fixed maturities, available for sale
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total fixed maturities, available for sale	21,810.3	20,736.0
Fair Value, Measurements, Recurring | Significant other observable inputs (Level 2) | Equity securities
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Trading securities	0.0	0.0
Fair Value, Measurements, Recurring | Significant unobservable inputs (Level 3)
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Trading securities	0.0	0.0
Investments held by variable interest entities	5.0	0.0
Assets held in separate accounts	0.0	0.0
Total assets carried at fair value by category	346.2	385.4
Fair Value, Measurements, Recurring | Significant unobservable inputs (Level 3) | Embedded derivatives associated with fixed index annuity products
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Future policy benefits - embedded derivatives associated with fixed index annuity products	1,249.3	1,092.3
Fair Value, Measurements, Recurring | Significant unobservable inputs (Level 3) | Derivatives
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Other invested assets - derivatives	0.0	0.0
Fair Value, Measurements, Recurring | Significant unobservable inputs (Level 3) | Corporate securities
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total fixed maturities, available for sale	255.7	258.5
Equity securities - corporate securities	21.6	25.2
Trading securities	0.0	0.0
Fair Value, Measurements, Recurring | Significant unobservable inputs (Level 3) | United States Treasury securities and obligations of United States government corporations and agencies
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total fixed maturities, available for sale	0.0	0.0
Trading securities	0.0	0.0
Fair Value, Measurements, Recurring | Significant unobservable inputs (Level 3) | States and political subdivisions
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total fixed maturities, available for sale	0.0	0.0
Fair Value, Measurements, Recurring | Significant unobservable inputs (Level 3) | Debt securities issued by foreign governments
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total fixed maturities, available for sale	4.0	3.9
Fair Value, Measurements, Recurring | Significant unobservable inputs (Level 3) | Asset-backed securities
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total fixed maturities, available for sale	59.9	60.4
Trading securities	0.0	0.0
Fair Value, Measurements, Recurring | Significant unobservable inputs (Level 3) | Collateralized debt obligations
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total fixed maturities, available for sale	0.0	5.4
Trading securities	0.0	0.0
Fair Value, Measurements, Recurring | Significant unobservable inputs (Level 3) | Commercial mortgage-backed securities
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total fixed maturities, available for sale	0.0	32.0
Trading securities	0.0	0.0
Fair Value, Measurements, Recurring | Significant unobservable inputs (Level 3) | Mortgage pass-through securities
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total fixed maturities, available for sale	0.0	0.0
Fair Value, Measurements, Recurring | Significant unobservable inputs (Level 3) | Collateralized mortgage obligations
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total fixed maturities, available for sale	0.0	0.0
Trading securities	0.0	0.0
Fair Value, Measurements, Recurring | Significant unobservable inputs (Level 3) | Total fixed maturities, available for sale
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total fixed maturities, available for sale	319.6	360.2
Fair Value, Measurements, Recurring | Significant unobservable inputs (Level 3) | Equity securities
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Trading securities	$ 0.0	$ 0.0

XML

FAIR VALUE MEASUREMENTS - RECURRING BASIS (Details) - USD ($) $ in Millions	Sep. 30, 2017	Dec. 31, 2016	Sep. 30, 2016	Dec. 31, 2015
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents - unrestricted	$ 765.9	$ 478.9	$ 706.0	$ 432.3
Cash and cash equivalents held by variable interest entities	105.9	189.3
Fair Value, Measurements, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Mortgage loans	1,667.8	1,768.0
Policy loans	114.6	112.0
Company-owned life insurance	178.8	165.0
Cash and cash equivalents - unrestricted	765.9	478.9
Cash and cash equivalents held by variable interest entities	105.9	189.3
Policyholder account balances	11,113.5	10,912.7
Investment borrowings	1,646.9	1,647.4
Borrowings related to variable interest entities	1,198.2	1,662.8
Notes payable – direct corporate obligations	914.4	912.9
Fair Value, Measurements, Recurring | Estimate of fair value measurement
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Mortgage loans	1,705.8	1,800.1
Policy loans	114.6	112.0
Company-owned life insurance	178.8	165.0
Cash and cash equivalents - unrestricted	765.9	478.9
Cash and cash equivalents held by variable interest entities	105.9	189.3
Policyholder account balances	11,113.5	10,912.7
Investment borrowings	1,650.1	1,650.0
Borrowings related to variable interest entities	1,215.1	1,675.2
Notes payable – direct corporate obligations	970.5	931.9
Fair Value, Measurements, Recurring | Quoted prices in active markets for identical assets or liabilities (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Mortgage loans	0.0	0.0
Policy loans	0.0	0.0
Company-owned life insurance	0.0	0.0
Cash and cash equivalents - unrestricted	765.9	473.6
Cash and cash equivalents held by variable interest entities	105.9	189.3
Policyholder account balances	0.0	0.0
Investment borrowings	0.0	0.0
Borrowings related to variable interest entities	0.0	0.0
Notes payable – direct corporate obligations	0.0	0.0
Fair Value, Measurements, Recurring | Significant other observable inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Mortgage loans	0.0	0.0
Policy loans	0.0	0.0
Company-owned life insurance	178.8	165.0
Cash and cash equivalents - unrestricted	0.0	5.3
Cash and cash equivalents held by variable interest entities	0.0	0.0
Policyholder account balances	0.0	0.0
Investment borrowings	1,650.1	1,650.0
Borrowings related to variable interest entities	1,215.1	1,675.2
Notes payable – direct corporate obligations	970.5	931.9
Fair Value, Measurements, Recurring | Significant unobservable inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Mortgage loans	1,705.8	1,800.1
Policy loans	114.6	112.0
Company-owned life insurance	0.0	0.0
Cash and cash equivalents - unrestricted	0.0	0.0
Cash and cash equivalents held by variable interest entities	0.0	0.0
Policyholder account balances	11,113.5	10,912.7
Investment borrowings	0.0	0.0
Borrowings related to variable interest entities	0.0	0.0
Notes payable – direct corporate obligations	$ 0.0	$ 0.0

XML

FAIR VALUE MEASUREMENTS - BALANCE SHEET RECURRING (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Interest sensitive products
Liabilities:
Fair value, measurement with unobservable inputs reconciliation, beginning balance	$ (1,205.4)	$ (1,127.0)	$ (1,092.3)	$ (1,057.1)
Purchases, sales, issuances and settlements, net	(56.3)	(37.0)	(174.2)	(55.3)
Total realized and unrealized gains (losses) included in net income	12.4	18.3	17.2	(33.3)
Total realized and unrealized gains (losses) included in accumulated other comprehensive income (loss)	0.0	0.0	0.0	0.0
Transfers into level 3	0.0	0.0	0.0	0.0
Transfers out of level 3	0.0	0.0	0.0	0.0
Fair value, measurement with unobservable inputs reconciliation, ending balance	(1,249.3)	(1,145.7)	(1,249.3)	(1,145.7)
Amount of total gains (losses) for the period included in our net income relating to assets and liabilities still held as of the reporting date	12.4	18.3	17.2	(33.3)
Corporate securities
Assets:
Fair value, measurement with unobservable inputs reconciliation, beginning balance	263.3	174.6	258.5	170.4
Purchases, sales, issuances and settlements, net	(44.8)	118.8	(44.1)	104.4
Total realized and unrealized gains (losses) included in net income	1.7	0.0	9.5	(7.0)
Total realized and unrealized gains (losses) included in accumulated other comprehensive income (loss)	1.3	(4.9)	0.6	7.4
Transfers into level 3	34.2	0.0	31.2	20.3
Transfers out of level 3	0.0	0.0	0.0	(7.0)
Fair value, measurement with unobservable inputs reconciliation, ending balance	255.7	288.5	255.7	288.5
Amount of total gains (losses) for the period included in our net income relating to assets and liabilities still held as of the reporting date	(3.2)	0.0	(6.5)	(5.6)
Debt securities issued by foreign governments
Assets:
Fair value, measurement with unobservable inputs reconciliation, beginning balance	3.9	4.1	3.9	0.0
Purchases, sales, issuances and settlements, net	0.0	0.0	0.0	4.0
Total realized and unrealized gains (losses) included in net income	0.0	0.0	0.0	0.0
Total realized and unrealized gains (losses) included in accumulated other comprehensive income (loss)	0.1	0.0	0.1	0.1
Transfers into level 3	0.0	0.0	0.0	0.0
Transfers out of level 3	0.0	0.0	0.0	0.0
Fair value, measurement with unobservable inputs reconciliation, ending balance	4.0	4.1	4.0	4.1
Amount of total gains (losses) for the period included in our net income relating to assets and liabilities still held as of the reporting date	0.0	0.0	0.0	0.0
Asset-backed securities
Assets:
Fair value, measurement with unobservable inputs reconciliation, beginning balance	59.6	39.1	60.4	35.9
Purchases, sales, issuances and settlements, net	(1.3)	5.7	3.8	1.7
Total realized and unrealized gains (losses) included in net income	0.0	0.0	0.0	0.0
Total realized and unrealized gains (losses) included in accumulated other comprehensive income (loss)	0.7	2.1	2.3	4.0
Transfers into level 3	7.1	24.6	4.2	28.6
Transfers out of level 3	(6.2)	(15.0)	(10.8)	(13.7)
Fair value, measurement with unobservable inputs reconciliation, ending balance	59.9	56.5	59.9	56.5
Amount of total gains (losses) for the period included in our net income relating to assets and liabilities still held as of the reporting date	0.0	0.0	0.0	0.0
Collateralized debt obligations
Assets:
Fair value, measurement with unobservable inputs reconciliation, beginning balance	2.5	0.0	5.4	0.0
Purchases, sales, issuances and settlements, net	(2.5)	2.5	(2.5)	2.5
Total realized and unrealized gains (losses) included in net income	0.0	0.0	0.0	0.0
Total realized and unrealized gains (losses) included in accumulated other comprehensive income (loss)	0.0	0.0	0.0	0.0
Transfers into level 3	0.0	0.0	0.0	0.0
Transfers out of level 3	0.0	0.0	(2.9)	0.0
Fair value, measurement with unobservable inputs reconciliation, ending balance	0.0	2.5	0.0	2.5
Amount of total gains (losses) for the period included in our net income relating to assets and liabilities still held as of the reporting date	0.0	0.0	0.0	0.0
Collateralized mortgage obligations
Assets:
Fair value, measurement with unobservable inputs reconciliation, beginning balance	0.2	0.0		0.0
Purchases, sales, issuances and settlements, net	0.0	12.0		12.0
Total realized and unrealized gains (losses) included in net income	0.0	0.0		0.0
Total realized and unrealized gains (losses) included in accumulated other comprehensive income (loss)	(0.2)	0.0		0.0
Transfers into level 3	0.0	0.0		0.0
Transfers out of level 3	0.0	0.0		0.0
Fair value, measurement with unobservable inputs reconciliation, ending balance	0.0	12.0	0.0	12.0
Amount of total gains (losses) for the period included in our net income relating to assets and liabilities still held as of the reporting date	0.0	0.0		0.0
Commercial mortgage-backed securities
Assets:
Fair value, measurement with unobservable inputs reconciliation, beginning balance		1.1	32.0	1.1
Purchases, sales, issuances and settlements, net		17.0	0.0	17.0
Total realized and unrealized gains (losses) included in net income		0.0	0.0	0.0
Total realized and unrealized gains (losses) included in accumulated other comprehensive income (loss)		(0.1)	0.0	0.4
Transfers into level 3		14.4	0.0	13.9
Transfers out of level 3		0.0	(32.0)	0.0
Fair value, measurement with unobservable inputs reconciliation, ending balance	0.0	32.4	0.0	32.4
Amount of total gains (losses) for the period included in our net income relating to assets and liabilities still held as of the reporting date		0.0	0.0	0.0
Total fixed maturities, available for sale
Assets:
Fair value, measurement with unobservable inputs reconciliation, beginning balance	329.5	218.9	360.2	207.5
Purchases, sales, issuances and settlements, net	(48.6)	156.0	(42.8)	141.5
Total realized and unrealized gains (losses) included in net income	1.7	0.0	9.5	(7.0)
Total realized and unrealized gains (losses) included in accumulated other comprehensive income (loss)	1.9	(2.9)	3.0	11.9
Transfers into level 3	41.3	39.0	35.4	62.8
Transfers out of level 3	(6.2)	(15.0)	(45.7)	(20.7)
Fair value, measurement with unobservable inputs reconciliation, ending balance	319.6	396.0	319.6	396.0
Amount of total gains (losses) for the period included in our net income relating to assets and liabilities still held as of the reporting date	(3.2)	0.0	(6.5)	(5.6)
Investments held by variable interest entities - corporate securities
Assets:
Purchases, sales, issuances and settlements, net			5.0
Equity securities
Assets:
Fair value, measurement with unobservable inputs reconciliation, beginning balance	24.6	21.4	25.2	32.0
Purchases, sales, issuances and settlements, net	(8.3)	3.3	(8.5)	5.5
Total realized and unrealized gains (losses) included in net income	6.4	0.0	6.3	(12.8)
Total realized and unrealized gains (losses) included in accumulated other comprehensive income (loss)	(1.1)	(0.8)	(1.4)	(0.8)
Transfers into level 3	0.0	0.0	0.0	0.0
Transfers out of level 3	0.0	0.0	0.0	0.0
Fair value, measurement with unobservable inputs reconciliation, ending balance	21.6	23.9	21.6	23.9
Amount of total gains (losses) for the period included in our net income relating to assets and liabilities still held as of the reporting date	(0.5)	0.0	(0.5)	(12.8)
Mortgage pass-through securities
Assets:
Fair value, measurement with unobservable inputs reconciliation, beginning balance				0.1
Purchases, sales, issuances and settlements, net				(0.1)
Total realized and unrealized gains (losses) included in net income				0.0
Total realized and unrealized gains (losses) included in accumulated other comprehensive income (loss)				0.0
Transfers into level 3				0.0
Transfers out of level 3				0.0
Fair value, measurement with unobservable inputs reconciliation, ending balance		0.0		0.0
Amount of total gains (losses) for the period included in our net income relating to assets and liabilities still held as of the reporting date				0.0
Trading securities - commercial mortgage-backed securities
Assets:
Fair value, measurement with unobservable inputs reconciliation, beginning balance		0.0		39.9
Purchases, sales, issuances and settlements, net		0.0		0.0
Total realized and unrealized gains (losses) included in net income		0.0		0.0
Total realized and unrealized gains (losses) included in accumulated other comprehensive income (loss)		(1.7)		(1.4)
Transfers into level 3		10.0		0.0
Transfers out of level 3		0.0		(30.2)
Fair value, measurement with unobservable inputs reconciliation, ending balance		8.3		8.3
Amount of total gains (losses) for the period included in our net income relating to assets and liabilities still held as of the reporting date		$ (1.7)		$ (1.4)
Investments Held By Variable Interest Entities\ | Fair Value, Measurements, Recurring | Significant unobservable inputs (Level 3) | Investments held by variable interest entities - corporate securities
Assets:
Fair value, measurement with unobservable inputs reconciliation, beginning balance	0.0		0.0
Purchases, sales, issuances and settlements, net	0.0		5.0
Total realized and unrealized gains (losses) included in net income	0.0		0.0
Total realized and unrealized gains (losses) included in accumulated other comprehensive income (loss)	0.0		0.0
Transfers into level 3	5.0		0.0
Transfers out of level 3	0.0		0.0
Fair value, measurement with unobservable inputs reconciliation, ending balance	5.0		5.0
Amount of total gains (losses) for the period included in our net income relating to assets and liabilities still held as of the reporting date	$ 0.0		$ 0.0

XML

FAIR VALUE MEASUREMENTS - FAIR VALUE ACTIVITY (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Interest sensitive products
Liabilities:
Purchases	$ (41.0)	$ (38.5)	$ (130.1)	$ (101.9)
Received in reinsurance recapture		0.0		0.0
Sales	1.8	3.1	5.3	19.2
Issuances	(31.4)	(14.6)	(95.7)	(17.5)
Settlements	14.3	13.0	46.3	44.9
Purchases, sales, issuances and settlements, net	(56.3)	(37.0)	(174.2)	(55.3)
Debt securities issued by foreign governments
Assets:
Purchases				4.0
Received in reinsurance recapture				0.0
Sales				0.0
Issuances				0.0
Settlements				0.0
Purchases, sales, issuances and settlements, net	0.0	0.0	0.0	4.0
Corporate securities
Assets:
Purchases	15.3	1.1	64.3	1.1
Received in reinsurance recapture		118.6		118.6
Sales	(60.1)	(0.9)	(108.4)	(15.3)
Issuances	0.0	0.0	0.0	0.0
Settlements	0.0	0.0	0.0	0.0
Purchases, sales, issuances and settlements, net	(44.8)	118.8	(44.1)	104.4
Asset-backed securities
Assets:
Purchases	9.9	7.0	21.9	7.0
Received in reinsurance recapture		0.0		0.0
Sales	(11.2)	(1.3)	(18.1)	(5.3)
Issuances	0.0	0.0	0.0	0.0
Settlements	0.0	0.0	0.0	0.0
Purchases, sales, issuances and settlements, net	(1.3)	5.7	3.8	1.7
Collateralized debt obligations
Assets:
Purchases	0.0	2.5	0.0	2.5
Received in reinsurance recapture		0.0		0.0
Sales	(2.5)	0.0	(2.5)	0.0
Issuances	0.0	0.0	0.0	0.0
Settlements	0.0	0.0	0.0	0.0
Purchases, sales, issuances and settlements, net	(2.5)	2.5	(2.5)	2.5
Total fixed maturities, available for sale
Assets:
Purchases	25.2	27.6	86.2	31.6
Received in reinsurance recapture		130.6		130.6
Sales	(73.8)	(2.2)	(129.0)	(20.7)
Issuances	0.0	0.0	0.0	0.0
Settlements	0.0	0.0	0.0	0.0
Purchases, sales, issuances and settlements, net	(48.6)	156.0	(42.8)	141.5
Equity securities
Assets:
Purchases	0.0	1.1	0.0	3.3
Received in reinsurance recapture		2.2		2.2
Sales	(8.3)	0.0	(8.5)	0.0
Issuances	0.0	0.0	0.0	0.0
Settlements	0.0	0.0	0.0	0.0
Purchases, sales, issuances and settlements, net	(8.3)	3.3	(8.5)	5.5
Investments held by variable interest entities - corporate securities
Assets:
Purchases			5.0
Sales			0.0
Issuances			0.0
Settlements			0.0
Purchases, sales, issuances and settlements, net			5.0
Commercial mortgage-backed securities
Assets:
Purchases		17.0		17.0
Received in reinsurance recapture		0.0		0.0
Sales		0.0		0.0
Issuances		0.0		0.0
Settlements		0.0		0.0
Purchases, sales, issuances and settlements, net		17.0	$ 0.0	17.0
Mortgage pass-through securities
Assets:
Purchases				0.0
Received in reinsurance recapture				0.0
Sales				(0.1)
Issuances				0.0
Settlements				0.0
Purchases, sales, issuances and settlements, net				(0.1)
Collateralized mortgage obligations
Assets:
Purchases		0.0		0.0
Received in reinsurance recapture		12.0		12.0
Sales		0.0		0.0
Issuances		0.0		0.0
Settlements		0.0		0.0
Purchases, sales, issuances and settlements, net	$ 0.0	$ 12.0		$ 12.0

XML

FAIR VALUE MEASUREMENTS - FAIR VALUE INPUTS (Details) - USD ($) $ in Millions	9 Months Ended	12 Months Ended
	Sep. 30, 2017	Dec. 31, 2016
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Investments	$ 27,054.6	$ 26,237.6
Other invested assets	752.1	589.5
Significant unobservable inputs (Level 3)
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Investments	346.2	385.4
Other invested assets	158.2	172.9
Policyholder account balances	$ 1,249.3	$ 1,092.3
Significant unobservable inputs (Level 3) | Minimum | Interest sensitive products
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Projected portfolio yields	5.15%	5.15%
Discount rates	0.44%	0.18%
Surrender rates	0.94%	0.94%
Significant unobservable inputs (Level 3) | Maximum | Interest sensitive products
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Projected portfolio yields	5.61%	5.61%
Discount rates	2.80%	3.06%
Surrender rates	46.48%	46.48%
Significant unobservable inputs (Level 3) | Weighted Average | Interest sensitive products
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Projected portfolio yields	5.59%	5.59%
Discount rates	1.94%	2.07%
Surrender rates	13.52%	13.52%
Significant unobservable inputs (Level 3) | Corporate securities
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Investments	$ 138.4	$ 148.5
Significant unobservable inputs (Level 3) | Corporate securities | Minimum
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Discount rate	1.50%	1.35%
Significant unobservable inputs (Level 3) | Corporate securities | Maximum
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Discount rate	61.70%	27.71%
Significant unobservable inputs (Level 3) | Corporate securities | Weighted Average
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Discount rate	9.10%	13.52%
Significant unobservable inputs (Level 3) | Asset-backed securities
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Investments	$ 24.9	$ 24.0
Significant unobservable inputs (Level 3) | Asset-backed securities | Minimum
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Discount rate	1.77%	2.06%
Significant unobservable inputs (Level 3) | Asset-backed securities | Maximum
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Discount rate	3.36%	3.64%
Significant unobservable inputs (Level 3) | Asset-backed securities | Weighted Average
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Discount rate	2.54%	2.76%
Significant unobservable inputs (Level 3) | Equity securities
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Investments	$ 21.6	$ 25.2
Significant unobservable inputs (Level 3) | Equity securities | Minimum
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
EBITDA Multiple	50.00%	40.00%
Significant unobservable inputs (Level 3) | Equity securities | Maximum
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
EBITDA Multiple	620.00%	620.00%
Significant unobservable inputs (Level 3) | Equity securities | Weighted Average
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
EBITDA Multiple	590.00%	590.00%
Recovery method | Significant unobservable inputs (Level 3) | Corporate securities
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Investments	$ 3.1	$ 14.8
Recovery method | Significant unobservable inputs (Level 3) | Corporate securities | Minimum
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Discount rate	5.00%	5.00%
Recovery method | Significant unobservable inputs (Level 3) | Corporate securities | Maximum
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Discount rate	38.00%	69.00%
Recovery method | Significant unobservable inputs (Level 3) | Corporate securities | Weighted Average
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Discount rate	17.76%	55.00%

XML

SUBSEQUENT EVENT (Details) - USD ($)	Oct. 13, 2017	May 19, 2015
Line of credit | Revolving credit facility
Subsequent Event [Line Items]
Line of credit maximum borrowing capacity		$ 150,000,000
Remaining borrowing capacity		$ 50,000,000
Debt covenant, required minimum debt to total capitalization ratio		30.00%
Line of credit | Revolving credit facility | Subsequent Event
Subsequent Event [Line Items]
Line of credit maximum borrowing capacity	$ 250,000,000
Long-term line of credit	$ 100,000,000
Debt covenant, required minimum debt to total capitalization ratio	35.00%
Minimum | Line of credit | Revolving credit facility
Subsequent Event [Line Items]
Remaining borrowing capacity		$ 50,000,000
Maximum | Line of credit | Revolving credit facility | Subsequent Event
Subsequent Event [Line Items]
Remaining borrowing capacity	$ 100,000,000
Eurodollar | Line of credit | Revolving credit facility
Subsequent Event [Line Items]
Basis spread on variable rate		2.00%
Eurodollar | Minimum | Subsequent Event
Subsequent Event [Line Items]
Basis spread on variable rate	1.375%
Eurodollar | Maximum | Subsequent Event
Subsequent Event [Line Items]
Basis spread on variable rate	2.125%
Base Rate | Minimum | Subsequent Event
Subsequent Event [Line Items]
Basis spread on variable rate	0.375%
Base Rate | Maximum | Subsequent Event
Subsequent Event [Line Items]
Basis spread on variable rate	1.125%